{"aopId":1,"aopName":"Uncharacterized liver damage leading to hepatocellular carcinoma","aoId":334,"aoName":"Promotion Hepatocelluar carcinoma","aoNameRaw":"Promotion, Hepatocelluar carcinoma","keyEvents":[{"keId":294,"keName":"N/A, Unknown"},{"keId":57,"keName":"Proliferation, Cell proliferation in the absence of cytotoxicity"},{"keId":334,"keName":"Promotion, Hepatocelluar carcinoma"},{"keId":142,"keName":"Hyperplasia, Hyperplasia"}],"reference":"https://aopwiki.org/aops/1"}
{"aopId":3,"aopName":"Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits","targetName":"NADH-ubiquinone oxidoreductase chain 1","targetId":"ENSG00000198888","aoId":896,"aoName":"Parkinsonian motor deficits","aoNameRaw":"Parkinsonian motor deficits","keyEvents":[{"keId":890,"keName":"Degeneration of dopaminergic neurons of the nigrostriatal pathway"},{"keId":188,"keName":"Neuroinflammation"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":889,"keName":"Impaired, Proteostasis"},{"keId":888,"keName":"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)"},{"keId":896,"keName":"Parkinsonian motor deficits"},{"keId":887,"keName":"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/3"}
{"aopId":3,"aopName":"Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits","aoId":896,"aoName":"Parkinsonian motor deficits","aoNameRaw":"Parkinsonian motor deficits","keyEvents":[{"keId":890,"keName":"Degeneration of dopaminergic neurons of the nigrostriatal pathway"},{"keId":188,"keName":"Neuroinflammation"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":889,"keName":"Impaired, Proteostasis"},{"keId":888,"keName":"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)"},{"keId":896,"keName":"Parkinsonian motor deficits"},{"keId":887,"keName":"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/3"}
{"aopId":6,"aopName":"Antagonist binding to PPARα leading to body-weight loss","targetName":"nuclear receptor corepressor 2","targetId":"ENSG00000196498","aoId":864,"aoName":"Decreased Body Weight","aoNameRaw":"Decreased, Body Weight","aoMappedId":"HP_0004325","keyEvents":[{"keId":858,"keName":"Decreased, PPARalpha transactivation of gene expression"},{"keId":861,"keName":"Decreased, Ketogenesis (production of ketone bodies)"},{"keId":1000,"keName":"stabilization, PPAR alpha co-repressor"},{"keId":864,"keName":"Decreased, Body Weight"},{"keId":863,"keName":"Increased, Catabolism of Muscle Protein"},{"keId":1528,"keName":"Fatty Acid Beta Oxidation, Decreased"},{"keId":862,"keName":"Not Increased, Circulating Ketone Bodies"},{"keId":998,"keName":"Binding of antagonist, PPAR alpha"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/6"}
{"aopId":6,"aopName":"Antagonist binding to PPARα leading to body-weight loss","targetName":"nuclear receptor corepressor 1","targetId":"ENSG00000141027","aoId":864,"aoName":"Decreased Body Weight","aoNameRaw":"Decreased, Body Weight","aoMappedId":"HP_0004325","keyEvents":[{"keId":858,"keName":"Decreased, PPARalpha transactivation of gene expression"},{"keId":861,"keName":"Decreased, Ketogenesis (production of ketone bodies)"},{"keId":1000,"keName":"stabilization, PPAR alpha co-repressor"},{"keId":864,"keName":"Decreased, Body Weight"},{"keId":863,"keName":"Increased, Catabolism of Muscle Protein"},{"keId":1528,"keName":"Fatty Acid Beta Oxidation, Decreased"},{"keId":862,"keName":"Not Increased, Circulating Ketone Bodies"},{"keId":998,"keName":"Binding of antagonist, PPAR alpha"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/6"}
{"aopId":6,"aopName":"Antagonist binding to PPARα leading to body-weight loss","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":864,"aoName":"Decreased Body Weight","aoNameRaw":"Decreased, Body Weight","aoMappedId":"HP_0004325","keyEvents":[{"keId":858,"keName":"Decreased, PPARalpha transactivation of gene expression"},{"keId":861,"keName":"Decreased, Ketogenesis (production of ketone bodies)"},{"keId":1000,"keName":"stabilization, PPAR alpha co-repressor"},{"keId":864,"keName":"Decreased, Body Weight"},{"keId":863,"keName":"Increased, Catabolism of Muscle Protein"},{"keId":1528,"keName":"Fatty Acid Beta Oxidation, Decreased"},{"keId":862,"keName":"Not Increased, Circulating Ketone Bodies"},{"keId":998,"keName":"Binding of antagonist, PPAR alpha"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/6"}
{"aopId":6,"aopName":"Antagonist binding to PPARα leading to body-weight loss","aoId":864,"aoName":"Decreased Body Weight","aoNameRaw":"Decreased, Body Weight","aoMappedId":"HP_0004325","keyEvents":[{"keId":858,"keName":"Decreased, PPARalpha transactivation of gene expression"},{"keId":861,"keName":"Decreased, Ketogenesis (production of ketone bodies)"},{"keId":1000,"keName":"stabilization, PPAR alpha co-repressor"},{"keId":864,"keName":"Decreased, Body Weight"},{"keId":863,"keName":"Increased, Catabolism of Muscle Protein"},{"keId":1528,"keName":"Fatty Acid Beta Oxidation, Decreased"},{"keId":862,"keName":"Not Increased, Circulating Ketone Bodies"},{"keId":998,"keName":"Binding of antagonist, PPAR alpha"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/6"}
{"aopId":7,"aopName":"Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female","aoId":406,"keyEvents":[{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":406,"keName":"impaired, Fertility"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":405,"keName":"irregularities, ovarian cycle"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/7"}
{"aopId":7,"aopName":"Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female","targetName":"aromatase","targetId":"ENSG00000137869","aoId":406,"keyEvents":[{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":406,"keName":"impaired, Fertility"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":405,"keName":"irregularities, ovarian cycle"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/7"}
{"aopId":7,"aopName":"Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":406,"keName":"impaired, Fertility"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":405,"keName":"irregularities, ovarian cycle"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/7"}
{"aopId":7,"aopName":"Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female","targetName":"aromatase","targetId":"ENSG00000137869","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":406,"keName":"impaired, Fertility"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":405,"keName":"irregularities, ovarian cycle"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/7"}
{"aopId":7,"aopName":"Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female","aoId":405,"aoName":"irregularities ovarian cycle","aoNameRaw":"irregularities, ovarian cycle","keyEvents":[{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":406,"keName":"impaired, Fertility"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":405,"keName":"irregularities, ovarian cycle"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/7"}
{"aopId":7,"aopName":"Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female","targetName":"aromatase","targetId":"ENSG00000137869","aoId":405,"aoName":"irregularities ovarian cycle","aoNameRaw":"irregularities, ovarian cycle","keyEvents":[{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":406,"keName":"impaired, Fertility"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":405,"keName":"irregularities, ovarian cycle"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/7"}
{"aopId":8,"aopName":"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","targetName":"beta-1,3-glucuronyltransferase","aoId":319,"aoName":"Loss Cochlear function","aoNameRaw":"Loss, Cochlear function","keyEvents":[{"keId":295,"keName":"Induction, Upregulation of glucuronyltransferase activity"},{"keId":758,"keName":"Hippocampal Physiology, Altered"},{"keId":756,"keName":"Hippocampal gene expression, Altered "},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":401,"keName":"Increase, Biliary excretion TH glucuronide"},{"keId":239,"keName":"Activation, Pregnane-X receptor, NR1l2"},{"keId":319,"keName":"Loss, Cochlear function"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":757,"keName":"Hippocampal anatomy, Altered "}],"status":"Under Development","reference":"https://aopwiki.org/aops/8"}
{"aopId":8,"aopName":"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","targetName":"nuclear receptor subfamily 1 group I member 3","targetId":"ENSG00000143257","aoId":319,"aoName":"Loss Cochlear function","aoNameRaw":"Loss, Cochlear function","keyEvents":[{"keId":295,"keName":"Induction, Upregulation of glucuronyltransferase activity"},{"keId":758,"keName":"Hippocampal Physiology, Altered"},{"keId":756,"keName":"Hippocampal gene expression, Altered "},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":401,"keName":"Increase, Biliary excretion TH glucuronide"},{"keId":239,"keName":"Activation, Pregnane-X receptor, NR1l2"},{"keId":319,"keName":"Loss, Cochlear function"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":757,"keName":"Hippocampal anatomy, Altered "}],"status":"Under Development","reference":"https://aopwiki.org/aops/8"}
{"aopId":8,"aopName":"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","targetName":"nuclear receptor subfamily 1 group I member 2","targetId":"ENSG00000144852","aoId":319,"aoName":"Loss Cochlear function","aoNameRaw":"Loss, Cochlear function","keyEvents":[{"keId":295,"keName":"Induction, Upregulation of glucuronyltransferase activity"},{"keId":758,"keName":"Hippocampal Physiology, Altered"},{"keId":756,"keName":"Hippocampal gene expression, Altered "},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":401,"keName":"Increase, Biliary excretion TH glucuronide"},{"keId":239,"keName":"Activation, Pregnane-X receptor, NR1l2"},{"keId":319,"keName":"Loss, Cochlear function"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":757,"keName":"Hippocampal anatomy, Altered "}],"status":"Under Development","reference":"https://aopwiki.org/aops/8"}
{"aopId":8,"aopName":"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","aoId":319,"aoName":"Loss Cochlear function","aoNameRaw":"Loss, Cochlear function","keyEvents":[{"keId":295,"keName":"Induction, Upregulation of glucuronyltransferase activity"},{"keId":758,"keName":"Hippocampal Physiology, Altered"},{"keId":756,"keName":"Hippocampal gene expression, Altered "},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":401,"keName":"Increase, Biliary excretion TH glucuronide"},{"keId":239,"keName":"Activation, Pregnane-X receptor, NR1l2"},{"keId":319,"keName":"Loss, Cochlear function"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":757,"keName":"Hippocampal anatomy, Altered "}],"status":"Under Development","reference":"https://aopwiki.org/aops/8"}
{"aopId":10,"aopName":"Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain","targetName":"gamma-aminobutyric acid receptor subunit alpha-5","targetId":"ENSG00000186297","aoId":613,"aoName":"Occurrence Epileptic seizure","aoNameRaw":"Occurrence, Epileptic seizure","keyEvents":[{"keId":669,"keName":"Reduction, Neuronal synaptic inhibition"},{"keId":616,"keName":"Occurrence, A paroxysmal depolarizing shift"},{"keId":682,"keName":"Generation, Amplified excitatory postsynaptic potential (EPSP)"},{"keId":667,"keName":"Binding at picrotoxin site, iGABAR chloride channel"},{"keId":613,"keName":"Occurrence, Epileptic seizure"},{"keId":64,"keName":"Reduction, Ionotropic GABA receptor chloride channel conductance"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/10"}
{"aopId":10,"aopName":"Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain","targetName":"gamma-aminobutyric acid receptor subunit alpha-6","targetId":"ENSG00000145863","aoId":613,"aoName":"Occurrence Epileptic seizure","aoNameRaw":"Occurrence, Epileptic seizure","keyEvents":[{"keId":669,"keName":"Reduction, Neuronal synaptic inhibition"},{"keId":616,"keName":"Occurrence, A paroxysmal depolarizing shift"},{"keId":682,"keName":"Generation, Amplified excitatory postsynaptic potential (EPSP)"},{"keId":667,"keName":"Binding at picrotoxin site, iGABAR chloride channel"},{"keId":613,"keName":"Occurrence, Epileptic seizure"},{"keId":64,"keName":"Reduction, Ionotropic GABA receptor chloride channel conductance"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/10"}
{"aopId":10,"aopName":"Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain","targetName":"gamma-aminobutyric acid receptor subunit alpha-1","targetId":"ENSG00000022355","aoId":613,"aoName":"Occurrence Epileptic seizure","aoNameRaw":"Occurrence, Epileptic seizure","keyEvents":[{"keId":669,"keName":"Reduction, Neuronal synaptic inhibition"},{"keId":616,"keName":"Occurrence, A paroxysmal depolarizing shift"},{"keId":682,"keName":"Generation, Amplified excitatory postsynaptic potential (EPSP)"},{"keId":667,"keName":"Binding at picrotoxin site, iGABAR chloride channel"},{"keId":613,"keName":"Occurrence, Epileptic seizure"},{"keId":64,"keName":"Reduction, Ionotropic GABA receptor chloride channel conductance"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/10"}
{"aopId":10,"aopName":"Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain","aoId":613,"aoName":"Occurrence Epileptic seizure","aoNameRaw":"Occurrence, Epileptic seizure","keyEvents":[{"keId":669,"keName":"Reduction, Neuronal synaptic inhibition"},{"keId":616,"keName":"Occurrence, A paroxysmal depolarizing shift"},{"keId":682,"keName":"Generation, Amplified excitatory postsynaptic potential (EPSP)"},{"keId":667,"keName":"Binding at picrotoxin site, iGABAR chloride channel"},{"keId":613,"keName":"Occurrence, Epileptic seizure"},{"keId":64,"keName":"Reduction, Ionotropic GABA receptor chloride channel conductance"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/10"}
{"aopId":12,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging","targetName":"brain-derived neurotrophic factor","targetId":"ENSG00000176697","aoId":352,"aoName":"Neurodegeneration","aoNameRaw":"N/A, Neurodegeneration","aoMappedId":"HP_0002180","keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":188,"keName":"Neuroinflammation"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":55,"keName":"Cell injury/death"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/12"}
{"aopId":12,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging","aoId":352,"aoName":"Neurodegeneration","aoNameRaw":"N/A, Neurodegeneration","aoMappedId":"HP_0002180","keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":188,"keName":"Neuroinflammation"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":55,"keName":"Cell injury/death"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/12"}
{"aopId":12,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging","targetName":"brain-derived neurotrophic factor","targetId":"ENSG00000176697","aoId":341,"keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":188,"keName":"Neuroinflammation"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":55,"keName":"Cell injury/death"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/12"}
{"aopId":12,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging","aoId":341,"keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":188,"keName":"Neuroinflammation"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":55,"keName":"Cell injury/death"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/12"}
{"aopId":12,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging","targetName":"brain-derived neurotrophic factor","targetId":"ENSG00000176697","aoId":341,"aoName":"Impairment Learning and memory","aoNameRaw":"Impairment, Learning and memory","keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":188,"keName":"Neuroinflammation"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":55,"keName":"Cell injury/death"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/12"}
{"aopId":12,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging","aoId":341,"aoName":"Impairment Learning and memory","aoNameRaw":"Impairment, Learning and memory","keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":188,"keName":"Neuroinflammation"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":55,"keName":"Cell injury/death"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/12"}
{"aopId":12,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging","targetName":"brain-derived neurotrophic factor","targetId":"ENSG00000176697","aoId":352,"keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":188,"keName":"Neuroinflammation"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":55,"keName":"Cell injury/death"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/12"}
{"aopId":12,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging","aoId":352,"keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":188,"keName":"Neuroinflammation"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":55,"keName":"Cell injury/death"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/12"}
{"aopId":13,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities","targetName":"brain-derived neurotrophic factor","targetId":"ENSG00000176697","aoId":341,"aoName":"Impairment Learning and memory","aoNameRaw":"Impairment, Learning and memory","keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":383,"keName":"Reduced, Presynaptic release of glutamate"},{"keId":382,"keName":"Aberrant, Dendritic morphology"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":55,"keName":"Cell injury/death"},{"keId":385,"keName":"Decrease of synaptogenesis"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/13"}
{"aopId":13,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities","aoId":341,"aoName":"Impairment Learning and memory","aoNameRaw":"Impairment, Learning and memory","keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":383,"keName":"Reduced, Presynaptic release of glutamate"},{"keId":382,"keName":"Aberrant, Dendritic morphology"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":55,"keName":"Cell injury/death"},{"keId":385,"keName":"Decrease of synaptogenesis"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/13"}
{"aopId":13,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities","targetName":"brain-derived neurotrophic factor","targetId":"ENSG00000176697","aoId":341,"keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":383,"keName":"Reduced, Presynaptic release of glutamate"},{"keId":382,"keName":"Aberrant, Dendritic morphology"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":55,"keName":"Cell injury/death"},{"keId":385,"keName":"Decrease of synaptogenesis"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/13"}
{"aopId":13,"aopName":"Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities","aoId":341,"keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":52,"keName":"Decreased, Calcium influx"},{"keId":383,"keName":"Reduced, Presynaptic release of glutamate"},{"keId":382,"keName":"Aberrant, Dendritic morphology"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":201,"keName":"Binding of antagonist, NMDA receptors"},{"keId":195,"keName":"Inhibition, NMDARs"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":55,"keName":"Cell injury/death"},{"keId":385,"keName":"Decrease of synaptogenesis"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/13"}
{"aopId":14,"aopName":"Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility","targetName":"transcription factor NF-kappa-B subunit","aoId":323,"aoName":"Increased Disease susceptibility","aoNameRaw":"Increased, Disease susceptibility","keyEvents":[{"keId":152,"keName":"Suppression, Inflammatory cytokines"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":168,"keName":"Decreased, Lymphocytes"},{"keId":145,"keName":"Induction, IKB inhibitory protein"},{"keId":323,"keName":"Increased, Disease susceptibility"},{"keId":403,"keName":"Suppression, Immune system"},{"keId":202,"keName":"Inhibition, Nuclear factor kappa B (NF-kB)"}],"reference":"https://aopwiki.org/aops/14"}
{"aopId":14,"aopName":"Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility","targetName":"NF-kappa-B inhibitor","aoId":323,"aoName":"Increased Disease susceptibility","aoNameRaw":"Increased, Disease susceptibility","keyEvents":[{"keId":152,"keName":"Suppression, Inflammatory cytokines"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":168,"keName":"Decreased, Lymphocytes"},{"keId":145,"keName":"Induction, IKB inhibitory protein"},{"keId":323,"keName":"Increased, Disease susceptibility"},{"keId":403,"keName":"Suppression, Immune system"},{"keId":202,"keName":"Inhibition, Nuclear factor kappa B (NF-kB)"}],"reference":"https://aopwiki.org/aops/14"}
{"aopId":14,"aopName":"Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":323,"aoName":"Increased Disease susceptibility","aoNameRaw":"Increased, Disease susceptibility","keyEvents":[{"keId":152,"keName":"Suppression, Inflammatory cytokines"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":168,"keName":"Decreased, Lymphocytes"},{"keId":145,"keName":"Induction, IKB inhibitory protein"},{"keId":323,"keName":"Increased, Disease susceptibility"},{"keId":403,"keName":"Suppression, Immune system"},{"keId":202,"keName":"Inhibition, Nuclear factor kappa B (NF-kB)"}],"reference":"https://aopwiki.org/aops/14"}
{"aopId":14,"aopName":"Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility","aoId":323,"aoName":"Increased Disease susceptibility","aoNameRaw":"Increased, Disease susceptibility","keyEvents":[{"keId":152,"keName":"Suppression, Inflammatory cytokines"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":168,"keName":"Decreased, Lymphocytes"},{"keId":145,"keName":"Induction, IKB inhibitory protein"},{"keId":323,"keName":"Increased, Disease susceptibility"},{"keId":403,"keName":"Suppression, Immune system"},{"keId":202,"keName":"Inhibition, Nuclear factor kappa B (NF-kB)"}],"reference":"https://aopwiki.org/aops/14"}
{"aopId":15,"aopName":"Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations","aoId":336,"aoName":"Increase Heritable mutations in offspring","aoNameRaw":"Increase, Heritable mutations in offspring","keyEvents":[{"keId":185,"keName":"Increase, Mutations"},{"keId":97,"keName":"Alkylation, DNA"},{"keId":336,"keName":"Increase, Heritable mutations in offspring"},{"keId":155,"keName":"N/A, Inadequate DNA repair"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/15"}
{"aopId":16,"aopName":"Acetylcholinesterase inhibition leading to acute mortality","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":39,"keName":"Increased Cholinergic Signaling"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1703,"keName":"Dysregulation of heart rate and vascular tone"},{"keId":445,"keName":"Respiratory distress/arrest"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"}],"status":"Under Development","reference":"https://aopwiki.org/aops/16"}
{"aopId":16,"aopName":"Acetylcholinesterase inhibition leading to acute mortality","targetName":"acetylcholinesterase","targetId":"ENSG00000087085","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":39,"keName":"Increased Cholinergic Signaling"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1703,"keName":"Dysregulation of heart rate and vascular tone"},{"keId":445,"keName":"Respiratory distress/arrest"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"}],"status":"Under Development","reference":"https://aopwiki.org/aops/16"}
{"aopId":16,"aopName":"Acetylcholinesterase inhibition leading to acute mortality","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":39,"keName":"Increased Cholinergic Signaling"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1703,"keName":"Dysregulation of heart rate and vascular tone"},{"keId":445,"keName":"Respiratory distress/arrest"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"}],"status":"Under Development","reference":"https://aopwiki.org/aops/16"}
{"aopId":16,"aopName":"Acetylcholinesterase inhibition leading to acute mortality","targetName":"acetylcholinesterase","targetId":"ENSG00000087085","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":39,"keName":"Increased Cholinergic Signaling"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1703,"keName":"Dysregulation of heart rate and vascular tone"},{"keId":445,"keName":"Respiratory distress/arrest"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"}],"status":"Under Development","reference":"https://aopwiki.org/aops/16"}
{"aopId":17,"aopName":"Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory","aoId":341,"keyEvents":[{"keId":188,"keName":"Neuroinflammation"},{"keId":1392,"keName":"Oxidative Stress "},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1487,"keName":"Binding, Thiol/seleno-proteins involved in protection against oxidative stress"},{"keId":1538,"keName":"Decreased protection against oxidative stress"},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1488,"keName":"Glutamate dyshomeostasis"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":55,"keName":"Cell injury/death"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/17"}
{"aopId":17,"aopName":"Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory","aoId":341,"aoName":"Impairment Learning and memory","aoNameRaw":"Impairment, Learning and memory","keyEvents":[{"keId":188,"keName":"Neuroinflammation"},{"keId":1392,"keName":"Oxidative Stress "},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1487,"keName":"Binding, Thiol/seleno-proteins involved in protection against oxidative stress"},{"keId":1538,"keName":"Decreased protection against oxidative stress"},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1488,"keName":"Glutamate dyshomeostasis"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":55,"keName":"Cell injury/death"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/17"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"translocator protein","targetId":"ENSG00000100300","aoId":406,"keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"STAR","targetId":"ENSG00000177675","aoId":406,"keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"STAR","targetId":"ENSG00000070019","aoId":406,"keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"STAR","targetId":"ENSG00000147465","aoId":406,"keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":406,"keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","aoId":406,"keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"translocator protein","targetId":"ENSG00000100300","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"STAR","targetId":"ENSG00000177675","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"STAR","targetId":"ENSG00000070019","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"STAR","targetId":"ENSG00000147465","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"translocator protein","targetId":"ENSG00000100300","aoId":348,"aoName":"Malformation Male reproductive tract","aoNameRaw":"Malformation, Male reproductive tract","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"STAR","targetId":"ENSG00000177675","aoId":348,"aoName":"Malformation Male reproductive tract","aoNameRaw":"Malformation, Male reproductive tract","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"STAR","targetId":"ENSG00000070019","aoId":348,"aoName":"Malformation Male reproductive tract","aoNameRaw":"Malformation, Male reproductive tract","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"STAR","targetId":"ENSG00000147465","aoId":348,"aoName":"Malformation Male reproductive tract","aoNameRaw":"Malformation, Male reproductive tract","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":348,"aoName":"Malformation Male reproductive tract","aoNameRaw":"Malformation, Male reproductive tract","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":18,"aopName":"PPARα activation in utero leading to impaired fertility in males","aoId":348,"aoName":"Malformation Male reproductive tract","aoNameRaw":"Malformation, Male reproductive tract","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":289,"keName":"Decrease, Translocator protein (TSPO)"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":348,"keName":"Malformation, Male reproductive tract"},{"keId":266,"keName":"Decrease, Steroidogenic acute regulatory protein (STAR)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/18"}
{"aopId":19,"aopName":"Androgen receptor antagonism leading to adverse effects in the male foetus (mammals)","aoId":337,"aoName":"Impairment of reproductive capacity","aoNameRaw":"N/A, Impairment of reproductive capacity","keyEvents":[{"keId":27,"keName":"N/A, Androgen receptor, Antagonism"},{"keId":310,"keName":"Alteration, Wnt pathway"},{"keId":240,"keName":"Feminisation or incomplete development, Primary and accessory male sex organs"},{"keId":286,"keName":"Altered, Transcription of genes by AR"},{"keId":337,"keName":"N/A, Impairment of reproductive capacity"}],"reference":"https://aopwiki.org/aops/19"}
{"aopId":19,"aopName":"Androgen receptor antagonism leading to adverse effects in the male foetus (mammals)","targetName":"androgen receptor","targetId":"ENSG00000169083","aoId":337,"aoName":"Impairment of reproductive capacity","aoNameRaw":"N/A, Impairment of reproductive capacity","keyEvents":[{"keId":27,"keName":"N/A, Androgen receptor, Antagonism"},{"keId":310,"keName":"Alteration, Wnt pathway"},{"keId":240,"keName":"Feminisation or incomplete development, Primary and accessory male sex organs"},{"keId":286,"keName":"Altered, Transcription of genes by AR"},{"keId":337,"keName":"N/A, Impairment of reproductive capacity"}],"reference":"https://aopwiki.org/aops/19"}
{"aopId":23,"aopName":"Androgen receptor agonism leading to reproductive dysfunction (in repeat-spawning fish)","targetName":"androgen receptor","targetId":"ENSG00000169083","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":129,"keName":"Reduction, Gonadotropins, circulating concentrations"},{"keId":25,"keName":"Agonism, Androgen receptor"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":274,"keName":"Reduction, Testosterone synthesis by ovarian theca cells"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/23"}
{"aopId":23,"aopName":"Androgen receptor agonism leading to reproductive dysfunction (in repeat-spawning fish)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":129,"keName":"Reduction, Gonadotropins, circulating concentrations"},{"keId":25,"keName":"Agonism, Androgen receptor"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":274,"keName":"Reduction, Testosterone synthesis by ovarian theca cells"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/23"}
{"aopId":25,"aopName":"Aromatase inhibition leading to reproductive dysfunction","targetName":"aromatase","targetId":"ENSG00000137869","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":36,"keName":"Inhibition, Aromatase"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/25"}
{"aopId":25,"aopName":"Aromatase inhibition leading to reproductive dysfunction","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":36,"keName":"Inhibition, Aromatase"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/25"}
{"aopId":26,"aopName":"Calcium-mediated neuronal ROS production and energy imbalance","aoId":356,"aoName":"Increased Oxidative damage","aoNameRaw":"Increased, Oxidative damage","keyEvents":[{"keId":40,"keName":"Decrease, Mitochondrial ATP production"},{"keId":166,"keName":"Decreased, Long-term potentiation (LTP)"},{"keId":178,"keName":"Disruption, Mitochondrial electron transport chain"},{"keId":356,"keName":"Increased, Oxidative damage"},{"keId":193,"keName":"Decreased, Nitric Oxide"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":50,"keName":"Increase, Ca++ (intracellular)"},{"keId":51,"keName":"Inhibition, Ca++ ATPase"}],"reference":"https://aopwiki.org/aops/26"}
{"aopId":27,"aopName":"Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)","targetName":"bile acid receptor","targetId":"ENSG00000012504","aoId":357,"aoName":"Cholestasis Pathology","aoNameRaw":"Cholestasis, Pathology","keyEvents":[{"keId":209,"keName":"Peptide Oxidation"},{"keId":357,"keName":"Cholestasis, Pathology"},{"keId":41,"keName":"Inhibition, Bile Salt Export Pump (ABCB11)"},{"keId":214,"keName":"Bile accumulation, Pathological condition"},{"keId":149,"keName":"Increase, Inflammation"},{"keId":87,"keName":"Release, Cytokine"},{"keId":288,"keName":"Activation of specific nuclear receptors, Transcriptional change"},{"keId":249,"keName":"Production, Reactive oxygen species"}],"status":"Under Development","reference":"https://aopwiki.org/aops/27"}
{"aopId":27,"aopName":"Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)","aoId":357,"aoName":"Cholestasis Pathology","aoNameRaw":"Cholestasis, Pathology","keyEvents":[{"keId":209,"keName":"Peptide Oxidation"},{"keId":357,"keName":"Cholestasis, Pathology"},{"keId":41,"keName":"Inhibition, Bile Salt Export Pump (ABCB11)"},{"keId":214,"keName":"Bile accumulation, Pathological condition"},{"keId":149,"keName":"Increase, Inflammation"},{"keId":87,"keName":"Release, Cytokine"},{"keId":288,"keName":"Activation of specific nuclear receptors, Transcriptional change"},{"keId":249,"keName":"Production, Reactive oxygen species"}],"status":"Under Development","reference":"https://aopwiki.org/aops/27"}
{"aopId":27,"aopName":"Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)","targetName":"bile salt export pump","targetId":"ENSG00000073734","aoId":357,"aoName":"Cholestasis Pathology","aoNameRaw":"Cholestasis, Pathology","keyEvents":[{"keId":209,"keName":"Peptide Oxidation"},{"keId":357,"keName":"Cholestasis, Pathology"},{"keId":41,"keName":"Inhibition, Bile Salt Export Pump (ABCB11)"},{"keId":214,"keName":"Bile accumulation, Pathological condition"},{"keId":149,"keName":"Increase, Inflammation"},{"keId":87,"keName":"Release, Cytokine"},{"keId":288,"keName":"Activation of specific nuclear receptors, Transcriptional change"},{"keId":249,"keName":"Production, Reactive oxygen species"}],"status":"Under Development","reference":"https://aopwiki.org/aops/27"}
{"aopId":28,"aopName":"Cyclooxygenase inhibition leading reproductive failure","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":253,"aoName":"Reproductive failure","aoNameRaw":"N/A, Reproductive failure","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":106,"keName":"Reduction, Eggshell thickness"},{"keId":253,"keName":"N/A, Reproductive failure"},{"keId":49,"keName":"Reduction, Ca and HCO3 transport to shell gland"},{"keId":119,"keName":"N/A, Gap"},{"keId":243,"keName":"Reduction, Prostaglandin E2 concentration"}],"reference":"https://aopwiki.org/aops/28"}
{"aopId":28,"aopName":"Cyclooxygenase inhibition leading reproductive failure","targetName":"prostaglandin G/H synthase 2","targetId":"ENSG00000073756","aoId":253,"aoName":"Reproductive failure","aoNameRaw":"N/A, Reproductive failure","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":106,"keName":"Reduction, Eggshell thickness"},{"keId":253,"keName":"N/A, Reproductive failure"},{"keId":49,"keName":"Reduction, Ca and HCO3 transport to shell gland"},{"keId":119,"keName":"N/A, Gap"},{"keId":243,"keName":"Reduction, Prostaglandin E2 concentration"}],"reference":"https://aopwiki.org/aops/28"}
{"aopId":28,"aopName":"Cyclooxygenase inhibition leading reproductive failure","aoId":253,"aoName":"Reproductive failure","aoNameRaw":"N/A, Reproductive failure","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":106,"keName":"Reduction, Eggshell thickness"},{"keId":253,"keName":"N/A, Reproductive failure"},{"keId":49,"keName":"Reduction, Ca and HCO3 transport to shell gland"},{"keId":119,"keName":"N/A, Gap"},{"keId":243,"keName":"Reduction, Prostaglandin E2 concentration"}],"reference":"https://aopwiki.org/aops/28"}
{"aopId":29,"aopName":"Estrogen receptor agonism leading to reproductive dysfunction","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":363,"aoName":"Altered Reproductive behaviour","aoNameRaw":"Altered, Reproductive behaviour","keyEvents":[{"keId":111,"keName":"Agonism, Estrogen receptor"},{"keId":252,"keName":"Increase, Renal pathology due to VTG deposition"},{"keId":364,"keName":"Impaired development of, Reproductive organs"},{"keId":363,"keName":"Altered, Reproductive behaviour"},{"keId":339,"keName":"Altered, Larval development"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":307,"keName":"Increase, Vitellogenin synthesis in liver"},{"keId":220,"keName":"Increase, Plasma vitellogenin concentrations"}],"reference":"https://aopwiki.org/aops/29"}
{"aopId":29,"aopName":"Estrogen receptor agonism leading to reproductive dysfunction","aoId":363,"aoName":"Altered Reproductive behaviour","aoNameRaw":"Altered, Reproductive behaviour","keyEvents":[{"keId":111,"keName":"Agonism, Estrogen receptor"},{"keId":252,"keName":"Increase, Renal pathology due to VTG deposition"},{"keId":364,"keName":"Impaired development of, Reproductive organs"},{"keId":363,"keName":"Altered, Reproductive behaviour"},{"keId":339,"keName":"Altered, Larval development"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":307,"keName":"Increase, Vitellogenin synthesis in liver"},{"keId":220,"keName":"Increase, Plasma vitellogenin concentrations"}],"reference":"https://aopwiki.org/aops/29"}
{"aopId":29,"aopName":"Estrogen receptor agonism leading to reproductive dysfunction","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":339,"aoName":"Altered Larval development","aoNameRaw":"Altered, Larval development","keyEvents":[{"keId":111,"keName":"Agonism, Estrogen receptor"},{"keId":252,"keName":"Increase, Renal pathology due to VTG deposition"},{"keId":364,"keName":"Impaired development of, Reproductive organs"},{"keId":363,"keName":"Altered, Reproductive behaviour"},{"keId":339,"keName":"Altered, Larval development"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":307,"keName":"Increase, Vitellogenin synthesis in liver"},{"keId":220,"keName":"Increase, Plasma vitellogenin concentrations"}],"reference":"https://aopwiki.org/aops/29"}
{"aopId":29,"aopName":"Estrogen receptor agonism leading to reproductive dysfunction","aoId":339,"aoName":"Altered Larval development","aoNameRaw":"Altered, Larval development","keyEvents":[{"keId":111,"keName":"Agonism, Estrogen receptor"},{"keId":252,"keName":"Increase, Renal pathology due to VTG deposition"},{"keId":364,"keName":"Impaired development of, Reproductive organs"},{"keId":363,"keName":"Altered, Reproductive behaviour"},{"keId":339,"keName":"Altered, Larval development"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":307,"keName":"Increase, Vitellogenin synthesis in liver"},{"keId":220,"keName":"Increase, Plasma vitellogenin concentrations"}],"reference":"https://aopwiki.org/aops/29"}
{"aopId":29,"aopName":"Estrogen receptor agonism leading to reproductive dysfunction","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":111,"keName":"Agonism, Estrogen receptor"},{"keId":252,"keName":"Increase, Renal pathology due to VTG deposition"},{"keId":364,"keName":"Impaired development of, Reproductive organs"},{"keId":363,"keName":"Altered, Reproductive behaviour"},{"keId":339,"keName":"Altered, Larval development"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":307,"keName":"Increase, Vitellogenin synthesis in liver"},{"keId":220,"keName":"Increase, Plasma vitellogenin concentrations"}],"reference":"https://aopwiki.org/aops/29"}
{"aopId":29,"aopName":"Estrogen receptor agonism leading to reproductive dysfunction","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":111,"keName":"Agonism, Estrogen receptor"},{"keId":252,"keName":"Increase, Renal pathology due to VTG deposition"},{"keId":364,"keName":"Impaired development of, Reproductive organs"},{"keId":363,"keName":"Altered, Reproductive behaviour"},{"keId":339,"keName":"Altered, Larval development"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":307,"keName":"Increase, Vitellogenin synthesis in liver"},{"keId":220,"keName":"Increase, Plasma vitellogenin concentrations"}],"reference":"https://aopwiki.org/aops/29"}
{"aopId":29,"aopName":"Estrogen receptor agonism leading to reproductive dysfunction","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":364,"aoName":"Impaired development of Reproductive organs","aoNameRaw":"Impaired development of, Reproductive organs","keyEvents":[{"keId":111,"keName":"Agonism, Estrogen receptor"},{"keId":252,"keName":"Increase, Renal pathology due to VTG deposition"},{"keId":364,"keName":"Impaired development of, Reproductive organs"},{"keId":363,"keName":"Altered, Reproductive behaviour"},{"keId":339,"keName":"Altered, Larval development"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":307,"keName":"Increase, Vitellogenin synthesis in liver"},{"keId":220,"keName":"Increase, Plasma vitellogenin concentrations"}],"reference":"https://aopwiki.org/aops/29"}
{"aopId":29,"aopName":"Estrogen receptor agonism leading to reproductive dysfunction","aoId":364,"aoName":"Impaired development of Reproductive organs","aoNameRaw":"Impaired development of, Reproductive organs","keyEvents":[{"keId":111,"keName":"Agonism, Estrogen receptor"},{"keId":252,"keName":"Increase, Renal pathology due to VTG deposition"},{"keId":364,"keName":"Impaired development of, Reproductive organs"},{"keId":363,"keName":"Altered, Reproductive behaviour"},{"keId":339,"keName":"Altered, Larval development"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":307,"keName":"Increase, Vitellogenin synthesis in liver"},{"keId":220,"keName":"Increase, Plasma vitellogenin concentrations"}],"reference":"https://aopwiki.org/aops/29"}
{"aopId":30,"aopName":"Estrogen receptor antagonism leading to reproductive dysfunction","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":112,"keName":"Antagonism, Estrogen receptor"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/30"}
{"aopId":30,"aopName":"Estrogen receptor antagonism leading to reproductive dysfunction","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":112,"keName":"Antagonism, Estrogen receptor"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/30"}
{"aopId":31,"aopName":"Oxidation of iron in hemoglobin leading to hematotoxicity","targetName":"hemoglobin subunit alpha (human)","aoId":321,"aoName":"Cyanosis occurs","aoNameRaw":"N/A, Cyanosis occurs","keyEvents":[{"keId":321,"keName":"N/A, Cyanosis occurs"},{"keId":246,"keName":"Increase, RBC congestion in liver"},{"keId":213,"keName":"N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)"},{"keId":173,"keName":"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number"},{"keId":118,"keName":"Formation, Formation of hemoglobin adducts"},{"keId":161,"keName":"Increase, Liver and splenic hemosiderosis"},{"keId":131,"keName":"Down Regulation, Gulcose-6-phosphate dehydrogenase"},{"keId":250,"keName":"Damaging, Red blood cells; hemolysis"},{"keId":21,"keName":"Altered regulation, Alpha hemoglobin"},{"keId":211,"keName":"Propagation, Oxidative stress"}],"status":"Under Development","reference":"https://aopwiki.org/aops/31"}
{"aopId":31,"aopName":"Oxidation of iron in hemoglobin leading to hematotoxicity","aoId":321,"aoName":"Cyanosis occurs","aoNameRaw":"N/A, Cyanosis occurs","keyEvents":[{"keId":321,"keName":"N/A, Cyanosis occurs"},{"keId":246,"keName":"Increase, RBC congestion in liver"},{"keId":213,"keName":"N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)"},{"keId":173,"keName":"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number"},{"keId":118,"keName":"Formation, Formation of hemoglobin adducts"},{"keId":161,"keName":"Increase, Liver and splenic hemosiderosis"},{"keId":131,"keName":"Down Regulation, Gulcose-6-phosphate dehydrogenase"},{"keId":250,"keName":"Damaging, Red blood cells; hemolysis"},{"keId":21,"keName":"Altered regulation, Alpha hemoglobin"},{"keId":211,"keName":"Propagation, Oxidative stress"}],"status":"Under Development","reference":"https://aopwiki.org/aops/31"}
{"aopId":31,"aopName":"Oxidation of iron in hemoglobin leading to hematotoxicity","targetName":"glucose-6-phosphate 1-dehydrogenase","targetId":"ENSG00000160211","aoId":321,"aoName":"Cyanosis occurs","aoNameRaw":"N/A, Cyanosis occurs","keyEvents":[{"keId":321,"keName":"N/A, Cyanosis occurs"},{"keId":246,"keName":"Increase, RBC congestion in liver"},{"keId":213,"keName":"N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)"},{"keId":173,"keName":"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number"},{"keId":118,"keName":"Formation, Formation of hemoglobin adducts"},{"keId":161,"keName":"Increase, Liver and splenic hemosiderosis"},{"keId":131,"keName":"Down Regulation, Gulcose-6-phosphate dehydrogenase"},{"keId":250,"keName":"Damaging, Red blood cells; hemolysis"},{"keId":21,"keName":"Altered regulation, Alpha hemoglobin"},{"keId":211,"keName":"Propagation, Oxidative stress"}],"status":"Under Development","reference":"https://aopwiki.org/aops/31"}
{"aopId":33,"aopName":"Kidney toxicity induced by activation of 5HT2C","aoId":759,"aoName":"Increased Kidney Failure","aoNameRaw":"Increased, Kidney Failure","keyEvents":[{"keId":294,"keName":"N/A, Unknown"},{"keId":759,"keName":"Increased, Kidney Failure"},{"keId":9,"keName":"Activation, 5HT2c"}],"reference":"https://aopwiki.org/aops/33"}
{"aopId":33,"aopName":"Kidney toxicity induced by activation of 5HT2C","targetName":"5-hydroxytryptamine receptor 2C","targetId":"ENSG00000147246","aoId":759,"aoName":"Increased Kidney Failure","aoNameRaw":"Increased, Kidney Failure","keyEvents":[{"keId":294,"keName":"N/A, Unknown"},{"keId":759,"keName":"Increased, Kidney Failure"},{"keId":9,"keName":"Activation, 5HT2c"}],"reference":"https://aopwiki.org/aops/33"}
{"aopId":34,"aopName":"LXR activation leading to hepatic steatosis","targetName":"acyl-CoA desaturase","targetId":"ENSG00000099194","aoId":345,"aoName":"Liver Steatosis","aoNameRaw":"N/A, Liver Steatosis","aoMappedId":"HP_0001397","keyEvents":[{"keId":89,"keName":"Synthesis, De Novo FA"},{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":264,"keName":"Activation, SREBP-1c"},{"keId":116,"keName":"Activation, FAS"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":115,"keName":"Increase, FA Influx"},{"keId":345,"keName":"N/A, Liver Steatosis"},{"keId":258,"keName":"Activation, SCD-1"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":167,"keName":"Activation, LXR"}],"reference":"https://aopwiki.org/aops/34"}
{"aopId":34,"aopName":"LXR activation leading to hepatic steatosis","targetName":"fatty acid synthase","targetId":"ENSG00000169710","aoId":345,"aoName":"Liver Steatosis","aoNameRaw":"N/A, Liver Steatosis","aoMappedId":"HP_0001397","keyEvents":[{"keId":89,"keName":"Synthesis, De Novo FA"},{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":264,"keName":"Activation, SREBP-1c"},{"keId":116,"keName":"Activation, FAS"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":115,"keName":"Increase, FA Influx"},{"keId":345,"keName":"N/A, Liver Steatosis"},{"keId":258,"keName":"Activation, SCD-1"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":167,"keName":"Activation, LXR"}],"reference":"https://aopwiki.org/aops/34"}
{"aopId":34,"aopName":"LXR activation leading to hepatic steatosis","targetName":"platelet glycoprotein 4","targetId":"ENSG00000135218","aoId":345,"aoName":"Liver Steatosis","aoNameRaw":"N/A, Liver Steatosis","aoMappedId":"HP_0001397","keyEvents":[{"keId":89,"keName":"Synthesis, De Novo FA"},{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":264,"keName":"Activation, SREBP-1c"},{"keId":116,"keName":"Activation, FAS"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":115,"keName":"Increase, FA Influx"},{"keId":345,"keName":"N/A, Liver Steatosis"},{"keId":258,"keName":"Activation, SCD-1"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":167,"keName":"Activation, LXR"}],"reference":"https://aopwiki.org/aops/34"}
{"aopId":34,"aopName":"LXR activation leading to hepatic steatosis","targetName":"sterol regulatory element-binding protein 1","targetId":"ENSG00000072310","aoId":345,"aoName":"Liver Steatosis","aoNameRaw":"N/A, Liver Steatosis","aoMappedId":"HP_0001397","keyEvents":[{"keId":89,"keName":"Synthesis, De Novo FA"},{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":264,"keName":"Activation, SREBP-1c"},{"keId":116,"keName":"Activation, FAS"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":115,"keName":"Increase, FA Influx"},{"keId":345,"keName":"N/A, Liver Steatosis"},{"keId":258,"keName":"Activation, SCD-1"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":167,"keName":"Activation, LXR"}],"reference":"https://aopwiki.org/aops/34"}
{"aopId":34,"aopName":"LXR activation leading to hepatic steatosis","targetName":"peroxisome proliferator-activated receptor gamma","targetId":"ENSG00000132170","aoId":345,"aoName":"Liver Steatosis","aoNameRaw":"N/A, Liver Steatosis","aoMappedId":"HP_0001397","keyEvents":[{"keId":89,"keName":"Synthesis, De Novo FA"},{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":264,"keName":"Activation, SREBP-1c"},{"keId":116,"keName":"Activation, FAS"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":115,"keName":"Increase, FA Influx"},{"keId":345,"keName":"N/A, Liver Steatosis"},{"keId":258,"keName":"Activation, SCD-1"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":167,"keName":"Activation, LXR"}],"reference":"https://aopwiki.org/aops/34"}
{"aopId":34,"aopName":"LXR activation leading to hepatic steatosis","aoId":345,"aoName":"Liver Steatosis","aoNameRaw":"N/A, Liver Steatosis","aoMappedId":"HP_0001397","keyEvents":[{"keId":89,"keName":"Synthesis, De Novo FA"},{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":264,"keName":"Activation, SREBP-1c"},{"keId":116,"keName":"Activation, FAS"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":115,"keName":"Increase, FA Influx"},{"keId":345,"keName":"N/A, Liver Steatosis"},{"keId":258,"keName":"Activation, SCD-1"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":167,"keName":"Activation, LXR"}],"reference":"https://aopwiki.org/aops/34"}
{"aopId":34,"aopName":"LXR activation leading to hepatic steatosis","targetName":"oxysterols receptor LXR-alpha","targetId":"ENSG00000025434","aoId":345,"aoName":"Liver Steatosis","aoNameRaw":"N/A, Liver Steatosis","aoMappedId":"HP_0001397","keyEvents":[{"keId":89,"keName":"Synthesis, De Novo FA"},{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":264,"keName":"Activation, SREBP-1c"},{"keId":116,"keName":"Activation, FAS"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":115,"keName":"Increase, FA Influx"},{"keId":345,"keName":"N/A, Liver Steatosis"},{"keId":258,"keName":"Activation, SCD-1"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":167,"keName":"Activation, LXR"}],"reference":"https://aopwiki.org/aops/34"}
{"aopId":34,"aopName":"LXR activation leading to hepatic steatosis","targetName":"oxysterols receptor LXR-beta","targetId":"ENSG00000131408","aoId":345,"aoName":"Liver Steatosis","aoNameRaw":"N/A, Liver Steatosis","aoMappedId":"HP_0001397","keyEvents":[{"keId":89,"keName":"Synthesis, De Novo FA"},{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":264,"keName":"Activation, SREBP-1c"},{"keId":116,"keName":"Activation, FAS"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":115,"keName":"Increase, FA Influx"},{"keId":345,"keName":"N/A, Liver Steatosis"},{"keId":258,"keName":"Activation, SCD-1"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":167,"keName":"Activation, LXR"}],"reference":"https://aopwiki.org/aops/34"}
{"aopId":34,"aopName":"LXR activation leading to hepatic steatosis","targetName":"carbohydrate-responsive element-binding protein","targetId":"ENSG00000009950","aoId":345,"aoName":"Liver Steatosis","aoNameRaw":"N/A, Liver Steatosis","aoMappedId":"HP_0001397","keyEvents":[{"keId":89,"keName":"Synthesis, De Novo FA"},{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":264,"keName":"Activation, SREBP-1c"},{"keId":116,"keName":"Activation, FAS"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":115,"keName":"Increase, FA Influx"},{"keId":345,"keName":"N/A, Liver Steatosis"},{"keId":258,"keName":"Activation, SCD-1"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":167,"keName":"Activation, LXR"}],"reference":"https://aopwiki.org/aops/34"}
{"aopId":36,"aopName":"Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","targetName":"peroxisome proliferator-activated receptor gamma","targetId":"ENSG00000132170","aoId":459,"keyEvents":[{"keId":233,"keName":"Decreased, PPAR-gamma activation"},{"keId":232,"keName":"Decreased, PPAR-beta activation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":8,"keName":"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"},{"keId":140,"keName":"Decreased, HSD17B10 expression"},{"keId":231,"keName":"Decreased, PPAR-alpha activation"}],"reference":"https://aopwiki.org/aops/36"}
{"aopId":36,"aopName":"Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":459,"keyEvents":[{"keId":233,"keName":"Decreased, PPAR-gamma activation"},{"keId":232,"keName":"Decreased, PPAR-beta activation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":8,"keName":"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"},{"keId":140,"keName":"Decreased, HSD17B10 expression"},{"keId":231,"keName":"Decreased, PPAR-alpha activation"}],"reference":"https://aopwiki.org/aops/36"}
{"aopId":36,"aopName":"Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","aoId":459,"keyEvents":[{"keId":233,"keName":"Decreased, PPAR-gamma activation"},{"keId":232,"keName":"Decreased, PPAR-beta activation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":8,"keName":"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"},{"keId":140,"keName":"Decreased, HSD17B10 expression"},{"keId":231,"keName":"Decreased, PPAR-alpha activation"}],"reference":"https://aopwiki.org/aops/36"}
{"aopId":36,"aopName":"Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","targetName":"peroxisome proliferator-activated receptor delta","targetId":"ENSG00000112033","aoId":459,"keyEvents":[{"keId":233,"keName":"Decreased, PPAR-gamma activation"},{"keId":232,"keName":"Decreased, PPAR-beta activation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":8,"keName":"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"},{"keId":140,"keName":"Decreased, HSD17B10 expression"},{"keId":231,"keName":"Decreased, PPAR-alpha activation"}],"reference":"https://aopwiki.org/aops/36"}
{"aopId":36,"aopName":"Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","targetName":"3-hydroxyacyl-CoA dehydrogenase type-2","targetId":"ENSG00000072506","aoId":459,"keyEvents":[{"keId":233,"keName":"Decreased, PPAR-gamma activation"},{"keId":232,"keName":"Decreased, PPAR-beta activation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":8,"keName":"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"},{"keId":140,"keName":"Decreased, HSD17B10 expression"},{"keId":231,"keName":"Decreased, PPAR-alpha activation"}],"reference":"https://aopwiki.org/aops/36"}
{"aopId":36,"aopName":"Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","targetName":"peroxisome proliferator-activated receptor gamma","targetId":"ENSG00000132170","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":233,"keName":"Decreased, PPAR-gamma activation"},{"keId":232,"keName":"Decreased, PPAR-beta activation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":8,"keName":"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"},{"keId":140,"keName":"Decreased, HSD17B10 expression"},{"keId":231,"keName":"Decreased, PPAR-alpha activation"}],"reference":"https://aopwiki.org/aops/36"}
{"aopId":36,"aopName":"Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":233,"keName":"Decreased, PPAR-gamma activation"},{"keId":232,"keName":"Decreased, PPAR-beta activation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":8,"keName":"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"},{"keId":140,"keName":"Decreased, HSD17B10 expression"},{"keId":231,"keName":"Decreased, PPAR-alpha activation"}],"reference":"https://aopwiki.org/aops/36"}
{"aopId":36,"aopName":"Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":233,"keName":"Decreased, PPAR-gamma activation"},{"keId":232,"keName":"Decreased, PPAR-beta activation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":8,"keName":"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"},{"keId":140,"keName":"Decreased, HSD17B10 expression"},{"keId":231,"keName":"Decreased, PPAR-alpha activation"}],"reference":"https://aopwiki.org/aops/36"}
{"aopId":36,"aopName":"Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","targetName":"peroxisome proliferator-activated receptor delta","targetId":"ENSG00000112033","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":233,"keName":"Decreased, PPAR-gamma activation"},{"keId":232,"keName":"Decreased, PPAR-beta activation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":8,"keName":"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"},{"keId":140,"keName":"Decreased, HSD17B10 expression"},{"keId":231,"keName":"Decreased, PPAR-alpha activation"}],"reference":"https://aopwiki.org/aops/36"}
{"aopId":36,"aopName":"Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","targetName":"3-hydroxyacyl-CoA dehydrogenase type-2","targetId":"ENSG00000072506","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":233,"keName":"Decreased, PPAR-gamma activation"},{"keId":232,"keName":"Decreased, PPAR-beta activation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":8,"keName":"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity"},{"keId":140,"keName":"Decreased, HSD17B10 expression"},{"keId":231,"keName":"Decreased, PPAR-alpha activation"}],"reference":"https://aopwiki.org/aops/36"}
{"aopId":37,"aopName":"PPARα activation leading to hepatocellular adenomas and carcinomas in rodents","aoId":719,"aoName":"Increase hepatocellular adenomas and carcinomas","aoNameRaw":"Increase, hepatocellular adenomas and carcinomas","keyEvents":[{"keId":719,"keName":"Increase, hepatocellular adenomas and carcinomas"},{"keId":716,"keName":"Increase, cell proliferation (hepatocytes)"},{"keId":1170,"keName":"Increase, Phenotypic enzyme activity"},{"keId":1171,"keName":"Increase, Clonal Expansion of Altered Hepatic Foci"},{"keId":227,"keName":"Activation, PPARα"}],"status":"Under Development","reference":"https://aopwiki.org/aops/37"}
{"aopId":37,"aopName":"PPARα activation leading to hepatocellular adenomas and carcinomas in rodents","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":719,"aoName":"Increase hepatocellular adenomas and carcinomas","aoNameRaw":"Increase, hepatocellular adenomas and carcinomas","keyEvents":[{"keId":719,"keName":"Increase, hepatocellular adenomas and carcinomas"},{"keId":716,"keName":"Increase, cell proliferation (hepatocytes)"},{"keId":1170,"keName":"Increase, Phenotypic enzyme activity"},{"keId":1171,"keName":"Increase, Clonal Expansion of Altered Hepatic Foci"},{"keId":227,"keName":"Activation, PPARα"}],"status":"Under Development","reference":"https://aopwiki.org/aops/37"}
{"aopId":38,"aopName":"Protein Alkylation leading to Liver Fibrosis","aoId":344,"aoName":"Liver fibrosis","aoNameRaw":"N/A, Liver fibrosis","aoMappedId":"HP_0001395","keyEvents":[{"keId":68,"keName":"Accumulation, Collagen"},{"keId":244,"keName":"Alkylation, Protein"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":265,"keName":"Activation, Stellate cells"},{"keId":344,"keName":"N/A, Liver fibrosis"},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":55,"keName":"Cell injury/death"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/38"}
{"aopId":39,"aopName":"Covalent Binding of Low Molecular Weight Organic Chemicals to Proteins leads to Sensitisation (Sensitization) of the Respiratory Tract","aoId":313,"aoName":"Increase Allergic Respiratory Hypersensitivity Response","aoNameRaw":"Increase, Allergic Respiratory Hypersensitivity Response","keyEvents":[{"keId":151,"keName":"Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways"},{"keId":398,"keName":"Activation, Dendritic Cells"},{"keId":396,"keName":"Covalent Binding, Protein"},{"keId":313,"keName":"Increase, Allergic Respiratory Hypersensitivity Response"},{"keId":272,"keName":"Activation/Proliferation, T-cells"}],"status":"Under Development","reference":"https://aopwiki.org/aops/39"}
{"aopId":40,"aopName":"Covalent Protein binding leading to Skin Sensitisation","aoId":827,"aoName":"sensitisation skin","aoNameRaw":"sensitisation, skin","keyEvents":[{"keId":827,"keName":"sensitisation, skin"},{"keId":826,"keName":"Activation, Keratinocytes"},{"keId":398,"keName":"Activation, Dendritic Cells"},{"keId":396,"keName":"Covalent Binding, Protein"},{"keId":272,"keName":"Activation/Proliferation, T-cells"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/40"}
{"aopId":41,"aopName":"Sustained AhR Activation leading to Rodent Liver Tumours","aoId":856,"aoName":"Formation Hepatocellular and Bile duct tumors","aoNameRaw":"Formation, Hepatocellular and Bile duct tumors","keyEvents":[{"keId":165,"keName":"Activation, Long term AHR receptor driven direct and indirect gene expression changes"},{"keId":856,"keName":"Formation, Hepatocellular and Bile duct tumors"},{"keId":854,"keName":"Alterations, Cellular proliferation / hyperplasia"},{"keId":853,"keName":"Changes/Inhibition, Cellular Homeostasis and Apoptosis"},{"keId":139,"keName":"N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/41"}
{"aopId":41,"aopName":"Sustained AhR Activation leading to Rodent Liver Tumours","targetName":"aryl hydrocarbon receptor","targetId":"ENSG00000106546","aoId":856,"aoName":"Formation Hepatocellular and Bile duct tumors","aoNameRaw":"Formation, Hepatocellular and Bile duct tumors","keyEvents":[{"keId":165,"keName":"Activation, Long term AHR receptor driven direct and indirect gene expression changes"},{"keId":856,"keName":"Formation, Hepatocellular and Bile duct tumors"},{"keId":854,"keName":"Alterations, Cellular proliferation / hyperplasia"},{"keId":853,"keName":"Changes/Inhibition, Cellular Homeostasis and Apoptosis"},{"keId":139,"keName":"N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/41"}
{"aopId":42,"aopName":"Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":402,"aoName":"Cognitive Function Decreased","aoNameRaw":"Cognitive Function, Decreased ","keyEvents":[{"keId":758,"keName":"Hippocampal Physiology, Altered"},{"keId":756,"keName":"Hippocampal gene expression, Altered "},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":402,"keName":"Cognitive Function, Decreased "},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":757,"keName":"Hippocampal anatomy, Altered "}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/42"}
{"aopId":42,"aopName":"Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","aoId":402,"aoName":"Cognitive Function Decreased","aoNameRaw":"Cognitive Function, Decreased ","keyEvents":[{"keId":758,"keName":"Hippocampal Physiology, Altered"},{"keId":756,"keName":"Hippocampal gene expression, Altered "},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":402,"keName":"Cognitive Function, Decreased "},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":757,"keName":"Hippocampal anatomy, Altered "}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/42"}
{"aopId":43,"aopName":"Disruption of VEGFR Signaling Leading to Developmental Defects","targetName":"vascular endothelial growth factor receptor 2","targetId":"ENSG00000128052","aoId":1001,"aoName":"Increased Developmental Defects","aoNameRaw":"Increased, Developmental Defects","keyEvents":[{"keId":298,"keName":"Insufficiency, Vascular"},{"keId":1001,"keName":"Increased, Developmental Defects"},{"keId":305,"keName":"Inhibition, VegfR2"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":28,"keName":"Reduction, Angiogenesis"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/43"}
{"aopId":43,"aopName":"Disruption of VEGFR Signaling Leading to Developmental Defects","targetName":"vascular endothelial growth factor receptor 1","targetId":"ENSG00000102755","aoId":1001,"aoName":"Increased Developmental Defects","aoNameRaw":"Increased, Developmental Defects","keyEvents":[{"keId":298,"keName":"Insufficiency, Vascular"},{"keId":1001,"keName":"Increased, Developmental Defects"},{"keId":305,"keName":"Inhibition, VegfR2"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":28,"keName":"Reduction, Angiogenesis"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/43"}
{"aopId":43,"aopName":"Disruption of VEGFR Signaling Leading to Developmental Defects","aoId":1001,"aoName":"Increased Developmental Defects","aoNameRaw":"Increased, Developmental Defects","keyEvents":[{"keId":298,"keName":"Insufficiency, Vascular"},{"keId":1001,"keName":"Increased, Developmental Defects"},{"keId":305,"keName":"Inhibition, VegfR2"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":28,"keName":"Reduction, Angiogenesis"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/43"}
{"aopId":46,"aopName":"AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)","targetName":"cellular tumor antigen p53","targetId":"ENSG00000141510","aoId":378,"aoName":"Tumorigenesis Hepatocellular carcinoma","aoNameRaw":"Tumorigenesis, Hepatocellular carcinoma","keyEvents":[{"keId":378,"keName":"Tumorigenesis, Hepatocellular carcinoma"},{"keId":409,"keName":"Metabolism of AFB1, Production of Reactive Electrophiles"},{"keId":376,"keName":"Increased, Induced Mutations in Critical Genes"},{"keId":491,"keName":"Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF)"},{"keId":493,"keName":"Increased, Insufficient repair or mis-repair of pro-mutagenic DNA adducts"},{"keId":373,"keName":"Formation, Pro-mutagenic DNA Adducts"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/46"}
{"aopId":46,"aopName":"AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)","aoId":378,"aoName":"Tumorigenesis Hepatocellular carcinoma","aoNameRaw":"Tumorigenesis, Hepatocellular carcinoma","keyEvents":[{"keId":378,"keName":"Tumorigenesis, Hepatocellular carcinoma"},{"keId":409,"keName":"Metabolism of AFB1, Production of Reactive Electrophiles"},{"keId":376,"keName":"Increased, Induced Mutations in Critical Genes"},{"keId":491,"keName":"Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF)"},{"keId":493,"keName":"Increased, Insufficient repair or mis-repair of pro-mutagenic DNA adducts"},{"keId":373,"keName":"Formation, Pro-mutagenic DNA Adducts"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/46"}
{"aopId":48,"aopName":"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.","aoId":341,"keyEvents":[{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":388,"keName":"Overactivation, NMDARs"},{"keId":188,"keName":"Neuroinflammation"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":875,"keName":"Binding of agonist, Ionotropic glutamate receptors"},{"keId":389,"keName":"Increased, Intracellular Calcium overload"},{"keId":618,"keName":"Decreased, Neuronal network function in adult brain"},{"keId":55,"keName":"Cell injury/death"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/48"}
{"aopId":48,"aopName":"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.","aoId":341,"aoName":"Impairment Learning and memory","aoNameRaw":"Impairment, Learning and memory","keyEvents":[{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":388,"keName":"Overactivation, NMDARs"},{"keId":188,"keName":"Neuroinflammation"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":875,"keName":"Binding of agonist, Ionotropic glutamate receptors"},{"keId":389,"keName":"Increased, Intracellular Calcium overload"},{"keId":618,"keName":"Decreased, Neuronal network function in adult brain"},{"keId":55,"keName":"Cell injury/death"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/48"}
{"aopId":51,"aopName":"PPARα activation leading to impaired fertility in adult male rodents ","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":406,"keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":415,"keName":"Hyperplasia, Leydig cell"},{"keId":416,"keName":"Increase proliferation, Leydig cell "},{"keId":414,"keName":"Increase, Luteinizing hormone (LH) "}],"status":"Under Development","reference":"https://aopwiki.org/aops/51"}
{"aopId":51,"aopName":"PPARα activation leading to impaired fertility in adult male rodents ","aoId":406,"keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":415,"keName":"Hyperplasia, Leydig cell"},{"keId":416,"keName":"Increase proliferation, Leydig cell "},{"keId":414,"keName":"Increase, Luteinizing hormone (LH) "}],"status":"Under Development","reference":"https://aopwiki.org/aops/51"}
{"aopId":51,"aopName":"PPARα activation leading to impaired fertility in adult male rodents ","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":415,"keName":"Hyperplasia, Leydig cell"},{"keId":416,"keName":"Increase proliferation, Leydig cell "},{"keId":414,"keName":"Increase, Luteinizing hormone (LH) "}],"status":"Under Development","reference":"https://aopwiki.org/aops/51"}
{"aopId":51,"aopName":"PPARα activation leading to impaired fertility in adult male rodents ","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":447,"keName":"Reduction, Cholesterol transport in mitochondria"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":406,"keName":"impaired, Fertility"},{"keId":227,"keName":"Activation, PPARα"},{"keId":415,"keName":"Hyperplasia, Leydig cell"},{"keId":416,"keName":"Increase proliferation, Leydig cell "},{"keId":414,"keName":"Increase, Luteinizing hormone (LH) "}],"status":"Under Development","reference":"https://aopwiki.org/aops/51"}
{"aopId":52,"aopName":"ER agonism leading to skewed sex ratios due to altered sexual differentiation in males","aoId":417,"aoName":"skewed sex ratio","aoNameRaw":"skewed, sex ratio","keyEvents":[{"keId":111,"keName":"Agonism, Estrogen receptor"},{"keId":417,"keName":"skewed, sex ratio"}],"reference":"https://aopwiki.org/aops/52"}
{"aopId":52,"aopName":"ER agonism leading to skewed sex ratios due to altered sexual differentiation in males","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":417,"aoName":"skewed sex ratio","aoNameRaw":"skewed, sex ratio","keyEvents":[{"keId":111,"keName":"Agonism, Estrogen receptor"},{"keId":417,"keName":"skewed, sex ratio"}],"reference":"https://aopwiki.org/aops/52"}
{"aopId":54,"aopName":"Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment ","targetName":"brain-derived neurotrophic factor","targetId":"ENSG00000176697","aoId":341,"keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":851,"keName":"Decrease of GABAergic interneurons"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":425,"keName":"Decrease of Thyroidal iodide"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":385,"keName":"Decrease of synaptogenesis"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/54"}
{"aopId":54,"aopName":"Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment ","targetName":"sodium/iodide cotransporter","targetId":"ENSG00000105641","aoId":341,"keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":851,"keName":"Decrease of GABAergic interneurons"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":425,"keName":"Decrease of Thyroidal iodide"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":385,"keName":"Decrease of synaptogenesis"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/54"}
{"aopId":54,"aopName":"Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment ","aoId":341,"keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":851,"keName":"Decrease of GABAergic interneurons"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":425,"keName":"Decrease of Thyroidal iodide"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":385,"keName":"Decrease of synaptogenesis"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/54"}
{"aopId":54,"aopName":"Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment ","targetName":"brain-derived neurotrophic factor","targetId":"ENSG00000176697","aoId":341,"aoName":"Impairment Learning and memory","aoNameRaw":"Impairment, Learning and memory","keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":851,"keName":"Decrease of GABAergic interneurons"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":425,"keName":"Decrease of Thyroidal iodide"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":385,"keName":"Decrease of synaptogenesis"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/54"}
{"aopId":54,"aopName":"Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment ","targetName":"sodium/iodide cotransporter","targetId":"ENSG00000105641","aoId":341,"aoName":"Impairment Learning and memory","aoNameRaw":"Impairment, Learning and memory","keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":851,"keName":"Decrease of GABAergic interneurons"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":425,"keName":"Decrease of Thyroidal iodide"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":385,"keName":"Decrease of synaptogenesis"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/54"}
{"aopId":54,"aopName":"Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment ","aoId":341,"aoName":"Impairment Learning and memory","aoNameRaw":"Impairment, Learning and memory","keyEvents":[{"keId":381,"keName":"Reduced levels of BDNF"},{"keId":851,"keName":"Decrease of GABAergic interneurons"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":386,"keName":"Decrease of neuronal network function"},{"keId":425,"keName":"Decrease of Thyroidal iodide"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":385,"keName":"Decrease of synaptogenesis"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/54"}
{"aopId":57,"aopName":"AhR activation leading to hepatic steatosis","targetName":"phosphoenolpyruvate carboxykinase, cytosolic [GTP]","targetId":"ENSG00000124253","aoId":455,"aoName":"Accumulation Liver lipid","aoNameRaw":"Accumulation, Liver lipid","keyEvents":[{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":467,"keName":"Increased, LDL uptake"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":466,"keName":"Up Regulation, LDLR (low density lipoprotein receptor)"},{"keId":80,"keName":"Up Regulation, CYP1A1"},{"keId":455,"keName":"Accumulation, Liver lipid"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":450,"keName":"Suppression, VLDL secretion"},{"keId":216,"keName":"Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway)"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/57"}
{"aopId":57,"aopName":"AhR activation leading to hepatic steatosis","targetName":"platelet glycoprotein 4","targetId":"ENSG00000135218","aoId":455,"aoName":"Accumulation Liver lipid","aoNameRaw":"Accumulation, Liver lipid","keyEvents":[{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":467,"keName":"Increased, LDL uptake"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":466,"keName":"Up Regulation, LDLR (low density lipoprotein receptor)"},{"keId":80,"keName":"Up Regulation, CYP1A1"},{"keId":455,"keName":"Accumulation, Liver lipid"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":450,"keName":"Suppression, VLDL secretion"},{"keId":216,"keName":"Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway)"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/57"}
{"aopId":57,"aopName":"AhR activation leading to hepatic steatosis","targetName":"low-density lipoprotein receptor","targetId":"ENSG00000130164","aoId":455,"aoName":"Accumulation Liver lipid","aoNameRaw":"Accumulation, Liver lipid","keyEvents":[{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":467,"keName":"Increased, LDL uptake"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":466,"keName":"Up Regulation, LDLR (low density lipoprotein receptor)"},{"keId":80,"keName":"Up Regulation, CYP1A1"},{"keId":455,"keName":"Accumulation, Liver lipid"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":450,"keName":"Suppression, VLDL secretion"},{"keId":216,"keName":"Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway)"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/57"}
{"aopId":57,"aopName":"AhR activation leading to hepatic steatosis","targetName":"acyl-CoA desaturase","targetId":"ENSG00000099194","aoId":455,"aoName":"Accumulation Liver lipid","aoNameRaw":"Accumulation, Liver lipid","keyEvents":[{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":467,"keName":"Increased, LDL uptake"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":466,"keName":"Up Regulation, LDLR (low density lipoprotein receptor)"},{"keId":80,"keName":"Up Regulation, CYP1A1"},{"keId":455,"keName":"Accumulation, Liver lipid"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":450,"keName":"Suppression, VLDL secretion"},{"keId":216,"keName":"Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway)"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/57"}
{"aopId":57,"aopName":"AhR activation leading to hepatic steatosis","aoId":455,"aoName":"Accumulation Liver lipid","aoNameRaw":"Accumulation, Liver lipid","keyEvents":[{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":467,"keName":"Increased, LDL uptake"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":466,"keName":"Up Regulation, LDLR (low density lipoprotein receptor)"},{"keId":80,"keName":"Up Regulation, CYP1A1"},{"keId":455,"keName":"Accumulation, Liver lipid"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":450,"keName":"Suppression, VLDL secretion"},{"keId":216,"keName":"Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway)"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/57"}
{"aopId":57,"aopName":"AhR activation leading to hepatic steatosis","targetName":"aryl hydrocarbon receptor","targetId":"ENSG00000106546","aoId":455,"aoName":"Accumulation Liver lipid","aoNameRaw":"Accumulation, Liver lipid","keyEvents":[{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":467,"keName":"Increased, LDL uptake"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":466,"keName":"Up Regulation, LDLR (low density lipoprotein receptor)"},{"keId":80,"keName":"Up Regulation, CYP1A1"},{"keId":455,"keName":"Accumulation, Liver lipid"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":450,"keName":"Suppression, VLDL secretion"},{"keId":216,"keName":"Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway)"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/57"}
{"aopId":57,"aopName":"AhR activation leading to hepatic steatosis","targetName":"cytochrome P450 1A1","targetId":"ENSG00000140465","aoId":455,"aoName":"Accumulation Liver lipid","aoNameRaw":"Accumulation, Liver lipid","keyEvents":[{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":467,"keName":"Increased, LDL uptake"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":466,"keName":"Up Regulation, LDLR (low density lipoprotein receptor)"},{"keId":80,"keName":"Up Regulation, CYP1A1"},{"keId":455,"keName":"Accumulation, Liver lipid"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":450,"keName":"Suppression, VLDL secretion"},{"keId":216,"keName":"Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway)"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/57"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"acetyl-CoA carboxylase 1","targetId":"ENSG00000278540","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"fatty acid synthase","targetId":"ENSG00000169710","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"sterol regulatory element-binding protein 1","targetId":"ENSG00000072310","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"platelet glycoprotein 4","targetId":"ENSG00000135218","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"acyl-CoA desaturase","targetId":"ENSG00000099194","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"peroxisome proliferator-activated receptor gamma","targetId":"ENSG00000132170","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"carbohydrate-responsive element-binding protein","targetId":"ENSG00000009950","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"nuclear receptor subfamily 1 group I member 3","targetId":"ENSG00000143257","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"oxysterols receptor LXR-alpha","targetId":"ENSG00000025434","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"oxysterols receptor LXR-beta","targetId":"ENSG00000131408","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","aoId":459,"keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"acetyl-CoA carboxylase 1","targetId":"ENSG00000278540","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"fatty acid synthase","targetId":"ENSG00000169710","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"sterol regulatory element-binding protein 1","targetId":"ENSG00000072310","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"platelet glycoprotein 4","targetId":"ENSG00000135218","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"acyl-CoA desaturase","targetId":"ENSG00000099194","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"peroxisome proliferator-activated receptor gamma","targetId":"ENSG00000132170","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"carbohydrate-responsive element-binding protein","targetId":"ENSG00000009950","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"nuclear receptor subfamily 1 group I member 3","targetId":"ENSG00000143257","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"oxysterols receptor LXR-alpha","targetId":"ENSG00000025434","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","targetName":"oxysterols receptor LXR-beta","targetId":"ENSG00000131408","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":58,"aopName":"NR1I3 (CAR) suppression leading to hepatic steatosis","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":456,"keName":"Suppression, Constitutive androstane receptor, NR1l3"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":470,"keName":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)"},{"keId":167,"keName":"Activation, LXR"},{"keId":468,"keName":"Inhibition, PPAR alpha"},{"keId":463,"keName":"Up Regulation, FAS"},{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":66,"keName":"Activation, ChREBP"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/58"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"platelet glycoprotein 4","targetId":"ENSG00000135218","aoId":459,"keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"carnitine O-palmitoyltransferase 1, liver isoform","targetId":"ENSG00000110090","aoId":459,"keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"hydroxymethylglutaryl-CoA synthase, mitochondrial","targetId":"ENSG00000134240","aoId":459,"keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"hepatocyte nuclear factor 3-beta","targetId":"ENSG00000125798","aoId":459,"keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","aoId":459,"keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"nuclear receptor subfamily 1 group I member 2","targetId":"ENSG00000144852","aoId":459,"keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"acyl-CoA desaturase","targetId":"ENSG00000099194","aoId":459,"keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"platelet glycoprotein 4","targetId":"ENSG00000135218","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"carnitine O-palmitoyltransferase 1, liver isoform","targetId":"ENSG00000110090","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"hydroxymethylglutaryl-CoA synthase, mitochondrial","targetId":"ENSG00000134240","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"hepatocyte nuclear factor 3-beta","targetId":"ENSG00000125798","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"nuclear receptor subfamily 1 group I member 2","targetId":"ENSG00000144852","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":60,"aopName":"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis","targetName":"acyl-CoA desaturase","targetId":"ENSG00000099194","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":454,"keName":"Increased, Triglyceride formation"},{"keId":327,"keName":"Accumulation, Fatty acid"},{"keId":462,"keName":"Up Regulation, SCD-1"},{"keId":54,"keName":"Up Regulation, CD36"},{"keId":179,"keName":"Decreased, Mitochondrial fatty acid beta-oxidation"},{"keId":472,"keName":"Down Regulation, CPT1A"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":465,"keName":"Increased, FA Influx"},{"keId":474,"keName":"Down Regulation, HMGCS2"},{"keId":245,"keName":"Activation, PXR/SXR"},{"keId":471,"keName":"Inhibition, FoxA2"},{"keId":477,"keName":"Decreased, Ketogenesis"}],"reference":"https://aopwiki.org/aops/60"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":459,"keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"microsomal triglyceride transfer protein large subunit MTTP","aoId":459,"keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"17-beta-hydroxysteroid dehydrogenase 14","targetId":"ENSG00000087076","aoId":459,"keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"oxysterols receptor LXR-alpha","targetId":"ENSG00000025434","aoId":459,"keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"apolipoprotein B-100","targetId":"ENSG00000084674","aoId":459,"keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"nuclear factor erythroid 2-related factor 2","targetId":"ENSG00000116044","aoId":459,"keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"nuclear receptor subfamily 0 group B member 2","targetId":"ENSG00000131910","aoId":459,"keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"sterol regulatory element-binding protein 1","targetId":"ENSG00000072310","aoId":459,"keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"bile acid receptor","targetId":"ENSG00000012504","aoId":459,"keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","aoId":459,"keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"microsomal triglyceride transfer protein large subunit MTTP","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"17-beta-hydroxysteroid dehydrogenase 14","targetId":"ENSG00000087076","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"oxysterols receptor LXR-alpha","targetId":"ENSG00000025434","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"apolipoprotein B-100","targetId":"ENSG00000084674","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"nuclear factor erythroid 2-related factor 2","targetId":"ENSG00000116044","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"nuclear receptor subfamily 0 group B member 2","targetId":"ENSG00000131910","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"sterol regulatory element-binding protein 1","targetId":"ENSG00000072310","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","targetName":"bile acid receptor","targetId":"ENSG00000012504","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":61,"aopName":"NFE2L2/FXR activation leading to hepatic steatosis","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":879,"keName":"Activation, MTTP"},{"keId":451,"keName":"Inhibition, Mitochondrial fatty acid beta-oxidation"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":227,"keName":"Activation, PPARα"},{"keId":483,"keName":"Activation, LXR alpha"},{"keId":878,"keName":"Inhibition, SREBP1c"},{"keId":478,"keName":"Activation, NRF2"},{"keId":881,"keName":"Increased, Triglyceride"},{"keId":458,"keName":"Increased, De Novo FA synthesis"},{"keId":479,"keName":"Activation, NR1H4"},{"keId":880,"keName":"Increased, ApoB100"},{"keId":480,"keName":"Activation, SHP"},{"keId":482,"keName":"Decreased, DHB4/HSD17B4"}],"reference":"https://aopwiki.org/aops/61"}
{"aopId":62,"aopName":"AKT2 activation leading to hepatic steatosis","targetName":"sterol regulatory element-binding protein 1","targetId":"ENSG00000072310","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":486,"keName":"systemic inflammation leading to hepatic steatosis"},{"keId":484,"keName":"Activation, AKT2"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/62"}
{"aopId":62,"aopName":"AKT2 activation leading to hepatic steatosis","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":486,"keName":"systemic inflammation leading to hepatic steatosis"},{"keId":484,"keName":"Activation, AKT2"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/62"}
{"aopId":62,"aopName":"AKT2 activation leading to hepatic steatosis","targetName":"RAC-beta serine/threonine-protein kinase","targetId":"ENSG00000105221","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":486,"keName":"systemic inflammation leading to hepatic steatosis"},{"keId":484,"keName":"Activation, AKT2"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/62"}
{"aopId":62,"aopName":"AKT2 activation leading to hepatic steatosis","targetName":"sterol regulatory element-binding protein 1","targetId":"ENSG00000072310","aoId":459,"keyEvents":[{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":486,"keName":"systemic inflammation leading to hepatic steatosis"},{"keId":484,"keName":"Activation, AKT2"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/62"}
{"aopId":62,"aopName":"AKT2 activation leading to hepatic steatosis","aoId":459,"keyEvents":[{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":486,"keName":"systemic inflammation leading to hepatic steatosis"},{"keId":484,"keName":"Activation, AKT2"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/62"}
{"aopId":62,"aopName":"AKT2 activation leading to hepatic steatosis","targetName":"RAC-beta serine/threonine-protein kinase","targetId":"ENSG00000105221","aoId":459,"keyEvents":[{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":486,"keName":"systemic inflammation leading to hepatic steatosis"},{"keId":484,"keName":"Activation, AKT2"},{"keId":457,"keName":"Activation, SREBF1"}],"reference":"https://aopwiki.org/aops/62"}
{"aopId":63,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":685,"keName":"Reduced, Prostaglandins, ovary"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":488,"keName":"Decrease, Ovulation"}],"reference":"https://aopwiki.org/aops/63"}
{"aopId":63,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":685,"keName":"Reduced, Prostaglandins, ovary"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":488,"keName":"Decrease, Ovulation"}],"reference":"https://aopwiki.org/aops/63"}
{"aopId":63,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction","targetName":"prostaglandin G/H synthase 2","targetId":"ENSG00000073756","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":685,"keName":"Reduced, Prostaglandins, ovary"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":488,"keName":"Decrease, Ovulation"}],"reference":"https://aopwiki.org/aops/63"}
{"aopId":63,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":685,"keName":"Reduced, Prostaglandins, ovary"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":488,"keName":"Decrease, Ovulation"}],"reference":"https://aopwiki.org/aops/63"}
{"aopId":63,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":685,"keName":"Reduced, Prostaglandins, ovary"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":488,"keName":"Decrease, Ovulation"}],"reference":"https://aopwiki.org/aops/63"}
{"aopId":63,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction","targetName":"prostaglandin G/H synthase 2","targetId":"ENSG00000073756","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":685,"keName":"Reduced, Prostaglandins, ovary"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":488,"keName":"Decrease, Ovulation"}],"reference":"https://aopwiki.org/aops/63"}
{"aopId":64,"aopName":"Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":496,"keName":"Increased apoptosis, decreased number of adult Leydig Cells "},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":494,"keName":"Glucocorticoid Receptor Agonist, Activation"},{"keId":406,"keName":"impaired, Fertility"},{"keId":495,"keName":"Repressed expression of steroidogenic enzymes "},{"keId":520,"keName":"Decreased sperm quantity or quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/64"}
{"aopId":64,"aopName":"Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":406,"aoName":"impaired Fertility","aoNameRaw":"impaired, Fertility","keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":496,"keName":"Increased apoptosis, decreased number of adult Leydig Cells "},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":494,"keName":"Glucocorticoid Receptor Agonist, Activation"},{"keId":406,"keName":"impaired, Fertility"},{"keId":495,"keName":"Repressed expression of steroidogenic enzymes "},{"keId":520,"keName":"Decreased sperm quantity or quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/64"}
{"aopId":64,"aopName":"Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility","aoId":406,"keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":496,"keName":"Increased apoptosis, decreased number of adult Leydig Cells "},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":494,"keName":"Glucocorticoid Receptor Agonist, Activation"},{"keId":406,"keName":"impaired, Fertility"},{"keId":495,"keName":"Repressed expression of steroidogenic enzymes "},{"keId":520,"keName":"Decreased sperm quantity or quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/64"}
{"aopId":64,"aopName":"Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":406,"keyEvents":[{"keId":446,"keName":"Reduction, testosterone level"},{"keId":496,"keName":"Increased apoptosis, decreased number of adult Leydig Cells "},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":494,"keName":"Glucocorticoid Receptor Agonist, Activation"},{"keId":406,"keName":"impaired, Fertility"},{"keId":495,"keName":"Repressed expression of steroidogenic enzymes "},{"keId":520,"keName":"Decreased sperm quantity or quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/64"}
{"aopId":65,"aopName":"XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","targetName":"sodium/iodide cotransporter","targetId":"ENSG00000105641","aoId":402,"aoName":"Cognitive Function Decreased","aoNameRaw":"Cognitive Function, Decreased ","keyEvents":[{"keId":186,"keName":"Altered, Neuroanatomy"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":402,"keName":"Cognitive Function, Decreased "},{"keId":192,"keName":"Altered, Neurophysiology"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "}],"reference":"https://aopwiki.org/aops/65"}
{"aopId":65,"aopName":"XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","aoId":402,"aoName":"Cognitive Function Decreased","aoNameRaw":"Cognitive Function, Decreased ","keyEvents":[{"keId":186,"keName":"Altered, Neuroanatomy"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":402,"keName":"Cognitive Function, Decreased "},{"keId":192,"keName":"Altered, Neurophysiology"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "}],"reference":"https://aopwiki.org/aops/65"}
{"aopId":66,"aopName":"Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":505,"aoName":"Decreased sperm quantity / quality in the adult Decreased fertility","aoNameRaw":"Decreased sperm quantity / quality in the adult, Decreased fertility ","keyEvents":[{"keId":656,"keName":"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells"},{"keId":653,"keName":"Decreased testosterone by the fetal Leydig cells, Increased corticosterone"},{"keId":655,"keName":"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"},{"keId":657,"keName":"Decreased testosterone by the fetal Leydig cells, Dysgenesis of fetal Leydig cells"},{"keId":654,"keName":"Decreased testosterone by the fetal Leydig cells, Activation by other glucocorticoid receptor agonists"},{"keId":505,"keName":"Decreased sperm quantity / quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/66"}
{"aopId":66,"aopName":"Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis","targetName":"COUP transcription factor 2","targetId":"ENSG00000185551","aoId":505,"aoName":"Decreased sperm quantity / quality in the adult Decreased fertility","aoNameRaw":"Decreased sperm quantity / quality in the adult, Decreased fertility ","keyEvents":[{"keId":656,"keName":"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells"},{"keId":653,"keName":"Decreased testosterone by the fetal Leydig cells, Increased corticosterone"},{"keId":655,"keName":"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"},{"keId":657,"keName":"Decreased testosterone by the fetal Leydig cells, Dysgenesis of fetal Leydig cells"},{"keId":654,"keName":"Decreased testosterone by the fetal Leydig cells, Activation by other glucocorticoid receptor agonists"},{"keId":505,"keName":"Decreased sperm quantity / quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/66"}
{"aopId":66,"aopName":"Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis","aoId":505,"aoName":"Decreased sperm quantity / quality in the adult Decreased fertility","aoNameRaw":"Decreased sperm quantity / quality in the adult, Decreased fertility ","keyEvents":[{"keId":656,"keName":"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells"},{"keId":653,"keName":"Decreased testosterone by the fetal Leydig cells, Increased corticosterone"},{"keId":655,"keName":"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"},{"keId":657,"keName":"Decreased testosterone by the fetal Leydig cells, Dysgenesis of fetal Leydig cells"},{"keId":654,"keName":"Decreased testosterone by the fetal Leydig cells, Activation by other glucocorticoid receptor agonists"},{"keId":505,"keName":"Decreased sperm quantity / quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/66"}
{"aopId":67,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis","targetName":"COUP transcription factor 2","targetId":"ENSG00000185551","aoId":505,"aoName":"Decreased sperm quantity / quality in the adult Decreased fertility","aoNameRaw":"Decreased sperm quantity / quality in the adult, Decreased fertility ","keyEvents":[{"keId":656,"keName":"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells"},{"keId":659,"keName":"Decreased testosterone by the fetal Leydig cells, Activation by other estradiol agonists"},{"keId":658,"keName":"Decreased testosterone by the fetal Leydig cells, Increased estradiol"},{"keId":655,"keName":"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"},{"keId":505,"keName":"Decreased sperm quantity / quality in the adult, Decreased fertility "},{"keId":660,"keName":"decreased testosterone by fetal Leydig cells, Dysgenesis of fetal Leydig cells"}],"reference":"https://aopwiki.org/aops/67"}
{"aopId":67,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis","aoId":505,"aoName":"Decreased sperm quantity / quality in the adult Decreased fertility","aoNameRaw":"Decreased sperm quantity / quality in the adult, Decreased fertility ","keyEvents":[{"keId":656,"keName":"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells"},{"keId":659,"keName":"Decreased testosterone by the fetal Leydig cells, Activation by other estradiol agonists"},{"keId":658,"keName":"Decreased testosterone by the fetal Leydig cells, Increased estradiol"},{"keId":655,"keName":"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"},{"keId":505,"keName":"Decreased sperm quantity / quality in the adult, Decreased fertility "},{"keId":660,"keName":"decreased testosterone by fetal Leydig cells, Dysgenesis of fetal Leydig cells"}],"reference":"https://aopwiki.org/aops/67"}
{"aopId":67,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":505,"aoName":"Decreased sperm quantity / quality in the adult Decreased fertility","aoNameRaw":"Decreased sperm quantity / quality in the adult, Decreased fertility ","keyEvents":[{"keId":656,"keName":"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells"},{"keId":659,"keName":"Decreased testosterone by the fetal Leydig cells, Activation by other estradiol agonists"},{"keId":658,"keName":"Decreased testosterone by the fetal Leydig cells, Increased estradiol"},{"keId":655,"keName":"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"},{"keId":505,"keName":"Decreased sperm quantity / quality in the adult, Decreased fertility "},{"keId":660,"keName":"decreased testosterone by fetal Leydig cells, Dysgenesis of fetal Leydig cells"}],"reference":"https://aopwiki.org/aops/67"}
{"aopId":68,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Alterations in the Fetal Testis Protome","aoId":505,"aoName":"Decreased sperm quantity / quality in the adult Decreased fertility","aoNameRaw":"Decreased sperm quantity / quality in the adult, Decreased fertility ","keyEvents":[{"keId":656,"keName":"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells"},{"keId":655,"keName":"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"},{"keId":657,"keName":"Decreased testosterone by the fetal Leydig cells, Dysgenesis of fetal Leydig cells"},{"keId":661,"keName":"Decreased testosterone by the fetal Leydig cells, Alterations in the fetal testis proteome"},{"keId":505,"keName":"Decreased sperm quantity / quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/68"}
{"aopId":68,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Alterations in the Fetal Testis Protome","targetName":"COUP transcription factor 2","targetId":"ENSG00000185551","aoId":505,"aoName":"Decreased sperm quantity / quality in the adult Decreased fertility","aoNameRaw":"Decreased sperm quantity / quality in the adult, Decreased fertility ","keyEvents":[{"keId":656,"keName":"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells"},{"keId":655,"keName":"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"},{"keId":657,"keName":"Decreased testosterone by the fetal Leydig cells, Dysgenesis of fetal Leydig cells"},{"keId":661,"keName":"Decreased testosterone by the fetal Leydig cells, Alterations in the fetal testis proteome"},{"keId":505,"keName":"Decreased sperm quantity / quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/68"}
{"aopId":69,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell","aoId":646,"aoName":"Decreased Cholesterol Decreased sperm quantity and/or quality in the adult testis","aoNameRaw":"Decreased Cholesterol, Decreased sperm quantity and/or quality in the adult testis","keyEvents":[{"keId":645,"keName":"Decreased Cholesterol, Decreased Testosterone Production by Adult Leydig Cells"},{"keId":646,"keName":"Decreased Cholesterol, Decreased sperm quantity and/or quality in the adult testis"},{"keId":642,"keName":"Decreased Cholesterol, Decreased De Novo Biosynthesis of Choleseterol"},{"keId":644,"keName":"Decreased Cholesterol, Decreased Transport of Cholesterol to the Inner Mitochondrial Membrane"},{"keId":643,"keName":"Decreased Cholesterol, Decreased Uptake of Lipoproteins"}],"reference":"https://aopwiki.org/aops/69"}
{"aopId":70,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell","aoId":520,"aoName":"Decreased sperm quantity or quality in the adult Decreased fertility","aoNameRaw":"Decreased sperm quantity or quality in the adult, Decreased fertility ","keyEvents":[{"keId":647,"keName":"Decreased steroidogenesis, Decreased Activity of Steroidogenic Enzymes in Adult Leydig cells"},{"keId":640,"keName":"Decreased steroidogenesis, Proteomic alterations in the adult Leydig cell"},{"keId":649,"keName":"Decreased steroidogenesis, Alterations in the Leydig Cell Cytoskeleton"},{"keId":520,"keName":"Decreased sperm quantity or quality in the adult, Decreased fertility "},{"keId":648,"keName":"Decreased steroidogenesis, Increased Apoptosis of Adult Leydig Cells"}],"reference":"https://aopwiki.org/aops/70"}
{"aopId":70,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell","aoId":520,"keyEvents":[{"keId":647,"keName":"Decreased steroidogenesis, Decreased Activity of Steroidogenic Enzymes in Adult Leydig cells"},{"keId":640,"keName":"Decreased steroidogenesis, Proteomic alterations in the adult Leydig cell"},{"keId":649,"keName":"Decreased steroidogenesis, Alterations in the Leydig Cell Cytoskeleton"},{"keId":520,"keName":"Decreased sperm quantity or quality in the adult, Decreased fertility "},{"keId":648,"keName":"Decreased steroidogenesis, Increased Apoptosis of Adult Leydig Cells"}],"reference":"https://aopwiki.org/aops/70"}
{"aopId":71,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":520,"aoName":"Decreased sperm quantity or quality in the adult Decreased fertility","aoNameRaw":"Decreased sperm quantity or quality in the adult, Decreased fertility ","keyEvents":[{"keId":652,"keName":"Direct effects of Corticosterone on steroidogenesis, Decreased testosterone by adult Leydig cells"},{"keId":525,"keName":"Apoptosis of adult Leydig cells, Decreased testosterone by adult Leydig cells"},{"keId":651,"keName":"Glucocorticoid Receptor mediated alterations in steriodogenic enzymes, Decreased testosterone by adult Leydig cells"},{"keId":650,"keName":"Stimulation of adult Leydig cells via the Adrenal Corticosterone, Increased Glucocorticoid"},{"keId":520,"keName":"Decreased sperm quantity or quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/71"}
{"aopId":71,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation","aoId":520,"aoName":"Decreased sperm quantity or quality in the adult Decreased fertility","aoNameRaw":"Decreased sperm quantity or quality in the adult, Decreased fertility ","keyEvents":[{"keId":652,"keName":"Direct effects of Corticosterone on steroidogenesis, Decreased testosterone by adult Leydig cells"},{"keId":525,"keName":"Apoptosis of adult Leydig cells, Decreased testosterone by adult Leydig cells"},{"keId":651,"keName":"Glucocorticoid Receptor mediated alterations in steriodogenic enzymes, Decreased testosterone by adult Leydig cells"},{"keId":650,"keName":"Stimulation of adult Leydig cells via the Adrenal Corticosterone, Increased Glucocorticoid"},{"keId":520,"keName":"Decreased sperm quantity or quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/71"}
{"aopId":71,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":520,"keyEvents":[{"keId":652,"keName":"Direct effects of Corticosterone on steroidogenesis, Decreased testosterone by adult Leydig cells"},{"keId":525,"keName":"Apoptosis of adult Leydig cells, Decreased testosterone by adult Leydig cells"},{"keId":651,"keName":"Glucocorticoid Receptor mediated alterations in steriodogenic enzymes, Decreased testosterone by adult Leydig cells"},{"keId":650,"keName":"Stimulation of adult Leydig cells via the Adrenal Corticosterone, Increased Glucocorticoid"},{"keId":520,"keName":"Decreased sperm quantity or quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/71"}
{"aopId":71,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation","aoId":520,"keyEvents":[{"keId":652,"keName":"Direct effects of Corticosterone on steroidogenesis, Decreased testosterone by adult Leydig cells"},{"keId":525,"keName":"Apoptosis of adult Leydig cells, Decreased testosterone by adult Leydig cells"},{"keId":651,"keName":"Glucocorticoid Receptor mediated alterations in steriodogenic enzymes, Decreased testosterone by adult Leydig cells"},{"keId":650,"keName":"Stimulation of adult Leydig cells via the Adrenal Corticosterone, Increased Glucocorticoid"},{"keId":520,"keName":"Decreased sperm quantity or quality in the adult, Decreased fertility "}],"reference":"https://aopwiki.org/aops/71"}
{"aopId":72,"aopName":"Epigenetic modification of PPARG leading to adipogenesis","targetName":"peroxisome proliferator-activated receptor gamma","targetId":"ENSG00000132170","aoId":1447,"aoName":"obesity","aoNameRaw":"obesity","aoMappedId":"EFO_0001073","keyEvents":[{"keId":1447,"keName":"obesity"},{"keId":1448,"keName":"activation of CCAAT/enhancer-binding protein alpha"},{"keId":1451,"keName":"decreased reward"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":1452,"keName":"decreased DNA methylation of tyrosine hydroxylase"},{"keId":1449,"keName":"increased adipogenesis"},{"keId":1450,"keName":"decreased dopamine"},{"keId":1453,"keName":"decreased methylation of dopamine transporter promoter"},{"keId":1454,"keName":"chronic high fat diet"},{"keId":1028,"keName":"Activation of specific nuclear receptors, PPAR-gamma activation"}],"reference":"https://aopwiki.org/aops/72"}
{"aopId":72,"aopName":"Epigenetic modification of PPARG leading to adipogenesis","aoId":1447,"aoName":"obesity","aoNameRaw":"obesity","aoMappedId":"EFO_0001073","keyEvents":[{"keId":1447,"keName":"obesity"},{"keId":1448,"keName":"activation of CCAAT/enhancer-binding protein alpha"},{"keId":1451,"keName":"decreased reward"},{"keId":228,"keName":"peroxisome proliferator activated receptor promoter demethylation"},{"keId":1452,"keName":"decreased DNA methylation of tyrosine hydroxylase"},{"keId":1449,"keName":"increased adipogenesis"},{"keId":1450,"keName":"decreased dopamine"},{"keId":1453,"keName":"decreased methylation of dopamine transporter promoter"},{"keId":1454,"keName":"chronic high fat diet"},{"keId":1028,"keName":"Activation of specific nuclear receptors, PPAR-gamma activation"}],"reference":"https://aopwiki.org/aops/72"}
{"aopId":73,"aopName":"Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity","targetName":"proto-oncogene c-Fos (mouse)","aoId":527,"aoName":"Decreased Decreased fecundity","aoNameRaw":"Decreased, Decreased fecundity ","keyEvents":[{"keId":526,"keName":"Inhibition, Inhibition of Dopamine-beta-hydroxylase"},{"keId":532,"keName":"Delayed, Ovulation"},{"keId":533,"keName":"Decreased, Cortical granule release/distribution upon fertilization"},{"keId":527,"keName":"Decreased, Decreased fecundity "},{"keId":528,"keName":"Decreased, Synthesis of NE"},{"keId":534,"keName":"Altered, Formation of cortical envelope"},{"keId":536,"keName":"Altered, Chromosome number (polyploid) zygote"},{"keId":530,"keName":"Decreased, GnRH pulsatility/release"},{"keId":529,"keName":"Decreased, GnRH cfos activity"},{"keId":531,"keName":"Decreased, LH Surge"},{"keId":535,"keName":"Abnormal, Sperm penetration (polyspermy)"}],"reference":"https://aopwiki.org/aops/73"}
{"aopId":73,"aopName":"Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity","targetName":"dopamine beta-hydroxylase","targetId":"ENSG00000123454","aoId":527,"aoName":"Decreased Decreased fecundity","aoNameRaw":"Decreased, Decreased fecundity ","keyEvents":[{"keId":526,"keName":"Inhibition, Inhibition of Dopamine-beta-hydroxylase"},{"keId":532,"keName":"Delayed, Ovulation"},{"keId":533,"keName":"Decreased, Cortical granule release/distribution upon fertilization"},{"keId":527,"keName":"Decreased, Decreased fecundity "},{"keId":528,"keName":"Decreased, Synthesis of NE"},{"keId":534,"keName":"Altered, Formation of cortical envelope"},{"keId":536,"keName":"Altered, Chromosome number (polyploid) zygote"},{"keId":530,"keName":"Decreased, GnRH pulsatility/release"},{"keId":529,"keName":"Decreased, GnRH cfos activity"},{"keId":531,"keName":"Decreased, LH Surge"},{"keId":535,"keName":"Abnormal, Sperm penetration (polyspermy)"}],"reference":"https://aopwiki.org/aops/73"}
{"aopId":73,"aopName":"Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity","aoId":527,"aoName":"Decreased Decreased fecundity","aoNameRaw":"Decreased, Decreased fecundity ","keyEvents":[{"keId":526,"keName":"Inhibition, Inhibition of Dopamine-beta-hydroxylase"},{"keId":532,"keName":"Delayed, Ovulation"},{"keId":533,"keName":"Decreased, Cortical granule release/distribution upon fertilization"},{"keId":527,"keName":"Decreased, Decreased fecundity "},{"keId":528,"keName":"Decreased, Synthesis of NE"},{"keId":534,"keName":"Altered, Formation of cortical envelope"},{"keId":536,"keName":"Altered, Chromosome number (polyploid) zygote"},{"keId":530,"keName":"Decreased, GnRH pulsatility/release"},{"keId":529,"keName":"Decreased, GnRH cfos activity"},{"keId":531,"keName":"Decreased, LH Surge"},{"keId":535,"keName":"Abnormal, Sperm penetration (polyspermy)"}],"reference":"https://aopwiki.org/aops/73"}
{"aopId":74,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis","targetName":"COUP transcription factor 2","targetId":"ENSG00000185551","aoId":543,"aoName":"Decreased fertility in the adult Decreased sperm quantity and/or quality in the adult testis","aoNameRaw":"Decreased fertility in the adult, Decreased sperm quantity and/or quality in the adult testis","keyEvents":[{"keId":541,"keName":"Decreased testosterone by the fetal Leydig cells, Decreased COUP-TFII stem Leydig cells"},{"keId":540,"keName":"Decreased testosterone by the fetal Leydig cells, Dysgensis of fetal Leydig cells"},{"keId":655,"keName":"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"},{"keId":543,"keName":"Decreased fertility in the adult, Decreased sperm quantity and/or quality in the adult testis"},{"keId":662,"keName":"Decreased testosterone by the fetal Leydig cells, Hypermethylation in the fetal testis"}],"reference":"https://aopwiki.org/aops/74"}
{"aopId":74,"aopName":"Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis","aoId":543,"aoName":"Decreased fertility in the adult Decreased sperm quantity and/or quality in the adult testis","aoNameRaw":"Decreased fertility in the adult, Decreased sperm quantity and/or quality in the adult testis","keyEvents":[{"keId":541,"keName":"Decreased testosterone by the fetal Leydig cells, Decreased COUP-TFII stem Leydig cells"},{"keId":540,"keName":"Decreased testosterone by the fetal Leydig cells, Dysgensis of fetal Leydig cells"},{"keId":655,"keName":"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells"},{"keId":543,"keName":"Decreased fertility in the adult, Decreased sperm quantity and/or quality in the adult testis"},{"keId":662,"keName":"Decreased testosterone by the fetal Leydig cells, Hypermethylation in the fetal testis"}],"reference":"https://aopwiki.org/aops/74"}
{"aopId":77,"aopName":"Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony death/failure 1","targetName":"calmodulin","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":1243,"keName":"Altered, Ca2+-calmodulin activated signal transduction"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/77"}
{"aopId":77,"aopName":"Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony death/failure 1","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":1243,"keName":"Altered, Ca2+-calmodulin activated signal transduction"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/77"}
{"aopId":78,"aopName":"Nicotinic acetylcholine receptor activation contributes to abnormal role change within the worker bee caste leading to colony death failure 1","aoId":566,"aoName":"impaired Larval development","aoNameRaw":"impaired, Larval development","keyEvents":[{"keId":565,"keName":"Reduced, Brood care"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":566,"keName":"impaired, Larval development"},{"keId":564,"keName":"Abnormal, Roll change within caste"},{"keId":386,"keName":"Decrease of neuronal network function"}],"reference":"https://aopwiki.org/aops/78"}
{"aopId":78,"aopName":"Nicotinic acetylcholine receptor activation contributes to abnormal role change within the worker bee caste leading to colony death failure 1","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":565,"keName":"Reduced, Brood care"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":566,"keName":"impaired, Larval development"},{"keId":564,"keName":"Abnormal, Roll change within caste"},{"keId":386,"keName":"Decrease of neuronal network function"}],"reference":"https://aopwiki.org/aops/78"}
{"aopId":79,"aopName":"Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":563,"keName":"Death/Failure, Colony"},{"keId":568,"keName":"impaired, Hive thermoregulation"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/79"}
{"aopId":80,"aopName":"Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":571,"keName":"Accelerated, Aging"},{"keId":664,"keName":"Overwhelmed, Mitochondrial DNA repair mechanisms"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":568,"keName":"impaired, Hive thermoregulation"},{"keId":570,"keName":"Accumulation, Damaged mitochondrial DNA"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":572,"keName":"Decrease, Number of worker bees"}],"reference":"https://aopwiki.org/aops/80"}
{"aopId":80,"aopName":"Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure","aoId":572,"aoName":"Decrease Number of worker bees","aoNameRaw":"Decrease, Number of worker bees","keyEvents":[{"keId":571,"keName":"Accelerated, Aging"},{"keId":664,"keName":"Overwhelmed, Mitochondrial DNA repair mechanisms"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":568,"keName":"impaired, Hive thermoregulation"},{"keId":570,"keName":"Accumulation, Damaged mitochondrial DNA"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":572,"keName":"Decrease, Number of worker bees"}],"reference":"https://aopwiki.org/aops/80"}
{"aopId":80,"aopName":"Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure","aoId":568,"aoName":"impaired Hive thermoregulation","aoNameRaw":"impaired, Hive thermoregulation","keyEvents":[{"keId":571,"keName":"Accelerated, Aging"},{"keId":664,"keName":"Overwhelmed, Mitochondrial DNA repair mechanisms"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":568,"keName":"impaired, Hive thermoregulation"},{"keId":570,"keName":"Accumulation, Damaged mitochondrial DNA"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":572,"keName":"Decrease, Number of worker bees"}],"reference":"https://aopwiki.org/aops/80"}
{"aopId":80,"aopName":"Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure","aoId":568,"keyEvents":[{"keId":571,"keName":"Accelerated, Aging"},{"keId":664,"keName":"Overwhelmed, Mitochondrial DNA repair mechanisms"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":568,"keName":"impaired, Hive thermoregulation"},{"keId":570,"keName":"Accumulation, Damaged mitochondrial DNA"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":572,"keName":"Decrease, Number of worker bees"}],"reference":"https://aopwiki.org/aops/80"}
{"aopId":81,"aopName":"Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure","aoId":572,"aoName":"Decrease Number of worker bees","aoNameRaw":"Decrease, Number of worker bees","keyEvents":[{"keId":573,"keName":"Increase, Energetic demands and therefore metabolic stress"},{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":574,"keName":"Increased, Appetite and hunger"},{"keId":572,"keName":"Decrease, Number of worker bees"}],"reference":"https://aopwiki.org/aops/81"}
{"aopId":81,"aopName":"Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":573,"keName":"Increase, Energetic demands and therefore metabolic stress"},{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":574,"keName":"Increased, Appetite and hunger"},{"keId":572,"keName":"Decrease, Number of worker bees"}],"reference":"https://aopwiki.org/aops/81"}
{"aopId":82,"aopName":"Abnormal role change in worker caste contributes to reduced brood care and leads to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":565,"keName":"Reduced, Brood care"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":566,"keName":"impaired, Larval development"},{"keId":564,"keName":"Abnormal, Roll change within caste"}],"reference":"https://aopwiki.org/aops/82"}
{"aopId":82,"aopName":"Abnormal role change in worker caste contributes to reduced brood care and leads to colony loss/failure","aoId":566,"aoName":"impaired Larval development","aoNameRaw":"impaired, Larval development","keyEvents":[{"keId":565,"keName":"Reduced, Brood care"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":566,"keName":"impaired, Larval development"},{"keId":564,"keName":"Abnormal, Roll change within caste"}],"reference":"https://aopwiki.org/aops/82"}
{"aopId":84,"aopName":"Suppression of immune system contributes to impaired development and leads to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":576,"keName":"Increased, Viral susceptibility"},{"keId":577,"keName":"impaired, Development"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":568,"keName":"impaired, Hive thermoregulation"},{"keId":572,"keName":"Decrease, Number of worker bees"},{"keId":403,"keName":"Suppression, Immune system"}],"reference":"https://aopwiki.org/aops/84"}
{"aopId":84,"aopName":"Suppression of immune system contributes to impaired development and leads to colony loss/failure","aoId":568,"keyEvents":[{"keId":576,"keName":"Increased, Viral susceptibility"},{"keId":577,"keName":"impaired, Development"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":568,"keName":"impaired, Hive thermoregulation"},{"keId":572,"keName":"Decrease, Number of worker bees"},{"keId":403,"keName":"Suppression, Immune system"}],"reference":"https://aopwiki.org/aops/84"}
{"aopId":84,"aopName":"Suppression of immune system contributes to impaired development and leads to colony loss/failure","aoId":572,"aoName":"Decrease Number of worker bees","aoNameRaw":"Decrease, Number of worker bees","keyEvents":[{"keId":576,"keName":"Increased, Viral susceptibility"},{"keId":577,"keName":"impaired, Development"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":568,"keName":"impaired, Hive thermoregulation"},{"keId":572,"keName":"Decrease, Number of worker bees"},{"keId":403,"keName":"Suppression, Immune system"}],"reference":"https://aopwiki.org/aops/84"}
{"aopId":84,"aopName":"Suppression of immune system contributes to impaired development and leads to colony loss/failure","aoId":568,"aoName":"impaired Hive thermoregulation","aoNameRaw":"impaired, Hive thermoregulation","keyEvents":[{"keId":576,"keName":"Increased, Viral susceptibility"},{"keId":577,"keName":"impaired, Development"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":568,"keName":"impaired, Hive thermoregulation"},{"keId":572,"keName":"Decrease, Number of worker bees"},{"keId":403,"keName":"Suppression, Immune system"}],"reference":"https://aopwiki.org/aops/84"}
{"aopId":85,"aopName":"Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":576,"keName":"Increased, Viral susceptibility"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":572,"keName":"Decrease, Number of worker bees"},{"keId":403,"keName":"Suppression, Immune system"}],"reference":"https://aopwiki.org/aops/85"}
{"aopId":85,"aopName":"Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure","aoId":572,"aoName":"Decrease Number of worker bees","aoNameRaw":"Decrease, Number of worker bees","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":576,"keName":"Increased, Viral susceptibility"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":572,"keName":"Decrease, Number of worker bees"},{"keId":403,"keName":"Suppression, Immune system"}],"reference":"https://aopwiki.org/aops/85"}
{"aopId":86,"aopName":"Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure","aoId":566,"aoName":"impaired Larval development","aoNameRaw":"impaired, Larval development","keyEvents":[{"keId":579,"keName":"Decreased, Hydrogen peroxide production"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":580,"keName":"Reduced, Antiseptic incorporated in food"},{"keId":578,"keName":"Decreased, Glucose oxidase enzyme activity"},{"keId":561,"keName":"Reduced, Food storage"},{"keId":566,"keName":"impaired, Larval development"},{"keId":564,"keName":"Abnormal, Roll change within caste"}],"reference":"https://aopwiki.org/aops/86"}
{"aopId":86,"aopName":"Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":579,"keName":"Decreased, Hydrogen peroxide production"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":580,"keName":"Reduced, Antiseptic incorporated in food"},{"keId":578,"keName":"Decreased, Glucose oxidase enzyme activity"},{"keId":561,"keName":"Reduced, Food storage"},{"keId":566,"keName":"impaired, Larval development"},{"keId":564,"keName":"Abnormal, Roll change within caste"}],"reference":"https://aopwiki.org/aops/86"}
{"aopId":87,"aopName":"Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure ","targetName":"calmodulin","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":1108,"keName":"Abnormal, Role change within caste"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":1243,"keName":"Altered, Ca2+-calmodulin activated signal transduction"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/87"}
{"aopId":87,"aopName":"Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure ","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":1108,"keName":"Abnormal, Role change within caste"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":1243,"keName":"Altered, Ca2+-calmodulin activated signal transduction"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/87"}
{"aopId":88,"aopName":"Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste","targetName":"calmodulin","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":663,"keName":"Desensitization, Nicotinic acetylcholine receptor"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":1243,"keName":"Altered, Ca2+-calmodulin activated signal transduction"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/88"}
{"aopId":88,"aopName":"Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":663,"keName":"Desensitization, Nicotinic acetylcholine receptor"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":1243,"keName":"Altered, Ca2+-calmodulin activated signal transduction"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/88"}
{"aopId":89,"aopName":"Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure","targetName":"calmodulin","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":1108,"keName":"Abnormal, Role change within caste"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":663,"keName":"Desensitization, Nicotinic acetylcholine receptor"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":1243,"keName":"Altered, Ca2+-calmodulin activated signal transduction"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/89"}
{"aopId":89,"aopName":"Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":1108,"keName":"Abnormal, Role change within caste"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":663,"keName":"Desensitization, Nicotinic acetylcholine receptor"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":1243,"keName":"Altered, Ca2+-calmodulin activated signal transduction"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/89"}
{"aopId":90,"aopName":"Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure 2","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":565,"keName":"Reduced, Brood care"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":663,"keName":"Desensitization, Nicotinic acetylcholine receptor"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":566,"keName":"impaired, Larval development"},{"keId":564,"keName":"Abnormal, Roll change within caste"},{"keId":386,"keName":"Decrease of neuronal network function"}],"reference":"https://aopwiki.org/aops/90"}
{"aopId":90,"aopName":"Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure 2","aoId":566,"aoName":"impaired Larval development","aoNameRaw":"impaired, Larval development","keyEvents":[{"keId":565,"keName":"Reduced, Brood care"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":663,"keName":"Desensitization, Nicotinic acetylcholine receptor"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":566,"keName":"impaired, Larval development"},{"keId":564,"keName":"Abnormal, Roll change within caste"},{"keId":386,"keName":"Decrease of neuronal network function"}],"reference":"https://aopwiki.org/aops/90"}
{"aopId":91,"aopName":"Sodium channel inhibition leading to reduced survival","targetName":"sodium channel protein type 1 subunit alpha","targetId":"ENSG00000144285","aoId":592,"aoName":"Reduced survival","aoNameRaw":"Reduced, survival","keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/91"}
{"aopId":91,"aopName":"Sodium channel inhibition leading to reduced survival","aoId":592,"aoName":"Reduced survival","aoNameRaw":"Reduced, survival","keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/91"}
{"aopId":91,"aopName":"Sodium channel inhibition leading to reduced survival","targetName":"sodium channel protein type 1 subunit alpha","targetId":"ENSG00000144285","aoId":587,"aoName":"Reduced feeding 1","aoNameRaw":"Reduced, feeding 1","keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/91"}
{"aopId":91,"aopName":"Sodium channel inhibition leading to reduced survival","aoId":587,"aoName":"Reduced feeding 1","aoNameRaw":"Reduced, feeding 1","keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/91"}
{"aopId":91,"aopName":"Sodium channel inhibition leading to reduced survival","targetName":"sodium channel protein type 1 subunit alpha","targetId":"ENSG00000144285","aoId":587,"keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/91"}
{"aopId":91,"aopName":"Sodium channel inhibition leading to reduced survival","aoId":587,"keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/91"}
{"aopId":91,"aopName":"Sodium channel inhibition leading to reduced survival","targetName":"sodium channel protein type 1 subunit alpha","targetId":"ENSG00000144285","aoId":588,"aoName":"Increased predation","aoNameRaw":"Increased, predation","keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/91"}
{"aopId":91,"aopName":"Sodium channel inhibition leading to reduced survival","aoId":588,"aoName":"Increased predation","aoNameRaw":"Increased, predation","keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/91"}
{"aopId":91,"aopName":"Sodium channel inhibition leading to reduced survival","targetName":"sodium channel protein type 1 subunit alpha","targetId":"ENSG00000144285","aoId":588,"keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/91"}
{"aopId":91,"aopName":"Sodium channel inhibition leading to reduced survival","aoId":588,"keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/91"}
{"aopId":93,"aopName":"sodium channel inhibition leading to increased predation","targetName":"sodium channel protein type 1 subunit alpha","targetId":"ENSG00000144285","aoId":588,"keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/93"}
{"aopId":93,"aopName":"sodium channel inhibition leading to increased predation","aoId":588,"keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/93"}
{"aopId":93,"aopName":"sodium channel inhibition leading to increased predation","targetName":"sodium channel protein type 1 subunit alpha","targetId":"ENSG00000144285","aoId":588,"aoName":"Increased predation","aoNameRaw":"Increased, predation","keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/93"}
{"aopId":93,"aopName":"sodium channel inhibition leading to increased predation","aoId":588,"aoName":"Increased predation","aoNameRaw":"Increased, predation","keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/93"}
{"aopId":94,"aopName":"Sodium channel inhibition leading to congenital malformations","aoId":591,"aoName":"Increased amputations","aoNameRaw":"Increased, amputations","keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":590,"keName":"N/A, hypoxia"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":444,"keName":"Increased, Atrioventricular block and bradycardia"},{"keId":591,"keName":"Increased, amputations"},{"keId":445,"keName":"Respiratory distress/arrest"}],"reference":"https://aopwiki.org/aops/94"}
{"aopId":94,"aopName":"Sodium channel inhibition leading to congenital malformations","targetName":"sodium channel protein type 1 subunit alpha","targetId":"ENSG00000144285","aoId":591,"aoName":"Increased amputations","aoNameRaw":"Increased, amputations","keyEvents":[{"keId":584,"keName":"Inhibition, sodium channel"},{"keId":590,"keName":"N/A, hypoxia"},{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":444,"keName":"Increased, Atrioventricular block and bradycardia"},{"keId":591,"keName":"Increased, amputations"},{"keId":445,"keName":"Respiratory distress/arrest"}],"reference":"https://aopwiki.org/aops/94"}
{"aopId":95,"aopName":"Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival","targetName":"potassium voltage-gated channel subfamily H member 2 (human)","aoId":592,"aoName":"Reduced survival","aoNameRaw":"Reduced, survival","keyEvents":[{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":593,"keName":"Inhibition, Ether-a-go-go (ERG) voltage-gated potassium channel "},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/95"}
{"aopId":95,"aopName":"Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival","aoId":592,"aoName":"Reduced survival","aoNameRaw":"Reduced, survival","keyEvents":[{"keId":585,"keName":"Decreased, Sodium conductance 1"},{"keId":586,"keName":"Reduced, swimming speed"},{"keId":592,"keName":"Reduced, survival"},{"keId":587,"keName":"Reduced, feeding 1"},{"keId":593,"keName":"Inhibition, Ether-a-go-go (ERG) voltage-gated potassium channel "},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/95"}
{"aopId":96,"aopName":"Axonal sodium channel modulation leading to acute mortality","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":602,"keName":"Increased, Ataxia, paralysis, or hyperactivity"},{"keId":351,"keName":"Increased Mortality"},{"keId":601,"keName":"Overactivation, muscle contraction"},{"keId":600,"keName":"Overactivation, Neuronotransmitter release"},{"keId":598,"keName":"modulation, sodium channel"},{"keId":599,"keName":"prolonged, Depolarization of neuronal membrane"}],"reference":"https://aopwiki.org/aops/96"}
{"aopId":96,"aopName":"Axonal sodium channel modulation leading to acute mortality","targetName":"sodium channel protein type 1 subunit alpha","targetId":"ENSG00000144285","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":602,"keName":"Increased, Ataxia, paralysis, or hyperactivity"},{"keId":351,"keName":"Increased Mortality"},{"keId":601,"keName":"Overactivation, muscle contraction"},{"keId":600,"keName":"Overactivation, Neuronotransmitter release"},{"keId":598,"keName":"modulation, sodium channel"},{"keId":599,"keName":"prolonged, Depolarization of neuronal membrane"}],"reference":"https://aopwiki.org/aops/96"}
{"aopId":97,"aopName":"5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline","targetName":"sodium-dependent serotonin transporter","targetId":"ENSG00000108576","aoId":623,"aoName":"Increase predation","aoNameRaw":"Increase, predation","keyEvents":[{"keId":623,"keName":"Increase, predation"},{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":622,"keName":"Increased, locomotion"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":625,"keName":"Increased, muscular waves in foot"},{"keId":1143,"keName":"Depletion, energy reserves"},{"keId":624,"keName":"Increased, foot detachment"},{"keId":1139,"keName":"Increased, water retention in foot"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/97"}
{"aopId":97,"aopName":"5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline","aoId":623,"aoName":"Increase predation","aoNameRaw":"Increase, predation","keyEvents":[{"keId":623,"keName":"Increase, predation"},{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":622,"keName":"Increased, locomotion"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":625,"keName":"Increased, muscular waves in foot"},{"keId":1143,"keName":"Depletion, energy reserves"},{"keId":624,"keName":"Increased, foot detachment"},{"keId":1139,"keName":"Increased, water retention in foot"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/97"}
{"aopId":97,"aopName":"5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline","targetName":"sodium-dependent serotonin transporter","targetId":"ENSG00000108576","aoId":361,"aoName":"Decline Population","aoNameRaw":"Decline, Population","keyEvents":[{"keId":623,"keName":"Increase, predation"},{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":622,"keName":"Increased, locomotion"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":625,"keName":"Increased, muscular waves in foot"},{"keId":1143,"keName":"Depletion, energy reserves"},{"keId":624,"keName":"Increased, foot detachment"},{"keId":1139,"keName":"Increased, water retention in foot"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/97"}
{"aopId":97,"aopName":"5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline","aoId":361,"aoName":"Decline Population","aoNameRaw":"Decline, Population","keyEvents":[{"keId":623,"keName":"Increase, predation"},{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":622,"keName":"Increased, locomotion"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":625,"keName":"Increased, muscular waves in foot"},{"keId":1143,"keName":"Depletion, energy reserves"},{"keId":624,"keName":"Increased, foot detachment"},{"keId":1139,"keName":"Increased, water retention in foot"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/97"}
{"aopId":98,"aopName":"5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation","targetName":"sodium-dependent serotonin transporter","targetId":"ENSG00000108576","aoId":588,"keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":627,"keName":"Decreased, anxiety"},{"keId":629,"keName":"Decreased, sheltering"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/98"}
{"aopId":98,"aopName":"5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation","aoId":588,"keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":627,"keName":"Decreased, anxiety"},{"keId":629,"keName":"Decreased, sheltering"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/98"}
{"aopId":98,"aopName":"5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation","targetName":"sodium-dependent serotonin transporter","targetId":"ENSG00000108576","aoId":588,"aoName":"Increased predation","aoNameRaw":"Increased, predation","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":627,"keName":"Decreased, anxiety"},{"keId":629,"keName":"Decreased, sheltering"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/98"}
{"aopId":98,"aopName":"5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation","aoId":588,"aoName":"Increased predation","aoNameRaw":"Increased, predation","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":627,"keName":"Decreased, anxiety"},{"keId":629,"keName":"Decreased, sheltering"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/98"}
{"aopId":99,"aopName":"Histamine (H2) receptor antagonism leading to reduced survival","targetName":"histamine H2 receptor","targetId":"ENSG00000113749","aoId":636,"aoName":"Decreased survival","aoNameRaw":"Decreased, survival","keyEvents":[{"keId":635,"keName":"Decreased, locomotion"},{"keId":638,"keName":"Antagonism, Histamine Receptor (H2)"},{"keId":636,"keName":"Decreased, survival"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":633,"keName":"Decrease, histaminergic neuron excitation"},{"keId":634,"keName":"N/A, sedation"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/99"}
{"aopId":99,"aopName":"Histamine (H2) receptor antagonism leading to reduced survival","aoId":636,"aoName":"Decreased survival","aoNameRaw":"Decreased, survival","keyEvents":[{"keId":635,"keName":"Decreased, locomotion"},{"keId":638,"keName":"Antagonism, Histamine Receptor (H2)"},{"keId":636,"keName":"Decreased, survival"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":633,"keName":"Decrease, histaminergic neuron excitation"},{"keId":634,"keName":"N/A, sedation"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/99"}
{"aopId":99,"aopName":"Histamine (H2) receptor antagonism leading to reduced survival","targetName":"histamine H2 receptor","targetId":"ENSG00000113749","aoId":588,"keyEvents":[{"keId":635,"keName":"Decreased, locomotion"},{"keId":638,"keName":"Antagonism, Histamine Receptor (H2)"},{"keId":636,"keName":"Decreased, survival"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":633,"keName":"Decrease, histaminergic neuron excitation"},{"keId":634,"keName":"N/A, sedation"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/99"}
{"aopId":99,"aopName":"Histamine (H2) receptor antagonism leading to reduced survival","aoId":588,"keyEvents":[{"keId":635,"keName":"Decreased, locomotion"},{"keId":638,"keName":"Antagonism, Histamine Receptor (H2)"},{"keId":636,"keName":"Decreased, survival"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":633,"keName":"Decrease, histaminergic neuron excitation"},{"keId":634,"keName":"N/A, sedation"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/99"}
{"aopId":99,"aopName":"Histamine (H2) receptor antagonism leading to reduced survival","targetName":"histamine H2 receptor","targetId":"ENSG00000113749","aoId":588,"aoName":"Increased predation","aoNameRaw":"Increased, predation","keyEvents":[{"keId":635,"keName":"Decreased, locomotion"},{"keId":638,"keName":"Antagonism, Histamine Receptor (H2)"},{"keId":636,"keName":"Decreased, survival"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":633,"keName":"Decrease, histaminergic neuron excitation"},{"keId":634,"keName":"N/A, sedation"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/99"}
{"aopId":99,"aopName":"Histamine (H2) receptor antagonism leading to reduced survival","aoId":588,"aoName":"Increased predation","aoNameRaw":"Increased, predation","keyEvents":[{"keId":635,"keName":"Decreased, locomotion"},{"keId":638,"keName":"Antagonism, Histamine Receptor (H2)"},{"keId":636,"keName":"Decreased, survival"},{"keId":341,"keName":"Impairment, Learning and memory"},{"keId":633,"keName":"Decrease, histaminergic neuron excitation"},{"keId":634,"keName":"N/A, sedation"},{"keId":588,"keName":"Increased, predation"}],"reference":"https://aopwiki.org/aops/99"}
{"aopId":100,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":672,"keName":"Reduced, Prostaglandin F2alpha synthesis, ovary  "},{"keId":673,"keName":"Reduced, Spawning behavior"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"}],"reference":"https://aopwiki.org/aops/100"}
{"aopId":100,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior","targetName":"prostaglandin G/H synthase 2","targetId":"ENSG00000073756","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":672,"keName":"Reduced, Prostaglandin F2alpha synthesis, ovary  "},{"keId":673,"keName":"Reduced, Spawning behavior"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"}],"reference":"https://aopwiki.org/aops/100"}
{"aopId":100,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":672,"keName":"Reduced, Prostaglandin F2alpha synthesis, ovary  "},{"keId":673,"keName":"Reduced, Spawning behavior"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"}],"reference":"https://aopwiki.org/aops/100"}
{"aopId":100,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":672,"keName":"Reduced, Prostaglandin F2alpha synthesis, ovary  "},{"keId":673,"keName":"Reduced, Spawning behavior"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"}],"reference":"https://aopwiki.org/aops/100"}
{"aopId":100,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior","targetName":"prostaglandin G/H synthase 2","targetId":"ENSG00000073756","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":672,"keName":"Reduced, Prostaglandin F2alpha synthesis, ovary  "},{"keId":673,"keName":"Reduced, Spawning behavior"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"}],"reference":"https://aopwiki.org/aops/100"}
{"aopId":100,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":672,"keName":"Reduced, Prostaglandin F2alpha synthesis, ovary  "},{"keId":673,"keName":"Reduced, Spawning behavior"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"}],"reference":"https://aopwiki.org/aops/100"}
{"aopId":101,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":681,"keName":"Decreased, Prostaglandin F2alpha synthesis, ovary  "},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"},{"keId":678,"keName":"Reduced, Pheromone release"}],"reference":"https://aopwiki.org/aops/101"}
{"aopId":101,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":681,"keName":"Decreased, Prostaglandin F2alpha synthesis, ovary  "},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"},{"keId":678,"keName":"Reduced, Pheromone release"}],"reference":"https://aopwiki.org/aops/101"}
{"aopId":101,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release","targetName":"prostaglandin G/H synthase 2","targetId":"ENSG00000073756","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":681,"keName":"Decreased, Prostaglandin F2alpha synthesis, ovary  "},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"},{"keId":678,"keName":"Reduced, Pheromone release"}],"reference":"https://aopwiki.org/aops/101"}
{"aopId":101,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":681,"keName":"Decreased, Prostaglandin F2alpha synthesis, ovary  "},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"},{"keId":678,"keName":"Reduced, Pheromone release"}],"reference":"https://aopwiki.org/aops/101"}
{"aopId":101,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":681,"keName":"Decreased, Prostaglandin F2alpha synthesis, ovary  "},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"},{"keId":678,"keName":"Reduced, Pheromone release"}],"reference":"https://aopwiki.org/aops/101"}
{"aopId":101,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release","targetName":"prostaglandin G/H synthase 2","targetId":"ENSG00000073756","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":681,"keName":"Decreased, Prostaglandin F2alpha synthesis, ovary  "},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":671,"keName":"Reduced, Prostaglandin F2alpha concentration, plasma "},{"keId":674,"keName":"Reduced, Ability to attract spawning mates"},{"keId":678,"keName":"Reduced, Pheromone release"}],"reference":"https://aopwiki.org/aops/101"}
{"aopId":102,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":694,"keName":"Reduced, Meiotic prophase I/metaphase I transition, oocyte"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":693,"keName":"Increased, cyclic adenosine monophosphate"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "}],"reference":"https://aopwiki.org/aops/102"}
{"aopId":102,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":694,"keName":"Reduced, Meiotic prophase I/metaphase I transition, oocyte"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":693,"keName":"Increased, cyclic adenosine monophosphate"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "}],"reference":"https://aopwiki.org/aops/102"}
{"aopId":102,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","targetName":"prostaglandin G/H synthase 2","targetId":"ENSG00000073756","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":694,"keName":"Reduced, Meiotic prophase I/metaphase I transition, oocyte"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":693,"keName":"Increased, cyclic adenosine monophosphate"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "}],"reference":"https://aopwiki.org/aops/102"}
{"aopId":102,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":694,"keName":"Reduced, Meiotic prophase I/metaphase I transition, oocyte"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":693,"keName":"Increased, cyclic adenosine monophosphate"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "}],"reference":"https://aopwiki.org/aops/102"}
{"aopId":102,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":694,"keName":"Reduced, Meiotic prophase I/metaphase I transition, oocyte"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":693,"keName":"Increased, cyclic adenosine monophosphate"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "}],"reference":"https://aopwiki.org/aops/102"}
{"aopId":102,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","targetName":"prostaglandin G/H synthase 2","targetId":"ENSG00000073756","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":694,"keName":"Reduced, Meiotic prophase I/metaphase I transition, oocyte"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":693,"keName":"Increased, cyclic adenosine monophosphate"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "}],"reference":"https://aopwiki.org/aops/102"}
{"aopId":103,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint","targetName":"MAD2 like protein (fruit fly)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":696,"keName":"Increased, Chromosome misseggregation"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":695,"keName":"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"}],"reference":"https://aopwiki.org/aops/103"}
{"aopId":103,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":696,"keName":"Increased, Chromosome misseggregation"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":695,"keName":"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"}],"reference":"https://aopwiki.org/aops/103"}
{"aopId":103,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":696,"keName":"Increased, Chromosome misseggregation"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":695,"keName":"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"}],"reference":"https://aopwiki.org/aops/103"}
{"aopId":103,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint","targetName":"prostaglandin G/H synthase 2","targetId":"ENSG00000073756","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":696,"keName":"Increased, Chromosome misseggregation"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":695,"keName":"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"}],"reference":"https://aopwiki.org/aops/103"}
{"aopId":103,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint","targetName":"MAD2 like protein (fruit fly)","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":696,"keName":"Increased, Chromosome misseggregation"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":695,"keName":"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"}],"reference":"https://aopwiki.org/aops/103"}
{"aopId":103,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":696,"keName":"Increased, Chromosome misseggregation"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":695,"keName":"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"}],"reference":"https://aopwiki.org/aops/103"}
{"aopId":103,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":696,"keName":"Increased, Chromosome misseggregation"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":695,"keName":"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"}],"reference":"https://aopwiki.org/aops/103"}
{"aopId":103,"aopName":"Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint","targetName":"prostaglandin G/H synthase 2","targetId":"ENSG00000073756","aoId":675,"aoName":"Reduced Reproductive Success","aoNameRaw":"Reduced, Reproductive Success","keyEvents":[{"keId":691,"keName":"Reduced, Maturation inducing steroid, plasma"},{"keId":696,"keName":"Increased, Chromosome misseggregation"},{"keId":79,"keName":"Inhibition, Cyclooxygenase activity"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":692,"keName":"Reduced, Maturation inducing steroid receptor signalling, oocyte"},{"keId":689,"keName":"Reduced, Gonadotropin releasing hormone, hypothalamus"},{"keId":675,"keName":"Reduced, Reproductive Success"},{"keId":695,"keName":"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte"},{"keId":690,"keName":"Reduced, Luteinizing hormone (LH), plasma "},{"keId":687,"keName":"Reduced, Prostaglandin E2 concentration, hypothalamus"}],"reference":"https://aopwiki.org/aops/103"}
{"aopId":104,"aopName":"Altered ion channel activity leading impaired heart function","targetName":"potassium voltage-gated channel subfamily H member 2 (human)","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":699,"keName":"Increased, cardiac arrthymia"},{"keId":697,"keName":"impaired, ion channels"},{"keId":698,"keName":"Altered, Action Potential"}],"reference":"https://aopwiki.org/aops/104"}
{"aopId":104,"aopName":"Altered ion channel activity leading impaired heart function","targetName":"ATP-sensitive inward rectifier potassium channel 1","targetId":"ENSG00000151704","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":699,"keName":"Increased, cardiac arrthymia"},{"keId":697,"keName":"impaired, ion channels"},{"keId":698,"keName":"Altered, Action Potential"}],"reference":"https://aopwiki.org/aops/104"}
{"aopId":104,"aopName":"Altered ion channel activity leading impaired heart function","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":699,"keName":"Increased, cardiac arrthymia"},{"keId":697,"keName":"impaired, ion channels"},{"keId":698,"keName":"Altered, Action Potential"}],"reference":"https://aopwiki.org/aops/104"}
{"aopId":105,"aopName":"Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)","targetName":"major urinary protein (rat)","aoId":713,"aoName":"Increase Adenomas/carcinomas (renal tubular)","aoNameRaw":"Increase, Adenomas/carcinomas (renal tubular)","keyEvents":[{"keId":767,"keName":"Increase, Hyperplasia (renal tubular cells)"},{"keId":714,"keName":"Increased, Binding of chemicals to 2u (serum)"},{"keId":713,"keName":"Increase, Adenomas/carcinomas (renal tubular)"},{"keId":709,"keName":"Increase, Cytotoxicity (renal tubular cell)"},{"keId":708,"keName":"Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium)"},{"keId":710,"keName":"Increase, Regenerative cell proliferation (tubular epithelial cells)"}],"reference":"https://aopwiki.org/aops/105"}
{"aopId":105,"aopName":"Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)","aoId":713,"aoName":"Increase Adenomas/carcinomas (renal tubular)","aoNameRaw":"Increase, Adenomas/carcinomas (renal tubular)","keyEvents":[{"keId":767,"keName":"Increase, Hyperplasia (renal tubular cells)"},{"keId":714,"keName":"Increased, Binding of chemicals to 2u (serum)"},{"keId":713,"keName":"Increase, Adenomas/carcinomas (renal tubular)"},{"keId":709,"keName":"Increase, Cytotoxicity (renal tubular cell)"},{"keId":708,"keName":"Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium)"},{"keId":710,"keName":"Increase, Regenerative cell proliferation (tubular epithelial cells)"}],"reference":"https://aopwiki.org/aops/105"}
{"aopId":106,"aopName":"Chemical binding to tubulin in oocytes leading to aneuploid offspring","targetName":"tubulin","aoId":728,"aoName":"Increase Aneuploid offspring","aoNameRaw":"Increase, Aneuploid offspring","keyEvents":[{"keId":718,"keName":"Binding, Tubulin"},{"keId":723,"keName":"Altered, Chromosome number"},{"keId":728,"keName":"Increase, Aneuploid offspring"},{"keId":752,"keName":"Altered, Meiotic chromosome dynamics"},{"keId":720,"keName":"Disruption, Microtubule dynamics"},{"keId":721,"keName":"Disorganization, Meiotic Spindle"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/106"}
{"aopId":106,"aopName":"Chemical binding to tubulin in oocytes leading to aneuploid offspring","aoId":728,"aoName":"Increase Aneuploid offspring","aoNameRaw":"Increase, Aneuploid offspring","keyEvents":[{"keId":718,"keName":"Binding, Tubulin"},{"keId":723,"keName":"Altered, Chromosome number"},{"keId":728,"keName":"Increase, Aneuploid offspring"},{"keId":752,"keName":"Altered, Meiotic chromosome dynamics"},{"keId":720,"keName":"Disruption, Microtubule dynamics"},{"keId":721,"keName":"Disorganization, Meiotic Spindle"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/106"}
{"aopId":107,"aopName":"Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat","targetName":"nuclear receptor subfamily 1 group I member 3","targetId":"ENSG00000143257","aoId":719,"aoName":"Increase hepatocellular adenomas and carcinomas","aoNameRaw":"Increase, hepatocellular adenomas and carcinomas","keyEvents":[{"keId":774,"keName":"Increase, Preneoplastic foci (hepatocytes)"},{"keId":719,"keName":"Increase, hepatocellular adenomas and carcinomas"},{"keId":715,"keName":"Activation, Constitutive androstane receptor"},{"keId":716,"keName":"Increase, cell proliferation (hepatocytes)"},{"keId":1214,"keName":"Altered gene expression specific to CAR activation, Hepatocytes"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/107"}
{"aopId":107,"aopName":"Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat","aoId":719,"aoName":"Increase hepatocellular adenomas and carcinomas","aoNameRaw":"Increase, hepatocellular adenomas and carcinomas","keyEvents":[{"keId":774,"keName":"Increase, Preneoplastic foci (hepatocytes)"},{"keId":719,"keName":"Increase, hepatocellular adenomas and carcinomas"},{"keId":715,"keName":"Activation, Constitutive androstane receptor"},{"keId":716,"keName":"Increase, cell proliferation (hepatocytes)"},{"keId":1214,"keName":"Altered gene expression specific to CAR activation, Hepatocytes"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/107"}
{"aopId":108,"aopName":"Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)","targetName":"pyruvate dehydrogenase [ubiquinone]","aoId":719,"aoName":"Increase hepatocellular adenomas and carcinomas","aoNameRaw":"Increase, hepatocellular adenomas and carcinomas","keyEvents":[{"keId":719,"keName":"Increase, hepatocellular adenomas and carcinomas"},{"keId":209,"keName":"Peptide Oxidation"},{"keId":724,"keName":"Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme"},{"keId":769,"keName":"Increase, Oxidative metabolism"},{"keId":726,"keName":"Increased, Induction of pyruvate dehydrogenase (PDH)"},{"keId":768,"keName":"Increase, Cytotoxicity"}],"reference":"https://aopwiki.org/aops/108"}
{"aopId":108,"aopName":"Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)","targetName":"Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (rat)","aoId":719,"aoName":"Increase hepatocellular adenomas and carcinomas","aoNameRaw":"Increase, hepatocellular adenomas and carcinomas","keyEvents":[{"keId":719,"keName":"Increase, hepatocellular adenomas and carcinomas"},{"keId":209,"keName":"Peptide Oxidation"},{"keId":724,"keName":"Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme"},{"keId":769,"keName":"Increase, Oxidative metabolism"},{"keId":726,"keName":"Increased, Induction of pyruvate dehydrogenase (PDH)"},{"keId":768,"keName":"Increase, Cytotoxicity"}],"reference":"https://aopwiki.org/aops/108"}
{"aopId":108,"aopName":"Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)","aoId":719,"aoName":"Increase hepatocellular adenomas and carcinomas","aoNameRaw":"Increase, hepatocellular adenomas and carcinomas","keyEvents":[{"keId":719,"keName":"Increase, hepatocellular adenomas and carcinomas"},{"keId":209,"keName":"Peptide Oxidation"},{"keId":724,"keName":"Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme"},{"keId":769,"keName":"Increase, Oxidative metabolism"},{"keId":726,"keName":"Increased, Induction of pyruvate dehydrogenase (PDH)"},{"keId":768,"keName":"Increase, Cytotoxicity"}],"reference":"https://aopwiki.org/aops/108"}
{"aopId":109,"aopName":"Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse)","aoId":736,"aoName":"Increase Adenomas/carcinomas (bronchioloalveolar)","aoNameRaw":"Increase, Adenomas/carcinomas (bronchioloalveolar)","keyEvents":[{"keId":734,"keName":"Increase, Regenerative cell proliferation (terminal bronchiolar epithelial cells)"},{"keId":736,"keName":"Increase, Adenomas/carcinomas (bronchioloalveolar)"},{"keId":733,"keName":"Increase, Necrosis (terminal bronchiolar cells)"},{"keId":770,"keName":"Increase, Cytotoxicity (club cells)"},{"keId":735,"keName":"Increase, Hyperplasia (terminal bronchiolar cells)"}],"reference":"https://aopwiki.org/aops/109"}
{"aopId":110,"aopName":"Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)","aoId":741,"aoName":"Increase Adenomas/carcinomas (follicular cell)","aoNameRaw":"Increase, Adenomas/carcinomas (follicular cell)","keyEvents":[{"keId":741,"keName":"Increase, Adenomas/carcinomas (follicular cell)"},{"keId":739,"keName":"Increase, Hypertrophy and proliferation (follicular cell)"},{"keId":771,"keName":"Decrease, Serum thyroid hormone (T4/T3)"},{"keId":740,"keName":"Increase, Hyperplasia (follicular cells)"},{"keId":753,"keName":"Increase, Thyroid-stimulating hormone (TSH)"},{"keId":737,"keName":"Decreased, Uptake of inorganic iodide"}],"reference":"https://aopwiki.org/aops/110"}
{"aopId":111,"aopName":"Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)","targetName":"androgen receptor","targetId":"ENSG00000169083","aoId":745,"aoName":"Increase Leydig cell tumors","aoNameRaw":"Increase, Leydig cell tumors","keyEvents":[{"keId":743,"keName":"Decreased, Testosterone binding to androgen receptor (hypothalamus)"},{"keId":754,"keName":"Increased, Luteinizing hormone (LH) "},{"keId":742,"keName":"Decreased, Androgen receptor activity"},{"keId":744,"keName":"Increase, Hyperplasia (Leydig cells)"},{"keId":745,"keName":"Increase, Leydig cell tumors"}],"reference":"https://aopwiki.org/aops/111"}
{"aopId":111,"aopName":"Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)","aoId":745,"aoName":"Increase Leydig cell tumors","aoNameRaw":"Increase, Leydig cell tumors","keyEvents":[{"keId":743,"keName":"Decreased, Testosterone binding to androgen receptor (hypothalamus)"},{"keId":754,"keName":"Increased, Luteinizing hormone (LH) "},{"keId":742,"keName":"Decreased, Androgen receptor activity"},{"keId":744,"keName":"Increase, Hyperplasia (Leydig cells)"},{"keId":745,"keName":"Increase, Leydig cell tumors"}],"reference":"https://aopwiki.org/aops/111"}
{"aopId":112,"aopName":"Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":773,"aoName":"Increase Endometrial adenocarcinomas","aoNameRaw":"Increase, Endometrial adenocarcinomas","keyEvents":[{"keId":773,"keName":"Increase, Endometrial adenocarcinomas"},{"keId":747,"keName":"Decreased, Prolactin"},{"keId":748,"keName":"Increased, Estrogen receptor (ER) activity"},{"keId":749,"keName":"Decreased, Progesterone from corpus luteum"},{"keId":772,"keName":"Increase, Hyperplasia (glandular epithelial cells of endometrium)"},{"keId":746,"keName":"Increase, Dopaminergic activity"}],"reference":"https://aopwiki.org/aops/112"}
{"aopId":112,"aopName":"Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)","aoId":773,"aoName":"Increase Endometrial adenocarcinomas","aoNameRaw":"Increase, Endometrial adenocarcinomas","keyEvents":[{"keId":773,"keName":"Increase, Endometrial adenocarcinomas"},{"keId":747,"keName":"Decreased, Prolactin"},{"keId":748,"keName":"Increased, Estrogen receptor (ER) activity"},{"keId":749,"keName":"Decreased, Progesterone from corpus luteum"},{"keId":772,"keName":"Increase, Hyperplasia (glandular epithelial cells of endometrium)"},{"keId":746,"keName":"Increase, Dopaminergic activity"}],"reference":"https://aopwiki.org/aops/112"}
{"aopId":113,"aopName":"Glutamate-gated chloride channel activation leading to acute mortality","targetName":"glutamate-gated chloride channel (fruit fly)","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":765,"keName":"Decreased, population 1"},{"keId":761,"keName":"Increased, Chloride conductance"},{"keId":763,"keName":"hyperpolarisation, neuron"},{"keId":760,"keName":"Activation, Glutamate-gated chloride channel"},{"keId":764,"keName":"N/A, Ataxia, paralysis, or hyperactivity"}],"reference":"https://aopwiki.org/aops/113"}
{"aopId":113,"aopName":"Glutamate-gated chloride channel activation leading to acute mortality","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":765,"keName":"Decreased, population 1"},{"keId":761,"keName":"Increased, Chloride conductance"},{"keId":763,"keName":"hyperpolarisation, neuron"},{"keId":760,"keName":"Activation, Glutamate-gated chloride channel"},{"keId":764,"keName":"N/A, Ataxia, paralysis, or hyperactivity"}],"reference":"https://aopwiki.org/aops/113"}
{"aopId":113,"aopName":"Glutamate-gated chloride channel activation leading to acute mortality","targetName":"glutamate-gated chloride channel (fruit fly)","aoId":765,"aoName":"Decreased population 1","aoNameRaw":"Decreased, population 1","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":765,"keName":"Decreased, population 1"},{"keId":761,"keName":"Increased, Chloride conductance"},{"keId":763,"keName":"hyperpolarisation, neuron"},{"keId":760,"keName":"Activation, Glutamate-gated chloride channel"},{"keId":764,"keName":"N/A, Ataxia, paralysis, or hyperactivity"}],"reference":"https://aopwiki.org/aops/113"}
{"aopId":113,"aopName":"Glutamate-gated chloride channel activation leading to acute mortality","aoId":765,"aoName":"Decreased population 1","aoNameRaw":"Decreased, population 1","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":765,"keName":"Decreased, population 1"},{"keId":761,"keName":"Increased, Chloride conductance"},{"keId":763,"keName":"hyperpolarisation, neuron"},{"keId":760,"keName":"Activation, Glutamate-gated chloride channel"},{"keId":764,"keName":"N/A, Ataxia, paralysis, or hyperactivity"}],"reference":"https://aopwiki.org/aops/113"}
{"aopId":114,"aopName":"HPPD inhibition leading to corneal papillomas and carcinomas (in rat)","targetName":"4-hydroxyphenylpyruvate dioxygenase (rat)","aoId":779,"aoName":"Increase Papillomas/carcinomas (squamous cells)","aoNameRaw":"Increase, Papillomas/carcinomas (squamous cells)","keyEvents":[{"keId":775,"keName":"Increased, Plasma tyrosine"},{"keId":766,"keName":"Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme"},{"keId":776,"keName":"Increase, Cytotoxicity (corneal cells)"},{"keId":777,"keName":"Increase, Inflammation (corneal cells)"},{"keId":778,"keName":"Increase, Regenerative cell proliferation (corneal cells)"},{"keId":779,"keName":"Increase, Papillomas/carcinomas (squamous cells)"}],"reference":"https://aopwiki.org/aops/114"}
{"aopId":114,"aopName":"HPPD inhibition leading to corneal papillomas and carcinomas (in rat)","aoId":779,"aoName":"Increase Papillomas/carcinomas (squamous cells)","aoNameRaw":"Increase, Papillomas/carcinomas (squamous cells)","keyEvents":[{"keId":775,"keName":"Increased, Plasma tyrosine"},{"keId":766,"keName":"Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme"},{"keId":776,"keName":"Increase, Cytotoxicity (corneal cells)"},{"keId":777,"keName":"Increase, Inflammation (corneal cells)"},{"keId":778,"keName":"Increase, Regenerative cell proliferation (corneal cells)"},{"keId":779,"keName":"Increase, Papillomas/carcinomas (squamous cells)"}],"reference":"https://aopwiki.org/aops/114"}
{"aopId":115,"aopName":"Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat)","aoId":779,"aoName":"Increase Papillomas/carcinomas (squamous cells)","aoNameRaw":"Increase, Papillomas/carcinomas (squamous cells)","keyEvents":[{"keId":149,"keName":"Increase, Inflammation"},{"keId":781,"keName":"Increase, Regenerative cell proliferation (forestomach epithelial cells)"},{"keId":782,"keName":"Increase, Hyperplasia (forestomach epithelial cells)"},{"keId":779,"keName":"Increase, Papillomas/carcinomas (squamous cells)"},{"keId":780,"keName":"Increase, Cytotoxicity (epithelial cells)"}],"reference":"https://aopwiki.org/aops/115"}
{"aopId":116,"aopName":"Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat) ","aoId":713,"aoName":"Increase Adenomas/carcinomas (renal tubular)","aoNameRaw":"Increase, Adenomas/carcinomas (renal tubular)","keyEvents":[{"keId":713,"keName":"Increase, Adenomas/carcinomas (renal tubular)"},{"keId":783,"keName":"Increase, Cytotoxicity (tubular epithelial cells)"},{"keId":784,"keName":"Increase, Hyperplasia (tubular epithelial cells)"},{"keId":710,"keName":"Increase, Regenerative cell proliferation (tubular epithelial cells)"}],"reference":"https://aopwiki.org/aops/116"}
{"aopId":117,"aopName":"Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)","targetName":"androgen receptor","targetId":"ENSG00000169083","aoId":719,"aoName":"Increase hepatocellular adenomas and carcinomas","aoNameRaw":"Increase, hepatocellular adenomas and carcinomas","keyEvents":[{"keId":774,"keName":"Increase, Preneoplastic foci (hepatocytes)"},{"keId":719,"keName":"Increase, hepatocellular adenomas and carcinomas"},{"keId":716,"keName":"Increase, cell proliferation (hepatocytes)"},{"keId":785,"keName":"Activation, Androgen receptor"}],"status":"Under Development","reference":"https://aopwiki.org/aops/117"}
{"aopId":117,"aopName":"Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)","aoId":719,"aoName":"Increase hepatocellular adenomas and carcinomas","aoNameRaw":"Increase, hepatocellular adenomas and carcinomas","keyEvents":[{"keId":774,"keName":"Increase, Preneoplastic foci (hepatocytes)"},{"keId":719,"keName":"Increase, hepatocellular adenomas and carcinomas"},{"keId":716,"keName":"Increase, cell proliferation (hepatocytes)"},{"keId":785,"keName":"Activation, Androgen receptor"}],"status":"Under Development","reference":"https://aopwiki.org/aops/117"}
{"aopId":118,"aopName":"Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat)","aoId":719,"aoName":"Increase hepatocellular adenomas and carcinomas","aoNameRaw":"Increase, hepatocellular adenomas and carcinomas","keyEvents":[{"keId":774,"keName":"Increase, Preneoplastic foci (hepatocytes)"},{"keId":719,"keName":"Increase, hepatocellular adenomas and carcinomas"},{"keId":787,"keName":"Increase, Regenerative cell proliferation (hepatocytes)"},{"keId":786,"keName":"Increase, Cytotoxicity (hepatocytes)"}],"reference":"https://aopwiki.org/aops/118"}
{"aopId":119,"aopName":"Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)","targetName":"iodotyrosine deiodinase 1 (mouse)","aoId":741,"aoName":"Increase Adenomas/carcinomas (follicular cell)","aoNameRaw":"Increase, Adenomas/carcinomas (follicular cell)","keyEvents":[{"keId":741,"keName":"Increase, Adenomas/carcinomas (follicular cell)"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":739,"keName":"Increase, Hypertrophy and proliferation (follicular cell)"},{"keId":771,"keName":"Decrease, Serum thyroid hormone (T4/T3)"},{"keId":740,"keName":"Increase, Hyperplasia (follicular cells)"},{"keId":753,"keName":"Increase, Thyroid-stimulating hormone (TSH)"},{"keId":788,"keName":"Decrease, Incorporation of active iodide into iodotyrosines"}],"reference":"https://aopwiki.org/aops/119"}
{"aopId":119,"aopName":"Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":741,"aoName":"Increase Adenomas/carcinomas (follicular cell)","aoNameRaw":"Increase, Adenomas/carcinomas (follicular cell)","keyEvents":[{"keId":741,"keName":"Increase, Adenomas/carcinomas (follicular cell)"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":739,"keName":"Increase, Hypertrophy and proliferation (follicular cell)"},{"keId":771,"keName":"Decrease, Serum thyroid hormone (T4/T3)"},{"keId":740,"keName":"Increase, Hyperplasia (follicular cells)"},{"keId":753,"keName":"Increase, Thyroid-stimulating hormone (TSH)"},{"keId":788,"keName":"Decrease, Incorporation of active iodide into iodotyrosines"}],"reference":"https://aopwiki.org/aops/119"}
{"aopId":119,"aopName":"Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)","aoId":741,"aoName":"Increase Adenomas/carcinomas (follicular cell)","aoNameRaw":"Increase, Adenomas/carcinomas (follicular cell)","keyEvents":[{"keId":741,"keName":"Increase, Adenomas/carcinomas (follicular cell)"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":739,"keName":"Increase, Hypertrophy and proliferation (follicular cell)"},{"keId":771,"keName":"Decrease, Serum thyroid hormone (T4/T3)"},{"keId":740,"keName":"Increase, Hyperplasia (follicular cells)"},{"keId":753,"keName":"Increase, Thyroid-stimulating hormone (TSH)"},{"keId":788,"keName":"Decrease, Incorporation of active iodide into iodotyrosines"}],"reference":"https://aopwiki.org/aops/119"}
{"aopId":120,"aopName":"Inhibition of 5α-reductase leading to Leydig cell tumors (in rat)","targetName":"3-oxo-5-alpha-steroid 4-dehydrogenase 2 (rat)","aoId":745,"aoName":"Increase Leydig cell tumors","aoNameRaw":"Increase, Leydig cell tumors","keyEvents":[{"keId":790,"keName":"Inhibition, 5α-reductase activity"},{"keId":792,"keName":"Decrease, Bioactivation of testosterone"},{"keId":791,"keName":"Increased, Leutinizing hormone (LH)"},{"keId":745,"keName":"Increase, Leydig cell tumors"},{"keId":744,"keName":"Increase, Hyperplasia (Leydig cells)"}],"reference":"https://aopwiki.org/aops/120"}
{"aopId":120,"aopName":"Inhibition of 5α-reductase leading to Leydig cell tumors (in rat)","aoId":745,"aoName":"Increase Leydig cell tumors","aoNameRaw":"Increase, Leydig cell tumors","keyEvents":[{"keId":790,"keName":"Inhibition, 5α-reductase activity"},{"keId":792,"keName":"Decrease, Bioactivation of testosterone"},{"keId":791,"keName":"Increased, Leutinizing hormone (LH)"},{"keId":745,"keName":"Increase, Leydig cell tumors"},{"keId":744,"keName":"Increase, Hyperplasia (Leydig cells)"}],"reference":"https://aopwiki.org/aops/120"}
{"aopId":121,"aopName":"Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat)","aoId":797,"aoName":"Increase Adenomas/carcinomas (urothelial)","aoNameRaw":"Increase, Adenomas/carcinomas (urothelial)","keyEvents":[{"keId":795,"keName":"Increase, Regenerative cell proliferation (urothelial cells)"},{"keId":794,"keName":"Increase, Cytotoxicity (urothelial cells)"},{"keId":796,"keName":"Increase, Hyperplasia (urothelial)"},{"keId":793,"keName":"Increase, Urinary bladder calculi"},{"keId":797,"keName":"Increase, Adenomas/carcinomas (urothelial)"}],"reference":"https://aopwiki.org/aops/121"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"hypoxia-inducible factor 1-alpha","targetId":"ENSG00000100644","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"hypoxia-inducible factor 1 (Caenorhabditis elegans)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"aromatase isoform 1","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"aromatase","targetId":"ENSG00000137869","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"hypoxia-inducible factor 1-alpha","targetId":"ENSG00000100644","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"hypoxia-inducible factor 1 (Caenorhabditis elegans)","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"aromatase isoform 1","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"aromatase","targetId":"ENSG00000137869","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"hypoxia-inducible factor 1-alpha","targetId":"ENSG00000100644","aoId":78,"keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"hypoxia-inducible factor 1 (Caenorhabditis elegans)","aoId":78,"keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","aoId":78,"keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"aromatase isoform 1","aoId":78,"keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":122,"aopName":"Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","targetName":"aromatase","targetId":"ENSG00000137869","aoId":78,"keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":798,"keName":"Inhibition, Prolyl hydroxylases"}],"reference":"https://aopwiki.org/aops/122"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"aromatase isoform 1","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"aromatase","targetId":"ENSG00000137869","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"hypoxia-inducible factor 1 (Caenorhabditis elegans)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"hypoxia-inducible factor 1-alpha","targetId":"ENSG00000100644","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"aromatase isoform 1","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"aromatase","targetId":"ENSG00000137869","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"hypoxia-inducible factor 1 (Caenorhabditis elegans)","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"hypoxia-inducible factor 1-alpha","targetId":"ENSG00000100644","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"aromatase isoform 1","aoId":78,"keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"aromatase","targetId":"ENSG00000137869","aoId":78,"keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"hypoxia-inducible factor 1 (Caenorhabditis elegans)","aoId":78,"keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","targetName":"hypoxia-inducible factor 1-alpha","targetId":"ENSG00000100644","aoId":78,"keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":123,"aopName":"Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","aoId":78,"keyEvents":[{"keId":799,"keName":"Increased, HIF-1 heterodimer"},{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":800,"keName":"Decreased, Aromatase (Cyp19a1) mRNA"},{"keId":802,"keName":"Increased, HIF-1 alpha transcription"},{"keId":801,"keName":"modulation, Unknown"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"reference":"https://aopwiki.org/aops/123"}
{"aopId":124,"aopName":"HMG-CoA reductase inhibition leading to decreased fertility","targetName":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","targetId":"ENSG00000113161","aoId":330,"aoName":"Decrease Fertility","aoNameRaw":"Decrease, Fertility","keyEvents":[{"keId":808,"keName":"Decreased, Testosterone"},{"keId":330,"keName":"Decrease, Fertility"},{"keId":805,"keName":"Decreased, mevalonate"},{"keId":807,"keName":"Decreased, cholesterol"},{"keId":809,"keName":"malformed, Male reproductive tract"},{"keId":804,"keName":"Inhibition, HMG-CoA reductase"}],"reference":"https://aopwiki.org/aops/124"}
{"aopId":124,"aopName":"HMG-CoA reductase inhibition leading to decreased fertility","aoId":330,"aoName":"Decrease Fertility","aoNameRaw":"Decrease, Fertility","keyEvents":[{"keId":808,"keName":"Decreased, Testosterone"},{"keId":330,"keName":"Decrease, Fertility"},{"keId":805,"keName":"Decreased, mevalonate"},{"keId":807,"keName":"Decreased, cholesterol"},{"keId":809,"keName":"malformed, Male reproductive tract"},{"keId":804,"keName":"Inhibition, HMG-CoA reductase"}],"reference":"https://aopwiki.org/aops/124"}
{"aopId":126,"aopName":"Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation","targetName":"proto-oncogene c-Fos (mouse)","aoId":527,"aoName":"Decreased Decreased fecundity","aoNameRaw":"Decreased, Decreased fecundity ","keyEvents":[{"keId":532,"keName":"Delayed, Ovulation"},{"keId":848,"keName":"Decreased, Binding of NE to NE receptors on GnRH neurons"},{"keId":533,"keName":"Decreased, Cortical granule release/distribution upon fertilization"},{"keId":849,"keName":"Inhibition, Antgonism of NE receptor"},{"keId":527,"keName":"Decreased, Decreased fecundity "},{"keId":534,"keName":"Altered, Formation of cortical envelope"},{"keId":536,"keName":"Altered, Chromosome number (polyploid) zygote"},{"keId":530,"keName":"Decreased, GnRH pulsatility/release"},{"keId":529,"keName":"Decreased, GnRH cfos activity"},{"keId":531,"keName":"Decreased, LH Surge"},{"keId":535,"keName":"Abnormal, Sperm penetration (polyspermy)"}],"reference":"https://aopwiki.org/aops/126"}
{"aopId":126,"aopName":"Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation","aoId":527,"aoName":"Decreased Decreased fecundity","aoNameRaw":"Decreased, Decreased fecundity ","keyEvents":[{"keId":532,"keName":"Delayed, Ovulation"},{"keId":848,"keName":"Decreased, Binding of NE to NE receptors on GnRH neurons"},{"keId":533,"keName":"Decreased, Cortical granule release/distribution upon fertilization"},{"keId":849,"keName":"Inhibition, Antgonism of NE receptor"},{"keId":527,"keName":"Decreased, Decreased fecundity "},{"keId":534,"keName":"Altered, Formation of cortical envelope"},{"keId":536,"keName":"Altered, Chromosome number (polyploid) zygote"},{"keId":530,"keName":"Decreased, GnRH pulsatility/release"},{"keId":529,"keName":"Decreased, GnRH cfos activity"},{"keId":531,"keName":"Decreased, LH Surge"},{"keId":535,"keName":"Abnormal, Sperm penetration (polyspermy)"}],"reference":"https://aopwiki.org/aops/126"}
{"aopId":126,"aopName":"Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation","targetName":"alpha-2A adrenergic receptor","targetId":"ENSG00000150594","aoId":527,"aoName":"Decreased Decreased fecundity","aoNameRaw":"Decreased, Decreased fecundity ","keyEvents":[{"keId":532,"keName":"Delayed, Ovulation"},{"keId":848,"keName":"Decreased, Binding of NE to NE receptors on GnRH neurons"},{"keId":533,"keName":"Decreased, Cortical granule release/distribution upon fertilization"},{"keId":849,"keName":"Inhibition, Antgonism of NE receptor"},{"keId":527,"keName":"Decreased, Decreased fecundity "},{"keId":534,"keName":"Altered, Formation of cortical envelope"},{"keId":536,"keName":"Altered, Chromosome number (polyploid) zygote"},{"keId":530,"keName":"Decreased, GnRH pulsatility/release"},{"keId":529,"keName":"Decreased, GnRH cfos activity"},{"keId":531,"keName":"Decreased, LH Surge"},{"keId":535,"keName":"Abnormal, Sperm penetration (polyspermy)"}],"reference":"https://aopwiki.org/aops/126"}
{"aopId":128,"aopName":"Kidney dysfunction by decreased thyroid hormone","aoId":814,"aoName":"Occurrence Kidney toxicity","aoNameRaw":"Occurrence, Kidney toxicity","keyEvents":[{"keId":814,"keName":"Occurrence, Kidney toxicity"},{"keId":824,"keName":"Occurrence, Cytoplasmic vacuolization (podocyte)"},{"keId":819,"keName":"Decreased, Glomerular filtration"},{"keId":813,"keName":"Increased, Serum creatinine"},{"keId":825,"keName":"Decreased, Renal ability to dilute urine"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":426,"keName":"Decreased, Thyroxine (T4) in serum"},{"keId":818,"keName":"Occurrence, Cytoplasmic vacuolization (Renal tubule)"},{"keId":823,"keName":"Occurrence, Cystic dilatation (renal tubule)"},{"keId":820,"keName":"Decreased, Renal plasma flow"},{"keId":821,"keName":"Decreased, Sodium reabsorption"}],"status":"Under Development","reference":"https://aopwiki.org/aops/128"}
{"aopId":130,"aopName":"Phospholipase A inhibitors lead to hepatotoxicity","targetName":"phospholipase A1 member A (human)","aoId":840,"aoName":"Formation Liver fibrosis","aoNameRaw":"Formation, Liver fibrosis","keyEvents":[{"keId":828,"keName":"Inhibition, Phospholipase A"},{"keId":840,"keName":"Formation, Liver fibrosis"},{"keId":836,"keName":"Occurrence, Cytoplasmic vacuolization (Bile duct cell)"},{"keId":831,"keName":"Disturbance, Lysosomal function"},{"keId":839,"keName":"Formation, Mallory body"},{"keId":838,"keName":"Induction, Microvesicular fat"},{"keId":829,"keName":"Damage, Lipid bilayer"},{"keId":833,"keName":"Occurrence, Cytoplasmic vacuolization (hepatocyte)"},{"keId":832,"keName":"Injury, Mitochondria"},{"keId":837,"keName":"Occurrence, Cytoplasmic vacuolization (kupffer cell)"},{"keId":835,"keName":"Occurrence, Ballooning degeneration (hepatocyte)"}],"status":"Under Development","reference":"https://aopwiki.org/aops/130"}
{"aopId":130,"aopName":"Phospholipase A inhibitors lead to hepatotoxicity","aoId":840,"aoName":"Formation Liver fibrosis","aoNameRaw":"Formation, Liver fibrosis","keyEvents":[{"keId":828,"keName":"Inhibition, Phospholipase A"},{"keId":840,"keName":"Formation, Liver fibrosis"},{"keId":836,"keName":"Occurrence, Cytoplasmic vacuolization (Bile duct cell)"},{"keId":831,"keName":"Disturbance, Lysosomal function"},{"keId":839,"keName":"Formation, Mallory body"},{"keId":838,"keName":"Induction, Microvesicular fat"},{"keId":829,"keName":"Damage, Lipid bilayer"},{"keId":833,"keName":"Occurrence, Cytoplasmic vacuolization (hepatocyte)"},{"keId":832,"keName":"Injury, Mitochondria"},{"keId":837,"keName":"Occurrence, Cytoplasmic vacuolization (kupffer cell)"},{"keId":835,"keName":"Occurrence, Ballooning degeneration (hepatocyte)"}],"status":"Under Development","reference":"https://aopwiki.org/aops/130"}
{"aopId":131,"aopName":"Aryl hydrocarbon receptor activation leading to uroporphyria","targetName":"uroporphyrinogen decarboxylase","targetId":"ENSG00000126088","aoId":369,"aoName":"Uroporphyria","aoNameRaw":"Uroporphyria","keyEvents":[{"keId":18,"keName":"Activation, AhR"},{"keId":846,"keName":"Accumulation, Highly carboxylated porphyrins"},{"keId":369,"keName":"Uroporphyria"},{"keId":845,"keName":"Inhibition, UROD"},{"keId":844,"keName":"Oxidation, Uroporphyrinogen"},{"keId":850,"keName":"Induction, CYP1A2/CYP1A5"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/131"}
{"aopId":131,"aopName":"Aryl hydrocarbon receptor activation leading to uroporphyria","aoId":369,"aoName":"Uroporphyria","aoNameRaw":"Uroporphyria","keyEvents":[{"keId":18,"keName":"Activation, AhR"},{"keId":846,"keName":"Accumulation, Highly carboxylated porphyrins"},{"keId":369,"keName":"Uroporphyria"},{"keId":845,"keName":"Inhibition, UROD"},{"keId":844,"keName":"Oxidation, Uroporphyrinogen"},{"keId":850,"keName":"Induction, CYP1A2/CYP1A5"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/131"}
{"aopId":131,"aopName":"Aryl hydrocarbon receptor activation leading to uroporphyria","targetName":"aryl hydrocarbon receptor","targetId":"ENSG00000106546","aoId":369,"aoName":"Uroporphyria","aoNameRaw":"Uroporphyria","keyEvents":[{"keId":18,"keName":"Activation, AhR"},{"keId":846,"keName":"Accumulation, Highly carboxylated porphyrins"},{"keId":369,"keName":"Uroporphyria"},{"keId":845,"keName":"Inhibition, UROD"},{"keId":844,"keName":"Oxidation, Uroporphyrinogen"},{"keId":850,"keName":"Induction, CYP1A2/CYP1A5"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/131"}
{"aopId":131,"aopName":"Aryl hydrocarbon receptor activation leading to uroporphyria","targetName":"cytochrome P450 1A5 (chicken)","aoId":369,"aoName":"Uroporphyria","aoNameRaw":"Uroporphyria","keyEvents":[{"keId":18,"keName":"Activation, AhR"},{"keId":846,"keName":"Accumulation, Highly carboxylated porphyrins"},{"keId":369,"keName":"Uroporphyria"},{"keId":845,"keName":"Inhibition, UROD"},{"keId":844,"keName":"Oxidation, Uroporphyrinogen"},{"keId":850,"keName":"Induction, CYP1A2/CYP1A5"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/131"}
{"aopId":131,"aopName":"Aryl hydrocarbon receptor activation leading to uroporphyria","targetName":"cytochrome P450 1A2","targetId":"ENSG00000140505","aoId":369,"aoName":"Uroporphyria","aoNameRaw":"Uroporphyria","keyEvents":[{"keId":18,"keName":"Activation, AhR"},{"keId":846,"keName":"Accumulation, Highly carboxylated porphyrins"},{"keId":369,"keName":"Uroporphyria"},{"keId":845,"keName":"Inhibition, UROD"},{"keId":844,"keName":"Oxidation, Uroporphyrinogen"},{"keId":850,"keName":"Induction, CYP1A2/CYP1A5"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/131"}
{"aopId":134,"aopName":"Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","targetName":"sodium/iodide cotransporter","targetId":"ENSG00000105641","aoId":402,"aoName":"Cognitive Function Decreased","aoNameRaw":"Cognitive Function, Decreased ","keyEvents":[{"keId":758,"keName":"Hippocampal Physiology, Altered"},{"keId":756,"keName":"Hippocampal gene expression, Altered "},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":402,"keName":"Cognitive Function, Decreased "},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":426,"keName":"Decreased, Thyroxine (T4) in serum"},{"keId":757,"keName":"Hippocampal anatomy, Altered "},{"keId":425,"keName":"Decrease of Thyroidal iodide"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "}],"reference":"https://aopwiki.org/aops/134"}
{"aopId":134,"aopName":"Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","aoId":402,"aoName":"Cognitive Function Decreased","aoNameRaw":"Cognitive Function, Decreased ","keyEvents":[{"keId":758,"keName":"Hippocampal Physiology, Altered"},{"keId":756,"keName":"Hippocampal gene expression, Altered "},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":402,"keName":"Cognitive Function, Decreased "},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":426,"keName":"Decreased, Thyroxine (T4) in serum"},{"keId":757,"keName":"Hippocampal anatomy, Altered "},{"keId":425,"keName":"Decrease of Thyroidal iodide"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "}],"reference":"https://aopwiki.org/aops/134"}
{"aopId":136,"aopName":"Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors","aoId":872,"aoName":"Increase Site of Contact Nasal Tumors","aoNameRaw":"Increase, Site of Contact Nasal Tumors","keyEvents":[{"keId":867,"keName":"Decrease, Intracellular pH"},{"keId":876,"keName":"Increase, Mutations in Critical Genes"},{"keId":868,"keName":"Increase, Tissue Degeneration, Necrosis & Atrophy "},{"keId":872,"keName":"Increase, Site of Contact Nasal Tumors"},{"keId":869,"keName":"Increase, Respiratory or Squamous Metaplasia"},{"keId":870,"keName":"Increase, Cell Proliferation"},{"keId":768,"keName":"Increase, Cytotoxicity"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/136"}
{"aopId":138,"aopName":"Organic anion transporter (OAT1) inhibition leading to renal failure and mortality","targetName":"solute carrier family 22 member 6","targetId":"ENSG00000197901","aoId":361,"aoName":"Decline Population","aoNameRaw":"Decline, Population","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1106,"keName":"Occurrence, cardiac arrhythmia"},{"keId":1097,"keName":"Occurrence, renal proximal tubular necrosis"},{"keId":877,"keName":"Inhibition, organic anion transporter 1 (OAT1)"},{"keId":1096,"keName":"Increased, blood uric acid concentration"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1098,"keName":"Increased, blood potassium concentration"},{"keId":1102,"keName":"Occurrence, tophi (urate) deposition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/138"}
{"aopId":138,"aopName":"Organic anion transporter (OAT1) inhibition leading to renal failure and mortality","aoId":361,"aoName":"Decline Population","aoNameRaw":"Decline, Population","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1106,"keName":"Occurrence, cardiac arrhythmia"},{"keId":1097,"keName":"Occurrence, renal proximal tubular necrosis"},{"keId":877,"keName":"Inhibition, organic anion transporter 1 (OAT1)"},{"keId":1096,"keName":"Increased, blood uric acid concentration"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1098,"keName":"Increased, blood potassium concentration"},{"keId":1102,"keName":"Occurrence, tophi (urate) deposition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/138"}
{"aopId":138,"aopName":"Organic anion transporter (OAT1) inhibition leading to renal failure and mortality","targetName":"solute carrier family 22 member 6","targetId":"ENSG00000197901","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1106,"keName":"Occurrence, cardiac arrhythmia"},{"keId":1097,"keName":"Occurrence, renal proximal tubular necrosis"},{"keId":877,"keName":"Inhibition, organic anion transporter 1 (OAT1)"},{"keId":1096,"keName":"Increased, blood uric acid concentration"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1098,"keName":"Increased, blood potassium concentration"},{"keId":1102,"keName":"Occurrence, tophi (urate) deposition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/138"}
{"aopId":138,"aopName":"Organic anion transporter (OAT1) inhibition leading to renal failure and mortality","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1106,"keName":"Occurrence, cardiac arrhythmia"},{"keId":1097,"keName":"Occurrence, renal proximal tubular necrosis"},{"keId":877,"keName":"Inhibition, organic anion transporter 1 (OAT1)"},{"keId":1096,"keName":"Increased, blood uric acid concentration"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1098,"keName":"Increased, blood potassium concentration"},{"keId":1102,"keName":"Occurrence, tophi (urate) deposition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/138"}
{"aopId":139,"aopName":"Alkylation of DNA leading to cancer 1","aoId":885,"aoName":"Increase Cancer","aoNameRaw":"Increase, Cancer","keyEvents":[{"keId":185,"keName":"Increase, Mutations"},{"keId":97,"keName":"Alkylation, DNA"},{"keId":155,"keName":"N/A, Inadequate DNA repair"},{"keId":885,"keName":"Increase, Cancer"}],"reference":"https://aopwiki.org/aops/139"}
{"aopId":141,"aopName":"Alkylation of DNA leading to cancer 2","aoId":885,"aoName":"Increase Cancer","aoNameRaw":"Increase, Cancer","keyEvents":[{"keId":185,"keName":"Increase, Mutations"},{"keId":97,"keName":"Alkylation, DNA"},{"keId":155,"keName":"N/A, Inadequate DNA repair"},{"keId":885,"keName":"Increase, Cancer"}],"reference":"https://aopwiki.org/aops/141"}
{"aopId":144,"aopName":"Endocytic lysosomal uptake leading to liver fibrosis","aoId":344,"aoName":"Liver fibrosis","aoNameRaw":"N/A, Liver fibrosis","aoMappedId":"HP_0001395","keyEvents":[{"keId":68,"keName":"Accumulation, Collagen"},{"keId":898,"keName":"Disruption, Lysosome"},{"keId":1539,"keName":"Endocytotic lysosomal uptake"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":265,"keName":"Activation, Stellate cells"},{"keId":344,"keName":"N/A, Liver fibrosis"},{"keId":55,"keName":"Cell injury/death"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/144"}
{"aopId":148,"aopName":"EGFR Activation Leading to Decreased Lung Function","targetName":"mucin-5AC","targetId":"ENSG00000215182","aoId":1250,"aoName":"Decrease Lung function","aoNameRaw":"Decrease, Lung function","keyEvents":[{"keId":919,"keName":"Occurrence, Transdifferentiation of ciliated epithelial cells"},{"keId":1250,"keName":"Decrease, Lung function"},{"keId":920,"keName":"Occurrence, Metaplasia of goblet cells"},{"keId":914,"keName":"Decrease, Apoptosis of ciliated epithelial cells"},{"keId":921,"keName":"Occurrence, Hyperplasia of goblet cells"},{"keId":1251,"keName":"Chronic, Mucus hypersecretion"},{"keId":923,"keName":"Increase, Proliferation of goblet cells"},{"keId":924,"keName":"Activation, Sp1"},{"keId":962,"keName":"Increase, Mucin production"},{"keId":941,"keName":"Activation, EGFR"}],"status":"Under Development","reference":"https://aopwiki.org/aops/148"}
{"aopId":148,"aopName":"EGFR Activation Leading to Decreased Lung Function","targetName":"transcription factor Sp1","targetId":"ENSG00000185591","aoId":1250,"aoName":"Decrease Lung function","aoNameRaw":"Decrease, Lung function","keyEvents":[{"keId":919,"keName":"Occurrence, Transdifferentiation of ciliated epithelial cells"},{"keId":1250,"keName":"Decrease, Lung function"},{"keId":920,"keName":"Occurrence, Metaplasia of goblet cells"},{"keId":914,"keName":"Decrease, Apoptosis of ciliated epithelial cells"},{"keId":921,"keName":"Occurrence, Hyperplasia of goblet cells"},{"keId":1251,"keName":"Chronic, Mucus hypersecretion"},{"keId":923,"keName":"Increase, Proliferation of goblet cells"},{"keId":924,"keName":"Activation, Sp1"},{"keId":962,"keName":"Increase, Mucin production"},{"keId":941,"keName":"Activation, EGFR"}],"status":"Under Development","reference":"https://aopwiki.org/aops/148"}
{"aopId":148,"aopName":"EGFR Activation Leading to Decreased Lung Function","targetName":"epidermal growth factor receptor","targetId":"ENSG00000146648","aoId":1250,"aoName":"Decrease Lung function","aoNameRaw":"Decrease, Lung function","keyEvents":[{"keId":919,"keName":"Occurrence, Transdifferentiation of ciliated epithelial cells"},{"keId":1250,"keName":"Decrease, Lung function"},{"keId":920,"keName":"Occurrence, Metaplasia of goblet cells"},{"keId":914,"keName":"Decrease, Apoptosis of ciliated epithelial cells"},{"keId":921,"keName":"Occurrence, Hyperplasia of goblet cells"},{"keId":1251,"keName":"Chronic, Mucus hypersecretion"},{"keId":923,"keName":"Increase, Proliferation of goblet cells"},{"keId":924,"keName":"Activation, Sp1"},{"keId":962,"keName":"Increase, Mucin production"},{"keId":941,"keName":"Activation, EGFR"}],"status":"Under Development","reference":"https://aopwiki.org/aops/148"}
{"aopId":148,"aopName":"EGFR Activation Leading to Decreased Lung Function","aoId":1250,"aoName":"Decrease Lung function","aoNameRaw":"Decrease, Lung function","keyEvents":[{"keId":919,"keName":"Occurrence, Transdifferentiation of ciliated epithelial cells"},{"keId":1250,"keName":"Decrease, Lung function"},{"keId":920,"keName":"Occurrence, Metaplasia of goblet cells"},{"keId":914,"keName":"Decrease, Apoptosis of ciliated epithelial cells"},{"keId":921,"keName":"Occurrence, Hyperplasia of goblet cells"},{"keId":1251,"keName":"Chronic, Mucus hypersecretion"},{"keId":923,"keName":"Increase, Proliferation of goblet cells"},{"keId":924,"keName":"Activation, Sp1"},{"keId":962,"keName":"Increase, Mucin production"},{"keId":941,"keName":"Activation, EGFR"}],"status":"Under Development","reference":"https://aopwiki.org/aops/148"}
{"aopId":149,"aopName":"Peptide Oxidation Leading to Hypertension","targetName":"AKT kinase","aoId":952,"aoName":"Hypertension","aoNameRaw":"Hypertension","aoMappedId":"EFO_0000537","keyEvents":[{"keId":937,"keName":"KE7 : Impaired, Vasodilation"},{"keId":209,"keName":"Peptide Oxidation"},{"keId":933,"keName":"KE6 : Depletion, Nitric Oxide"},{"keId":952,"keName":"Hypertension"},{"keId":951,"keName":"KE8 : Increase, Vascular Resistance"},{"keId":935,"keName":"KE2 : Decrease, GTPCH-1"},{"keId":927,"keName":"KE1 : S-Glutathionylation, eNOS"},{"keId":934,"keName":"KE3 : Decrease, Tetrahydrobiopterin"},{"keId":973,"keName":"KE5 : Decrease, AKT/eNOS activity"},{"keId":932,"keName":"KE4 : Uncoupling, eNOS"}],"status":"Under Development","reference":"https://aopwiki.org/aops/149"}
{"aopId":149,"aopName":"Peptide Oxidation Leading to Hypertension","targetName":"GTP cyclohydrolase 1","targetId":"ENSG00000131979","aoId":952,"aoName":"Hypertension","aoNameRaw":"Hypertension","aoMappedId":"EFO_0000537","keyEvents":[{"keId":937,"keName":"KE7 : Impaired, Vasodilation"},{"keId":209,"keName":"Peptide Oxidation"},{"keId":933,"keName":"KE6 : Depletion, Nitric Oxide"},{"keId":952,"keName":"Hypertension"},{"keId":951,"keName":"KE8 : Increase, Vascular Resistance"},{"keId":935,"keName":"KE2 : Decrease, GTPCH-1"},{"keId":927,"keName":"KE1 : S-Glutathionylation, eNOS"},{"keId":934,"keName":"KE3 : Decrease, Tetrahydrobiopterin"},{"keId":973,"keName":"KE5 : Decrease, AKT/eNOS activity"},{"keId":932,"keName":"KE4 : Uncoupling, eNOS"}],"status":"Under Development","reference":"https://aopwiki.org/aops/149"}
{"aopId":149,"aopName":"Peptide Oxidation Leading to Hypertension","targetName":"nitric oxide synthase, endothelial","targetId":"ENSG00000164867","aoId":952,"aoName":"Hypertension","aoNameRaw":"Hypertension","aoMappedId":"EFO_0000537","keyEvents":[{"keId":937,"keName":"KE7 : Impaired, Vasodilation"},{"keId":209,"keName":"Peptide Oxidation"},{"keId":933,"keName":"KE6 : Depletion, Nitric Oxide"},{"keId":952,"keName":"Hypertension"},{"keId":951,"keName":"KE8 : Increase, Vascular Resistance"},{"keId":935,"keName":"KE2 : Decrease, GTPCH-1"},{"keId":927,"keName":"KE1 : S-Glutathionylation, eNOS"},{"keId":934,"keName":"KE3 : Decrease, Tetrahydrobiopterin"},{"keId":973,"keName":"KE5 : Decrease, AKT/eNOS activity"},{"keId":932,"keName":"KE4 : Uncoupling, eNOS"}],"status":"Under Development","reference":"https://aopwiki.org/aops/149"}
{"aopId":149,"aopName":"Peptide Oxidation Leading to Hypertension","aoId":952,"aoName":"Hypertension","aoNameRaw":"Hypertension","aoMappedId":"EFO_0000537","keyEvents":[{"keId":937,"keName":"KE7 : Impaired, Vasodilation"},{"keId":209,"keName":"Peptide Oxidation"},{"keId":933,"keName":"KE6 : Depletion, Nitric Oxide"},{"keId":952,"keName":"Hypertension"},{"keId":951,"keName":"KE8 : Increase, Vascular Resistance"},{"keId":935,"keName":"KE2 : Decrease, GTPCH-1"},{"keId":927,"keName":"KE1 : S-Glutathionylation, eNOS"},{"keId":934,"keName":"KE3 : Decrease, Tetrahydrobiopterin"},{"keId":973,"keName":"KE5 : Decrease, AKT/eNOS activity"},{"keId":932,"keName":"KE4 : Uncoupling, eNOS"}],"status":"Under Development","reference":"https://aopwiki.org/aops/149"}
{"aopId":150,"aopName":"Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","targetName":"hypoxia-inducible factor 1-alpha","targetId":"ENSG00000100644","aoId":947,"keyEvents":[{"keId":947,"keName":"Increase, Early Life Stage Mortality"},{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":317,"keName":"Altered, Cardiovascular development/function"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":18,"keName":"Activation, AhR"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/150"}
{"aopId":150,"aopName":"Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","targetName":"aryl hydrocarbon receptor nuclear translocator","targetId":"ENSG00000143437","aoId":947,"keyEvents":[{"keId":947,"keName":"Increase, Early Life Stage Mortality"},{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":317,"keName":"Altered, Cardiovascular development/function"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":18,"keName":"Activation, AhR"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/150"}
{"aopId":150,"aopName":"Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","aoId":947,"keyEvents":[{"keId":947,"keName":"Increase, Early Life Stage Mortality"},{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":317,"keName":"Altered, Cardiovascular development/function"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":18,"keName":"Activation, AhR"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/150"}
{"aopId":150,"aopName":"Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","targetName":"aryl hydrocarbon receptor","targetId":"ENSG00000106546","aoId":947,"keyEvents":[{"keId":947,"keName":"Increase, Early Life Stage Mortality"},{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":317,"keName":"Altered, Cardiovascular development/function"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":18,"keName":"Activation, AhR"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/150"}
{"aopId":150,"aopName":"Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","targetName":"vascular endothelial growth factor A","targetId":"ENSG00000112715","aoId":947,"keyEvents":[{"keId":947,"keName":"Increase, Early Life Stage Mortality"},{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":317,"keName":"Altered, Cardiovascular development/function"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":18,"keName":"Activation, AhR"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/150"}
{"aopId":150,"aopName":"Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","targetName":"hypoxia-inducible factor 1-alpha","targetId":"ENSG00000100644","aoId":947,"aoName":"Increase Early Life Stage Mortality","aoNameRaw":"Increase, Early Life Stage Mortality","keyEvents":[{"keId":947,"keName":"Increase, Early Life Stage Mortality"},{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":317,"keName":"Altered, Cardiovascular development/function"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":18,"keName":"Activation, AhR"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/150"}
{"aopId":150,"aopName":"Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","targetName":"aryl hydrocarbon receptor nuclear translocator","targetId":"ENSG00000143437","aoId":947,"aoName":"Increase Early Life Stage Mortality","aoNameRaw":"Increase, Early Life Stage Mortality","keyEvents":[{"keId":947,"keName":"Increase, Early Life Stage Mortality"},{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":317,"keName":"Altered, Cardiovascular development/function"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":18,"keName":"Activation, AhR"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/150"}
{"aopId":150,"aopName":"Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","aoId":947,"aoName":"Increase Early Life Stage Mortality","aoNameRaw":"Increase, Early Life Stage Mortality","keyEvents":[{"keId":947,"keName":"Increase, Early Life Stage Mortality"},{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":317,"keName":"Altered, Cardiovascular development/function"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":18,"keName":"Activation, AhR"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/150"}
{"aopId":150,"aopName":"Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","targetName":"aryl hydrocarbon receptor","targetId":"ENSG00000106546","aoId":947,"aoName":"Increase Early Life Stage Mortality","aoNameRaw":"Increase, Early Life Stage Mortality","keyEvents":[{"keId":947,"keName":"Increase, Early Life Stage Mortality"},{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":317,"keName":"Altered, Cardiovascular development/function"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":18,"keName":"Activation, AhR"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/150"}
{"aopId":150,"aopName":"Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","targetName":"vascular endothelial growth factor A","targetId":"ENSG00000112715","aoId":947,"aoName":"Increase Early Life Stage Mortality","aoNameRaw":"Increase, Early Life Stage Mortality","keyEvents":[{"keId":947,"keName":"Increase, Early Life Stage Mortality"},{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":317,"keName":"Altered, Cardiovascular development/function"},{"keId":110,"keName":"Impairment, Endothelial network"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":18,"keName":"Activation, AhR"}],"status":"TFHA/WNT Endorsed","reference":"https://aopwiki.org/aops/150"}
{"aopId":151,"aopName":"AhR activation leading to preeclampsia","targetName":"vascular endothelial growth factor A","targetId":"ENSG00000112715","aoId":1893,"aoName":"increase Preeclampsia","aoNameRaw":"increase, Preeclampsia","keyEvents":[{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":1892,"keName":"increase, placental insufficiency"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":1893,"keName":"increase, Preeclampsia"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":1891,"keName":"abnormal, placental labyrinth vasculature morphology"},{"keId":18,"keName":"Activation, AhR"}],"status":"Under Development","reference":"https://aopwiki.org/aops/151"}
{"aopId":151,"aopName":"AhR activation leading to preeclampsia","targetName":"hypoxia-inducible factor 1-alpha","targetId":"ENSG00000100644","aoId":1893,"aoName":"increase Preeclampsia","aoNameRaw":"increase, Preeclampsia","keyEvents":[{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":1892,"keName":"increase, placental insufficiency"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":1893,"keName":"increase, Preeclampsia"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":1891,"keName":"abnormal, placental labyrinth vasculature morphology"},{"keId":18,"keName":"Activation, AhR"}],"status":"Under Development","reference":"https://aopwiki.org/aops/151"}
{"aopId":151,"aopName":"AhR activation leading to preeclampsia","targetName":"aryl hydrocarbon receptor nuclear translocator","targetId":"ENSG00000143437","aoId":1893,"aoName":"increase Preeclampsia","aoNameRaw":"increase, Preeclampsia","keyEvents":[{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":1892,"keName":"increase, placental insufficiency"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":1893,"keName":"increase, Preeclampsia"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":1891,"keName":"abnormal, placental labyrinth vasculature morphology"},{"keId":18,"keName":"Activation, AhR"}],"status":"Under Development","reference":"https://aopwiki.org/aops/151"}
{"aopId":151,"aopName":"AhR activation leading to preeclampsia","targetName":"aryl hydrocarbon receptor","targetId":"ENSG00000106546","aoId":1893,"aoName":"increase Preeclampsia","aoNameRaw":"increase, Preeclampsia","keyEvents":[{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":1892,"keName":"increase, placental insufficiency"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":1893,"keName":"increase, Preeclampsia"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":1891,"keName":"abnormal, placental labyrinth vasculature morphology"},{"keId":18,"keName":"Activation, AhR"}],"status":"Under Development","reference":"https://aopwiki.org/aops/151"}
{"aopId":151,"aopName":"AhR activation leading to preeclampsia","aoId":1893,"aoName":"increase Preeclampsia","aoNameRaw":"increase, Preeclampsia","keyEvents":[{"keId":945,"keName":"reduced dimerization, ARNT/HIF1-alpha"},{"keId":1892,"keName":"increase, placental insufficiency"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":1893,"keName":"increase, Preeclampsia"},{"keId":948,"keName":"reduced production, VEGF"},{"keId":1891,"keName":"abnormal, placental labyrinth vasculature morphology"},{"keId":18,"keName":"Activation, AhR"}],"status":"Under Development","reference":"https://aopwiki.org/aops/151"}
{"aopId":152,"aopName":"Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity ","targetName":"transthyretin","targetId":"ENSG00000118271","aoId":402,"aoName":"Cognitive Function Decreased","aoNameRaw":"Cognitive Function, Decreased ","keyEvents":[{"keId":958,"keName":"Displacement, Serum thyroxine (T4) from transthyretin"},{"keId":758,"keName":"Hippocampal Physiology, Altered"},{"keId":961,"keName":"Increased, Clearance of thyroxine from serum"},{"keId":756,"keName":"Hippocampal gene expression, Altered "},{"keId":960,"keName":"Increased, Uptake of thyroxine into tissue"},{"keId":959,"keName":"Increased, Free serum thyroxine (T4)"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":402,"keName":"Cognitive Function, Decreased "},{"keId":957,"keName":"Binding, Transthyretin in serum"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":757,"keName":"Hippocampal anatomy, Altered "}],"status":"Under Development","reference":"https://aopwiki.org/aops/152"}
{"aopId":152,"aopName":"Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity ","aoId":402,"aoName":"Cognitive Function Decreased","aoNameRaw":"Cognitive Function, Decreased ","keyEvents":[{"keId":958,"keName":"Displacement, Serum thyroxine (T4) from transthyretin"},{"keId":758,"keName":"Hippocampal Physiology, Altered"},{"keId":961,"keName":"Increased, Clearance of thyroxine from serum"},{"keId":756,"keName":"Hippocampal gene expression, Altered "},{"keId":960,"keName":"Increased, Uptake of thyroxine into tissue"},{"keId":959,"keName":"Increased, Free serum thyroxine (T4)"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":402,"keName":"Cognitive Function, Decreased "},{"keId":957,"keName":"Binding, Transthyretin in serum"},{"keId":280,"keName":"Thyroxine (T4) in neuronal tissue, Decreased "},{"keId":757,"keName":"Hippocampal anatomy, Altered "}],"status":"Under Development","reference":"https://aopwiki.org/aops/152"}
{"aopId":153,"aopName":"Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats","targetName":"metastasis-suppressor KiSS-1 (rat)","aoId":972,"aoName":"Decreased fertility Reduced number of oocytes ovulated","aoNameRaw":"Decreased fertility, Reduced number of oocytes ovulated ","keyEvents":[{"keId":967,"keName":"Decreased positive estrogenic feedback on hypothalamus, Reduced estradiol in circulation decreases estrogen concentration at hypothalamus"},{"keId":972,"keName":"Decreased fertility, Reduced number of oocytes ovulated "},{"keId":964,"keName":"Inhibition of Aromatase Enzyme, Chemical exposure during critical window of estrous cycle between diestrus 2 and proestrus inhibits aromatase conversion of testosterone to estradiol"},{"keId":965,"keName":"reduction in ovarian granulosa cells synthesis of estradiol, Reduced steroidogenic production of estradiol in granulosa cells"},{"keId":966,"keName":"Reduced Estradiol in Circulation, Reduced steroidogenic production of estradiol in granulosa cells leading to decreased estradiol in circulation"},{"keId":971,"keName":"Ovulation of oocytes Reduced, Delayed, or Blocked, Decrease or delay in LH surge required for ovulation "},{"keId":969,"keName":"Decreased GnRH Release, Decreased Kisspeptin stimulation of GnRH neurons "},{"keId":970,"keName":"Decreased LH release from Anterior Pituitary, Decreased GnRH stimulation of Anterior Pituitary Gonadotrophs"},{"keId":968,"keName":"Decreased Kisspeptin release from neurons in AVPV, Decreased hypothalamic estrogen reduces kisspeptinergic neuron response "}],"reference":"https://aopwiki.org/aops/153"}
{"aopId":153,"aopName":"Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats","targetName":"aromatase","targetId":"ENSG00000137869","aoId":972,"aoName":"Decreased fertility Reduced number of oocytes ovulated","aoNameRaw":"Decreased fertility, Reduced number of oocytes ovulated ","keyEvents":[{"keId":967,"keName":"Decreased positive estrogenic feedback on hypothalamus, Reduced estradiol in circulation decreases estrogen concentration at hypothalamus"},{"keId":972,"keName":"Decreased fertility, Reduced number of oocytes ovulated "},{"keId":964,"keName":"Inhibition of Aromatase Enzyme, Chemical exposure during critical window of estrous cycle between diestrus 2 and proestrus inhibits aromatase conversion of testosterone to estradiol"},{"keId":965,"keName":"reduction in ovarian granulosa cells synthesis of estradiol, Reduced steroidogenic production of estradiol in granulosa cells"},{"keId":966,"keName":"Reduced Estradiol in Circulation, Reduced steroidogenic production of estradiol in granulosa cells leading to decreased estradiol in circulation"},{"keId":971,"keName":"Ovulation of oocytes Reduced, Delayed, or Blocked, Decrease or delay in LH surge required for ovulation "},{"keId":969,"keName":"Decreased GnRH Release, Decreased Kisspeptin stimulation of GnRH neurons "},{"keId":970,"keName":"Decreased LH release from Anterior Pituitary, Decreased GnRH stimulation of Anterior Pituitary Gonadotrophs"},{"keId":968,"keName":"Decreased Kisspeptin release from neurons in AVPV, Decreased hypothalamic estrogen reduces kisspeptinergic neuron response "}],"reference":"https://aopwiki.org/aops/153"}
{"aopId":153,"aopName":"Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats","aoId":972,"aoName":"Decreased fertility Reduced number of oocytes ovulated","aoNameRaw":"Decreased fertility, Reduced number of oocytes ovulated ","keyEvents":[{"keId":967,"keName":"Decreased positive estrogenic feedback on hypothalamus, Reduced estradiol in circulation decreases estrogen concentration at hypothalamus"},{"keId":972,"keName":"Decreased fertility, Reduced number of oocytes ovulated "},{"keId":964,"keName":"Inhibition of Aromatase Enzyme, Chemical exposure during critical window of estrous cycle between diestrus 2 and proestrus inhibits aromatase conversion of testosterone to estradiol"},{"keId":965,"keName":"reduction in ovarian granulosa cells synthesis of estradiol, Reduced steroidogenic production of estradiol in granulosa cells"},{"keId":966,"keName":"Reduced Estradiol in Circulation, Reduced steroidogenic production of estradiol in granulosa cells leading to decreased estradiol in circulation"},{"keId":971,"keName":"Ovulation of oocytes Reduced, Delayed, or Blocked, Decrease or delay in LH surge required for ovulation "},{"keId":969,"keName":"Decreased GnRH Release, Decreased Kisspeptin stimulation of GnRH neurons "},{"keId":970,"keName":"Decreased LH release from Anterior Pituitary, Decreased GnRH stimulation of Anterior Pituitary Gonadotrophs"},{"keId":968,"keName":"Decreased Kisspeptin release from neurons in AVPV, Decreased hypothalamic estrogen reduces kisspeptinergic neuron response "}],"reference":"https://aopwiki.org/aops/153"}
{"aopId":154,"aopName":"Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response","targetName":"interleukin-4","targetId":"ENSG00000113520","aoId":984,"aoName":"Impairment T-cell dependent antibody response","aoNameRaw":"Impairment, T-cell dependent antibody response","keyEvents":[{"keId":979,"keName":"Interference, nuclear localization of NFAT"},{"keId":1202,"keName":"Suppression, IL-2 and IL-4 production"},{"keId":980,"keName":"Inhibition, Calcineurin Activity"},{"keId":984,"keName":"Impairment, T-cell dependent antibody response"},{"keId":981,"keName":"Reduction, NFAT/AP-1 complex formation"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/154"}
{"aopId":154,"aopName":"Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response","targetName":"interleukin-2","targetId":"ENSG00000109471","aoId":984,"aoName":"Impairment T-cell dependent antibody response","aoNameRaw":"Impairment, T-cell dependent antibody response","keyEvents":[{"keId":979,"keName":"Interference, nuclear localization of NFAT"},{"keId":1202,"keName":"Suppression, IL-2 and IL-4 production"},{"keId":980,"keName":"Inhibition, Calcineurin Activity"},{"keId":984,"keName":"Impairment, T-cell dependent antibody response"},{"keId":981,"keName":"Reduction, NFAT/AP-1 complex formation"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/154"}
{"aopId":154,"aopName":"Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response","targetName":"NFAT activation molecule 1","targetId":"ENSG00000235568","aoId":984,"aoName":"Impairment T-cell dependent antibody response","aoNameRaw":"Impairment, T-cell dependent antibody response","keyEvents":[{"keId":979,"keName":"Interference, nuclear localization of NFAT"},{"keId":1202,"keName":"Suppression, IL-2 and IL-4 production"},{"keId":980,"keName":"Inhibition, Calcineurin Activity"},{"keId":984,"keName":"Impairment, T-cell dependent antibody response"},{"keId":981,"keName":"Reduction, NFAT/AP-1 complex formation"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/154"}
{"aopId":154,"aopName":"Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response","aoId":984,"aoName":"Impairment T-cell dependent antibody response","aoNameRaw":"Impairment, T-cell dependent antibody response","keyEvents":[{"keId":979,"keName":"Interference, nuclear localization of NFAT"},{"keId":1202,"keName":"Suppression, IL-2 and IL-4 production"},{"keId":980,"keName":"Inhibition, Calcineurin Activity"},{"keId":984,"keName":"Impairment, T-cell dependent antibody response"},{"keId":981,"keName":"Reduction, NFAT/AP-1 complex formation"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/154"}
{"aopId":154,"aopName":"Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response","targetName":"FK506-binding protein 15","targetId":"ENSG00000119321","aoId":984,"aoName":"Impairment T-cell dependent antibody response","aoNameRaw":"Impairment, T-cell dependent antibody response","keyEvents":[{"keId":979,"keName":"Interference, nuclear localization of NFAT"},{"keId":1202,"keName":"Suppression, IL-2 and IL-4 production"},{"keId":980,"keName":"Inhibition, Calcineurin Activity"},{"keId":984,"keName":"Impairment, T-cell dependent antibody response"},{"keId":981,"keName":"Reduction, NFAT/AP-1 complex formation"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/154"}
{"aopId":154,"aopName":"Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response","targetName":"NFAT protein","aoId":984,"aoName":"Impairment T-cell dependent antibody response","aoNameRaw":"Impairment, T-cell dependent antibody response","keyEvents":[{"keId":979,"keName":"Interference, nuclear localization of NFAT"},{"keId":1202,"keName":"Suppression, IL-2 and IL-4 production"},{"keId":980,"keName":"Inhibition, Calcineurin Activity"},{"keId":984,"keName":"Impairment, T-cell dependent antibody response"},{"keId":981,"keName":"Reduction, NFAT/AP-1 complex formation"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/154"}
{"aopId":155,"aopName":"Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation","targetName":"type II iodothyronine deiodinase","targetId":"ENSG00000211448","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1002,"keName":"Inhibition, Deiodinase 2"},{"keId":1004,"keName":"Reduced, Posterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/155"}
{"aopId":155,"aopName":"Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1002,"keName":"Inhibition, Deiodinase 2"},{"keId":1004,"keName":"Reduced, Posterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/155"}
{"aopId":155,"aopName":"Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation","targetName":"type II iodothyronine deiodinase","targetId":"ENSG00000211448","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1002,"keName":"Inhibition, Deiodinase 2"},{"keId":1004,"keName":"Reduced, Posterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/155"}
{"aopId":155,"aopName":"Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1002,"keName":"Inhibition, Deiodinase 2"},{"keId":1004,"keName":"Reduced, Posterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/155"}
{"aopId":156,"aopName":"Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation","targetName":"type II iodothyronine deiodinase","targetId":"ENSG00000211448","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1002,"keName":"Inhibition, Deiodinase 2"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/156"}
{"aopId":156,"aopName":"Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1002,"keName":"Inhibition, Deiodinase 2"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/156"}
{"aopId":156,"aopName":"Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation","targetName":"type II iodothyronine deiodinase","targetId":"ENSG00000211448","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1002,"keName":"Inhibition, Deiodinase 2"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/156"}
{"aopId":156,"aopName":"Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1002,"keName":"Inhibition, Deiodinase 2"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/156"}
{"aopId":157,"aopName":"Deiodinase 1 inhibition leading to increased mortality via reduced posterior swim bladder inflation ","targetName":"type I iodothyronine deiodinase","targetId":"ENSG00000211452","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1004,"keName":"Reduced, Posterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":1009,"keName":"Inhibition, Deiodinase 1"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/157"}
{"aopId":157,"aopName":"Deiodinase 1 inhibition leading to increased mortality via reduced posterior swim bladder inflation ","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1004,"keName":"Reduced, Posterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":1009,"keName":"Inhibition, Deiodinase 1"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/157"}
{"aopId":157,"aopName":"Deiodinase 1 inhibition leading to increased mortality via reduced posterior swim bladder inflation ","targetName":"type I iodothyronine deiodinase","targetId":"ENSG00000211452","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1004,"keName":"Reduced, Posterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":1009,"keName":"Inhibition, Deiodinase 1"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/157"}
{"aopId":157,"aopName":"Deiodinase 1 inhibition leading to increased mortality via reduced posterior swim bladder inflation ","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1004,"keName":"Reduced, Posterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":1009,"keName":"Inhibition, Deiodinase 1"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/157"}
{"aopId":158,"aopName":"Deiodinase 1 inhibition leading to increased mortality via reduced anterior swim bladder inflation","targetName":"type I iodothyronine deiodinase","targetId":"ENSG00000211452","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":1009,"keName":"Inhibition, Deiodinase 1"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/158"}
{"aopId":158,"aopName":"Deiodinase 1 inhibition leading to increased mortality via reduced anterior swim bladder inflation","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":1009,"keName":"Inhibition, Deiodinase 1"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/158"}
{"aopId":158,"aopName":"Deiodinase 1 inhibition leading to increased mortality via reduced anterior swim bladder inflation","targetName":"type I iodothyronine deiodinase","targetId":"ENSG00000211452","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":1009,"keName":"Inhibition, Deiodinase 1"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/158"}
{"aopId":158,"aopName":"Deiodinase 1 inhibition leading to increased mortality via reduced anterior swim bladder inflation","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":1009,"keName":"Inhibition, Deiodinase 1"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/158"}
{"aopId":159,"aopName":"Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/159"}
{"aopId":159,"aopName":"Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/159"}
{"aopId":159,"aopName":"Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/159"}
{"aopId":159,"aopName":"Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1007,"keName":"Reduced, Anterior swim bladder inflation"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/159"}
{"aopId":160,"aopName":"Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":762,"keName":"Activation, ionotropic GABA Receptor chloride channel"},{"keId":1015,"keName":"Increased, Neuronal synaptic inhibition"},{"keId":1014,"keName":"Induction, Somatic muscle paralysis"},{"keId":1016,"keName":"Inhibition, Feeding"},{"keId":761,"keName":"Increased, Chloride conductance"},{"keId":1012,"keName":"Increased, Inhibitory postsynaptic potential"}],"reference":"https://aopwiki.org/aops/160"}
{"aopId":161,"aopName":"Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality","targetName":"glutamate-gated chloride channel (fruit fly)","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1019,"keName":"Induction, pharyngeal muscle paralysis"},{"keId":1015,"keName":"Increased, Neuronal synaptic inhibition"},{"keId":1016,"keName":"Inhibition, Feeding"},{"keId":761,"keName":"Increased, Chloride conductance"},{"keId":1012,"keName":"Increased, Inhibitory postsynaptic potential"},{"keId":1018,"keName":"Activation, Glutamate-gated chloride channels"}],"reference":"https://aopwiki.org/aops/161"}
{"aopId":161,"aopName":"Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1019,"keName":"Induction, pharyngeal muscle paralysis"},{"keId":1015,"keName":"Increased, Neuronal synaptic inhibition"},{"keId":1016,"keName":"Inhibition, Feeding"},{"keId":761,"keName":"Increased, Chloride conductance"},{"keId":1012,"keName":"Increased, Inhibitory postsynaptic potential"},{"keId":1018,"keName":"Activation, Glutamate-gated chloride channels"}],"reference":"https://aopwiki.org/aops/161"}
{"aopId":162,"aopName":"Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas in the rat and mouse","aoId":1026,"aoName":"Increased Apoptosis Adenomas/carcinomas (follicular cell)","aoNameRaw":"Increased Apoptosis, Adenomas/carcinomas (follicular cell)","keyEvents":[{"keId":1021,"keName":"Increased, T4/T3 catabolism"},{"keId":1020,"keName":"Increased, induction of UDPGT's in liver"},{"keId":1026,"keName":"Increased Apoptosis, Adenomas/carcinomas (follicular cell)"},{"keId":1025,"keName":"Increased, Hyperplasia (follicular cells)"},{"keId":1022,"keName":"Decreased, serum T4/T3"},{"keId":1024,"keName":"Increased, Hypertrophy and proliferation (follicular cell)"},{"keId":1023,"keName":"Increased, Thyroid-stimulating hormone (TSH)"}],"reference":"https://aopwiki.org/aops/162"}
{"aopId":162,"aopName":"Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas in the rat and mouse","targetName":"UDP-glucuronosyltransferase","aoId":1026,"aoName":"Increased Apoptosis Adenomas/carcinomas (follicular cell)","aoNameRaw":"Increased Apoptosis, Adenomas/carcinomas (follicular cell)","keyEvents":[{"keId":1021,"keName":"Increased, T4/T3 catabolism"},{"keId":1020,"keName":"Increased, induction of UDPGT's in liver"},{"keId":1026,"keName":"Increased Apoptosis, Adenomas/carcinomas (follicular cell)"},{"keId":1025,"keName":"Increased, Hyperplasia (follicular cells)"},{"keId":1022,"keName":"Decreased, serum T4/T3"},{"keId":1024,"keName":"Increased, Hypertrophy and proliferation (follicular cell)"},{"keId":1023,"keName":"Increased, Thyroid-stimulating hormone (TSH)"}],"reference":"https://aopwiki.org/aops/162"}
{"aopId":164,"aopName":"Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse","targetName":"beta-2 adrenergic receptor","targetId":"ENSG00000169252","aoId":1044,"aoName":"Promotion mesovarian leiomyomas","aoNameRaw":"Promotion, mesovarian leiomyomas","keyEvents":[{"keId":1038,"keName":"Activation, beta-2 adrenergic receptor"},{"keId":1043,"keName":"Hypertrophy/hyperplasia, smooth muscle"},{"keId":1042,"keName":"Proliferation/Clonal Expansion, smooth muscle"},{"keId":1039,"keName":"Increased activity, beta-2 adrenergic receptor"},{"keId":1044,"keName":"Promotion, mesovarian leiomyomas"},{"keId":1040,"keName":"relaxation, smooth muscle"}],"reference":"https://aopwiki.org/aops/164"}
{"aopId":164,"aopName":"Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse","aoId":1044,"aoName":"Promotion mesovarian leiomyomas","aoNameRaw":"Promotion, mesovarian leiomyomas","keyEvents":[{"keId":1038,"keName":"Activation, beta-2 adrenergic receptor"},{"keId":1043,"keName":"Hypertrophy/hyperplasia, smooth muscle"},{"keId":1042,"keName":"Proliferation/Clonal Expansion, smooth muscle"},{"keId":1039,"keName":"Increased activity, beta-2 adrenergic receptor"},{"keId":1044,"keName":"Promotion, mesovarian leiomyomas"},{"keId":1040,"keName":"relaxation, smooth muscle"}],"reference":"https://aopwiki.org/aops/164"}
{"aopId":165,"aopName":"Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","aoId":1053,"aoName":"Promotion ovarian adenomas","aoNameRaw":"Promotion, ovarian adenomas","keyEvents":[{"keId":1054,"keName":"Promotion, ovarian granular cell tumors"},{"keId":1047,"keName":"Increased, secretion of GnRH from hypothalamus"},{"keId":1049,"keName":"Increased, secrection of FSH from anterior pituitary"},{"keId":1056,"keName":"Decrease, E2 blood concentrations at hypothalamus"},{"keId":1046,"keName":"Suppression, Estrogen receptor (ER) activity"},{"keId":1045,"keName":"Decreased, Ovarian E2"},{"keId":1050,"keName":"Increased, secretion of LH from anterior pituitary"},{"keId":1051,"keName":"Hyperplasia, ovarian stromal cells"},{"keId":1052,"keName":"Hyperplasia, ovarian epithelium"},{"keId":1053,"keName":"Promotion, ovarian adenomas"}],"reference":"https://aopwiki.org/aops/165"}
{"aopId":165,"aopName":"Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":1053,"aoName":"Promotion ovarian adenomas","aoNameRaw":"Promotion, ovarian adenomas","keyEvents":[{"keId":1054,"keName":"Promotion, ovarian granular cell tumors"},{"keId":1047,"keName":"Increased, secretion of GnRH from hypothalamus"},{"keId":1049,"keName":"Increased, secrection of FSH from anterior pituitary"},{"keId":1056,"keName":"Decrease, E2 blood concentrations at hypothalamus"},{"keId":1046,"keName":"Suppression, Estrogen receptor (ER) activity"},{"keId":1045,"keName":"Decreased, Ovarian E2"},{"keId":1050,"keName":"Increased, secretion of LH from anterior pituitary"},{"keId":1051,"keName":"Hyperplasia, ovarian stromal cells"},{"keId":1052,"keName":"Hyperplasia, ovarian epithelium"},{"keId":1053,"keName":"Promotion, ovarian adenomas"}],"reference":"https://aopwiki.org/aops/165"}
{"aopId":165,"aopName":"Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","aoId":1054,"aoName":"Promotion ovarian granular cell tumors","aoNameRaw":"Promotion, ovarian granular cell tumors","keyEvents":[{"keId":1054,"keName":"Promotion, ovarian granular cell tumors"},{"keId":1047,"keName":"Increased, secretion of GnRH from hypothalamus"},{"keId":1049,"keName":"Increased, secrection of FSH from anterior pituitary"},{"keId":1056,"keName":"Decrease, E2 blood concentrations at hypothalamus"},{"keId":1046,"keName":"Suppression, Estrogen receptor (ER) activity"},{"keId":1045,"keName":"Decreased, Ovarian E2"},{"keId":1050,"keName":"Increased, secretion of LH from anterior pituitary"},{"keId":1051,"keName":"Hyperplasia, ovarian stromal cells"},{"keId":1052,"keName":"Hyperplasia, ovarian epithelium"},{"keId":1053,"keName":"Promotion, ovarian adenomas"}],"reference":"https://aopwiki.org/aops/165"}
{"aopId":165,"aopName":"Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":1054,"aoName":"Promotion ovarian granular cell tumors","aoNameRaw":"Promotion, ovarian granular cell tumors","keyEvents":[{"keId":1054,"keName":"Promotion, ovarian granular cell tumors"},{"keId":1047,"keName":"Increased, secretion of GnRH from hypothalamus"},{"keId":1049,"keName":"Increased, secrection of FSH from anterior pituitary"},{"keId":1056,"keName":"Decrease, E2 blood concentrations at hypothalamus"},{"keId":1046,"keName":"Suppression, Estrogen receptor (ER) activity"},{"keId":1045,"keName":"Decreased, Ovarian E2"},{"keId":1050,"keName":"Increased, secretion of LH from anterior pituitary"},{"keId":1051,"keName":"Hyperplasia, ovarian stromal cells"},{"keId":1052,"keName":"Hyperplasia, ovarian epithelium"},{"keId":1053,"keName":"Promotion, ovarian adenomas"}],"reference":"https://aopwiki.org/aops/165"}
{"aopId":166,"aopName":"PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse","targetName":"peroxisome proliferator-activated receptor alpha","targetId":"ENSG00000186951","aoId":1063,"aoName":"Increased Pancreatic acinar tumors","aoNameRaw":"Increased, Pancreatic acinar tumors","keyEvents":[{"keId":1057,"keName":"Increased, PPAR-alpha activation"},{"keId":1063,"keName":"Increased, Pancreatic acinar tumors"},{"keId":1058,"keName":"Decreased, bile flow"},{"keId":1061,"keName":"prolonged, elevation of serun CCK"},{"keId":1060,"keName":"Alteration, lipid metabolism"},{"keId":1062,"keName":"Increased, Cellular proliferation / hyperplasia of acinar cells"},{"keId":1059,"keName":"Increased, cholestasis"}],"reference":"https://aopwiki.org/aops/166"}
{"aopId":166,"aopName":"PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse","targetName":"cholecystokinin","targetId":"ENSG00000187094","aoId":1063,"aoName":"Increased Pancreatic acinar tumors","aoNameRaw":"Increased, Pancreatic acinar tumors","keyEvents":[{"keId":1057,"keName":"Increased, PPAR-alpha activation"},{"keId":1063,"keName":"Increased, Pancreatic acinar tumors"},{"keId":1058,"keName":"Decreased, bile flow"},{"keId":1061,"keName":"prolonged, elevation of serun CCK"},{"keId":1060,"keName":"Alteration, lipid metabolism"},{"keId":1062,"keName":"Increased, Cellular proliferation / hyperplasia of acinar cells"},{"keId":1059,"keName":"Increased, cholestasis"}],"reference":"https://aopwiki.org/aops/166"}
{"aopId":166,"aopName":"PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse","aoId":1063,"aoName":"Increased Pancreatic acinar tumors","aoNameRaw":"Increased, Pancreatic acinar tumors","keyEvents":[{"keId":1057,"keName":"Increased, PPAR-alpha activation"},{"keId":1063,"keName":"Increased, Pancreatic acinar tumors"},{"keId":1058,"keName":"Decreased, bile flow"},{"keId":1061,"keName":"prolonged, elevation of serun CCK"},{"keId":1060,"keName":"Alteration, lipid metabolism"},{"keId":1062,"keName":"Increased, Cellular proliferation / hyperplasia of acinar cells"},{"keId":1059,"keName":"Increased, cholestasis"}],"reference":"https://aopwiki.org/aops/166"}
{"aopId":167,"aopName":"Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.","targetName":"homeobox protein SIX1","targetId":"ENSG00000126778","aoId":1070,"aoName":"Increased adenosquamous carcinomas of endometrium","aoNameRaw":"Increased, adenosquamous carcinomas of endometrium","keyEvents":[{"keId":1070,"keName":"Increased, adenosquamous carcinomas of endometrium"},{"keId":1067,"keName":"Proliferation/Clonal Expansion, aberrant basal cells"},{"keId":1069,"keName":"Increased, Hyperplasia (glandular epithelial cells of endometrium)"},{"keId":1065,"keName":"Activation, estrogen receptor alpha"},{"keId":1064,"keName":"prepubertal increase, Estrogen receptor (ER) activity"},{"keId":1068,"keName":"squamous metaplasia, aberrant basal cells"},{"keId":1066,"keName":"Promotion, SIX-1 postive basal-type progenitor cells"}],"reference":"https://aopwiki.org/aops/167"}
{"aopId":167,"aopName":"Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.","targetName":"estrogen receptor alpha complex","aoId":1070,"aoName":"Increased adenosquamous carcinomas of endometrium","aoNameRaw":"Increased, adenosquamous carcinomas of endometrium","keyEvents":[{"keId":1070,"keName":"Increased, adenosquamous carcinomas of endometrium"},{"keId":1067,"keName":"Proliferation/Clonal Expansion, aberrant basal cells"},{"keId":1069,"keName":"Increased, Hyperplasia (glandular epithelial cells of endometrium)"},{"keId":1065,"keName":"Activation, estrogen receptor alpha"},{"keId":1064,"keName":"prepubertal increase, Estrogen receptor (ER) activity"},{"keId":1068,"keName":"squamous metaplasia, aberrant basal cells"},{"keId":1066,"keName":"Promotion, SIX-1 postive basal-type progenitor cells"}],"reference":"https://aopwiki.org/aops/167"}
{"aopId":167,"aopName":"Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":1070,"aoName":"Increased adenosquamous carcinomas of endometrium","aoNameRaw":"Increased, adenosquamous carcinomas of endometrium","keyEvents":[{"keId":1070,"keName":"Increased, adenosquamous carcinomas of endometrium"},{"keId":1067,"keName":"Proliferation/Clonal Expansion, aberrant basal cells"},{"keId":1069,"keName":"Increased, Hyperplasia (glandular epithelial cells of endometrium)"},{"keId":1065,"keName":"Activation, estrogen receptor alpha"},{"keId":1064,"keName":"prepubertal increase, Estrogen receptor (ER) activity"},{"keId":1068,"keName":"squamous metaplasia, aberrant basal cells"},{"keId":1066,"keName":"Promotion, SIX-1 postive basal-type progenitor cells"}],"reference":"https://aopwiki.org/aops/167"}
{"aopId":167,"aopName":"Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.","aoId":1070,"aoName":"Increased adenosquamous carcinomas of endometrium","aoNameRaw":"Increased, adenosquamous carcinomas of endometrium","keyEvents":[{"keId":1070,"keName":"Increased, adenosquamous carcinomas of endometrium"},{"keId":1067,"keName":"Proliferation/Clonal Expansion, aberrant basal cells"},{"keId":1069,"keName":"Increased, Hyperplasia (glandular epithelial cells of endometrium)"},{"keId":1065,"keName":"Activation, estrogen receptor alpha"},{"keId":1064,"keName":"prepubertal increase, Estrogen receptor (ER) activity"},{"keId":1068,"keName":"squamous metaplasia, aberrant basal cells"},{"keId":1066,"keName":"Promotion, SIX-1 postive basal-type progenitor cells"}],"reference":"https://aopwiki.org/aops/167"}
{"aopId":168,"aopName":"GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.","targetName":"prolactin","targetId":"ENSG00000172179","aoId":1079,"aoName":"Increased Adenomas/carcinomas (mammary)","aoNameRaw":"Increased, Adenomas/carcinomas (mammary)","keyEvents":[{"keId":1075,"keName":"prolonged, estrus"},{"keId":1072,"keName":"Decreased, LH Surge from anterior pituitary"},{"keId":1077,"keName":"Increased, prolactin exposure"},{"keId":1071,"keName":"Decreased, GnRH pulsatility/release in hypothalamus"},{"keId":1074,"keName":"interruption, Ovulation"},{"keId":1078,"keName":"Hyperplasia, Mammary gland"},{"keId":1079,"keName":"Increased, Adenomas/carcinomas (mammary)"},{"keId":1080,"keName":"Increased, latency period"},{"keId":1076,"keName":"Increased, circulating estrogen levels"}],"reference":"https://aopwiki.org/aops/168"}
{"aopId":168,"aopName":"GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.","aoId":1079,"aoName":"Increased Adenomas/carcinomas (mammary)","aoNameRaw":"Increased, Adenomas/carcinomas (mammary)","keyEvents":[{"keId":1075,"keName":"prolonged, estrus"},{"keId":1072,"keName":"Decreased, LH Surge from anterior pituitary"},{"keId":1077,"keName":"Increased, prolactin exposure"},{"keId":1071,"keName":"Decreased, GnRH pulsatility/release in hypothalamus"},{"keId":1074,"keName":"interruption, Ovulation"},{"keId":1078,"keName":"Hyperplasia, Mammary gland"},{"keId":1079,"keName":"Increased, Adenomas/carcinomas (mammary)"},{"keId":1080,"keName":"Increased, latency period"},{"keId":1076,"keName":"Increased, circulating estrogen levels"}],"reference":"https://aopwiki.org/aops/168"}
{"aopId":169,"aopName":"GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.","aoId":1082,"aoName":"Increased adenomas (pituitary)","aoNameRaw":"Increased, adenomas (pituitary)","keyEvents":[{"keId":1075,"keName":"prolonged, estrus"},{"keId":1072,"keName":"Decreased, LH Surge from anterior pituitary"},{"keId":1071,"keName":"Decreased, GnRH pulsatility/release in hypothalamus"},{"keId":1082,"keName":"Increased, adenomas (pituitary)"},{"keId":1074,"keName":"interruption, Ovulation"},{"keId":1081,"keName":"Increased, lactotroph hyperplasia and hypertrophy"},{"keId":1076,"keName":"Increased, circulating estrogen levels"}],"reference":"https://aopwiki.org/aops/169"}
{"aopId":170,"aopName":"Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the SD rat","targetName":"prolactin","targetId":"ENSG00000172179","aoId":1079,"aoName":"Increased Adenomas/carcinomas (mammary)","aoNameRaw":"Increased, Adenomas/carcinomas (mammary)","keyEvents":[{"keId":1085,"keName":"Increased, hyperplasia (mammary gland)"},{"keId":1083,"keName":"Decreased, Dopaminergic activity"},{"keId":1079,"keName":"Increased, Adenomas/carcinomas (mammary)"},{"keId":1084,"keName":"Increased, prolactin secretion"},{"keId":1080,"keName":"Increased, latency period"}],"reference":"https://aopwiki.org/aops/170"}
{"aopId":170,"aopName":"Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the SD rat","aoId":1079,"aoName":"Increased Adenomas/carcinomas (mammary)","aoNameRaw":"Increased, Adenomas/carcinomas (mammary)","keyEvents":[{"keId":1085,"keName":"Increased, hyperplasia (mammary gland)"},{"keId":1083,"keName":"Decreased, Dopaminergic activity"},{"keId":1079,"keName":"Increased, Adenomas/carcinomas (mammary)"},{"keId":1084,"keName":"Increased, prolactin secretion"},{"keId":1080,"keName":"Increased, latency period"}],"reference":"https://aopwiki.org/aops/170"}
{"aopId":171,"aopName":"Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.","targetName":"eukaryotic protein","aoId":1090,"aoName":"Increased mesotheliomas","aoNameRaw":"Increased, mesotheliomas","keyEvents":[{"keId":1090,"keName":"Increased, mesotheliomas"},{"keId":1089,"keName":"Increased, Cell Proliferation (mesothelium)"},{"keId":1086,"keName":"persistent, cytotoxicity (pleura or peritoneum)"},{"keId":1087,"keName":"Increased, inflammation"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1032,"keName":"Increased, secretion of local growth factors"}],"reference":"https://aopwiki.org/aops/171"}
{"aopId":171,"aopName":"Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.","aoId":1090,"aoName":"Increased mesotheliomas","aoNameRaw":"Increased, mesotheliomas","keyEvents":[{"keId":1090,"keName":"Increased, mesotheliomas"},{"keId":1089,"keName":"Increased, Cell Proliferation (mesothelium)"},{"keId":1086,"keName":"persistent, cytotoxicity (pleura or peritoneum)"},{"keId":1087,"keName":"Increased, inflammation"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1032,"keName":"Increased, secretion of local growth factors"}],"reference":"https://aopwiki.org/aops/171"}
{"aopId":173,"aopName":"Substance interaction with the lung resident cell membrane components leading to lung fibrosis","aoId":1458,"aoName":"Pulmonary fibrosis","aoNameRaw":"Pulmonary fibrosis","aoMappedId":"EFO_0009448","keyEvents":[{"keId":1496,"keName":"Increased, secretion of proinflammatory and profibrotic mediators"},{"keId":1499,"keName":"Increased, activation of T (T) helper (h) type 2 cells"},{"keId":1498,"keName":"Loss of alveolar capillary membrane integrity"},{"keId":1500,"keName":"Increased, fibroblast proliferation and myofibroblast differentiation"},{"keId":1458,"keName":"Pulmonary fibrosis"},{"keId":1501,"keName":"Increased, extracellular matrix deposition"},{"keId":1497,"keName":"Increased, recruitment of inflammatory cells"},{"keId":1495,"keName":"Interaction with the lung resident cell membrane components"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/173"}
{"aopId":175,"aopName":"Thyroperoxidase inhibition leading to altered amphibian metamorphosis","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/175"}
{"aopId":175,"aopName":"Thyroperoxidase inhibition leading to altered amphibian metamorphosis","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/175"}
{"aopId":176,"aopName":"Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis","targetName":"sodium/iodide cotransporter","targetId":"ENSG00000105641","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":425,"keName":"Decrease of Thyroidal iodide"}],"reference":"https://aopwiki.org/aops/176"}
{"aopId":176,"aopName":"Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":424,"keName":"Inhibition, Na+/I- symporter (NIS)"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":425,"keName":"Decrease of Thyroidal iodide"}],"reference":"https://aopwiki.org/aops/176"}
{"aopId":177,"aopName":"Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1106,"keName":"Occurrence, cardiac arrhythmia"},{"keId":1104,"keName":"Decreased, Prostaglandin F2alpha concentration, plasma "},{"keId":1097,"keName":"Occurrence, renal proximal tubular necrosis"},{"keId":1103,"keName":"Inhibition, Cyclooxygenase 1 activity"},{"keId":1096,"keName":"Increased, blood uric acid concentration"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1098,"keName":"Increased, blood potassium concentration"},{"keId":1105,"keName":"Occurrence, renal ischemia"},{"keId":1102,"keName":"Occurrence, tophi (urate) deposition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/177"}
{"aopId":177,"aopName":"Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1106,"keName":"Occurrence, cardiac arrhythmia"},{"keId":1104,"keName":"Decreased, Prostaglandin F2alpha concentration, plasma "},{"keId":1097,"keName":"Occurrence, renal proximal tubular necrosis"},{"keId":1103,"keName":"Inhibition, Cyclooxygenase 1 activity"},{"keId":1096,"keName":"Increased, blood uric acid concentration"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1098,"keName":"Increased, blood potassium concentration"},{"keId":1105,"keName":"Occurrence, renal ischemia"},{"keId":1102,"keName":"Occurrence, tophi (urate) deposition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/177"}
{"aopId":177,"aopName":"Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality","targetName":"prostaglandin G/H synthase 1","targetId":"ENSG00000095303","aoId":361,"aoName":"Decline Population","aoNameRaw":"Decline, Population","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1106,"keName":"Occurrence, cardiac arrhythmia"},{"keId":1104,"keName":"Decreased, Prostaglandin F2alpha concentration, plasma "},{"keId":1097,"keName":"Occurrence, renal proximal tubular necrosis"},{"keId":1103,"keName":"Inhibition, Cyclooxygenase 1 activity"},{"keId":1096,"keName":"Increased, blood uric acid concentration"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1098,"keName":"Increased, blood potassium concentration"},{"keId":1105,"keName":"Occurrence, renal ischemia"},{"keId":1102,"keName":"Occurrence, tophi (urate) deposition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/177"}
{"aopId":177,"aopName":"Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality","aoId":361,"aoName":"Decline Population","aoNameRaw":"Decline, Population","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1106,"keName":"Occurrence, cardiac arrhythmia"},{"keId":1104,"keName":"Decreased, Prostaglandin F2alpha concentration, plasma "},{"keId":1097,"keName":"Occurrence, renal proximal tubular necrosis"},{"keId":1103,"keName":"Inhibition, Cyclooxygenase 1 activity"},{"keId":1096,"keName":"Increased, blood uric acid concentration"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1098,"keName":"Increased, blood potassium concentration"},{"keId":1105,"keName":"Occurrence, renal ischemia"},{"keId":1102,"keName":"Occurrence, tophi (urate) deposition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/177"}
{"aopId":178,"aopName":"Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":563,"keName":"Death/Failure, Colony"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":559,"keName":"Activation, Nicotinic acetylcholine receptor"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/178"}
{"aopId":179,"aopName":"Varroa mite infestation increases virus levels leading to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":1109,"keName":"Increased, Deformed Wing Virus levels"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/179"}
{"aopId":180,"aopName":"Varroa mite infestation contributes to abnormal foraging leading to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/180"}
{"aopId":181,"aopName":"Weather event contributes to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":563,"keName":"Death/Failure, Colony"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/181"}
{"aopId":182,"aopName":"Weather event contributes abnormal foraging leading to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/182"}
{"aopId":183,"aopName":"Nosema infection increases energetic demands leading to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":560,"keName":"Abnormal, Foraging activity and behavior"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":1107,"keName":"Weakened, Colony"},{"keId":1110,"keName":"Increased, Energetic demands and therefore metabolic stress"}],"reference":"https://aopwiki.org/aops/183"}
{"aopId":184,"aopName":"Nosema infection causes abnormal role change that leads to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":1108,"keName":"Abnormal, Role change within caste"},{"keId":563,"keName":"Death/Failure, Colony"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/184"}
{"aopId":185,"aopName":"Queen egg-laying decrease leads to colony loss/failure","aoId":563,"aoName":"Death/Failure Colony","aoNameRaw":"Death/Failure, Colony","keyEvents":[{"keId":563,"keName":"Death/Failure, Colony"},{"keId":1107,"keName":"Weakened, Colony"}],"reference":"https://aopwiki.org/aops/185"}
{"aopId":186,"aopName":"unknown MIE leading to renal failure and mortality","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1106,"keName":"Occurrence, cardiac arrhythmia"},{"keId":1097,"keName":"Occurrence, renal proximal tubular necrosis"},{"keId":1115,"keName":"Increased, Reactive oxygen species"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1098,"keName":"Increased, blood potassium concentration"},{"keId":1114,"keName":"Unknown, MIE"}],"reference":"https://aopwiki.org/aops/186"}
{"aopId":187,"aopName":"Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","targetName":"androgen receptor","targetId":"ENSG00000169083","aoId":1136,"aoName":"Impaired recruitment  Population trajectory","aoNameRaw":"Impaired recruitment , Population trajectory","keyEvents":[{"keId":1135,"keName":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction"},{"keId":1122,"keName":"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis  "},{"keId":1169,"keName":"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin"},{"keId":1130,"keName":"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)"},{"keId":1133,"keName":"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors"},{"keId":1131,"keName":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) "},{"keId":1134,"keName":"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone"},{"keId":1132,"keName":"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal"},{"keId":1136,"keName":"Impaired recruitment , Population trajectory"},{"keId":1138,"keName":"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP"},{"keId":1151,"keName":"Osteoporosis and vascular calcification, Bone deterioration"}],"status":"Under Development","reference":"https://aopwiki.org/aops/187"}
{"aopId":187,"aopName":"Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","targetName":"matrix Gla protein (mouse)","aoId":1136,"aoName":"Impaired recruitment  Population trajectory","aoNameRaw":"Impaired recruitment , Population trajectory","keyEvents":[{"keId":1135,"keName":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction"},{"keId":1122,"keName":"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis  "},{"keId":1169,"keName":"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin"},{"keId":1130,"keName":"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)"},{"keId":1133,"keName":"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors"},{"keId":1131,"keName":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) "},{"keId":1134,"keName":"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone"},{"keId":1132,"keName":"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal"},{"keId":1136,"keName":"Impaired recruitment , Population trajectory"},{"keId":1138,"keName":"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP"},{"keId":1151,"keName":"Osteoporosis and vascular calcification, Bone deterioration"}],"status":"Under Development","reference":"https://aopwiki.org/aops/187"}
{"aopId":187,"aopName":"Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","targetName":"osteocalcin","targetId":"ENSG00000242252","aoId":1136,"aoName":"Impaired recruitment  Population trajectory","aoNameRaw":"Impaired recruitment , Population trajectory","keyEvents":[{"keId":1135,"keName":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction"},{"keId":1122,"keName":"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis  "},{"keId":1169,"keName":"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin"},{"keId":1130,"keName":"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)"},{"keId":1133,"keName":"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors"},{"keId":1131,"keName":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) "},{"keId":1134,"keName":"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone"},{"keId":1132,"keName":"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal"},{"keId":1136,"keName":"Impaired recruitment , Population trajectory"},{"keId":1138,"keName":"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP"},{"keId":1151,"keName":"Osteoporosis and vascular calcification, Bone deterioration"}],"status":"Under Development","reference":"https://aopwiki.org/aops/187"}
{"aopId":187,"aopName":"Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","targetName":"coagulation factor IX (mouse)","aoId":1136,"aoName":"Impaired recruitment  Population trajectory","aoNameRaw":"Impaired recruitment , Population trajectory","keyEvents":[{"keId":1135,"keName":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction"},{"keId":1122,"keName":"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis  "},{"keId":1169,"keName":"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin"},{"keId":1130,"keName":"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)"},{"keId":1133,"keName":"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors"},{"keId":1131,"keName":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) "},{"keId":1134,"keName":"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone"},{"keId":1132,"keName":"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal"},{"keId":1136,"keName":"Impaired recruitment , Population trajectory"},{"keId":1138,"keName":"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP"},{"keId":1151,"keName":"Osteoporosis and vascular calcification, Bone deterioration"}],"status":"Under Development","reference":"https://aopwiki.org/aops/187"}
{"aopId":187,"aopName":"Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","targetName":"prothrombin","targetId":"ENSG00000180210","aoId":1136,"aoName":"Impaired recruitment  Population trajectory","aoNameRaw":"Impaired recruitment , Population trajectory","keyEvents":[{"keId":1135,"keName":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction"},{"keId":1122,"keName":"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis  "},{"keId":1169,"keName":"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin"},{"keId":1130,"keName":"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)"},{"keId":1133,"keName":"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors"},{"keId":1131,"keName":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) "},{"keId":1134,"keName":"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone"},{"keId":1132,"keName":"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal"},{"keId":1136,"keName":"Impaired recruitment , Population trajectory"},{"keId":1138,"keName":"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP"},{"keId":1151,"keName":"Osteoporosis and vascular calcification, Bone deterioration"}],"status":"Under Development","reference":"https://aopwiki.org/aops/187"}
{"aopId":187,"aopName":"Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","targetName":"coagulation factor VII (mouse)","aoId":1136,"aoName":"Impaired recruitment  Population trajectory","aoNameRaw":"Impaired recruitment , Population trajectory","keyEvents":[{"keId":1135,"keName":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction"},{"keId":1122,"keName":"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis  "},{"keId":1169,"keName":"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin"},{"keId":1130,"keName":"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)"},{"keId":1133,"keName":"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors"},{"keId":1131,"keName":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) "},{"keId":1134,"keName":"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone"},{"keId":1132,"keName":"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal"},{"keId":1136,"keName":"Impaired recruitment , Population trajectory"},{"keId":1138,"keName":"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP"},{"keId":1151,"keName":"Osteoporosis and vascular calcification, Bone deterioration"}],"status":"Under Development","reference":"https://aopwiki.org/aops/187"}
{"aopId":187,"aopName":"Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","targetName":"coagulation factor X (mouse)","aoId":1136,"aoName":"Impaired recruitment  Population trajectory","aoNameRaw":"Impaired recruitment , Population trajectory","keyEvents":[{"keId":1135,"keName":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction"},{"keId":1122,"keName":"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis  "},{"keId":1169,"keName":"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin"},{"keId":1130,"keName":"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)"},{"keId":1133,"keName":"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors"},{"keId":1131,"keName":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) "},{"keId":1134,"keName":"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone"},{"keId":1132,"keName":"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal"},{"keId":1136,"keName":"Impaired recruitment , Population trajectory"},{"keId":1138,"keName":"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP"},{"keId":1151,"keName":"Osteoporosis and vascular calcification, Bone deterioration"}],"status":"Under Development","reference":"https://aopwiki.org/aops/187"}
{"aopId":187,"aopName":"Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","aoId":1136,"aoName":"Impaired recruitment  Population trajectory","aoNameRaw":"Impaired recruitment , Population trajectory","keyEvents":[{"keId":1135,"keName":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction"},{"keId":1122,"keName":"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis  "},{"keId":1169,"keName":"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin"},{"keId":1130,"keName":"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)"},{"keId":1133,"keName":"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors"},{"keId":1131,"keName":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) "},{"keId":1134,"keName":"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone"},{"keId":1132,"keName":"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal"},{"keId":1136,"keName":"Impaired recruitment , Population trajectory"},{"keId":1138,"keName":"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP"},{"keId":1151,"keName":"Osteoporosis and vascular calcification, Bone deterioration"}],"status":"Under Development","reference":"https://aopwiki.org/aops/187"}
{"aopId":188,"aopName":"Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1152,"keName":"Inhibition, Iodotyrosine deiodinase (IYD)"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":426,"keName":"Decreased, Thyroxine (T4) in serum"},{"keId":425,"keName":"Decrease of Thyroidal iodide"}],"reference":"https://aopwiki.org/aops/188"}
{"aopId":188,"aopName":"Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis","targetName":"iodotyrosine deiodinase 1 (human)","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1152,"keName":"Inhibition, Iodotyrosine deiodinase (IYD)"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":426,"keName":"Decreased, Thyroxine (T4) in serum"},{"keId":425,"keName":"Decrease of Thyroidal iodide"}],"reference":"https://aopwiki.org/aops/188"}
{"aopId":189,"aopName":"Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis","targetName":"type I iodothyronine deiodinase","targetId":"ENSG00000211452","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1116,"keName":"Decreased, Triiodothyronine (T3) in tissues"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":1009,"keName":"Inhibition, Deiodinase 1"}],"reference":"https://aopwiki.org/aops/189"}
{"aopId":189,"aopName":"Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1116,"keName":"Decreased, Triiodothyronine (T3) in tissues"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":1009,"keName":"Inhibition, Deiodinase 1"}],"reference":"https://aopwiki.org/aops/189"}
{"aopId":190,"aopName":"Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1002,"keName":"Inhibition, Deiodinase 2"},{"keId":1116,"keName":"Decreased, Triiodothyronine (T3) in tissues"},{"keId":1829,"keName":"Altered, Thyroid hormone-dependent gene expression"},{"keId":1828,"keName":"Increased, Thyroxine (T4) in serum"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":1023,"keName":"Increased, Thyroid-stimulating hormone (TSH)"}],"reference":"https://aopwiki.org/aops/190"}
{"aopId":190,"aopName":"Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis","targetName":"type II iodothyronine deiodinase","targetId":"ENSG00000211448","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1002,"keName":"Inhibition, Deiodinase 2"},{"keId":1116,"keName":"Decreased, Triiodothyronine (T3) in tissues"},{"keId":1829,"keName":"Altered, Thyroid hormone-dependent gene expression"},{"keId":1828,"keName":"Increased, Thyroxine (T4) in serum"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":1023,"keName":"Increased, Thyroid-stimulating hormone (TSH)"}],"reference":"https://aopwiki.org/aops/190"}
{"aopId":191,"aopName":"Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis","targetName":"type III iodothyronine deiodinase","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1829,"keName":"Altered, Thyroid hormone-dependent gene expression"},{"keId":1154,"keName":"Increased, Triiodothyronine (T3) in tissues"},{"keId":1153,"keName":"Inhibition, Deiodinase 3"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"}],"reference":"https://aopwiki.org/aops/191"}
{"aopId":191,"aopName":"Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1829,"keName":"Altered, Thyroid hormone-dependent gene expression"},{"keId":1154,"keName":"Increased, Triiodothyronine (T3) in tissues"},{"keId":1153,"keName":"Inhibition, Deiodinase 3"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"}],"reference":"https://aopwiki.org/aops/191"}
{"aopId":192,"aopName":"Pendrin inhibition leading to altered amphibian metamorphosis","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":426,"keName":"Decreased, Thyroxine (T4) in serum"},{"keId":1155,"keName":"Inhibition, Pendrin"}],"reference":"https://aopwiki.org/aops/192"}
{"aopId":192,"aopName":"Pendrin inhibition leading to altered amphibian metamorphosis","targetName":"pendrin","targetId":"ENSG00000091137","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":426,"keName":"Decreased, Thyroxine (T4) in serum"},{"keId":1155,"keName":"Inhibition, Pendrin"}],"reference":"https://aopwiki.org/aops/192"}
{"aopId":193,"aopName":"Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis","targetName":"dual oxidase 1","targetId":"ENSG00000137857","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":1156,"keName":"Inhibition, Dual oxidase"},{"keId":426,"keName":"Decreased, Thyroxine (T4) in serum"}],"reference":"https://aopwiki.org/aops/193"}
{"aopId":193,"aopName":"Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":1156,"keName":"Inhibition, Dual oxidase"},{"keId":426,"keName":"Decreased, Thyroxine (T4) in serum"}],"reference":"https://aopwiki.org/aops/193"}
{"aopId":194,"aopName":"Hepatic nuclear receptor activation leading to altered amphibian metamorphosis","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":295,"keName":"Induction, Upregulation of glucuronyltransferase activity"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":1158,"keName":"Increased, Hepatic thyroid hormone uptake/transport"},{"keId":401,"keName":"Increase, Biliary excretion TH glucuronide"},{"keId":1157,"keName":"Activation, Hepatic nuclear receptor(s)"}],"reference":"https://aopwiki.org/aops/194"}
{"aopId":194,"aopName":"Hepatic nuclear receptor activation leading to altered amphibian metamorphosis","targetName":"protein","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":295,"keName":"Induction, Upregulation of glucuronyltransferase activity"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":1158,"keName":"Increased, Hepatic thyroid hormone uptake/transport"},{"keId":401,"keName":"Increase, Biliary excretion TH glucuronide"},{"keId":1157,"keName":"Activation, Hepatic nuclear receptor(s)"}],"reference":"https://aopwiki.org/aops/194"}
{"aopId":194,"aopName":"Hepatic nuclear receptor activation leading to altered amphibian metamorphosis","targetName":"beta-1,3-glucuronyltransferase","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":295,"keName":"Induction, Upregulation of glucuronyltransferase activity"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":1158,"keName":"Increased, Hepatic thyroid hormone uptake/transport"},{"keId":401,"keName":"Increase, Biliary excretion TH glucuronide"},{"keId":1157,"keName":"Activation, Hepatic nuclear receptor(s)"}],"reference":"https://aopwiki.org/aops/194"}
{"aopId":195,"aopName":"5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase","aoId":1164,"aoName":"Increased Population","aoNameRaw":"Increased, Population","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1164,"keName":"Increased, Population"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1161,"keName":"Increased, oocyte maturation"},{"keId":1163,"keName":"Increased, Reproductive Success"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1255,"keName":"induced spawning"}],"reference":"https://aopwiki.org/aops/195"}
{"aopId":195,"aopName":"5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase","targetName":"sodium-dependent serotonin transporter","targetId":"ENSG00000108576","aoId":1164,"aoName":"Increased Population","aoNameRaw":"Increased, Population","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1164,"keName":"Increased, Population"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1161,"keName":"Increased, oocyte maturation"},{"keId":1163,"keName":"Increased, Reproductive Success"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1255,"keName":"induced spawning"}],"reference":"https://aopwiki.org/aops/195"}
{"aopId":196,"aopName":"Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation","targetName":"transient receptor potential cation channel TRPV1","aoId":1226,"aoName":"Increased Respiratory irritability and Chronic Cough","aoNameRaw":"Increased Respiratory irritability and Chronic Cough, ","keyEvents":[{"keId":1215,"keName":"TRPA1 activation, TRPA1 Receptor"},{"keId":1223,"keName":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea"},{"keId":1435,"keName":"Increased neurokinin A (NKA) by neuronal cells"},{"keId":1226,"keName":"Increased Respiratory irritability and Chronic Cough, "},{"keId":1218,"keName":"Opening of calcium channel, Calcium influx"},{"keId":1220,"keName":"Trigeminal nerve activation"},{"keId":1433,"keName":"Increased CGRP, neuronal release of CGRP"},{"keId":1434,"keName":"Irritation of nasal mucosa inducing sneeze reflex"},{"keId":1222,"keName":"SP (Substance P) release, Local increase of SP"}],"reference":"https://aopwiki.org/aops/196"}
{"aopId":196,"aopName":"Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation","aoId":1226,"aoName":"Increased Respiratory irritability and Chronic Cough","aoNameRaw":"Increased Respiratory irritability and Chronic Cough, ","keyEvents":[{"keId":1215,"keName":"TRPA1 activation, TRPA1 Receptor"},{"keId":1223,"keName":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea"},{"keId":1435,"keName":"Increased neurokinin A (NKA) by neuronal cells"},{"keId":1226,"keName":"Increased Respiratory irritability and Chronic Cough, "},{"keId":1218,"keName":"Opening of calcium channel, Calcium influx"},{"keId":1220,"keName":"Trigeminal nerve activation"},{"keId":1433,"keName":"Increased CGRP, neuronal release of CGRP"},{"keId":1434,"keName":"Irritation of nasal mucosa inducing sneeze reflex"},{"keId":1222,"keName":"SP (Substance P) release, Local increase of SP"}],"reference":"https://aopwiki.org/aops/196"}
{"aopId":196,"aopName":"Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation","targetName":"transient receptor potential cation channel TRPV1","aoId":1434,"aoName":"Irritation of nasal mucosa inducing sneeze reflex","aoNameRaw":"Irritation of nasal mucosa inducing sneeze reflex","keyEvents":[{"keId":1215,"keName":"TRPA1 activation, TRPA1 Receptor"},{"keId":1223,"keName":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea"},{"keId":1435,"keName":"Increased neurokinin A (NKA) by neuronal cells"},{"keId":1226,"keName":"Increased Respiratory irritability and Chronic Cough, "},{"keId":1218,"keName":"Opening of calcium channel, Calcium influx"},{"keId":1220,"keName":"Trigeminal nerve activation"},{"keId":1433,"keName":"Increased CGRP, neuronal release of CGRP"},{"keId":1434,"keName":"Irritation of nasal mucosa inducing sneeze reflex"},{"keId":1222,"keName":"SP (Substance P) release, Local increase of SP"}],"reference":"https://aopwiki.org/aops/196"}
{"aopId":196,"aopName":"Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation","aoId":1434,"aoName":"Irritation of nasal mucosa inducing sneeze reflex","aoNameRaw":"Irritation of nasal mucosa inducing sneeze reflex","keyEvents":[{"keId":1215,"keName":"TRPA1 activation, TRPA1 Receptor"},{"keId":1223,"keName":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea"},{"keId":1435,"keName":"Increased neurokinin A (NKA) by neuronal cells"},{"keId":1226,"keName":"Increased Respiratory irritability and Chronic Cough, "},{"keId":1218,"keName":"Opening of calcium channel, Calcium influx"},{"keId":1220,"keName":"Trigeminal nerve activation"},{"keId":1433,"keName":"Increased CGRP, neuronal release of CGRP"},{"keId":1434,"keName":"Irritation of nasal mucosa inducing sneeze reflex"},{"keId":1222,"keName":"SP (Substance P) release, Local increase of SP"}],"reference":"https://aopwiki.org/aops/196"}
{"aopId":196,"aopName":"Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation","targetName":"transient receptor potential cation channel TRPV1","aoId":1223,"aoName":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsivenessCough Dyspnea","aoNameRaw":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea","keyEvents":[{"keId":1215,"keName":"TRPA1 activation, TRPA1 Receptor"},{"keId":1223,"keName":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea"},{"keId":1435,"keName":"Increased neurokinin A (NKA) by neuronal cells"},{"keId":1226,"keName":"Increased Respiratory irritability and Chronic Cough, "},{"keId":1218,"keName":"Opening of calcium channel, Calcium influx"},{"keId":1220,"keName":"Trigeminal nerve activation"},{"keId":1433,"keName":"Increased CGRP, neuronal release of CGRP"},{"keId":1434,"keName":"Irritation of nasal mucosa inducing sneeze reflex"},{"keId":1222,"keName":"SP (Substance P) release, Local increase of SP"}],"reference":"https://aopwiki.org/aops/196"}
{"aopId":196,"aopName":"Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation","aoId":1223,"aoName":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsivenessCough Dyspnea","aoNameRaw":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea","keyEvents":[{"keId":1215,"keName":"TRPA1 activation, TRPA1 Receptor"},{"keId":1223,"keName":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea"},{"keId":1435,"keName":"Increased neurokinin A (NKA) by neuronal cells"},{"keId":1226,"keName":"Increased Respiratory irritability and Chronic Cough, "},{"keId":1218,"keName":"Opening of calcium channel, Calcium influx"},{"keId":1220,"keName":"Trigeminal nerve activation"},{"keId":1433,"keName":"Increased CGRP, neuronal release of CGRP"},{"keId":1434,"keName":"Irritation of nasal mucosa inducing sneeze reflex"},{"keId":1222,"keName":"SP (Substance P) release, Local increase of SP"}],"reference":"https://aopwiki.org/aops/196"}
{"aopId":200,"aopName":"Estrogen receptor activation leading to breast cancer  ","targetName":"protein","aoId":1193,"aoName":"Breast Cancer","aoNameRaw":"N/A, Breast Cancer","aoMappedId":"MONDO_0007254","keyEvents":[{"keId":1183,"keName":"Decreased, Apoptosis (Epithelial Cells)"},{"keId":1195,"keName":"modulation, Extracellular Matrix Composition "},{"keId":1241,"keName":"Increased, Motility"},{"keId":1242,"keName":"Increased, Second Messenger Production"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1188,"keName":"Increased, ER binding to T.F. to DNA (non-classical pathway)"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1197,"keName":"Activation, Fibroblasts"},{"keId":1191,"keName":"Increased, Non-genomic signaling"},{"keId":1189,"keName":"Increased, Proliferation (Endothelial cells) "},{"keId":1181,"keName":"Activation, Estrogen receptor"},{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":1196,"keName":"Increased, Invasion"},{"keId":1240,"keName":"Altered, Protein Production"},{"keId":1187,"keName":"Increased, ER binding to DNA (classical pathway) "},{"keId":1198,"keName":"Activation, Macrophages"},{"keId":1239,"keName":"Altered, Gene Expression"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1190,"keName":"Increased, Migration (Endothelial Cells)"},{"keId":1213,"keName":"Increased, Angiogenesis"}],"reference":"https://aopwiki.org/aops/200"}
{"aopId":200,"aopName":"Estrogen receptor activation leading to breast cancer  ","targetName":"serotransferrin","targetId":"ENSG00000091513","aoId":1193,"aoName":"Breast Cancer","aoNameRaw":"N/A, Breast Cancer","aoMappedId":"MONDO_0007254","keyEvents":[{"keId":1183,"keName":"Decreased, Apoptosis (Epithelial Cells)"},{"keId":1195,"keName":"modulation, Extracellular Matrix Composition "},{"keId":1241,"keName":"Increased, Motility"},{"keId":1242,"keName":"Increased, Second Messenger Production"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1188,"keName":"Increased, ER binding to T.F. to DNA (non-classical pathway)"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1197,"keName":"Activation, Fibroblasts"},{"keId":1191,"keName":"Increased, Non-genomic signaling"},{"keId":1189,"keName":"Increased, Proliferation (Endothelial cells) "},{"keId":1181,"keName":"Activation, Estrogen receptor"},{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":1196,"keName":"Increased, Invasion"},{"keId":1240,"keName":"Altered, Protein Production"},{"keId":1187,"keName":"Increased, ER binding to DNA (classical pathway) "},{"keId":1198,"keName":"Activation, Macrophages"},{"keId":1239,"keName":"Altered, Gene Expression"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1190,"keName":"Increased, Migration (Endothelial Cells)"},{"keId":1213,"keName":"Increased, Angiogenesis"}],"reference":"https://aopwiki.org/aops/200"}
{"aopId":200,"aopName":"Estrogen receptor activation leading to breast cancer  ","targetName":"estrogen receptor","targetId":"ENSG00000091831","aoId":1193,"aoName":"Breast Cancer","aoNameRaw":"N/A, Breast Cancer","aoMappedId":"MONDO_0007254","keyEvents":[{"keId":1183,"keName":"Decreased, Apoptosis (Epithelial Cells)"},{"keId":1195,"keName":"modulation, Extracellular Matrix Composition "},{"keId":1241,"keName":"Increased, Motility"},{"keId":1242,"keName":"Increased, Second Messenger Production"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1188,"keName":"Increased, ER binding to T.F. to DNA (non-classical pathway)"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1197,"keName":"Activation, Fibroblasts"},{"keId":1191,"keName":"Increased, Non-genomic signaling"},{"keId":1189,"keName":"Increased, Proliferation (Endothelial cells) "},{"keId":1181,"keName":"Activation, Estrogen receptor"},{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":1196,"keName":"Increased, Invasion"},{"keId":1240,"keName":"Altered, Protein Production"},{"keId":1187,"keName":"Increased, ER binding to DNA (classical pathway) "},{"keId":1198,"keName":"Activation, Macrophages"},{"keId":1239,"keName":"Altered, Gene Expression"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1190,"keName":"Increased, Migration (Endothelial Cells)"},{"keId":1213,"keName":"Increased, Angiogenesis"}],"reference":"https://aopwiki.org/aops/200"}
{"aopId":200,"aopName":"Estrogen receptor activation leading to breast cancer  ","aoId":1193,"aoName":"Breast Cancer","aoNameRaw":"N/A, Breast Cancer","aoMappedId":"MONDO_0007254","keyEvents":[{"keId":1183,"keName":"Decreased, Apoptosis (Epithelial Cells)"},{"keId":1195,"keName":"modulation, Extracellular Matrix Composition "},{"keId":1241,"keName":"Increased, Motility"},{"keId":1242,"keName":"Increased, Second Messenger Production"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1188,"keName":"Increased, ER binding to T.F. to DNA (non-classical pathway)"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1197,"keName":"Activation, Fibroblasts"},{"keId":1191,"keName":"Increased, Non-genomic signaling"},{"keId":1189,"keName":"Increased, Proliferation (Endothelial cells) "},{"keId":1181,"keName":"Activation, Estrogen receptor"},{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":1196,"keName":"Increased, Invasion"},{"keId":1240,"keName":"Altered, Protein Production"},{"keId":1187,"keName":"Increased, ER binding to DNA (classical pathway) "},{"keId":1198,"keName":"Activation, Macrophages"},{"keId":1239,"keName":"Altered, Gene Expression"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1190,"keName":"Increased, Migration (Endothelial Cells)"},{"keId":1213,"keName":"Increased, Angiogenesis"}],"reference":"https://aopwiki.org/aops/200"}
{"aopId":201,"aopName":"Juvenile hormone receptor agonism leading to male offspring induction associated population decline","aoId":1210,"aoName":"Alteration Food-web structures","aoNameRaw":"Alteration, Food-web structures","keyEvents":[{"keId":1210,"keName":"Alteration, Food-web structures"},{"keId":1208,"keName":"Increased, Male offspring"},{"keId":1205,"keName":"Activation, Juvenile hormone receptor"},{"keId":1209,"keName":"Induction, Male reproductive tract"},{"keId":1206,"keName":"Induction, Doublesex1 gene"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/201"}
{"aopId":201,"aopName":"Juvenile hormone receptor agonism leading to male offspring induction associated population decline","targetName":"protein doublesex (fruit fly)","aoId":1210,"aoName":"Alteration Food-web structures","aoNameRaw":"Alteration, Food-web structures","keyEvents":[{"keId":1210,"keName":"Alteration, Food-web structures"},{"keId":1208,"keName":"Increased, Male offspring"},{"keId":1205,"keName":"Activation, Juvenile hormone receptor"},{"keId":1209,"keName":"Induction, Male reproductive tract"},{"keId":1206,"keName":"Induction, Doublesex1 gene"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/201"}
{"aopId":201,"aopName":"Juvenile hormone receptor agonism leading to male offspring induction associated population decline","aoId":361,"aoName":"Decline Population","aoNameRaw":"Decline, Population","keyEvents":[{"keId":1210,"keName":"Alteration, Food-web structures"},{"keId":1208,"keName":"Increased, Male offspring"},{"keId":1205,"keName":"Activation, Juvenile hormone receptor"},{"keId":1209,"keName":"Induction, Male reproductive tract"},{"keId":1206,"keName":"Induction, Doublesex1 gene"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/201"}
{"aopId":201,"aopName":"Juvenile hormone receptor agonism leading to male offspring induction associated population decline","targetName":"protein doublesex (fruit fly)","aoId":361,"aoName":"Decline Population","aoNameRaw":"Decline, Population","keyEvents":[{"keId":1210,"keName":"Alteration, Food-web structures"},{"keId":1208,"keName":"Increased, Male offspring"},{"keId":1205,"keName":"Activation, Juvenile hormone receptor"},{"keId":1209,"keName":"Induction, Male reproductive tract"},{"keId":1206,"keName":"Induction, Doublesex1 gene"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/201"}
{"aopId":201,"aopName":"Juvenile hormone receptor agonism leading to male offspring induction associated population decline","aoId":1208,"aoName":"Increased Male offspring","aoNameRaw":"Increased, Male offspring","keyEvents":[{"keId":1210,"keName":"Alteration, Food-web structures"},{"keId":1208,"keName":"Increased, Male offspring"},{"keId":1205,"keName":"Activation, Juvenile hormone receptor"},{"keId":1209,"keName":"Induction, Male reproductive tract"},{"keId":1206,"keName":"Induction, Doublesex1 gene"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/201"}
{"aopId":201,"aopName":"Juvenile hormone receptor agonism leading to male offspring induction associated population decline","targetName":"protein doublesex (fruit fly)","aoId":1208,"aoName":"Increased Male offspring","aoNameRaw":"Increased, Male offspring","keyEvents":[{"keId":1210,"keName":"Alteration, Food-web structures"},{"keId":1208,"keName":"Increased, Male offspring"},{"keId":1205,"keName":"Activation, Juvenile hormone receptor"},{"keId":1209,"keName":"Induction, Male reproductive tract"},{"keId":1206,"keName":"Induction, Doublesex1 gene"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/201"}
{"aopId":202,"aopName":" Inhibitor binding to topoisomerase II leading to infant leukaemia","aoId":1254,"aoName":"Infant leukaemia","aoNameRaw":"Infant leukaemia","keyEvents":[{"keId":1252,"keName":"Binding to (interferes with) topoisomerase II enzyme"},{"keId":1254,"keName":"Infant leukaemia"},{"keId":1461,"keName":"DNA double-strand break "},{"keId":1253,"keName":" MLL chromosomal translocation"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/202"}
{"aopId":203,"aopName":"5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline","targetName":"sodium-dependent serotonin transporter","targetId":"ENSG00000108576","aoId":361,"aoName":"Decline Population","aoNameRaw":"Decline, Population","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":1141,"keName":"Decreased, Reproductive Success"},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/203"}
{"aopId":203,"aopName":"5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline","aoId":361,"aoName":"Decline Population","aoNameRaw":"Decline, Population","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":1141,"keName":"Decreased, Reproductive Success"},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/203"}
{"aopId":203,"aopName":"5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline","targetName":"sodium-dependent serotonin transporter","targetId":"ENSG00000108576","aoId":1141,"keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":1141,"keName":"Decreased, Reproductive Success"},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/203"}
{"aopId":203,"aopName":"5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline","aoId":1141,"keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":1141,"keName":"Decreased, Reproductive Success"},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/203"}
{"aopId":203,"aopName":"5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline","targetName":"sodium-dependent serotonin transporter","targetId":"ENSG00000108576","aoId":1141,"aoName":"Decreased Reproductive Success","aoNameRaw":"Decreased, Reproductive Success","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":1141,"keName":"Decreased, Reproductive Success"},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/203"}
{"aopId":203,"aopName":"5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline","aoId":1141,"aoName":"Decreased Reproductive Success","aoNameRaw":"Decreased, Reproductive Success","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":1141,"keName":"Decreased, Reproductive Success"},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"},{"keId":361,"keName":"Decline, Population"}],"reference":"https://aopwiki.org/aops/203"}
{"aopId":204,"aopName":"5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase","aoId":1164,"aoName":"Increased Population","aoNameRaw":"Increased, Population","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1164,"keName":"Increased, Population"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":1163,"keName":"Increased, Reproductive Success"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"}],"reference":"https://aopwiki.org/aops/204"}
{"aopId":204,"aopName":"5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase","targetName":"sodium-dependent serotonin transporter","targetId":"ENSG00000108576","aoId":1164,"aoName":"Increased Population","aoNameRaw":"Increased, Population","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1164,"keName":"Increased, Population"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":1163,"keName":"Increased, Reproductive Success"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"}],"reference":"https://aopwiki.org/aops/204"}
{"aopId":204,"aopName":"5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase","aoId":1163,"aoName":"Increased Reproductive Success","aoNameRaw":"Increased, Reproductive Success","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1164,"keName":"Increased, Population"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":1163,"keName":"Increased, Reproductive Success"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"}],"reference":"https://aopwiki.org/aops/204"}
{"aopId":204,"aopName":"5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase","targetName":"sodium-dependent serotonin transporter","targetId":"ENSG00000108576","aoId":1163,"aoName":"Increased Reproductive Success","aoNameRaw":"Increased, Reproductive Success","keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1164,"keName":"Increased, Population"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":1163,"keName":"Increased, Reproductive Success"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"}],"reference":"https://aopwiki.org/aops/204"}
{"aopId":204,"aopName":"5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase","aoId":1163,"keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1164,"keName":"Increased, Population"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":1163,"keName":"Increased, Reproductive Success"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"}],"reference":"https://aopwiki.org/aops/204"}
{"aopId":204,"aopName":"5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase","targetName":"sodium-dependent serotonin transporter","targetId":"ENSG00000108576","aoId":1163,"keyEvents":[{"keId":626,"keName":"Increased, serotonin (5-HT) "},{"keId":621,"keName":"Increase, cilia movement"},{"keId":1164,"keName":"Increased, Population"},{"keId":1142,"keName":"Increased, valve movement"},{"keId":1256,"keName":"increased mantel display"},{"keId":1163,"keName":"Increased, Reproductive Success"},{"keId":619,"keName":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)"},{"keId":1257,"keName":"Induced parturition"}],"reference":"https://aopwiki.org/aops/204"}
{"aopId":205,"aopName":"AOP from chemical insult to cell death","aoId":1262,"keyEvents":[{"keId":1260,"keName":"Direct mitochondrial inhibition"},{"keId":1258,"keName":"Decompartmentalization"},{"keId":1262,"keName":"Apoptosis"},{"keId":1263,"keName":"Necrosis"},{"keId":1259,"keName":"narcosis"},{"keId":1261,"keName":"Mitochondrial impairment"}],"reference":"https://aopwiki.org/aops/205"}
{"aopId":205,"aopName":"AOP from chemical insult to cell death","aoId":1263,"aoName":"Necrosis","aoNameRaw":"Necrosis","aoMappedId":"EFO_0009426","keyEvents":[{"keId":1260,"keName":"Direct mitochondrial inhibition"},{"keId":1258,"keName":"Decompartmentalization"},{"keId":1262,"keName":"Apoptosis"},{"keId":1263,"keName":"Necrosis"},{"keId":1259,"keName":"narcosis"},{"keId":1261,"keName":"Mitochondrial impairment"}],"reference":"https://aopwiki.org/aops/205"}
{"aopId":205,"aopName":"AOP from chemical insult to cell death","aoId":1262,"aoName":"Apoptosis","aoNameRaw":"Apoptosis","keyEvents":[{"keId":1260,"keName":"Direct mitochondrial inhibition"},{"keId":1258,"keName":"Decompartmentalization"},{"keId":1262,"keName":"Apoptosis"},{"keId":1263,"keName":"Necrosis"},{"keId":1259,"keName":"narcosis"},{"keId":1261,"keName":"Mitochondrial impairment"}],"reference":"https://aopwiki.org/aops/205"}
{"aopId":206,"aopName":"Peroxisome proliferator-activated receptors γ inactivation leading to lung fibrosis","aoId":1276,"aoName":"Lung fibrosis","aoNameRaw":"Lung fibrosis","keyEvents":[{"keId":1457,"keName":"Induction, Epithelial Mesenchymal Transition"},{"keId":1271,"keName":"Activation of TGF-β signaling"},{"keId":149,"keName":"Increase, Inflammation"},{"keId":1276,"keName":"Lung fibrosis"},{"keId":1275,"keName":"Collagen Deposition"},{"keId":1270,"keName":"Inactivation of PPARγ"}],"status":"Under Development","reference":"https://aopwiki.org/aops/206"}
{"aopId":207,"aopName":"NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans","targetName":"map kinase p38","aoId":1277,"aoName":"Reproductive failure","aoNameRaw":"Reproductive failure","keyEvents":[{"keId":1277,"keName":"Reproductive failure"},{"keId":1278,"keName":"ROS formation"},{"keId":1262,"keName":"Apoptosis"},{"keId":1280,"keName":"Activation, HIF-1"},{"keId":1281,"keName":"Increased, DNA Damage-Repair"},{"keId":1279,"keName":"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":1174,"keName":"Activation, NADPH Oxidase"}],"reference":"https://aopwiki.org/aops/207"}
{"aopId":207,"aopName":"NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans","targetName":"hypoxia-inducible factor 1 (Caenorhabditis elegans)","aoId":1277,"aoName":"Reproductive failure","aoNameRaw":"Reproductive failure","keyEvents":[{"keId":1277,"keName":"Reproductive failure"},{"keId":1278,"keName":"ROS formation"},{"keId":1262,"keName":"Apoptosis"},{"keId":1280,"keName":"Activation, HIF-1"},{"keId":1281,"keName":"Increased, DNA Damage-Repair"},{"keId":1279,"keName":"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":1174,"keName":"Activation, NADPH Oxidase"}],"reference":"https://aopwiki.org/aops/207"}
{"aopId":207,"aopName":"NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans","aoId":1277,"aoName":"Reproductive failure","aoNameRaw":"Reproductive failure","keyEvents":[{"keId":1277,"keName":"Reproductive failure"},{"keId":1278,"keName":"ROS formation"},{"keId":1262,"keName":"Apoptosis"},{"keId":1280,"keName":"Activation, HIF-1"},{"keId":1281,"keName":"Increased, DNA Damage-Repair"},{"keId":1279,"keName":"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK"},{"keId":176,"keName":"Damaging, Mitochondria"},{"keId":1174,"keName":"Activation, NADPH Oxidase"}],"reference":"https://aopwiki.org/aops/207"}
{"aopId":208,"aopName":"Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure","targetName":"TGF-beta","aoId":1277,"aoName":"Reproductive failure","aoNameRaw":"Reproductive failure","keyEvents":[{"keId":1277,"keName":"Reproductive failure"},{"keId":1283,"keName":"Activation, TGF-beta pathway"},{"keId":1282,"keName":"Activation, JAK/STAT pathway"}],"reference":"https://aopwiki.org/aops/208"}
{"aopId":208,"aopName":"Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure","aoId":1277,"aoName":"Reproductive failure","aoNameRaw":"Reproductive failure","keyEvents":[{"keId":1277,"keName":"Reproductive failure"},{"keId":1283,"keName":"Activation, TGF-beta pathway"},{"keId":1282,"keName":"Activation, JAK/STAT pathway"}],"reference":"https://aopwiki.org/aops/208"}
{"aopId":208,"aopName":"Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure","targetName":"signal transducer and transcription activator STAT","aoId":1277,"aoName":"Reproductive failure","aoNameRaw":"Reproductive failure","keyEvents":[{"keId":1277,"keName":"Reproductive failure"},{"keId":1283,"keName":"Activation, TGF-beta pathway"},{"keId":1282,"keName":"Activation, JAK/STAT pathway"}],"reference":"https://aopwiki.org/aops/208"}
{"aopId":208,"aopName":"Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure","targetName":"Janus kinase","aoId":1277,"aoName":"Reproductive failure","aoNameRaw":"Reproductive failure","keyEvents":[{"keId":1277,"keName":"Reproductive failure"},{"keId":1283,"keName":"Activation, TGF-beta pathway"},{"keId":1282,"keName":"Activation, JAK/STAT pathway"}],"reference":"https://aopwiki.org/aops/208"}
{"aopId":209,"aopName":"Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ","targetName":"3-hydroxyacyl-CoA dehydrogenase type-2","targetId":"ENSG00000072506","aoId":1291,"aoName":"Hepatotoxicity","aoNameRaw":"Hepatotoxicity","aoMappedId":"EFO_0011052","keyEvents":[{"keId":1284,"keName":"Up Regulation, SREBF2"},{"keId":1288,"keName":"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene"},{"keId":1285,"keName":"Up Regulation, Unsaturated fatty acid"},{"keId":1291,"keName":"Hepatotoxicity"},{"keId":1287,"keName":"Glutathione synthesis"},{"keId":1286,"keName":"Down Regulation, GSS and GSTs gene"},{"keId":1289,"keName":"Perturbation of cholesterol"},{"keId":1290,"keName":"Glutathione homeostasis"}],"reference":"https://aopwiki.org/aops/209"}
{"aopId":209,"aopName":"Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ","targetName":"glutathione S-transferase","aoId":1291,"aoName":"Hepatotoxicity","aoNameRaw":"Hepatotoxicity","aoMappedId":"EFO_0011052","keyEvents":[{"keId":1284,"keName":"Up Regulation, SREBF2"},{"keId":1288,"keName":"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene"},{"keId":1285,"keName":"Up Regulation, Unsaturated fatty acid"},{"keId":1291,"keName":"Hepatotoxicity"},{"keId":1287,"keName":"Glutathione synthesis"},{"keId":1286,"keName":"Down Regulation, GSS and GSTs gene"},{"keId":1289,"keName":"Perturbation of cholesterol"},{"keId":1290,"keName":"Glutathione homeostasis"}],"reference":"https://aopwiki.org/aops/209"}
{"aopId":209,"aopName":"Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ","targetName":"glutathione synthetase","targetId":"ENSG00000100983","aoId":1291,"aoName":"Hepatotoxicity","aoNameRaw":"Hepatotoxicity","aoMappedId":"EFO_0011052","keyEvents":[{"keId":1284,"keName":"Up Regulation, SREBF2"},{"keId":1288,"keName":"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene"},{"keId":1285,"keName":"Up Regulation, Unsaturated fatty acid"},{"keId":1291,"keName":"Hepatotoxicity"},{"keId":1287,"keName":"Glutathione synthesis"},{"keId":1286,"keName":"Down Regulation, GSS and GSTs gene"},{"keId":1289,"keName":"Perturbation of cholesterol"},{"keId":1290,"keName":"Glutathione homeostasis"}],"reference":"https://aopwiki.org/aops/209"}
{"aopId":209,"aopName":"Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ","targetName":"sterol regulatory element-binding protein 2 proteolytic cleavage product","aoId":1291,"aoName":"Hepatotoxicity","aoNameRaw":"Hepatotoxicity","aoMappedId":"EFO_0011052","keyEvents":[{"keId":1284,"keName":"Up Regulation, SREBF2"},{"keId":1288,"keName":"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene"},{"keId":1285,"keName":"Up Regulation, Unsaturated fatty acid"},{"keId":1291,"keName":"Hepatotoxicity"},{"keId":1287,"keName":"Glutathione synthesis"},{"keId":1286,"keName":"Down Regulation, GSS and GSTs gene"},{"keId":1289,"keName":"Perturbation of cholesterol"},{"keId":1290,"keName":"Glutathione homeostasis"}],"reference":"https://aopwiki.org/aops/209"}
{"aopId":209,"aopName":"Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP ","aoId":1291,"aoName":"Hepatotoxicity","aoNameRaw":"Hepatotoxicity","aoMappedId":"EFO_0011052","keyEvents":[{"keId":1284,"keName":"Up Regulation, SREBF2"},{"keId":1288,"keName":"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene"},{"keId":1285,"keName":"Up Regulation, Unsaturated fatty acid"},{"keId":1291,"keName":"Hepatotoxicity"},{"keId":1287,"keName":"Glutathione synthesis"},{"keId":1286,"keName":"Down Regulation, GSS and GSTs gene"},{"keId":1289,"keName":"Perturbation of cholesterol"},{"keId":1290,"keName":"Glutathione homeostasis"}],"reference":"https://aopwiki.org/aops/209"}
{"aopId":210,"aopName":"Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building","aoId":1277,"aoName":"Reproductive failure","aoNameRaw":"Reproductive failure","keyEvents":[{"keId":1277,"keName":"Reproductive failure"},{"keId":209,"keName":"Peptide Oxidation"},{"keId":1295,"keName":"Defect of Embryogenesis"},{"keId":1292,"keName":"Activation, JNK"},{"keId":1294,"keName":"Inhibition, Wnt pathway"},{"keId":1293,"keName":"Activation, FOXO"}],"reference":"https://aopwiki.org/aops/210"}
{"aopId":210,"aopName":"Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building","targetName":"forkhead box protein O (Caenorhabditis elegans)","aoId":1277,"aoName":"Reproductive failure","aoNameRaw":"Reproductive failure","keyEvents":[{"keId":1277,"keName":"Reproductive failure"},{"keId":209,"keName":"Peptide Oxidation"},{"keId":1295,"keName":"Defect of Embryogenesis"},{"keId":1292,"keName":"Activation, JNK"},{"keId":1294,"keName":"Inhibition, Wnt pathway"},{"keId":1293,"keName":"Activation, FOXO"}],"reference":"https://aopwiki.org/aops/210"}
{"aopId":212,"aopName":"Histone deacetylase inhibition leading to testicular atrophy","targetName":"cell cycle-related cyclin","aoId":1506,"aoName":"Testicular atrophy","aoNameRaw":"Testicular atrophy","aoMappedId":"HP_0000029","keyEvents":[{"keId":1262,"keName":"Apoptosis"},{"keId":1505,"keName":"Cell cycle, disrupted"},{"keId":1502,"keName":"Histone deacetylase inhibition"},{"keId":1515,"keName":"Spermatocyte depletion"},{"keId":1503,"keName":"Histone acetylation, increase"},{"keId":1506,"keName":"Testicular atrophy"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/212"}
{"aopId":212,"aopName":"Histone deacetylase inhibition leading to testicular atrophy","targetName":"histone deacetylase 1","targetId":"ENSG00000116478","aoId":1506,"aoName":"Testicular atrophy","aoNameRaw":"Testicular atrophy","aoMappedId":"HP_0000029","keyEvents":[{"keId":1262,"keName":"Apoptosis"},{"keId":1505,"keName":"Cell cycle, disrupted"},{"keId":1502,"keName":"Histone deacetylase inhibition"},{"keId":1515,"keName":"Spermatocyte depletion"},{"keId":1503,"keName":"Histone acetylation, increase"},{"keId":1506,"keName":"Testicular atrophy"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/212"}
{"aopId":212,"aopName":"Histone deacetylase inhibition leading to testicular atrophy","aoId":1506,"aoName":"Testicular atrophy","aoNameRaw":"Testicular atrophy","aoMappedId":"HP_0000029","keyEvents":[{"keId":1262,"keName":"Apoptosis"},{"keId":1505,"keName":"Cell cycle, disrupted"},{"keId":1502,"keName":"Histone deacetylase inhibition"},{"keId":1515,"keName":"Spermatocyte depletion"},{"keId":1503,"keName":"Histone acetylation, increase"},{"keId":1506,"keName":"Testicular atrophy"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/212"}
{"aopId":213,"aopName":"Inhibition of fatty acid beta oxidation leading to nonalcoholic steatohepatitis (NASH)","aoId":1489,"aoName":"Steatohepatisis","aoNameRaw":"N/A, Steatohepatisis","keyEvents":[{"keId":1489,"keName":"N/A, Steatohepatisis"},{"keId":1305,"keName":"Increase, cytosolic fatty acid"},{"keId":1115,"keName":"Increased, Reactive oxygen species"},{"keId":1491,"keName":"Increased, Oncotic Necrosis"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":1490,"keName":"Inhibition, Fatty Acid Beta Oxidation"}],"reference":"https://aopwiki.org/aops/213"}
{"aopId":214,"aopName":"Network of SSRIs (selective serotonin reuptake inhibitors)","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":1345,"aoName":"Increased agitation","aoNameRaw":"Increased, agitation","keyEvents":[{"keId":1326,"keName":"Increased, 5-HT3 (5-hydroxytryptamine)"},{"keId":1319,"keName":"Decreased, extracellular chloride (Cl-)"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1337,"keName":"Activate, PLC (Phospholipase C)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1334,"keName":"Increase, cortisone"},{"keId":1341,"keName":"Increase, myosin light chain phosphorylation"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1342,"keName":"Increase, vascular smooth muscle contraction"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1316,"keName":"Inhibit, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1339,"keName":"Increase, intracellular calcium"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1318,"keName":"Decreased, extracellular sodium (Na+) "},{"keId":1338,"keName":"Increase, inositol triphosphate"},{"keId":1346,"keName":"Increased, depression"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":1343,"keName":"Increase, hypertension"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1336,"keName":"Activation, 5-HT2A (Serotonin 2A)"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1340,"keName":"Activate, calmodulin"}],"reference":"https://aopwiki.org/aops/214"}
{"aopId":214,"aopName":"Network of SSRIs (selective serotonin reuptake inhibitors)","aoId":1345,"aoName":"Increased agitation","aoNameRaw":"Increased, agitation","keyEvents":[{"keId":1326,"keName":"Increased, 5-HT3 (5-hydroxytryptamine)"},{"keId":1319,"keName":"Decreased, extracellular chloride (Cl-)"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1337,"keName":"Activate, PLC (Phospholipase C)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1334,"keName":"Increase, cortisone"},{"keId":1341,"keName":"Increase, myosin light chain phosphorylation"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1342,"keName":"Increase, vascular smooth muscle contraction"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1316,"keName":"Inhibit, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1339,"keName":"Increase, intracellular calcium"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1318,"keName":"Decreased, extracellular sodium (Na+) "},{"keId":1338,"keName":"Increase, inositol triphosphate"},{"keId":1346,"keName":"Increased, depression"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":1343,"keName":"Increase, hypertension"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1336,"keName":"Activation, 5-HT2A (Serotonin 2A)"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1340,"keName":"Activate, calmodulin"}],"reference":"https://aopwiki.org/aops/214"}
{"aopId":214,"aopName":"Network of SSRIs (selective serotonin reuptake inhibitors)","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":1344,"aoName":"Increased seizure","aoNameRaw":"Increased, seizure","keyEvents":[{"keId":1326,"keName":"Increased, 5-HT3 (5-hydroxytryptamine)"},{"keId":1319,"keName":"Decreased, extracellular chloride (Cl-)"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1337,"keName":"Activate, PLC (Phospholipase C)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1334,"keName":"Increase, cortisone"},{"keId":1341,"keName":"Increase, myosin light chain phosphorylation"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1342,"keName":"Increase, vascular smooth muscle contraction"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1316,"keName":"Inhibit, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1339,"keName":"Increase, intracellular calcium"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1318,"keName":"Decreased, extracellular sodium (Na+) "},{"keId":1338,"keName":"Increase, inositol triphosphate"},{"keId":1346,"keName":"Increased, depression"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":1343,"keName":"Increase, hypertension"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1336,"keName":"Activation, 5-HT2A (Serotonin 2A)"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1340,"keName":"Activate, calmodulin"}],"reference":"https://aopwiki.org/aops/214"}
{"aopId":214,"aopName":"Network of SSRIs (selective serotonin reuptake inhibitors)","aoId":1344,"aoName":"Increased seizure","aoNameRaw":"Increased, seizure","keyEvents":[{"keId":1326,"keName":"Increased, 5-HT3 (5-hydroxytryptamine)"},{"keId":1319,"keName":"Decreased, extracellular chloride (Cl-)"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1337,"keName":"Activate, PLC (Phospholipase C)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1334,"keName":"Increase, cortisone"},{"keId":1341,"keName":"Increase, myosin light chain phosphorylation"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1342,"keName":"Increase, vascular smooth muscle contraction"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1316,"keName":"Inhibit, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1339,"keName":"Increase, intracellular calcium"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1318,"keName":"Decreased, extracellular sodium (Na+) "},{"keId":1338,"keName":"Increase, inositol triphosphate"},{"keId":1346,"keName":"Increased, depression"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":1343,"keName":"Increase, hypertension"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1336,"keName":"Activation, 5-HT2A (Serotonin 2A)"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1340,"keName":"Activate, calmodulin"}],"reference":"https://aopwiki.org/aops/214"}
{"aopId":214,"aopName":"Network of SSRIs (selective serotonin reuptake inhibitors)","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":1344,"keyEvents":[{"keId":1326,"keName":"Increased, 5-HT3 (5-hydroxytryptamine)"},{"keId":1319,"keName":"Decreased, extracellular chloride (Cl-)"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1337,"keName":"Activate, PLC (Phospholipase C)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1334,"keName":"Increase, cortisone"},{"keId":1341,"keName":"Increase, myosin light chain phosphorylation"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1342,"keName":"Increase, vascular smooth muscle contraction"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1316,"keName":"Inhibit, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1339,"keName":"Increase, intracellular calcium"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1318,"keName":"Decreased, extracellular sodium (Na+) "},{"keId":1338,"keName":"Increase, inositol triphosphate"},{"keId":1346,"keName":"Increased, depression"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":1343,"keName":"Increase, hypertension"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1336,"keName":"Activation, 5-HT2A (Serotonin 2A)"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1340,"keName":"Activate, calmodulin"}],"reference":"https://aopwiki.org/aops/214"}
{"aopId":214,"aopName":"Network of SSRIs (selective serotonin reuptake inhibitors)","aoId":1344,"keyEvents":[{"keId":1326,"keName":"Increased, 5-HT3 (5-hydroxytryptamine)"},{"keId":1319,"keName":"Decreased, extracellular chloride (Cl-)"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1337,"keName":"Activate, PLC (Phospholipase C)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1334,"keName":"Increase, cortisone"},{"keId":1341,"keName":"Increase, myosin light chain phosphorylation"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1342,"keName":"Increase, vascular smooth muscle contraction"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1316,"keName":"Inhibit, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1339,"keName":"Increase, intracellular calcium"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1318,"keName":"Decreased, extracellular sodium (Na+) "},{"keId":1338,"keName":"Increase, inositol triphosphate"},{"keId":1346,"keName":"Increased, depression"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":1343,"keName":"Increase, hypertension"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1336,"keName":"Activation, 5-HT2A (Serotonin 2A)"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1340,"keName":"Activate, calmodulin"}],"reference":"https://aopwiki.org/aops/214"}
{"aopId":214,"aopName":"Network of SSRIs (selective serotonin reuptake inhibitors)","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":1343,"aoName":"Increase hypertension","aoNameRaw":"Increase, hypertension","keyEvents":[{"keId":1326,"keName":"Increased, 5-HT3 (5-hydroxytryptamine)"},{"keId":1319,"keName":"Decreased, extracellular chloride (Cl-)"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1337,"keName":"Activate, PLC (Phospholipase C)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1334,"keName":"Increase, cortisone"},{"keId":1341,"keName":"Increase, myosin light chain phosphorylation"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1342,"keName":"Increase, vascular smooth muscle contraction"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1316,"keName":"Inhibit, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1339,"keName":"Increase, intracellular calcium"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1318,"keName":"Decreased, extracellular sodium (Na+) "},{"keId":1338,"keName":"Increase, inositol triphosphate"},{"keId":1346,"keName":"Increased, depression"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":1343,"keName":"Increase, hypertension"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1336,"keName":"Activation, 5-HT2A (Serotonin 2A)"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1340,"keName":"Activate, calmodulin"}],"reference":"https://aopwiki.org/aops/214"}
{"aopId":214,"aopName":"Network of SSRIs (selective serotonin reuptake inhibitors)","aoId":1343,"aoName":"Increase hypertension","aoNameRaw":"Increase, hypertension","keyEvents":[{"keId":1326,"keName":"Increased, 5-HT3 (5-hydroxytryptamine)"},{"keId":1319,"keName":"Decreased, extracellular chloride (Cl-)"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1337,"keName":"Activate, PLC (Phospholipase C)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1334,"keName":"Increase, cortisone"},{"keId":1341,"keName":"Increase, myosin light chain phosphorylation"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1342,"keName":"Increase, vascular smooth muscle contraction"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1316,"keName":"Inhibit, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1339,"keName":"Increase, intracellular calcium"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1318,"keName":"Decreased, extracellular sodium (Na+) "},{"keId":1338,"keName":"Increase, inositol triphosphate"},{"keId":1346,"keName":"Increased, depression"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":1343,"keName":"Increase, hypertension"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1336,"keName":"Activation, 5-HT2A (Serotonin 2A)"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1340,"keName":"Activate, calmodulin"}],"reference":"https://aopwiki.org/aops/214"}
{"aopId":214,"aopName":"Network of SSRIs (selective serotonin reuptake inhibitors)","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":1346,"aoName":"Increased depression","aoNameRaw":"Increased, depression","keyEvents":[{"keId":1326,"keName":"Increased, 5-HT3 (5-hydroxytryptamine)"},{"keId":1319,"keName":"Decreased, extracellular chloride (Cl-)"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1337,"keName":"Activate, PLC (Phospholipase C)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1334,"keName":"Increase, cortisone"},{"keId":1341,"keName":"Increase, myosin light chain phosphorylation"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1342,"keName":"Increase, vascular smooth muscle contraction"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1316,"keName":"Inhibit, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1339,"keName":"Increase, intracellular calcium"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1318,"keName":"Decreased, extracellular sodium (Na+) "},{"keId":1338,"keName":"Increase, inositol triphosphate"},{"keId":1346,"keName":"Increased, depression"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":1343,"keName":"Increase, hypertension"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1336,"keName":"Activation, 5-HT2A (Serotonin 2A)"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1340,"keName":"Activate, calmodulin"}],"reference":"https://aopwiki.org/aops/214"}
{"aopId":214,"aopName":"Network of SSRIs (selective serotonin reuptake inhibitors)","aoId":1346,"aoName":"Increased depression","aoNameRaw":"Increased, depression","keyEvents":[{"keId":1326,"keName":"Increased, 5-HT3 (5-hydroxytryptamine)"},{"keId":1319,"keName":"Decreased, extracellular chloride (Cl-)"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1337,"keName":"Activate, PLC (Phospholipase C)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1334,"keName":"Increase, cortisone"},{"keId":1341,"keName":"Increase, myosin light chain phosphorylation"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1342,"keName":"Increase, vascular smooth muscle contraction"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1316,"keName":"Inhibit, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1339,"keName":"Increase, intracellular calcium"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1318,"keName":"Decreased, extracellular sodium (Na+) "},{"keId":1338,"keName":"Increase, inositol triphosphate"},{"keId":1346,"keName":"Increased, depression"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":1343,"keName":"Increase, hypertension"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1336,"keName":"Activation, 5-HT2A (Serotonin 2A)"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1340,"keName":"Activate, calmodulin"}],"reference":"https://aopwiki.org/aops/214"}
{"aopId":215,"aopName":"Molecular events lead to epilepsy","aoId":1348,"aoName":"Increase seizure","aoNameRaw":"Increase, seizure","keyEvents":[{"keId":1351,"keName":"Activated, NMDA receptor"},{"keId":1349,"keName":"Activated, presynaptic neuron 1"},{"keId":1359,"keName":"Activate, GABA-A receptor"},{"keId":1357,"keName":"Increased, RDX dose"},{"keId":1362,"keName":"Increased, hippocampal hyperdepolarization"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1350,"keName":"Increased, glutamate"},{"keId":1348,"keName":"Increase, seizure"},{"keId":1355,"keName":"Activated, membrane depolarization"},{"keId":1361,"keName":"Increase, GABA"},{"keId":1354,"keName":"Treat, carbamazepine"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1360,"keName":"Activate, presynaptic neuron 2"},{"keId":1352,"keName":"Activated, voltage-gated sodium channel"},{"keId":1353,"keName":"Inhibit, voltage-gated sodium channel"},{"keId":1358,"keName":"Repress, GABA-A receptor"},{"keId":1356,"keName":"Inactive, membrane depolarization"},{"keId":1363,"keName":"Increased, epilepsy"}],"reference":"https://aopwiki.org/aops/215"}
{"aopId":215,"aopName":"Molecular events lead to epilepsy","aoId":1363,"aoName":"Increased epilepsy","aoNameRaw":"Increased, epilepsy","keyEvents":[{"keId":1351,"keName":"Activated, NMDA receptor"},{"keId":1349,"keName":"Activated, presynaptic neuron 1"},{"keId":1359,"keName":"Activate, GABA-A receptor"},{"keId":1357,"keName":"Increased, RDX dose"},{"keId":1362,"keName":"Increased, hippocampal hyperdepolarization"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1350,"keName":"Increased, glutamate"},{"keId":1348,"keName":"Increase, seizure"},{"keId":1355,"keName":"Activated, membrane depolarization"},{"keId":1361,"keName":"Increase, GABA"},{"keId":1354,"keName":"Treat, carbamazepine"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1360,"keName":"Activate, presynaptic neuron 2"},{"keId":1352,"keName":"Activated, voltage-gated sodium channel"},{"keId":1353,"keName":"Inhibit, voltage-gated sodium channel"},{"keId":1358,"keName":"Repress, GABA-A receptor"},{"keId":1356,"keName":"Inactive, membrane depolarization"},{"keId":1363,"keName":"Increased, epilepsy"}],"reference":"https://aopwiki.org/aops/215"}
{"aopId":215,"aopName":"Molecular events lead to epilepsy","aoId":1362,"aoName":"Increased hippocampal hyperdepolarization","aoNameRaw":"Increased, hippocampal hyperdepolarization","keyEvents":[{"keId":1351,"keName":"Activated, NMDA receptor"},{"keId":1349,"keName":"Activated, presynaptic neuron 1"},{"keId":1359,"keName":"Activate, GABA-A receptor"},{"keId":1357,"keName":"Increased, RDX dose"},{"keId":1362,"keName":"Increased, hippocampal hyperdepolarization"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1350,"keName":"Increased, glutamate"},{"keId":1348,"keName":"Increase, seizure"},{"keId":1355,"keName":"Activated, membrane depolarization"},{"keId":1361,"keName":"Increase, GABA"},{"keId":1354,"keName":"Treat, carbamazepine"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1360,"keName":"Activate, presynaptic neuron 2"},{"keId":1352,"keName":"Activated, voltage-gated sodium channel"},{"keId":1353,"keName":"Inhibit, voltage-gated sodium channel"},{"keId":1358,"keName":"Repress, GABA-A receptor"},{"keId":1356,"keName":"Inactive, membrane depolarization"},{"keId":1363,"keName":"Increased, epilepsy"}],"reference":"https://aopwiki.org/aops/215"}
{"aopId":215,"aopName":"Molecular events lead to epilepsy","aoId":1362,"keyEvents":[{"keId":1351,"keName":"Activated, NMDA receptor"},{"keId":1349,"keName":"Activated, presynaptic neuron 1"},{"keId":1359,"keName":"Activate, GABA-A receptor"},{"keId":1357,"keName":"Increased, RDX dose"},{"keId":1362,"keName":"Increased, hippocampal hyperdepolarization"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1350,"keName":"Increased, glutamate"},{"keId":1348,"keName":"Increase, seizure"},{"keId":1355,"keName":"Activated, membrane depolarization"},{"keId":1361,"keName":"Increase, GABA"},{"keId":1354,"keName":"Treat, carbamazepine"},{"keId":1322,"keName":"Increased, intracellular chloride (Cl-)"},{"keId":1360,"keName":"Activate, presynaptic neuron 2"},{"keId":1352,"keName":"Activated, voltage-gated sodium channel"},{"keId":1353,"keName":"Inhibit, voltage-gated sodium channel"},{"keId":1358,"keName":"Repress, GABA-A receptor"},{"keId":1356,"keName":"Inactive, membrane depolarization"},{"keId":1363,"keName":"Increased, epilepsy"}],"reference":"https://aopwiki.org/aops/215"}
{"aopId":216,"aopName":"Excessive reactive oxygen species production leading to population decline via follicular atresia","aoId":328,"aoName":"Decrease Fecundity","aoNameRaw":"Decrease, Fecundity","keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":1444,"keName":"Increase, Follicular atresia"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1608,"keName":"Increase, Oxidative DNA damage"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/216"}
{"aopId":216,"aopName":"Excessive reactive oxygen species production leading to population decline via follicular atresia","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":1444,"keName":"Increase, Follicular atresia"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1608,"keName":"Increase, Oxidative DNA damage"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/216"}
{"aopId":217,"aopName":"Gastric ulcer formation","aoId":1367,"aoName":"Inhibit gastric ulcer formation","aoNameRaw":"Inhibit, gastric ulcer formation","keyEvents":[{"keId":1384,"keName":"Increase, ammonium (NH4+)"},{"keId":1371,"keName":"Inhibition, PTGS-2 (Prostaglandin-endoperoxide synthase 2)"},{"keId":1373,"keName":"Increase, mucous"},{"keId":1381,"keName":"Increase, surfactant"},{"keId":1383,"keName":"Activate, phospholipase"},{"keId":1370,"keName":"Activation, PTGS-2 (Prostaglandin-endoperoxide synthase 2)"},{"keId":1380,"keName":"Activate, mucosal defense"},{"keId":1385,"keName":"Activated, gastric ulcer formation"},{"keId":1379,"keName":"Activate, leukocyte "},{"keId":1378,"keName":"Increase, leukocyte adherence"},{"keId":1377,"keName":"Decrease, leukocyte adherence"},{"keId":1372,"keName":"Increase, bicarbonate "},{"keId":1376,"keName":"Increase, angiogenesis"},{"keId":1375,"keName":"Increase, platelet aggregation"},{"keId":1368,"keName":"Inhibition, PTGS-1 (Prostaglandin-endoperoxide synthase 1)"},{"keId":1369,"keName":"Activation, PTGS-1 (Prostaglandin-endoperoxide synthase 1)"},{"keId":1382,"keName":"Decrease, surfactant"},{"keId":1374,"keName":"Increase, mucosal blood flow"},{"keId":1367,"keName":"Inhibit, gastric ulcer formation"}],"reference":"https://aopwiki.org/aops/217"}
{"aopId":217,"aopName":"Gastric ulcer formation","aoId":1385,"aoName":"Activated gastric ulcer formation","aoNameRaw":"Activated, gastric ulcer formation","keyEvents":[{"keId":1384,"keName":"Increase, ammonium (NH4+)"},{"keId":1371,"keName":"Inhibition, PTGS-2 (Prostaglandin-endoperoxide synthase 2)"},{"keId":1373,"keName":"Increase, mucous"},{"keId":1381,"keName":"Increase, surfactant"},{"keId":1383,"keName":"Activate, phospholipase"},{"keId":1370,"keName":"Activation, PTGS-2 (Prostaglandin-endoperoxide synthase 2)"},{"keId":1380,"keName":"Activate, mucosal defense"},{"keId":1385,"keName":"Activated, gastric ulcer formation"},{"keId":1379,"keName":"Activate, leukocyte "},{"keId":1378,"keName":"Increase, leukocyte adherence"},{"keId":1377,"keName":"Decrease, leukocyte adherence"},{"keId":1372,"keName":"Increase, bicarbonate "},{"keId":1376,"keName":"Increase, angiogenesis"},{"keId":1375,"keName":"Increase, platelet aggregation"},{"keId":1368,"keName":"Inhibition, PTGS-1 (Prostaglandin-endoperoxide synthase 1)"},{"keId":1369,"keName":"Activation, PTGS-1 (Prostaglandin-endoperoxide synthase 1)"},{"keId":1382,"keName":"Decrease, surfactant"},{"keId":1374,"keName":"Increase, mucosal blood flow"},{"keId":1367,"keName":"Inhibit, gastric ulcer formation"}],"reference":"https://aopwiki.org/aops/217"}
{"aopId":218,"aopName":"Inhibition of CYP7B activity leads to decreased reproductive success via decreased locomotor activity","aoId":442,"aoName":"Decreased Population trajectory","aoNameRaw":"Decreased, Population trajectory","keyEvents":[{"keId":1389,"keName":"Locomotor activity, decreased"},{"keId":1141,"keName":"Decreased, Reproductive Success"},{"keId":442,"keName":"Decreased, Population trajectory"},{"keId":1387,"keName":"7α-hydroxypregnenolone synthesis in the brain, decreased"},{"keId":1386,"keName":"CYP7B activity, inhibition"},{"keId":1388,"keName":"Dopamine release in the brain, decreased"}],"reference":"https://aopwiki.org/aops/218"}
{"aopId":219,"aopName":"Inhibition of CYP7B activity leads to decreased reproductive success via decreased sexual behavior","aoId":442,"aoName":"Decreased Population trajectory","aoNameRaw":"Decreased, Population trajectory","keyEvents":[{"keId":1141,"keName":"Decreased, Reproductive Success"},{"keId":442,"keName":"Decreased, Population trajectory"},{"keId":1387,"keName":"7α-hydroxypregnenolone synthesis in the brain, decreased"},{"keId":1386,"keName":"CYP7B activity, inhibition"},{"keId":1388,"keName":"Dopamine release in the brain, decreased"},{"keId":1390,"keName":"Sexual behavior, decreased"}],"reference":"https://aopwiki.org/aops/219"}
{"aopId":220,"aopName":"Cyp2E1 Activation Leading to Liver Cancer","aoId":1395,"aoName":"Liver Cancer","aoNameRaw":"Liver Cancer","aoMappedId":"MONDO_0002691","keyEvents":[{"keId":1395,"keName":"Liver Cancer"},{"keId":1394,"keName":"Induction, persistent proliferation/sustained proliferation"},{"keId":1391,"keName":"Activation of Cyp2E1"},{"keId":1392,"keName":"Oxidative Stress "},{"keId":1393,"keName":"Hepatocytotoxicity"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/220"}
{"aopId":220,"aopName":"Cyp2E1 Activation Leading to Liver Cancer","targetName":"hypoxia-inducible factor 1-alpha","targetId":"ENSG00000100644","aoId":1395,"aoName":"Liver Cancer","aoNameRaw":"Liver Cancer","aoMappedId":"MONDO_0002691","keyEvents":[{"keId":1395,"keName":"Liver Cancer"},{"keId":1394,"keName":"Induction, persistent proliferation/sustained proliferation"},{"keId":1391,"keName":"Activation of Cyp2E1"},{"keId":1392,"keName":"Oxidative Stress "},{"keId":1393,"keName":"Hepatocytotoxicity"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/220"}
{"aopId":220,"aopName":"Cyp2E1 Activation Leading to Liver Cancer","targetName":"von Hippel-Lindau disease tumor suppressor","targetId":"ENSG00000134086","aoId":1395,"aoName":"Liver Cancer","aoNameRaw":"Liver Cancer","aoMappedId":"MONDO_0002691","keyEvents":[{"keId":1395,"keName":"Liver Cancer"},{"keId":1394,"keName":"Induction, persistent proliferation/sustained proliferation"},{"keId":1391,"keName":"Activation of Cyp2E1"},{"keId":1392,"keName":"Oxidative Stress "},{"keId":1393,"keName":"Hepatocytotoxicity"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/220"}
{"aopId":221,"aopName":"Mental stress to depression","aoId":1346,"aoName":"Increased depression","aoNameRaw":"Increased, depression","keyEvents":[{"keId":1346,"keName":"Increased, depression"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1396,"keName":"Increased, glucocorticoid receptor activity"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1347,"keName":"Decreased, extracellular serotonin"}],"reference":"https://aopwiki.org/aops/221"}
{"aopId":222,"aopName":"Mental stress to agitation","aoId":1345,"aoName":"Increased agitation","aoNameRaw":"Increased, agitation","keyEvents":[{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1335,"keName":"Reduced, BDNF (Brain-derived neurotrophic factor)"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1396,"keName":"Increased, glucocorticoid receptor activity"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1347,"keName":"Decreased, extracellular serotonin"}],"reference":"https://aopwiki.org/aops/222"}
{"aopId":223,"aopName":"Serotonin transporter activation to seizure","aoId":1344,"keyEvents":[{"keId":1398,"keName":"Increased, intracellular serotonin"},{"keId":1397,"keName":"Increased, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1401,"keName":"Decreased, 5-HT3"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1399,"keName":"Increased, packaged serotonin"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1400,"keName":"Increased, synaptic release"}],"reference":"https://aopwiki.org/aops/223"}
{"aopId":223,"aopName":"Serotonin transporter activation to seizure","aoId":1344,"aoName":"Increased seizure","aoNameRaw":"Increased, seizure","keyEvents":[{"keId":1398,"keName":"Increased, intracellular serotonin"},{"keId":1397,"keName":"Increased, serotonin transporter activity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1401,"keName":"Decreased, 5-HT3"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1399,"keName":"Increased, packaged serotonin"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1400,"keName":"Increased, synaptic release"}],"reference":"https://aopwiki.org/aops/223"}
{"aopId":224,"aopName":"Serotonin transporter activation to depression","aoId":1346,"aoName":"Increased depression","aoNameRaw":"Increased, depression","keyEvents":[{"keId":1346,"keName":"Increased, depression"},{"keId":1398,"keName":"Increased, intracellular serotonin"},{"keId":1397,"keName":"Increased, serotonin transporter activity"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1399,"keName":"Increased, packaged serotonin"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1400,"keName":"Increased, synaptic release"}],"reference":"https://aopwiki.org/aops/224"}
{"aopId":225,"aopName":"Serotonin transporter activation to agitation","aoId":1345,"aoName":"Increased agitation","aoNameRaw":"Increased, agitation","keyEvents":[{"keId":1398,"keName":"Increased, intracellular serotonin"},{"keId":1397,"keName":"Increased, serotonin transporter activity"},{"keId":1330,"keName":"Decreased, neuroplasticity"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1345,"keName":"Increased, agitation"},{"keId":1328,"keName":"Inactivated, 5-HTR (serotonin receptors)"},{"keId":1329,"keName":"Reduce expression, BDNF (Brain-derived neurotrophic factor)"},{"keId":1399,"keName":"Increased, packaged serotonin"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1400,"keName":"Increased, synaptic release"}],"reference":"https://aopwiki.org/aops/225"}
{"aopId":226,"aopName":"SSRI (Selective serotonin reuptake inhibitor) to hypertension","aoId":1343,"aoName":"Increase hypertension","aoNameRaw":"Increase, hypertension","keyEvents":[{"keId":1343,"keName":"Increase, hypertension"},{"keId":1337,"keName":"Activate, PLC (Phospholipase C)"},{"keId":1323,"keName":"Decreased, intracellular serotonin"},{"keId":1341,"keName":"Increase, myosin light chain phosphorylation"},{"keId":1325,"keName":"Decreased, synaptic release"},{"keId":1342,"keName":"Increase, vascular smooth muscle contraction"},{"keId":1324,"keName":"Decreased, packaged serotonin"},{"keId":1336,"keName":"Activation, 5-HT2A (Serotonin 2A)"},{"keId":1320,"keName":"Increased, extracellular serotonin"},{"keId":1339,"keName":"Increase, intracellular calcium"},{"keId":1317,"keName":"Decreased, serotonin transporter activity"},{"keId":1338,"keName":"Increase, inositol triphosphate"},{"keId":1347,"keName":"Decreased, extracellular serotonin"},{"keId":1340,"keName":"Activate, calmodulin"}],"reference":"https://aopwiki.org/aops/226"}
{"aopId":227,"aopName":"NSAID induced PTGS1 inactivation to gastric ulcer","aoId":1385,"aoName":"Activated gastric ulcer formation","aoNameRaw":"Activated, gastric ulcer formation","keyEvents":[{"keId":1385,"keName":"Activated, gastric ulcer formation"},{"keId":1406,"keName":"Decreased, mucous"},{"keId":1407,"keName":"Decreased, bicarbonate"},{"keId":1405,"keName":"Reduced, mucosal defense"},{"keId":1403,"keName":"Reduced, platelet aggregation"},{"keId":1404,"keName":"Decreased, mucosal blood flow"},{"keId":1402,"keName":"Reduced, PTGS1 function"}],"reference":"https://aopwiki.org/aops/227"}
{"aopId":228,"aopName":"NSAID induced PTGS2 inactivation to gastric ulcer","aoId":1385,"aoName":"Activated gastric ulcer formation","aoNameRaw":"Activated, gastric ulcer formation","keyEvents":[{"keId":1385,"keName":"Activated, gastric ulcer formation"},{"keId":1408,"keName":"Reduced, PTGS2 function"},{"keId":1411,"keName":"Increased, leukocyte activation"},{"keId":1410,"keName":"Increased, leukocyte adherence"},{"keId":1409,"keName":"Decreased, angiogenesis"}],"reference":"https://aopwiki.org/aops/228"}
{"aopId":229,"aopName":"Helicobacter pylori to gastric ulcer","aoId":1385,"aoName":"Activated gastric ulcer formation","aoNameRaw":"Activated, gastric ulcer formation","keyEvents":[{"keId":1384,"keName":"Increase, ammonium (NH4+)"},{"keId":1385,"keName":"Activated, gastric ulcer formation"},{"keId":1412,"keName":"Helicobacter pylori infection"},{"keId":1405,"keName":"Reduced, mucosal defense"},{"keId":1383,"keName":"Activate, phospholipase"},{"keId":1382,"keName":"Decrease, surfactant"}],"reference":"https://aopwiki.org/aops/229"}
{"aopId":230,"aopName":"presynaptic neuron 1 activation to epilepsy","aoId":1363,"aoName":"Increased epilepsy","aoNameRaw":"Increased, epilepsy","keyEvents":[{"keId":1354,"keName":"Treat, carbamazepine"},{"keId":1351,"keName":"Activated, NMDA receptor"},{"keId":1352,"keName":"Activated, voltage-gated sodium channel"},{"keId":1353,"keName":"Inhibit, voltage-gated sodium channel"},{"keId":1349,"keName":"Activated, presynaptic neuron 1"},{"keId":1321,"keName":"Increased, intracellular sodium (Na+)"},{"keId":1362,"keName":"Increased, hippocampal hyperdepolarization"},{"keId":1350,"keName":"Increased, glutamate"},{"keId":1355,"keName":"Activated, membrane depolarization"},{"keId":1363,"keName":"Increased, epilepsy"},{"keId":1344,"keName":"Increased, seizure"}],"reference":"https://aopwiki.org/aops/230"}
{"aopId":231,"aopName":"presynaptic neuron 2 repression to epilepsy","aoId":1363,"aoName":"Increased epilepsy","aoNameRaw":"Increased, epilepsy","keyEvents":[{"keId":1416,"keName":"Decreased, intracellular chloride"},{"keId":1357,"keName":"Increased, RDX dose"},{"keId":1362,"keName":"Increased, hippocampal hyperdepolarization"},{"keId":1415,"keName":"Reduced, GABA-A receptor activation"},{"keId":1355,"keName":"Activated, membrane depolarization"},{"keId":1344,"keName":"Increased, seizure"},{"keId":1363,"keName":"Increased, epilepsy"},{"keId":1414,"keName":"Decreased, GABA"},{"keId":1413,"keName":"Reduced, presynaptic neuron 2 activity"}],"reference":"https://aopwiki.org/aops/231"}
{"aopId":232,"aopName":"NFE2/Nrf2 repression to steatosis","aoId":1418,"aoName":"Increased steatosis","aoNameRaw":"Increased, steatosis","keyEvents":[{"keId":1420,"keName":"Reduced, SHP activity"},{"keId":1424,"keName":"Reduced, fatty acid beta oxidation"},{"keId":1422,"keName":"Reduced, PPARalpha"},{"keId":1418,"keName":"Increased, steatosis"},{"keId":1421,"keName":"Activated, LXR"},{"keId":1419,"keName":"Reduced, FXR activity"},{"keId":1423,"keName":"Reduced, HSD17B4 activity"},{"keId":1417,"keName":"NFE2/Nrf2 repression"}],"reference":"https://aopwiki.org/aops/232"}
{"aopId":233,"aopName":"Mu Opioid Receptor Agonism leading to Analgesia via K Channel Opening","aoId":1428,"aoName":"Analgesia","aoNameRaw":"Analgesia","aoMappedId":"EFO_1001484","keyEvents":[{"keId":1426,"keName":"Release of G Proteins"},{"keId":1425,"keName":"Mu Opioid Receptor Agonism"},{"keId":1427,"keName":"Opening of G protein gated inward rectifying K channels"},{"keId":763,"keName":"hyperpolarisation, neuron"},{"keId":1428,"keName":"Analgesia"}],"reference":"https://aopwiki.org/aops/233"}
{"aopId":234,"aopName":"Mu Opioid Receptor Agonism leading to Analgesia via Ca Channel Inhibition","aoId":1428,"aoName":"Analgesia","aoNameRaw":"Analgesia","aoMappedId":"EFO_1001484","keyEvents":[{"keId":1430,"keName":"Inhibition of neurotransmitter vesicle release"},{"keId":1426,"keName":"Release of G Proteins"},{"keId":1425,"keName":"Mu Opioid Receptor Agonism"},{"keId":1428,"keName":"Analgesia"},{"keId":1429,"keName":"Inhibition of N-type Ca ion channels"}],"reference":"https://aopwiki.org/aops/234"}
{"aopId":235,"aopName":"Serotonin 1A Receptor Agonism leading to Anti-depressant Activity via K Channel Opening","aoId":1432,"aoName":"Anti-depressant Activity","aoNameRaw":"Anti-depressant Activity","keyEvents":[{"keId":1426,"keName":"Release of G Proteins"},{"keId":1431,"keName":"Serotonin 1A Receptor Agonism"},{"keId":1427,"keName":"Opening of G protein gated inward rectifying K channels"},{"keId":1432,"keName":"Anti-depressant Activity"},{"keId":763,"keName":"hyperpolarisation, neuron"}],"reference":"https://aopwiki.org/aops/235"}
{"aopId":236,"aopName":"Serotonin 1A Receptor Agonism leading to Anti-depressant Activity via Ca Channel Inhibition","aoId":1432,"aoName":"Anti-depressant Activity","aoNameRaw":"Anti-depressant Activity","keyEvents":[{"keId":1430,"keName":"Inhibition of neurotransmitter vesicle release"},{"keId":1426,"keName":"Release of G Proteins"},{"keId":1431,"keName":"Serotonin 1A Receptor Agonism"},{"keId":1432,"keName":"Anti-depressant Activity"},{"keId":1429,"keName":"Inhibition of N-type Ca ion channels"}],"reference":"https://aopwiki.org/aops/236"}
{"aopId":237,"aopName":"Secretion of inflammatory cytokines after cellular sensing of the stressor leading to plaque progression","aoId":1443,"aoName":"Plaque progression in arteries","aoNameRaw":"Plaque progression in arteries","keyEvents":[{"keId":1443,"keName":"Plaque progression in arteries"},{"keId":1442,"keName":"Foam cell formation"},{"keId":1437,"keName":"Sensing of the stressor by pulmonary cells"},{"keId":1440,"keName":"Formation of HDL-SAA"},{"keId":1439,"keName":"Increased production of pulmonary SAA"},{"keId":1441,"keName":"Increased systemic total cholesterol pool"},{"keId":1438,"keName":"Increased production of pulmonary, pro-inflammatory cytokines"}],"status":"Under Development","reference":"https://aopwiki.org/aops/237"}
{"aopId":238,"aopName":"Excessive reactive oxygen species production leading to population decline via lipid peroxidation","aoId":328,"aoName":"Decrease Fecundity","aoNameRaw":"Decrease, Fecundity","keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":1444,"keName":"Increase, Follicular atresia"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1445,"keName":"Increase, Lipid peroxidation"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/238"}
{"aopId":238,"aopName":"Excessive reactive oxygen species production leading to population decline via lipid peroxidation","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":1444,"keName":"Increase, Follicular atresia"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1445,"keName":"Increase, Lipid peroxidation"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/238"}
{"aopId":241,"aopName":"Latent Transforming Growth Factor beta1 activation leads to pulmonary fibrosis","aoId":1458,"aoName":"Pulmonary fibrosis","aoNameRaw":"Pulmonary fibrosis","aoMappedId":"EFO_0009448","keyEvents":[{"keId":68,"keName":"Accumulation, Collagen"},{"keId":1456,"keName":"Increase, Differentiation of fibroblasts"},{"keId":1469,"keName":"Activation, Transforming Growth Factor beta pathway"},{"keId":1457,"keName":"Induction, Epithelial Mesenchymal Transition"},{"keId":1458,"keName":"Pulmonary fibrosis"},{"keId":1468,"keName":"Activation, Latent Transforming Growth Factor Beta 1"}],"reference":"https://aopwiki.org/aops/241"}
{"aopId":242,"aopName":"Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity","aoId":1467,"aoName":"Growth reduction","aoNameRaw":"Growth, reduction","keyEvents":[{"keId":1462,"keName":"Thiol group of chemicals interact with sulfuhydryl groups of proteins to form thiol adducts"},{"keId":1466,"keName":"Notochord distortion or malformations"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":636,"keName":"Decreased, survival"},{"keId":1464,"keName":"Reduction of collagen crosslinking"},{"keId":1467,"keName":"Growth, reduction"},{"keId":1465,"keName":"Weak collagen matrix"},{"keId":1463,"keName":"Inhibition of lysyl oxidase"}],"reference":"https://aopwiki.org/aops/242"}
{"aopId":242,"aopName":"Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity","aoId":636,"aoName":"Decreased survival","aoNameRaw":"Decreased, survival","keyEvents":[{"keId":1462,"keName":"Thiol group of chemicals interact with sulfuhydryl groups of proteins to form thiol adducts"},{"keId":1466,"keName":"Notochord distortion or malformations"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":636,"keName":"Decreased, survival"},{"keId":1464,"keName":"Reduction of collagen crosslinking"},{"keId":1467,"keName":"Growth, reduction"},{"keId":1465,"keName":"Weak collagen matrix"},{"keId":1463,"keName":"Inhibition of lysyl oxidase"}],"reference":"https://aopwiki.org/aops/242"}
{"aopId":245,"aopName":"Reduction in photophosphorylation leading to growth inhibition in aquatic plants","aoId":1521,"aoName":"Decrease Growth","aoNameRaw":"Decrease, Growth","keyEvents":[{"keId":1477,"keName":"Decrease, Oxidative phosphorylation"},{"keId":1471,"keName":"Increase, Uncoupling of photophosphorylation"},{"keId":40,"keName":"Decrease, Mitochondrial ATP production"},{"keId":1474,"keName":"Decrease, Light harvest capacity"},{"keId":1521,"keName":"Decrease, Growth"},{"keId":1472,"keName":"Decrease, ATP production"},{"keId":1473,"keName":"Decrease, Chlorophyll synthesis"},{"keId":1475,"keName":"Decrease, Photosynthesis"},{"keId":1478,"keName":"Decrease, Leaf cell mitosis"},{"keId":1476,"keName":"Decrease, Glycolysis"},{"keId":1479,"keName":"Decrease, Leaf development"}],"reference":"https://aopwiki.org/aops/245"}
{"aopId":256,"aopName":"Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity","aoId":814,"aoName":"Occurrence Kidney toxicity","aoNameRaw":"Occurrence, Kidney toxicity","keyEvents":[{"keId":814,"keName":"Occurrence, Kidney toxicity"},{"keId":709,"keName":"Increase, Cytotoxicity (renal tubular cell)"},{"keId":1481,"keName":"Inhibition of mitochondrial DNA polymerase gamma (Pol gamma)"},{"keId":1482,"keName":"Depletion, mtDNA "},{"keId":1483,"keName":"Dysfunction, Mitochondria "}],"status":"Under Development","reference":"https://aopwiki.org/aops/256"}
{"aopId":257,"aopName":"Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity","aoId":814,"aoName":"Occurrence Kidney toxicity","aoNameRaw":"Occurrence, Kidney toxicity","keyEvents":[{"keId":814,"keName":"Occurrence, Kidney toxicity"},{"keId":898,"keName":"Disruption, Lysosome"},{"keId":831,"keName":"Disturbance, Lysosomal function"},{"keId":709,"keName":"Increase, Cytotoxicity (renal tubular cell)"},{"keId":1486,"keName":"Binding of substrate, endocytic receptor"}],"status":"Under Development","reference":"https://aopwiki.org/aops/257"}
{"aopId":258,"aopName":"Renal protein alkylation leading to kidney toxicity","aoId":814,"aoName":"Occurrence Kidney toxicity","aoNameRaw":"Occurrence, Kidney toxicity","keyEvents":[{"keId":814,"keName":"Occurrence, Kidney toxicity"},{"keId":40,"keName":"Decrease, Mitochondrial ATP production"},{"keId":244,"keName":"Alkylation, Protein"},{"keId":709,"keName":"Increase, Cytotoxicity (renal tubular cell)"},{"keId":1483,"keName":"Dysfunction, Mitochondria "}],"status":"Under Development","reference":"https://aopwiki.org/aops/258"}
{"aopId":260,"aopName":"CYP2E1 activation and formation of protein adducts leading to neurodegeneration","aoId":1514,"aoName":"Neurodegeneration","aoNameRaw":"Neurodegeneration","aoMappedId":"HP_0002180","keyEvents":[{"keId":1509,"keName":"Protein Adduct Formation"},{"keId":1512,"keName":"Unfolded Protein Response"},{"keId":1508,"keName":"CYP2E1 Activation"},{"keId":1513,"keName":"General Apoptosis"},{"keId":1514,"keName":"Neurodegeneration"},{"keId":1511,"keName":"Lipid Peroxidation"},{"keId":1510,"keName":"Oxidative Stress in Brain"}],"reference":"https://aopwiki.org/aops/260"}
{"aopId":261,"aopName":"L-type calcium channel blockade leading to heart failure via decrease in cardiac contractility","aoId":1535,"aoName":"Heart failure","aoNameRaw":"Heart failure ","aoMappedId":"EFO_0003144","keyEvents":[{"keId":1537,"keName":"Disruption, Sarcomere assembly"},{"keId":1536,"keName":"Disruption, Intracellular calcium mobilization"},{"keId":1535,"keName":"Heart failure "},{"keId":1532,"keName":"Decrease, Cardiac contractility "},{"keId":1533,"keName":"Decrease, Cardiac ejection fraction "},{"keId":1529,"keName":"Blockade, L-Type Calcium Channels "},{"keId":1530,"keName":"Decrease, Calcium currents"},{"keId":1531,"keName":"Decrease, Calcium binding to Troponin C"}],"status":"Under Development","reference":"https://aopwiki.org/aops/261"}
{"aopId":263,"aopName":"Uncoupling of oxidative phosphorylation leading to  growth inhibition via decreased cell proliferation","aoId":1521,"aoName":"Decrease Growth","aoNameRaw":"Decrease, Growth","keyEvents":[{"keId":1521,"keName":"Decrease, Growth"},{"keId":1446,"keName":"Decrease, Coupling of oxidative phosphorylation"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1821,"keName":"Decrease, Cell proliferation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/263"}
{"aopId":264,"aopName":"Uncoupling of oxidative phosphorylation leading to growth inhibition via increased cell death","aoId":1521,"aoName":"Decrease Growth","aoNameRaw":"Decrease, Growth","keyEvents":[{"keId":1521,"keName":"Decrease, Growth"},{"keId":1446,"keName":"Decrease, Coupling of oxidative phosphorylation"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1825,"keName":"Increase, Cell death"}],"status":"Under Development","reference":"https://aopwiki.org/aops/264"}
{"aopId":265,"aopName":"Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased lipid storage","aoId":1521,"aoName":"Decrease Growth","aoNameRaw":"Decrease, Growth","keyEvents":[{"keId":1521,"keName":"Decrease, Growth"},{"keId":1312,"keName":"Increase, Fatty acid beta-oxidation"},{"keId":1823,"keName":"Decrease, Lipid storage"},{"keId":1446,"keName":"Decrease, Coupling of oxidative phosphorylation"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"}],"status":"Under Development","reference":"https://aopwiki.org/aops/265"}
{"aopId":266,"aopName":"Uncoupling of oxidative phosphorylation leading to growth inhibition via oxidative DNA damage","aoId":1521,"aoName":"Decrease Growth","aoNameRaw":"Decrease, Growth","keyEvents":[{"keId":1826,"keName":"Increase, Oxygen consumption"},{"keId":1521,"keName":"Decrease, Growth"},{"keId":1446,"keName":"Decrease, Coupling of oxidative phosphorylation"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1825,"keName":"Increase, Cell death"},{"keId":1608,"keName":"Increase, Oxidative DNA damage"}],"status":"Under Development","reference":"https://aopwiki.org/aops/266"}
{"aopId":267,"aopName":"Uncoupling of oxidative phosphorylation leading to growth inhibition via increased lipid peroxidation","aoId":1521,"aoName":"Decrease Growth","aoNameRaw":"Decrease, Growth","keyEvents":[{"keId":1826,"keName":"Increase, Oxygen consumption"},{"keId":1521,"keName":"Decrease, Growth"},{"keId":1445,"keName":"Increase, Lipid peroxidation"},{"keId":1446,"keName":"Decrease, Coupling of oxidative phosphorylation"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1825,"keName":"Increase, Cell death"}],"status":"Under Development","reference":"https://aopwiki.org/aops/267"}
{"aopId":268,"aopName":"Uncoupling of oxidative phosphorylation leading to growth inhibition via increased protein oxidation","aoId":1521,"aoName":"Decrease Growth","aoNameRaw":"Decrease, Growth","keyEvents":[{"keId":1826,"keName":"Increase, Oxygen consumption"},{"keId":1521,"keName":"Decrease, Growth"},{"keId":1767,"keName":"Increase, Protein oxidation"},{"keId":1446,"keName":"Decrease, Coupling of oxidative phosphorylation"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1825,"keName":"Increase, Cell death"}],"status":"Under Development","reference":"https://aopwiki.org/aops/268"}
{"aopId":271,"aopName":"Inhibition of thyroid peroxidase leading to impaired fertility in fish","aoId":78,"keyEvents":[{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"status":"Under Development","reference":"https://aopwiki.org/aops/271"}
{"aopId":271,"aopName":"Inhibition of thyroid peroxidase leading to impaired fertility in fish","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":78,"keyEvents":[{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"status":"Under Development","reference":"https://aopwiki.org/aops/271"}
{"aopId":271,"aopName":"Inhibition of thyroid peroxidase leading to impaired fertility in fish","targetName":"aromatase","targetId":"ENSG00000137869","aoId":78,"keyEvents":[{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"status":"Under Development","reference":"https://aopwiki.org/aops/271"}
{"aopId":271,"aopName":"Inhibition of thyroid peroxidase leading to impaired fertility in fish","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"status":"Under Development","reference":"https://aopwiki.org/aops/271"}
{"aopId":271,"aopName":"Inhibition of thyroid peroxidase leading to impaired fertility in fish","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"status":"Under Development","reference":"https://aopwiki.org/aops/271"}
{"aopId":271,"aopName":"Inhibition of thyroid peroxidase leading to impaired fertility in fish","targetName":"aromatase","targetId":"ENSG00000137869","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":408,"keName":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"status":"Under Development","reference":"https://aopwiki.org/aops/271"}
{"aopId":272,"aopName":"Deposition of energy leading to lung cancer","aoId":1556,"aoName":"Increase lung cancer","aoNameRaw":"Increase, lung cancer","keyEvents":[{"keId":185,"keName":"Increase, Mutations"},{"keId":1636,"keName":"Increase, Chromosomal aberrations"},{"keId":1556,"keName":"Increase, lung cancer"},{"keId":155,"keName":"N/A, Inadequate DNA repair"},{"keId":870,"keName":"Increase, Cell Proliferation"},{"keId":1686,"keName":"Direct Deposition of Energy"},{"keId":1635,"keName":"Increase, DNA strand breaks"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/272"}
{"aopId":273,"aopName":"Mitochondrial complex inhibition leading to liver injury","targetName":"NADH-ubiquinone oxidoreductase chain 1","targetId":"ENSG00000198888","aoId":1548,"aoName":"Necrotic Tissue","aoNameRaw":"Necrotic Tissue","keyEvents":[{"keId":1548,"keName":"Necrotic Tissue"},{"keId":1543,"keName":"Mitochondrial Complex IV inhibition"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":889,"keName":"Impaired, Proteostasis"},{"keId":1546,"keName":"Increased reactive oxygen species (in the mitochondria)"},{"keId":888,"keName":"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)"},{"keId":1544,"keName":"Mitochondrial Complex V inhibition"},{"keId":55,"keName":"Cell injury/death"},{"keId":1654,"keName":"Binding of inhibitor to mitochondrial complex IV"},{"keId":1547,"keName":"Mitochondrial Injury"},{"keId":1545,"keName":"Decrease in mitochondrial oxidative phosphorylation"},{"keId":1549,"keName":"Liver Injury"},{"keId":1655,"keName":"Binding of inhibitor to mitochondrial complex V"},{"keId":1542,"keName":"Increase, Mitochondrial complex III antagonism"},{"keId":1653,"keName":"Binding of inhibitor to mitochondrial complex III"},{"keId":887,"keName":"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)"}],"reference":"https://aopwiki.org/aops/273"}
{"aopId":273,"aopName":"Mitochondrial complex inhibition leading to liver injury","aoId":1548,"aoName":"Necrotic Tissue","aoNameRaw":"Necrotic Tissue","keyEvents":[{"keId":1548,"keName":"Necrotic Tissue"},{"keId":1543,"keName":"Mitochondrial Complex IV inhibition"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":889,"keName":"Impaired, Proteostasis"},{"keId":1546,"keName":"Increased reactive oxygen species (in the mitochondria)"},{"keId":888,"keName":"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)"},{"keId":1544,"keName":"Mitochondrial Complex V inhibition"},{"keId":55,"keName":"Cell injury/death"},{"keId":1654,"keName":"Binding of inhibitor to mitochondrial complex IV"},{"keId":1547,"keName":"Mitochondrial Injury"},{"keId":1545,"keName":"Decrease in mitochondrial oxidative phosphorylation"},{"keId":1549,"keName":"Liver Injury"},{"keId":1655,"keName":"Binding of inhibitor to mitochondrial complex V"},{"keId":1542,"keName":"Increase, Mitochondrial complex III antagonism"},{"keId":1653,"keName":"Binding of inhibitor to mitochondrial complex III"},{"keId":887,"keName":"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)"}],"reference":"https://aopwiki.org/aops/273"}
{"aopId":273,"aopName":"Mitochondrial complex inhibition leading to liver injury","targetName":"NADH-ubiquinone oxidoreductase chain 1","targetId":"ENSG00000198888","aoId":1549,"aoName":"Liver Injury","aoNameRaw":"Liver Injury","keyEvents":[{"keId":1548,"keName":"Necrotic Tissue"},{"keId":1543,"keName":"Mitochondrial Complex IV inhibition"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":889,"keName":"Impaired, Proteostasis"},{"keId":1546,"keName":"Increased reactive oxygen species (in the mitochondria)"},{"keId":888,"keName":"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)"},{"keId":1544,"keName":"Mitochondrial Complex V inhibition"},{"keId":55,"keName":"Cell injury/death"},{"keId":1654,"keName":"Binding of inhibitor to mitochondrial complex IV"},{"keId":1547,"keName":"Mitochondrial Injury"},{"keId":1545,"keName":"Decrease in mitochondrial oxidative phosphorylation"},{"keId":1549,"keName":"Liver Injury"},{"keId":1655,"keName":"Binding of inhibitor to mitochondrial complex V"},{"keId":1542,"keName":"Increase, Mitochondrial complex III antagonism"},{"keId":1653,"keName":"Binding of inhibitor to mitochondrial complex III"},{"keId":887,"keName":"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)"}],"reference":"https://aopwiki.org/aops/273"}
{"aopId":273,"aopName":"Mitochondrial complex inhibition leading to liver injury","aoId":1549,"aoName":"Liver Injury","aoNameRaw":"Liver Injury","keyEvents":[{"keId":1548,"keName":"Necrotic Tissue"},{"keId":1543,"keName":"Mitochondrial Complex IV inhibition"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":889,"keName":"Impaired, Proteostasis"},{"keId":1546,"keName":"Increased reactive oxygen species (in the mitochondria)"},{"keId":888,"keName":"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)"},{"keId":1544,"keName":"Mitochondrial Complex V inhibition"},{"keId":55,"keName":"Cell injury/death"},{"keId":1654,"keName":"Binding of inhibitor to mitochondrial complex IV"},{"keId":1547,"keName":"Mitochondrial Injury"},{"keId":1545,"keName":"Decrease in mitochondrial oxidative phosphorylation"},{"keId":1549,"keName":"Liver Injury"},{"keId":1655,"keName":"Binding of inhibitor to mitochondrial complex V"},{"keId":1542,"keName":"Increase, Mitochondrial complex III antagonism"},{"keId":1653,"keName":"Binding of inhibitor to mitochondrial complex III"},{"keId":887,"keName":"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)"}],"reference":"https://aopwiki.org/aops/273"}
{"aopId":274,"aopName":"Histone deacetylase inhibition leads to impeded craniofacial development","aoId":1559,"aoName":"Facial cartilage structures are reduced in size and morphologically distorted","aoNameRaw":"Facial cartilage structures are reduced in size and morphologically distorted","keyEvents":[{"keId":1557,"keName":"Neural crest cell migration, reduced"},{"keId":1502,"keName":"Histone deacetylase inhibition"},{"keId":1559,"keName":"Facial cartilage structures are reduced in size and morphologically distorted"},{"keId":1558,"keName":"Collagen production, reduced"}],"reference":"https://aopwiki.org/aops/274"}
{"aopId":274,"aopName":"Histone deacetylase inhibition leads to impeded craniofacial development","targetName":"histone deacetylase 1","targetId":"ENSG00000116478","aoId":1559,"aoName":"Facial cartilage structures are reduced in size and morphologically distorted","aoNameRaw":"Facial cartilage structures are reduced in size and morphologically distorted","keyEvents":[{"keId":1557,"keName":"Neural crest cell migration, reduced"},{"keId":1502,"keName":"Histone deacetylase inhibition"},{"keId":1559,"keName":"Facial cartilage structures are reduced in size and morphologically distorted"},{"keId":1558,"keName":"Collagen production, reduced"}],"reference":"https://aopwiki.org/aops/274"}
{"aopId":275,"aopName":"Histone deacetylase inhibition leads to neural tube defects","targetName":"histone deacetylase 1","targetId":"ENSG00000116478","aoId":1561,"aoName":"Neural tube defects","aoNameRaw":"Neural tube defects","keyEvents":[{"keId":1239,"keName":"Altered, Gene Expression"},{"keId":1502,"keName":"Histone deacetylase inhibition"},{"keId":1503,"keName":"Histone acetylation, increase"},{"keId":1561,"keName":"Neural tube defects"},{"keId":1560,"keName":"Altered differentiation"}],"reference":"https://aopwiki.org/aops/275"}
{"aopId":275,"aopName":"Histone deacetylase inhibition leads to neural tube defects","aoId":1561,"aoName":"Neural tube defects","aoNameRaw":"Neural tube defects","keyEvents":[{"keId":1239,"keName":"Altered, Gene Expression"},{"keId":1502,"keName":"Histone deacetylase inhibition"},{"keId":1503,"keName":"Histone acetylation, increase"},{"keId":1561,"keName":"Neural tube defects"},{"keId":1560,"keName":"Altered differentiation"}],"reference":"https://aopwiki.org/aops/275"}
{"aopId":276,"aopName":"Inhibition of complex I of the electron transport chain leading to chemical induced Fanconi syndrome","aoId":1564,"aoName":"Chemical induced Fanconi syndrome","aoNameRaw":"Chemical induced Fanconi syndrome","keyEvents":[{"keId":1477,"keName":"Decrease, Oxidative phosphorylation"},{"keId":1564,"keName":"Chemical induced Fanconi syndrome"},{"keId":1562,"keName":"Decreased Na/K ATPase activity"},{"keId":888,"keName":"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)"},{"keId":1563,"keName":"Decreased proximal tubular vectorial transport"},{"keId":887,"keName":"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)"}],"reference":"https://aopwiki.org/aops/276"}
{"aopId":276,"aopName":"Inhibition of complex I of the electron transport chain leading to chemical induced Fanconi syndrome","targetName":"NADH-ubiquinone oxidoreductase chain 1","targetId":"ENSG00000198888","aoId":1564,"aoName":"Chemical induced Fanconi syndrome","aoNameRaw":"Chemical induced Fanconi syndrome","keyEvents":[{"keId":1477,"keName":"Decrease, Oxidative phosphorylation"},{"keId":1564,"keName":"Chemical induced Fanconi syndrome"},{"keId":1562,"keName":"Decreased Na/K ATPase activity"},{"keId":888,"keName":"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)"},{"keId":1563,"keName":"Decreased proximal tubular vectorial transport"},{"keId":887,"keName":"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)"}],"reference":"https://aopwiki.org/aops/276"}
{"aopId":277,"aopName":"Impaired IL-1R1 signaling leading to increased susceptibility to infection","targetName":"transcription factor NF-kappa-B subunit","aoId":986,"aoName":"Increase Increased susceptibility to infection","aoNameRaw":"Increase, Increased susceptibility to infection","keyEvents":[{"keId":986,"keName":"Increase, Increased susceptibility to infection"},{"keId":1702,"keName":"Suppression of  T cell activation"},{"keId":1700,"keName":"Impaired IL-1R1 signaling"},{"keId":202,"keName":"Inhibition, Nuclear factor kappa B (NF-kB)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/277"}
{"aopId":277,"aopName":"Impaired IL-1R1 signaling leading to increased susceptibility to infection","aoId":986,"aoName":"Increase Increased susceptibility to infection","aoNameRaw":"Increase, Increased susceptibility to infection","keyEvents":[{"keId":986,"keName":"Increase, Increased susceptibility to infection"},{"keId":1702,"keName":"Suppression of  T cell activation"},{"keId":1700,"keName":"Impaired IL-1R1 signaling"},{"keId":202,"keName":"Inhibition, Nuclear factor kappa B (NF-kB)"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/277"}
{"aopId":278,"aopName":"IKK complex inhibition leading to liver injury","targetName":"transcription factor NF-kappa-B subunit","aoId":1548,"aoName":"Necrotic Tissue","aoNameRaw":"Necrotic Tissue","keyEvents":[{"keId":1574,"keName":"Inhibition, IKK complex"},{"keId":1579,"keName":"Increase, proinflammatory mediators (TNFalpha)"},{"keId":1548,"keName":"Necrotic Tissue"},{"keId":1575,"keName":"Activation, Caspase 8 pathway"},{"keId":1549,"keName":"Liver Injury"},{"keId":1576,"keName":"Activation, Tissue resident cells (Kuppfer cells)"},{"keId":55,"keName":"Cell injury/death"},{"keId":202,"keName":"Inhibition, Nuclear factor kappa B (NF-kB)"}],"reference":"https://aopwiki.org/aops/278"}
{"aopId":278,"aopName":"IKK complex inhibition leading to liver injury","aoId":1548,"aoName":"Necrotic Tissue","aoNameRaw":"Necrotic Tissue","keyEvents":[{"keId":1574,"keName":"Inhibition, IKK complex"},{"keId":1579,"keName":"Increase, proinflammatory mediators (TNFalpha)"},{"keId":1548,"keName":"Necrotic Tissue"},{"keId":1575,"keName":"Activation, Caspase 8 pathway"},{"keId":1549,"keName":"Liver Injury"},{"keId":1576,"keName":"Activation, Tissue resident cells (Kuppfer cells)"},{"keId":55,"keName":"Cell injury/death"},{"keId":202,"keName":"Inhibition, Nuclear factor kappa B (NF-kB)"}],"reference":"https://aopwiki.org/aops/278"}
{"aopId":278,"aopName":"IKK complex inhibition leading to liver injury","targetName":"transcription factor NF-kappa-B subunit","aoId":1549,"aoName":"Liver Injury","aoNameRaw":"Liver Injury","keyEvents":[{"keId":1574,"keName":"Inhibition, IKK complex"},{"keId":1579,"keName":"Increase, proinflammatory mediators (TNFalpha)"},{"keId":1548,"keName":"Necrotic Tissue"},{"keId":1575,"keName":"Activation, Caspase 8 pathway"},{"keId":1549,"keName":"Liver Injury"},{"keId":1576,"keName":"Activation, Tissue resident cells (Kuppfer cells)"},{"keId":55,"keName":"Cell injury/death"},{"keId":202,"keName":"Inhibition, Nuclear factor kappa B (NF-kB)"}],"reference":"https://aopwiki.org/aops/278"}
{"aopId":278,"aopName":"IKK complex inhibition leading to liver injury","aoId":1549,"aoName":"Liver Injury","aoNameRaw":"Liver Injury","keyEvents":[{"keId":1574,"keName":"Inhibition, IKK complex"},{"keId":1579,"keName":"Increase, proinflammatory mediators (TNFalpha)"},{"keId":1548,"keName":"Necrotic Tissue"},{"keId":1575,"keName":"Activation, Caspase 8 pathway"},{"keId":1549,"keName":"Liver Injury"},{"keId":1576,"keName":"Activation, Tissue resident cells (Kuppfer cells)"},{"keId":55,"keName":"Cell injury/death"},{"keId":202,"keName":"Inhibition, Nuclear factor kappa B (NF-kB)"}],"reference":"https://aopwiki.org/aops/278"}
{"aopId":279,"aopName":"Microtubule interacting drugs lead to peripheral neuropathy","aoId":1583,"aoName":"Sensory axonal peripheral neuropathy","aoNameRaw":"Sensory axonal peripheral neuropathy","keyEvents":[{"keId":1581,"keName":"Disturbance in microtubule dynamic instability"},{"keId":1580,"keName":"Binding of microtubule stabilizing agents (MSA) to microtubules"},{"keId":1582,"keName":"Impaired axonial transport"},{"keId":1583,"keName":"Sensory axonal peripheral neuropathy"}],"reference":"https://aopwiki.org/aops/279"}
{"aopId":280,"aopName":"α-diketone-induced bronchiolitis obliterans","aoId":1588,"aoName":"Bronchiolitis obliterans","aoNameRaw":"Bronchiolitis obliterans","aoMappedId":"EFO_0007183","keyEvents":[{"keId":1585,"keName":"Proteasomal dysfunction"},{"keId":1587,"keName":"Fibroproliferative airway lesions"},{"keId":1457,"keName":"Induction, Epithelial Mesenchymal Transition"},{"keId":1586,"keName":"Airway epithelial injury"},{"keId":149,"keName":"Increase, Inflammation"},{"keId":1588,"keName":"Bronchiolitis obliterans"},{"keId":1584,"keName":"Interaction of α-diketones with arginine residues"}],"reference":"https://aopwiki.org/aops/280"}
{"aopId":281,"aopName":"Acetylcholinesterase Inhibition Leading to Neurodegeneration","targetName":"muscarinic acetylcholine receptor","aoId":352,"keyEvents":[{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":388,"keName":"Overactivation, NMDARs"},{"keId":1623,"keName":"Occurrence, Focal Seizure"},{"keId":1788,"keName":"Status epilepticus"},{"keId":1602,"keName":"Activation, Muscarinic Acetylcholine Receptors"},{"keId":389,"keName":"Increased, Intracellular Calcium overload"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"},{"keId":55,"keName":"Cell injury/death"}],"reference":"https://aopwiki.org/aops/281"}
{"aopId":281,"aopName":"Acetylcholinesterase Inhibition Leading to Neurodegeneration","targetName":"acetylcholinesterase","targetId":"ENSG00000087085","aoId":352,"keyEvents":[{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":388,"keName":"Overactivation, NMDARs"},{"keId":1623,"keName":"Occurrence, Focal Seizure"},{"keId":1788,"keName":"Status epilepticus"},{"keId":1602,"keName":"Activation, Muscarinic Acetylcholine Receptors"},{"keId":389,"keName":"Increased, Intracellular Calcium overload"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"},{"keId":55,"keName":"Cell injury/death"}],"reference":"https://aopwiki.org/aops/281"}
{"aopId":281,"aopName":"Acetylcholinesterase Inhibition Leading to Neurodegeneration","aoId":352,"keyEvents":[{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":388,"keName":"Overactivation, NMDARs"},{"keId":1623,"keName":"Occurrence, Focal Seizure"},{"keId":1788,"keName":"Status epilepticus"},{"keId":1602,"keName":"Activation, Muscarinic Acetylcholine Receptors"},{"keId":389,"keName":"Increased, Intracellular Calcium overload"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"},{"keId":55,"keName":"Cell injury/death"}],"reference":"https://aopwiki.org/aops/281"}
{"aopId":281,"aopName":"Acetylcholinesterase Inhibition Leading to Neurodegeneration","targetName":"muscarinic acetylcholine receptor","aoId":352,"aoName":"Neurodegeneration","aoNameRaw":"N/A, Neurodegeneration","aoMappedId":"HP_0002180","keyEvents":[{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":388,"keName":"Overactivation, NMDARs"},{"keId":1623,"keName":"Occurrence, Focal Seizure"},{"keId":1788,"keName":"Status epilepticus"},{"keId":1602,"keName":"Activation, Muscarinic Acetylcholine Receptors"},{"keId":389,"keName":"Increased, Intracellular Calcium overload"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"},{"keId":55,"keName":"Cell injury/death"}],"reference":"https://aopwiki.org/aops/281"}
{"aopId":281,"aopName":"Acetylcholinesterase Inhibition Leading to Neurodegeneration","targetName":"acetylcholinesterase","targetId":"ENSG00000087085","aoId":352,"aoName":"Neurodegeneration","aoNameRaw":"N/A, Neurodegeneration","aoMappedId":"HP_0002180","keyEvents":[{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":388,"keName":"Overactivation, NMDARs"},{"keId":1623,"keName":"Occurrence, Focal Seizure"},{"keId":1788,"keName":"Status epilepticus"},{"keId":1602,"keName":"Activation, Muscarinic Acetylcholine Receptors"},{"keId":389,"keName":"Increased, Intracellular Calcium overload"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"},{"keId":55,"keName":"Cell injury/death"}],"reference":"https://aopwiki.org/aops/281"}
{"aopId":281,"aopName":"Acetylcholinesterase Inhibition Leading to Neurodegeneration","aoId":352,"aoName":"Neurodegeneration","aoNameRaw":"N/A, Neurodegeneration","aoMappedId":"HP_0002180","keyEvents":[{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":388,"keName":"Overactivation, NMDARs"},{"keId":1623,"keName":"Occurrence, Focal Seizure"},{"keId":1788,"keName":"Status epilepticus"},{"keId":1602,"keName":"Activation, Muscarinic Acetylcholine Receptors"},{"keId":389,"keName":"Increased, Intracellular Calcium overload"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"},{"keId":55,"keName":"Cell injury/death"}],"reference":"https://aopwiki.org/aops/281"}
{"aopId":282,"aopName":"Reactive oxygen species generated from photoreactive chemicals leading to phototoxic reactions","aoId":1599,"aoName":"Inflamatory events in light-exposed tissues","aoNameRaw":"Inflamatory events in light-exposed tissues","keyEvents":[{"keId":1592,"keName":"ROS generation from photoactivated chemicals"},{"keId":1599,"keName":"Inflamatory events in light-exposed tissues"},{"keId":1594,"keName":"Oxidation of membrane lipids"},{"keId":1595,"keName":"Oxidation/denatuation of membrane proteins"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/282"}
{"aopId":284,"aopName":"Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress leads to chronic kidney disease","aoId":1603,"aoName":"Chronic kidney disease","aoNameRaw":"Chronic kidney disease","aoMappedId":"EFO_0003884","keyEvents":[{"keId":178,"keName":"Disruption, Mitochondrial electron transport chain"},{"keId":1392,"keName":"Oxidative Stress "},{"keId":1487,"keName":"Binding, Thiol/seleno-proteins involved in protection against oxidative stress"},{"keId":1603,"keName":"Chronic kidney disease"},{"keId":926,"keName":"Oxidation, Glutathione (To be considered with MIE)"},{"keId":1538,"keName":"Decreased protection against oxidative stress"},{"keId":768,"keName":"Increase, Cytotoxicity"}],"reference":"https://aopwiki.org/aops/284"}
{"aopId":285,"aopName":"Inhibition of N-linked glycosylation leads to liver injury","aoId":1549,"aoName":"Liver Injury","aoNameRaw":"Liver Injury","keyEvents":[{"keId":1605,"keName":"Accumulation of misfolded proteins"},{"keId":1512,"keName":"Unfolded Protein Response"},{"keId":1262,"keName":"Apoptosis"},{"keId":1606,"keName":"Activation of hepatic stellate cells"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":1549,"keName":"Liver Injury"},{"keId":1604,"keName":"Inhibition of N-linked glycosylation"}],"reference":"https://aopwiki.org/aops/285"}
{"aopId":286,"aopName":"Mitochondrial complex III antagonism leading to growth inhibition (1)","aoId":1521,"aoName":"Decrease Growth","aoNameRaw":"Decrease, Growth","keyEvents":[{"keId":1521,"keName":"Decrease, Growth"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1821,"keName":"Decrease, Cell proliferation"},{"keId":1542,"keName":"Increase, Mitochondrial complex III antagonism"}],"reference":"https://aopwiki.org/aops/286"}
{"aopId":287,"aopName":"Mitochondrial complex III antagonism leading to growth inhibition (2)","aoId":1521,"aoName":"Decrease Growth","aoNameRaw":"Decrease, Growth","keyEvents":[{"keId":1521,"keName":"Decrease, Growth"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1825,"keName":"Increase, Cell death"},{"keId":1542,"keName":"Increase, Mitochondrial complex III antagonism"}],"reference":"https://aopwiki.org/aops/287"}
{"aopId":288,"aopName":"Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)","aoId":1616,"keyEvents":[{"keId":1611,"keName":"Reduction, 17-OH-progesterone conversion in androstenedione"},{"keId":1612,"keName":"Decrease, testosterone synthesis/level"},{"keId":1613,"keName":"Decrease, dihydrotestosterone (DHT) level"},{"keId":1609,"keName":"Inhibition, Cytochrome P450 enzyme (CYP17A1) activity"},{"keId":1616,"keName":"Malformation, cryptorchidism - maldescended testis"},{"keId":1614,"keName":"Decrease, androgen receptors (AR) activation"},{"keId":1610,"keName":"Reduction, 17-OH-pregnenolone conversion in DHEA"},{"keId":1615,"keName":"Impaired inguinoscrotal testicular descent phase"}],"reference":"https://aopwiki.org/aops/288"}
{"aopId":288,"aopName":"Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)","aoId":1616,"aoName":"Malformation cryptorchidism - maldescended testis","aoNameRaw":"Malformation, cryptorchidism - maldescended testis","keyEvents":[{"keId":1611,"keName":"Reduction, 17-OH-progesterone conversion in androstenedione"},{"keId":1612,"keName":"Decrease, testosterone synthesis/level"},{"keId":1613,"keName":"Decrease, dihydrotestosterone (DHT) level"},{"keId":1609,"keName":"Inhibition, Cytochrome P450 enzyme (CYP17A1) activity"},{"keId":1616,"keName":"Malformation, cryptorchidism - maldescended testis"},{"keId":1614,"keName":"Decrease, androgen receptors (AR) activation"},{"keId":1610,"keName":"Reduction, 17-OH-pregnenolone conversion in DHEA"},{"keId":1615,"keName":"Impaired inguinoscrotal testicular descent phase"}],"reference":"https://aopwiki.org/aops/288"}
{"aopId":289,"aopName":"Inhibition of 5α-reductase leading to impaired fecundity in female fish","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1613,"keName":"Decrease, dihydrotestosterone (DHT) level"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":1617,"keName":"5α-reductase, inhibition"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"}],"status":"Under Development","reference":"https://aopwiki.org/aops/289"}
{"aopId":290,"aopName":"Mitochondrial ATP synthase antagonism leading to growth inhibition (1)","aoId":1521,"aoName":"Decrease Growth","aoNameRaw":"Decrease, Growth","keyEvents":[{"keId":1521,"keName":"Decrease, Growth"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1785,"keName":"Increase, Mitochondrial ATP synthase antagonism"},{"keId":1821,"keName":"Decrease, Cell proliferation"}],"reference":"https://aopwiki.org/aops/290"}
{"aopId":291,"aopName":"Mitochondrial ATP synthase antagonism leading to growth inhibition (2)","aoId":1521,"aoName":"Decrease Growth","aoNameRaw":"Decrease, Growth","keyEvents":[{"keId":1521,"keName":"Decrease, Growth"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1785,"keName":"Increase, Mitochondrial ATP synthase antagonism"},{"keId":1825,"keName":"Increase, Cell death"}],"reference":"https://aopwiki.org/aops/291"}
{"aopId":292,"aopName":"Inhibition of tyrosinase leads to decreased population in fish","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1627,"keName":"Inhibition of tyrosinase "},{"keId":1629,"keName":"Reduction in melanin level"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1631,"keName":"Reduction fo Pigmentation pattern "},{"keId":1628,"keName":"Reduction of L-Dopaquinone"},{"keId":1630,"keName":"Reduction of melanosome level"}],"status":"Under Development","reference":"https://aopwiki.org/aops/292"}
{"aopId":293,"aopName":"Increased DNA damage leading to increased risk of breast cancer","aoId":1193,"aoName":"Breast Cancer","aoNameRaw":"N/A, Breast Cancer","aoMappedId":"MONDO_0007254","keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/293"}
{"aopId":293,"aopName":"Increased DNA damage leading to increased risk of breast cancer","aoId":185,"keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/293"}
{"aopId":293,"aopName":"Increased DNA damage leading to increased risk of breast cancer","aoId":185,"aoName":"Increase Mutations","aoNameRaw":"Increase, Mutations","keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/293"}
{"aopId":293,"aopName":"Increased DNA damage leading to increased risk of breast cancer","aoId":1192,"keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/293"}
{"aopId":293,"aopName":"Increased DNA damage leading to increased risk of breast cancer","aoId":1192,"aoName":"Increased Ductal Hyperplasia","aoNameRaw":"Increased, Ductal Hyperplasia ","keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/293"}
{"aopId":294,"aopName":"Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer","aoId":1192,"keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/294"}
{"aopId":294,"aopName":"Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer","aoId":1194,"keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/294"}
{"aopId":294,"aopName":"Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer","aoId":1194,"aoName":"Increase DNA damage","aoNameRaw":"Increase, DNA damage","keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/294"}
{"aopId":294,"aopName":"Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer","aoId":1192,"aoName":"Increased Ductal Hyperplasia","aoNameRaw":"Increased, Ductal Hyperplasia ","keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/294"}
{"aopId":294,"aopName":"Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer","aoId":1193,"aoName":"Breast Cancer","aoNameRaw":"N/A, Breast Cancer","aoMappedId":"MONDO_0007254","keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/294"}
{"aopId":294,"aopName":"Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer","aoId":185,"keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/294"}
{"aopId":294,"aopName":"Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer","aoId":185,"aoName":"Increase Mutations","aoNameRaw":"Increase, Mutations","keyEvents":[{"keId":1182,"keName":"Increase, Cell Proliferation (Epithelial Cells)"},{"keId":185,"keName":"Increase, Mutations"},{"keId":1632,"keName":"Increase in reactive oxygen and nitrogen species (RONS)"},{"keId":1493,"keName":"Increased Pro-inflammatory mediators"},{"keId":1193,"keName":"N/A, Breast Cancer"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1192,"keName":"Increased, Ductal Hyperplasia "},{"keId":1492,"keName":"Tissue resident cell activation"},{"keId":1494,"keName":"Leukocyte recruitment/activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/294"}
{"aopId":296,"aopName":"Oxidative DNA damage leading to chromosomal aberrations and mutations","aoId":1636,"aoName":"Increase Chromosomal aberrations","aoNameRaw":"Increase, Chromosomal aberrations","keyEvents":[{"keId":185,"keName":"Increase, Mutations"},{"keId":1636,"keName":"Increase, Chromosomal aberrations"},{"keId":155,"keName":"N/A, Inadequate DNA repair"},{"keId":1634,"keName":"Increase, Oxidative damage to DNA"},{"keId":1635,"keName":"Increase, DNA strand breaks"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/296"}
{"aopId":296,"aopName":"Oxidative DNA damage leading to chromosomal aberrations and mutations","aoId":1636,"keyEvents":[{"keId":185,"keName":"Increase, Mutations"},{"keId":1636,"keName":"Increase, Chromosomal aberrations"},{"keId":155,"keName":"N/A, Inadequate DNA repair"},{"keId":1634,"keName":"Increase, Oxidative damage to DNA"},{"keId":1635,"keName":"Increase, DNA strand breaks"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/296"}
{"aopId":296,"aopName":"Oxidative DNA damage leading to chromosomal aberrations and mutations","aoId":185,"aoName":"Increase Mutations","aoNameRaw":"Increase, Mutations","keyEvents":[{"keId":185,"keName":"Increase, Mutations"},{"keId":1636,"keName":"Increase, Chromosomal aberrations"},{"keId":155,"keName":"N/A, Inadequate DNA repair"},{"keId":1634,"keName":"Increase, Oxidative damage to DNA"},{"keId":1635,"keName":"Increase, DNA strand breaks"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/296"}
{"aopId":296,"aopName":"Oxidative DNA damage leading to chromosomal aberrations and mutations","aoId":185,"keyEvents":[{"keId":185,"keName":"Increase, Mutations"},{"keId":1636,"keName":"Increase, Chromosomal aberrations"},{"keId":155,"keName":"N/A, Inadequate DNA repair"},{"keId":1634,"keName":"Increase, Oxidative damage to DNA"},{"keId":1635,"keName":"Increase, DNA strand breaks"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/296"}
{"aopId":297,"aopName":"Inhibition of retinaldehyde dehydrogenase leads to population decline","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1640,"keName":"Altered, Photoreceptor patterning"},{"keId":1641,"keName":"Decreased retinoic acid (RA) synthesis"},{"keId":1637,"keName":"Retinaldehyde dehydrogenase inhibition"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1642,"keName":"Decreased plasma RA level"},{"keId":1643,"keName":"Altered, Visual function"}],"status":"Under Development","reference":"https://aopwiki.org/aops/297"}
{"aopId":298,"aopName":"Chronic reactive oxygen species leading to human treatment-resistant gastric cancer","targetName":"protein-serine O-palmitoleoyltransferase porcupine","targetId":"ENSG00000102312","aoId":1651,"aoName":"Treatment-resistant gastric cancer","aoNameRaw":"Treatment-resistant gastric cancer","keyEvents":[{"keId":1755,"keName":"Proliferation / beta-catenin activation"},{"keId":1650,"keName":"Epithelial-mesenchymal transition"},{"keId":1754,"keName":"Sustained tissue damage / macrophage activation / porcupine-induced Wnt secretion"},{"keId":1651,"keName":"Treatment-resistant gastric cancer"},{"keId":1753,"keName":"Chronic reactive oxygen species"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/298"}
{"aopId":298,"aopName":"Chronic reactive oxygen species leading to human treatment-resistant gastric cancer","aoId":1651,"aoName":"Treatment-resistant gastric cancer","aoNameRaw":"Treatment-resistant gastric cancer","keyEvents":[{"keId":1755,"keName":"Proliferation / beta-catenin activation"},{"keId":1650,"keName":"Epithelial-mesenchymal transition"},{"keId":1754,"keName":"Sustained tissue damage / macrophage activation / porcupine-induced Wnt secretion"},{"keId":1651,"keName":"Treatment-resistant gastric cancer"},{"keId":1753,"keName":"Chronic reactive oxygen species"}],"status":"EAGMST Under Review","reference":"https://aopwiki.org/aops/298"}
{"aopId":299,"aopName":"Excessive reactive oxygen species production leading to population decline via reduced fatty acid beta-oxidation","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1824,"keName":"Decrease, Fatty acid β-oxidation"},{"keId":1445,"keName":"Increase, Lipid peroxidation"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1823,"keName":"Decrease, Lipid storage"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/299"}
{"aopId":299,"aopName":"Excessive reactive oxygen species production leading to population decline via reduced fatty acid beta-oxidation","aoId":328,"aoName":"Decrease Fecundity","aoNameRaw":"Decrease, Fecundity","keyEvents":[{"keId":1824,"keName":"Decrease, Fatty acid β-oxidation"},{"keId":1445,"keName":"Increase, Lipid peroxidation"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1823,"keName":"Decrease, Lipid storage"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/299"}
{"aopId":300,"aopName":"Thyroid Receptor Antagonism and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","aoId":402,"aoName":"Cognitive Function Decreased","aoNameRaw":"Cognitive Function, Decreased ","keyEvents":[{"keId":758,"keName":"Hippocampal Physiology, Altered"},{"keId":1656,"keName":"Antagonism, Thyroid Receptor "},{"keId":756,"keName":"Hippocampal gene expression, Altered "},{"keId":402,"keName":"Cognitive Function, Decreased "},{"keId":757,"keName":"Hippocampal anatomy, Altered "}],"status":"Under Development","reference":"https://aopwiki.org/aops/300"}
{"aopId":301,"aopName":"Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis ","aoId":1667,"aoName":"Impairedanterior-posterior axis development","aoNameRaw":"Impaired,anterior-posterior axis development","keyEvents":[{"keId":1665,"keName":"Increased, Plasma HCY level"},{"keId":1657,"keName":"Inhibition of cystathionine beta-synthase"},{"keId":1667,"keName":"Impaired,anterior-posterior axis development"},{"keId":1666,"keName":"Induced, dysfunction of microcirculation"},{"keId":1661,"keName":"Increased Homocysteine level "}],"reference":"https://aopwiki.org/aops/301"}
{"aopId":302,"aopName":"Lung surfactant function inhibition leading to decreased lung function","aoId":1250,"aoName":"Decrease Lung function","aoNameRaw":"Decrease, Lung function","keyEvents":[{"keId":1250,"keName":"Decrease, Lung function"},{"keId":1677,"keName":"Reduced tidal volume "},{"keId":1498,"keName":"Loss of alveolar capillary membrane integrity"},{"keId":1673,"keName":"Alveolar collapse"},{"keId":1672,"keName":"Inhibition of lung surfactant function"}],"status":"Under Development","reference":"https://aopwiki.org/aops/302"}
{"aopId":303,"aopName":"Frustrated phagocytosis-induced lung cancer","aoId":1670,"aoName":"Lung cancer","aoNameRaw":"Lung cancer","aoMappedId":"MONDO_0008903","keyEvents":[{"keId":1668,"keName":"Frustrated phagoytosis"},{"keId":1670,"keName":"Lung cancer"},{"keId":1115,"keName":"Increased, Reactive oxygen species"},{"keId":870,"keName":"Increase, Cell Proliferation"},{"keId":1669,"keName":"Increased, DNA damage and mutation"},{"keId":87,"keName":"Release, Cytokine"},{"keId":1497,"keName":"Increased, recruitment of inflammatory cells"}],"status":"Under Development","reference":"https://aopwiki.org/aops/303"}
{"aopId":304,"aopName":"TBX1 inhibition leading to congenital cardiac conotruncal anomalies","aoId":1685,"aoName":"Anomalies Congenital cardiac conotruncal","aoNameRaw":"Anomalies, Congenital cardiac conotruncal","keyEvents":[{"keId":1683,"keName":"Impairment, Fourth pharyngeal arch development"},{"keId":1682,"keName":"Disruption, Progenitor cells of second heart field"},{"keId":1685,"keName":"Anomalies, Congenital cardiac conotruncal"},{"keId":1684,"keName":"Abnormalities, Cardiac outflow tract formation"},{"keId":1681,"keName":"Disruption, Neural crest cell migration"},{"keId":1680,"keName":"Inhibition, TBX1"}],"reference":"https://aopwiki.org/aops/304"}
{"aopId":305,"aopName":"5α-reductase inhibition leading to short anogenital distance (AGD) in male (mammalian) offspring","aoId":1688,"aoName":"decrease male anogenital distance","aoNameRaw":"decrease, male anogenital distance","keyEvents":[{"keId":1688,"keName":"decrease, male anogenital distance"},{"keId":1613,"keName":"Decrease, dihydrotestosterone (DHT) level"},{"keId":286,"keName":"Altered, Transcription of genes by AR"},{"keId":1617,"keName":"5α-reductase, inhibition"},{"keId":1614,"keName":"Decrease, androgen receptors (AR) activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/305"}
{"aopId":305,"aopName":"5α-reductase inhibition leading to short anogenital distance (AGD) in male (mammalian) offspring","targetName":"androgen receptor","targetId":"ENSG00000169083","aoId":1688,"aoName":"decrease male anogenital distance","aoNameRaw":"decrease, male anogenital distance","keyEvents":[{"keId":1688,"keName":"decrease, male anogenital distance"},{"keId":1613,"keName":"Decrease, dihydrotestosterone (DHT) level"},{"keId":286,"keName":"Altered, Transcription of genes by AR"},{"keId":1617,"keName":"5α-reductase, inhibition"},{"keId":1614,"keName":"Decrease, androgen receptors (AR) activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/305"}
{"aopId":306,"aopName":"Androgen receptor (AR) antagonism leading to short anogenital distance (AGD) in male (mammalian) offspring","aoId":1688,"aoName":"decrease male anogenital distance","aoNameRaw":"decrease, male anogenital distance","keyEvents":[{"keId":26,"keName":"Antagonism, Androgen receptor"},{"keId":1688,"keName":"decrease, male anogenital distance"},{"keId":1687,"keName":"decrease, transcription of genes by AR "},{"keId":1614,"keName":"Decrease, androgen receptors (AR) activation"}],"status":"Under Development","reference":"https://aopwiki.org/aops/306"}
{"aopId":307,"aopName":"Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring","targetName":"androgen receptor","targetId":"ENSG00000169083","aoId":1688,"aoName":"decrease male anogenital distance","aoNameRaw":"decrease, male anogenital distance","keyEvents":[{"keId":1688,"keName":"decrease, male anogenital distance"},{"keId":1613,"keName":"Decrease, dihydrotestosterone (DHT) level"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":286,"keName":"Altered, Transcription of genes by AR"},{"keId":1614,"keName":"Decrease, androgen receptors (AR) activation"},{"keId":1690,"keName":"reduction, testosterone levels "}],"status":"Under Development","reference":"https://aopwiki.org/aops/307"}
{"aopId":307,"aopName":"Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring","aoId":1688,"aoName":"decrease male anogenital distance","aoNameRaw":"decrease, male anogenital distance","keyEvents":[{"keId":1688,"keName":"decrease, male anogenital distance"},{"keId":1613,"keName":"Decrease, dihydrotestosterone (DHT) level"},{"keId":413,"keName":"Reduction, Testosterone synthesis in Leydig cells"},{"keId":286,"keName":"Altered, Transcription of genes by AR"},{"keId":1614,"keName":"Decrease, androgen receptors (AR) activation"},{"keId":1690,"keName":"reduction, testosterone levels "}],"status":"Under Development","reference":"https://aopwiki.org/aops/307"}
{"aopId":309,"aopName":"Luteinizing hormone receptor antagonism leading to reproductive dysfunction","aoId":679,"aoName":"Decline Population trajectory","aoNameRaw":"Decline, Population trajectory","keyEvents":[{"keId":1692,"keName":"Reduction, Progesterone synthesis"},{"keId":679,"keName":"Decline, Population trajectory"},{"keId":1693,"keName":"Reduction, Plasma progesterone concentration "},{"keId":1696,"keName":"Decrease of egg production and cummulative fecundity"},{"keId":1694,"keName":"Reduction, progesterone uptake, decresed maturation "},{"keId":1695,"keName":"Impaired ovulation"},{"keId":1691,"keName":"Antagonism,LH receptor"}],"reference":"https://aopwiki.org/aops/309"}
{"aopId":310,"aopName":"Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR","targetName":"aryl hydrocarbon receptor nuclear translocator","targetId":"ENSG00000143437","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1698,"keName":"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":1697,"keName":"Increase, DNA methyltransferase expression"},{"keId":1699,"keName":"Decrease, expression of gonadotropin releasing hormone receptor"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/310"}
{"aopId":310,"aopName":"Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR","targetName":"aryl hydrocarbon receptor","targetId":"ENSG00000106546","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1698,"keName":"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":1697,"keName":"Increase, DNA methyltransferase expression"},{"keId":1699,"keName":"Decrease, expression of gonadotropin releasing hormone receptor"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/310"}
{"aopId":310,"aopName":"Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1698,"keName":"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":1697,"keName":"Increase, DNA methyltransferase expression"},{"keId":1699,"keName":"Decrease, expression of gonadotropin releasing hormone receptor"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/310"}
{"aopId":310,"aopName":"Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR","targetName":"aryl hydrocarbon receptor nuclear translocator","targetId":"ENSG00000143437","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1698,"keName":"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":1697,"keName":"Increase, DNA methyltransferase expression"},{"keId":1699,"keName":"Decrease, expression of gonadotropin releasing hormone receptor"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/310"}
{"aopId":310,"aopName":"Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR","targetName":"aryl hydrocarbon receptor","targetId":"ENSG00000106546","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1698,"keName":"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":1697,"keName":"Increase, DNA methyltransferase expression"},{"keId":1699,"keName":"Decrease, expression of gonadotropin releasing hormone receptor"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/310"}
{"aopId":310,"aopName":"Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR","aoId":78,"aoName":"Reduction Cumulative fecundity and spawning","aoNameRaw":"Reduction, Cumulative fecundity and spawning","keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1698,"keName":"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":1697,"keName":"Increase, DNA methyltransferase expression"},{"keId":1699,"keName":"Decrease, expression of gonadotropin releasing hormone receptor"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/310"}
{"aopId":310,"aopName":"Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR","targetName":"aryl hydrocarbon receptor nuclear translocator","targetId":"ENSG00000143437","aoId":78,"keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1698,"keName":"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":1697,"keName":"Increase, DNA methyltransferase expression"},{"keId":1699,"keName":"Decrease, expression of gonadotropin releasing hormone receptor"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/310"}
{"aopId":310,"aopName":"Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR","targetName":"aryl hydrocarbon receptor","targetId":"ENSG00000106546","aoId":78,"keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1698,"keName":"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":1697,"keName":"Increase, DNA methyltransferase expression"},{"keId":1699,"keName":"Decrease, expression of gonadotropin releasing hormone receptor"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/310"}
{"aopId":310,"aopName":"Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR","aoId":78,"keyEvents":[{"keId":309,"keName":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development"},{"keId":285,"keName":"Reduction, Vitellogenin synthesis in liver"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1698,"keName":"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor"},{"keId":219,"keName":"Reduction, Plasma 17beta-estradiol concentrations"},{"keId":221,"keName":"Reduction, Plasma vitellogenin concentrations"},{"keId":1697,"keName":"Increase, DNA methyltransferase expression"},{"keId":1699,"keName":"Decrease, expression of gonadotropin releasing hormone receptor"},{"keId":944,"keName":"dimerization, AHR/ARNT"},{"keId":78,"keName":"Reduction, Cumulative fecundity and spawning"},{"keId":3,"keName":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells"},{"keId":18,"keName":"Activation, AhR"}],"reference":"https://aopwiki.org/aops/310"}
{"aopId":311,"aopName":"Excessive reactive oxygen species production leading to population decline via mitochondrial dysfunction","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1477,"keName":"Decrease, Oxidative phosphorylation"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1770,"keName":"Decrease, Mitochondrial membrane potential"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/311"}
{"aopId":311,"aopName":"Excessive reactive oxygen species production leading to population decline via mitochondrial dysfunction","aoId":328,"aoName":"Decrease Fecundity","aoNameRaw":"Decrease, Fecundity","keyEvents":[{"keId":1477,"keName":"Decrease, Oxidative phosphorylation"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1770,"keName":"Decrease, Mitochondrial membrane potential"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/311"}
{"aopId":312,"aopName":"Acetylcholinesterase Inhibition leading to Acute Mortality via Impaired Coordination & Movement​","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":39,"keName":"Increased Cholinergic Signaling"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1705,"keName":"Impaired coordination and movement"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"}],"reference":"https://aopwiki.org/aops/312"}
{"aopId":312,"aopName":"Acetylcholinesterase Inhibition leading to Acute Mortality via Impaired Coordination & Movement​","targetName":"acetylcholinesterase","targetId":"ENSG00000087085","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":39,"keName":"Increased Cholinergic Signaling"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1705,"keName":"Impaired coordination and movement"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"}],"reference":"https://aopwiki.org/aops/312"}
{"aopId":312,"aopName":"Acetylcholinesterase Inhibition leading to Acute Mortality via Impaired Coordination & Movement​","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":39,"keName":"Increased Cholinergic Signaling"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1705,"keName":"Impaired coordination and movement"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"}],"reference":"https://aopwiki.org/aops/312"}
{"aopId":312,"aopName":"Acetylcholinesterase Inhibition leading to Acute Mortality via Impaired Coordination & Movement​","targetName":"acetylcholinesterase","targetId":"ENSG00000087085","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":39,"keName":"Increased Cholinergic Signaling"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1705,"keName":"Impaired coordination and movement"},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"}],"reference":"https://aopwiki.org/aops/312"}
{"aopId":313,"aopName":"Stimulation of TLR7/8 in dendric cells leading to Psoriatic skin disease","aoId":1709,"aoName":"Psoriatic skin disease","aoNameRaw":"Psoriatic skin disease","keyEvents":[{"keId":1822,"keName":"Maturation of TNF/iNOS-Producing Dendritic Cells"},{"keId":1709,"keName":"Psoriatic skin disease"},{"keId":1706,"keName":"Stimulation, TLR7/8"},{"keId":1708,"keName":"Th17 cell migration and inflammation induction"},{"keId":1707,"keName":"Increase, IL-23 from matured dendritic cells"}],"status":"Under Development","reference":"https://aopwiki.org/aops/313"}
{"aopId":314,"aopName":"Binding to estrogen receptor (ER)-α in immune cells leading to exacerbation of systemic lupus erythematosus (SLE)","aoId":1714,"aoName":"Exacerbation of systemic lupus erythematosus (SLE)","aoNameRaw":"Exacerbation of systemic lupus erythematosus (SLE)","keyEvents":[{"keId":1714,"keName":"Exacerbation of systemic lupus erythematosus (SLE)"},{"keId":1711,"keName":"Induction of GATA3 expression"},{"keId":1712,"keName":"Increase of Th2 cells producing IL-4"},{"keId":1713,"keName":"Increase of anti-DNA antibody from autoreactive B cell"},{"keId":1710,"keName":"Binding to estrogen receptor (ER)-α in immune cells"}],"status":"Under Development","reference":"https://aopwiki.org/aops/314"}
{"aopId":315,"aopName":"Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response","targetName":"signal transducer and transcription activator STAT","aoId":1719,"aoName":"Impairment of T-cell dependent antibody response","aoNameRaw":"Impairment of T-cell dependent antibody response","keyEvents":[{"keId":1717,"keName":"Suppression of STAT5 binding to cytokine gene promoters"},{"keId":1716,"keName":"Blockade of STAT5 phosphorylation"},{"keId":1718,"keName":"Suppression of IL-4 production"},{"keId":1719,"keName":"Impairment of T-cell dependent antibody response"},{"keId":1715,"keName":"Inhibition of JAK3"}],"status":"Under Development","reference":"https://aopwiki.org/aops/315"}
{"aopId":315,"aopName":"Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response","targetName":"interleukin-4","targetId":"ENSG00000113520","aoId":1719,"aoName":"Impairment of T-cell dependent antibody response","aoNameRaw":"Impairment of T-cell dependent antibody response","keyEvents":[{"keId":1717,"keName":"Suppression of STAT5 binding to cytokine gene promoters"},{"keId":1716,"keName":"Blockade of STAT5 phosphorylation"},{"keId":1718,"keName":"Suppression of IL-4 production"},{"keId":1719,"keName":"Impairment of T-cell dependent antibody response"},{"keId":1715,"keName":"Inhibition of JAK3"}],"status":"Under Development","reference":"https://aopwiki.org/aops/315"}
{"aopId":315,"aopName":"Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response","targetName":"tyrosine-protein kinase JAK3","targetId":"ENSG00000105639","aoId":1719,"aoName":"Impairment of T-cell dependent antibody response","aoNameRaw":"Impairment of T-cell dependent antibody response","keyEvents":[{"keId":1717,"keName":"Suppression of STAT5 binding to cytokine gene promoters"},{"keId":1716,"keName":"Blockade of STAT5 phosphorylation"},{"keId":1718,"keName":"Suppression of IL-4 production"},{"keId":1719,"keName":"Impairment of T-cell dependent antibody response"},{"keId":1715,"keName":"Inhibition of JAK3"}],"status":"Under Development","reference":"https://aopwiki.org/aops/315"}
{"aopId":315,"aopName":"Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response","aoId":1719,"aoName":"Impairment of T-cell dependent antibody response","aoNameRaw":"Impairment of T-cell dependent antibody response","keyEvents":[{"keId":1717,"keName":"Suppression of STAT5 binding to cytokine gene promoters"},{"keId":1716,"keName":"Blockade of STAT5 phosphorylation"},{"keId":1718,"keName":"Suppression of IL-4 production"},{"keId":1719,"keName":"Impairment of T-cell dependent antibody response"},{"keId":1715,"keName":"Inhibition of JAK3"}],"status":"Under Development","reference":"https://aopwiki.org/aops/315"}
{"aopId":316,"aopName":"Trypsin inhibition leading to pancreatic acinar cell tumors","aoId":1725,"aoName":"Pancreatic acinar cell tumors","aoNameRaw":"Pancreatic acinar cell tumors","keyEvents":[{"keId":1722,"keName":"Increased blood CCK level"},{"keId":1721,"keName":"Increased intestinal monitor peptide level"},{"keId":1724,"keName":"Acinar cell proliferation"},{"keId":1720,"keName":"Trypsin inhibition"},{"keId":1725,"keName":"Pancreatic acinar cell tumors"},{"keId":1723,"keName":"Increased exocrine secretion from pancreatic acinar cells"}],"status":"Under Development","reference":"https://aopwiki.org/aops/316"}
{"aopId":318,"aopName":"Glucocorticoid Receptor activation leading to hepatic steatosis","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":459,"keyEvents":[{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":860,"keName":"Decreased, Mitochondrial Fatty Acid Beta Oxidation"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":1834,"keName":"Decrease, Acyl-CoA dehydrogenases"}],"reference":"https://aopwiki.org/aops/318"}
{"aopId":318,"aopName":"Glucocorticoid Receptor activation leading to hepatic steatosis","aoId":459,"keyEvents":[{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":860,"keName":"Decreased, Mitochondrial Fatty Acid Beta Oxidation"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":1834,"keName":"Decrease, Acyl-CoA dehydrogenases"}],"reference":"https://aopwiki.org/aops/318"}
{"aopId":318,"aopName":"Glucocorticoid Receptor activation leading to hepatic steatosis","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":860,"keName":"Decreased, Mitochondrial Fatty Acid Beta Oxidation"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":1834,"keName":"Decrease, Acyl-CoA dehydrogenases"}],"reference":"https://aopwiki.org/aops/318"}
{"aopId":318,"aopName":"Glucocorticoid Receptor activation leading to hepatic steatosis","aoId":459,"aoName":"Increased Liver Steatosis","aoNameRaw":"Increased, Liver Steatosis","keyEvents":[{"keId":291,"keName":"Accumulation, Triglyceride"},{"keId":860,"keName":"Decreased, Mitochondrial Fatty Acid Beta Oxidation"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":459,"keName":"Increased, Liver Steatosis"},{"keId":1834,"keName":"Decrease, Acyl-CoA dehydrogenases"}],"reference":"https://aopwiki.org/aops/318"}
{"aopId":319,"aopName":"Inhibition of Angiotensin-converting enzyme 2 leading to lung fibrosis","aoId":1276,"aoName":"Lung fibrosis","aoNameRaw":"Lung fibrosis","keyEvents":[{"keId":68,"keName":"Accumulation, Collagen"},{"keId":1743,"keName":"Increase plasma Ang II"},{"keId":1752,"keName":"Increased Angiotensin II "},{"keId":1276,"keName":"Lung fibrosis"},{"keId":1740,"keName":"ACE2 inhibition"}],"reference":"https://aopwiki.org/aops/319"}
{"aopId":320,"aopName":"Binding of viral S-glycoprotein to ACE2 receptor  leading to acute respiratory distress associated mortality","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":1496,"keName":"Increased, secretion of proinflammatory and profibrotic mediators"},{"keId":351,"keName":"Increased Mortality"},{"keId":1739,"keName":"ACE2 binding to viral S-protein "},{"keId":1750,"keName":"Increased inflammatory immune responses"},{"keId":1738,"keName":"Increased susceptibility to viral entry"},{"keId":1848,"keName":"Induced Toll Like Receptor (TLR) Dysregulation"},{"keId":1748,"keName":"Increase, the risk of acute respiratory failure"},{"keId":1847,"keName":"Increased coronavirus production"}],"reference":"https://aopwiki.org/aops/320"}
{"aopId":322,"aopName":"Alkylation of DNA leading to reduced sperm count","aoId":1757,"aoName":"Reduce Sperm count","aoNameRaw":"Reduce, Sperm count","keyEvents":[{"keId":97,"keName":"Alkylation, DNA"},{"keId":1757,"keName":"Reduce, Sperm count"},{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":155,"keName":"N/A, Inadequate DNA repair"},{"keId":1635,"keName":"Increase, DNA strand breaks"}],"reference":"https://aopwiki.org/aops/322"}
{"aopId":324,"aopName":"Thermal stress leading to population decline (1)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/324"}
{"aopId":324,"aopName":"Thermal stress leading to population decline (1)","aoId":328,"aoName":"Decrease Fecundity","aoNameRaw":"Decrease, Fecundity","keyEvents":[{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/324"}
{"aopId":325,"aopName":"Thermal stress leading to population decline (2)","aoId":328,"aoName":"Decrease Fecundity","aoNameRaw":"Decrease, Fecundity","keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":1364,"keName":"Increase, Reactive oxygen species"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1608,"keName":"Increase, Oxidative DNA damage"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/325"}
{"aopId":325,"aopName":"Thermal stress leading to population decline (2)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":1364,"keName":"Increase, Reactive oxygen species"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1608,"keName":"Increase, Oxidative DNA damage"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/325"}
{"aopId":326,"aopName":"Thermal stress leading to population decline (3)","aoId":328,"aoName":"Decrease Fecundity","aoNameRaw":"Decrease, Fecundity","keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":328,"keName":"Decrease, Fecundity"},{"keId":1827,"keName":"Increase, Global DNA methylation"}],"reference":"https://aopwiki.org/aops/326"}
{"aopId":326,"aopName":"Thermal stress leading to population decline (3)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":177,"keName":"N/A, Mitochondrial dysfunction 1"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":328,"keName":"Decrease, Fecundity"},{"keId":1827,"keName":"Increase, Global DNA methylation"}],"reference":"https://aopwiki.org/aops/326"}
{"aopId":327,"aopName":"Excessive reactive oxygen species production leading to mortality (1)","aoId":350,"aoName":"Increase Mortality","aoNameRaw":"Increase, Mortality","keyEvents":[{"keId":1769,"keName":"Increase, Body fluid overload"},{"keId":1768,"keName":"Increase, Abnormal osmoregulation"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1767,"keName":"Increase, Protein oxidation"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"}],"reference":"https://aopwiki.org/aops/327"}
{"aopId":327,"aopName":"Excessive reactive oxygen species production leading to mortality (1)","aoId":350,"keyEvents":[{"keId":1769,"keName":"Increase, Body fluid overload"},{"keId":1768,"keName":"Increase, Abnormal osmoregulation"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1767,"keName":"Increase, Protein oxidation"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"}],"reference":"https://aopwiki.org/aops/327"}
{"aopId":328,"aopName":"Excessive reactive oxygen species production leading to mortality (2)","aoId":350,"keyEvents":[{"keId":1477,"keName":"Decrease, Oxidative phosphorylation"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1770,"keName":"Decrease, Mitochondrial membrane potential"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"}],"reference":"https://aopwiki.org/aops/328"}
{"aopId":328,"aopName":"Excessive reactive oxygen species production leading to mortality (2)","aoId":350,"aoName":"Increase Mortality","aoNameRaw":"Increase, Mortality","keyEvents":[{"keId":1477,"keName":"Decrease, Oxidative phosphorylation"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1770,"keName":"Decrease, Mitochondrial membrane potential"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"}],"reference":"https://aopwiki.org/aops/328"}
{"aopId":329,"aopName":"Excessive reactive oxygen species production leading to mortality (3)","aoId":350,"aoName":"Increase Mortality","aoNameRaw":"Increase, Mortality","keyEvents":[{"keId":1772,"keName":"Decrease, Neutral lipids"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1445,"keName":"Increase, Lipid peroxidation"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"}],"reference":"https://aopwiki.org/aops/329"}
{"aopId":329,"aopName":"Excessive reactive oxygen species production leading to mortality (3)","aoId":350,"keyEvents":[{"keId":1772,"keName":"Decrease, Neutral lipids"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1445,"keName":"Increase, Lipid peroxidation"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1771,"keName":"Decrease, Adenosine triphosphate pool"}],"reference":"https://aopwiki.org/aops/329"}
{"aopId":330,"aopName":"Excessive reactive oxygen species production leading to mortality (4)","aoId":350,"aoName":"Increase Mortality","aoNameRaw":"Increase, Mortality","keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":350,"keName":"Increase, Mortality"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1766,"keName":"Increase, DNA double-strand break"},{"keId":1608,"keName":"Increase, Oxidative DNA damage"}],"reference":"https://aopwiki.org/aops/330"}
{"aopId":330,"aopName":"Excessive reactive oxygen species production leading to mortality (4)","aoId":350,"keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":350,"keName":"Increase, Mortality"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1766,"keName":"Increase, DNA double-strand break"},{"keId":1608,"keName":"Increase, Oxidative DNA damage"}],"reference":"https://aopwiki.org/aops/330"}
{"aopId":331,"aopName":"Formation of DNA photoproducts leading to growth inhibition (1)","aoId":350,"aoName":"Increase Mortality","aoNameRaw":"Increase, Mortality","keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1765,"keName":"Increase, Formation of DNA photoproducts"},{"keId":1766,"keName":"Increase, DNA double-strand break"}],"reference":"https://aopwiki.org/aops/331"}
{"aopId":331,"aopName":"Formation of DNA photoproducts leading to growth inhibition (1)","aoId":350,"keyEvents":[{"keId":1365,"keName":"Increase, Apoptosis"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1765,"keName":"Increase, Formation of DNA photoproducts"},{"keId":1766,"keName":"Increase, DNA double-strand break"}],"reference":"https://aopwiki.org/aops/331"}
{"aopId":334,"aopName":"Glucocorticoid Receptor Agonism Leading to Impaired Fin Regeneration","targetName":"teratocarcinoma-derived growth factor 1","targetId":"ENSG00000241186","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1761,"keName":"Inhibition, Fin regeneration"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1759,"keName":"Increase, Cripto-1 expression"},{"keId":1760,"keName":"Inhibition, Activin signaling"}],"reference":"https://aopwiki.org/aops/334"}
{"aopId":334,"aopName":"Glucocorticoid Receptor Agonism Leading to Impaired Fin Regeneration","targetName":"glucocorticoid receptor","targetId":"ENSG00000113580","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1761,"keName":"Inhibition, Fin regeneration"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1759,"keName":"Increase, Cripto-1 expression"},{"keId":1760,"keName":"Inhibition, Activin signaling"}],"reference":"https://aopwiki.org/aops/334"}
{"aopId":334,"aopName":"Glucocorticoid Receptor Agonism Leading to Impaired Fin Regeneration","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1761,"keName":"Inhibition, Fin regeneration"},{"keId":1005,"keName":"Reduced, Swimming performance"},{"keId":122,"keName":"Activation, Glucocorticoid Receptor"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1759,"keName":"Increase, Cripto-1 expression"},{"keId":1760,"keName":"Inhibition, Activin signaling"}],"reference":"https://aopwiki.org/aops/334"}
{"aopId":335,"aopName":"AOP for urothelial carcinogenesis due to chemical cytotoxicity by mitochondrial impairment ","aoId":1763,"aoName":"Urothelial Tumor","aoNameRaw":"Urothelial Tumor","keyEvents":[{"keId":795,"keName":"Increase, Regenerative cell proliferation (urothelial cells)"},{"keId":796,"keName":"Increase, Hyperplasia (urothelial)"},{"keId":1762,"keName":"Urothelial cell injury/death"},{"keId":1763,"keName":"Urothelial Tumor"},{"keId":1261,"keName":"Mitochondrial impairment"}],"reference":"https://aopwiki.org/aops/335"}
{"aopId":336,"aopName":"DNA methyltransferase inhibition leading to population decline (1)","aoId":328,"aoName":"Decrease Fecundity","aoNameRaw":"Decrease, Fecundity","keyEvents":[{"keId":1773,"keName":"Decrease, Global DNA methylation"},{"keId":1774,"keName":"Increase, Caspase transcription"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1775,"keName":"Increase, Oocyte apoptosis"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/336"}
{"aopId":336,"aopName":"DNA methyltransferase inhibition leading to population decline (1)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1773,"keName":"Decrease, Global DNA methylation"},{"keId":1774,"keName":"Increase, Caspase transcription"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1775,"keName":"Increase, Oocyte apoptosis"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/336"}
{"aopId":337,"aopName":"DNA methyltransferase inhibition leading to population decline (2)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1773,"keName":"Decrease, Global DNA methylation"},{"keId":1774,"keName":"Increase, Caspase transcription"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1777,"keName":"Increase, Ovarian follicle breakdown"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1776,"keName":"Increase, Ovarian somatic cell apoptosis"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/337"}
{"aopId":337,"aopName":"DNA methyltransferase inhibition leading to population decline (2)","aoId":328,"aoName":"Decrease Fecundity","aoNameRaw":"Decrease, Fecundity","keyEvents":[{"keId":1773,"keName":"Decrease, Global DNA methylation"},{"keId":1774,"keName":"Increase, Caspase transcription"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1777,"keName":"Increase, Ovarian follicle breakdown"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1776,"keName":"Increase, Ovarian somatic cell apoptosis"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/337"}
{"aopId":338,"aopName":"DNA methyltransferase inhibition leading to population decline (3)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1774,"keName":"Increase, Caspase transcription"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1766,"keName":"Increase, DNA double-strand break"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1775,"keName":"Increase, Oocyte apoptosis"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/338"}
{"aopId":338,"aopName":"DNA methyltransferase inhibition leading to population decline (3)","aoId":328,"aoName":"Decrease Fecundity","aoNameRaw":"Decrease, Fecundity","keyEvents":[{"keId":1774,"keName":"Increase, Caspase transcription"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1766,"keName":"Increase, DNA double-strand break"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1775,"keName":"Increase, Oocyte apoptosis"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/338"}
{"aopId":339,"aopName":"DNA methyltransferase inhibition leading to population decline (4)","aoId":328,"aoName":"Decrease Fecundity","aoNameRaw":"Decrease, Fecundity","keyEvents":[{"keId":1774,"keName":"Increase, Caspase transcription"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1777,"keName":"Increase, Ovarian follicle breakdown"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1766,"keName":"Increase, DNA double-strand break"},{"keId":1776,"keName":"Increase, Ovarian somatic cell apoptosis"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/339"}
{"aopId":339,"aopName":"DNA methyltransferase inhibition leading to population decline (4)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1774,"keName":"Increase, Caspase transcription"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1777,"keName":"Increase, Ovarian follicle breakdown"},{"keId":1366,"keName":"Decrease, Oogenesis"},{"keId":1766,"keName":"Increase, DNA double-strand break"},{"keId":1776,"keName":"Increase, Ovarian somatic cell apoptosis"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"},{"keId":328,"keName":"Decrease, Fecundity"}],"reference":"https://aopwiki.org/aops/339"}
{"aopId":340,"aopName":"DNA methyltransferase inhibition leading to transgenerational effects (1)","aoId":1781,"aoName":"Decrease Fecundity (F3)","aoNameRaw":"Decrease, Fecundity (F3)","keyEvents":[{"keId":1781,"keName":"Decrease, Fecundity (F3)"},{"keId":1778,"keName":"Decrease, Heritable DNA methylation (F3)"},{"keId":1773,"keName":"Decrease, Global DNA methylation"},{"keId":1779,"keName":"Increase, Caspase transcription (F3)"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1780,"keName":"Increase, Oocyte apoptosis (F3)"},{"keId":1782,"keName":"Decrease, Oogenesis (F3)"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"}],"reference":"https://aopwiki.org/aops/340"}
{"aopId":340,"aopName":"DNA methyltransferase inhibition leading to transgenerational effects (1)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1781,"keName":"Decrease, Fecundity (F3)"},{"keId":1778,"keName":"Decrease, Heritable DNA methylation (F3)"},{"keId":1773,"keName":"Decrease, Global DNA methylation"},{"keId":1779,"keName":"Increase, Caspase transcription (F3)"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1780,"keName":"Increase, Oocyte apoptosis (F3)"},{"keId":1782,"keName":"Decrease, Oogenesis (F3)"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"}],"reference":"https://aopwiki.org/aops/340"}
{"aopId":341,"aopName":"DNA methyltransferase inhibition leading to transgenerational effects (2)","aoId":1781,"aoName":"Decrease Fecundity (F3)","aoNameRaw":"Decrease, Fecundity (F3)","keyEvents":[{"keId":1781,"keName":"Decrease, Fecundity (F3)"},{"keId":1779,"keName":"Increase, Caspase transcription (F3)"},{"keId":1773,"keName":"Decrease, Global DNA methylation"},{"keId":1778,"keName":"Decrease, Heritable DNA methylation (F3)"},{"keId":1784,"keName":"Increase, Ovarian follicle breakdown (F3)"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1782,"keName":"Decrease, Oogenesis (F3)"},{"keId":1783,"keName":"Increase, Ovarian somatic cell apoptosis (F3)"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"}],"reference":"https://aopwiki.org/aops/341"}
{"aopId":341,"aopName":"DNA methyltransferase inhibition leading to transgenerational effects (2)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1781,"keName":"Decrease, Fecundity (F3)"},{"keId":1779,"keName":"Increase, Caspase transcription (F3)"},{"keId":1773,"keName":"Decrease, Global DNA methylation"},{"keId":1778,"keName":"Decrease, Heritable DNA methylation (F3)"},{"keId":1784,"keName":"Increase, Ovarian follicle breakdown (F3)"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1782,"keName":"Decrease, Oogenesis (F3)"},{"keId":1783,"keName":"Increase, Ovarian somatic cell apoptosis (F3)"},{"keId":1619,"keName":"Increase, DNA methyltransferase inhibition"}],"reference":"https://aopwiki.org/aops/341"}
{"aopId":342,"aopName":"S-adenosylmethionine depletion leading to population decline (1)","aoId":350,"keyEvents":[{"keId":350,"keName":"Increase, Mortality"},{"keId":1523,"keName":"Decrease, Cuticular chitin content"},{"keId":1524,"keName":"Increase, Premature molting"},{"keId":1522,"keName":"Inhibition, Chitin synthase 1"}],"reference":"https://aopwiki.org/aops/342"}
{"aopId":342,"aopName":"S-adenosylmethionine depletion leading to population decline (1)","aoId":350,"aoName":"Increase Mortality","aoNameRaw":"Increase, Mortality","keyEvents":[{"keId":350,"keName":"Increase, Mortality"},{"keId":1523,"keName":"Decrease, Cuticular chitin content"},{"keId":1524,"keName":"Increase, Premature molting"},{"keId":1522,"keName":"Inhibition, Chitin synthase 1"}],"reference":"https://aopwiki.org/aops/342"}
{"aopId":343,"aopName":"S-adenosylmethionine depletion leading to population decline (2)","aoId":350,"keyEvents":[{"keId":1525,"keName":"Increase, Sulfonylurea receptor binding"},{"keId":1526,"keName":"Increase, Opening of voltage-dependent calcium channel"},{"keId":1523,"keName":"Decrease, Cuticular chitin content"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1524,"keName":"Increase, Premature molting"},{"keId":1527,"keName":"Increase, Cell membrane depolarization"}],"reference":"https://aopwiki.org/aops/343"}
{"aopId":343,"aopName":"S-adenosylmethionine depletion leading to population decline (2)","aoId":350,"aoName":"Increase Mortality","aoNameRaw":"Increase, Mortality","keyEvents":[{"keId":1525,"keName":"Increase, Sulfonylurea receptor binding"},{"keId":1526,"keName":"Increase, Opening of voltage-dependent calcium channel"},{"keId":1523,"keName":"Decrease, Cuticular chitin content"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1524,"keName":"Increase, Premature molting"},{"keId":1527,"keName":"Increase, Cell membrane depolarization"}],"reference":"https://aopwiki.org/aops/343"}
{"aopId":344,"aopName":"Androgen receptor (AR) antagonism leading to nipple retention (NR) in male (mammalian) offspring","targetName":"androgen receptor","targetId":"ENSG00000169083","aoId":1786,"aoName":"increase retained nipples in males","aoNameRaw":"increase, retained nipples in males","keyEvents":[{"keId":26,"keName":"Antagonism, Androgen receptor"},{"keId":1786,"keName":"increase, retained nipples in males"},{"keId":286,"keName":"Altered, Transcription of genes by AR"},{"keId":1614,"keName":"Decrease, androgen receptors (AR) activation"}],"reference":"https://aopwiki.org/aops/344"}
{"aopId":344,"aopName":"Androgen receptor (AR) antagonism leading to nipple retention (NR) in male (mammalian) offspring","aoId":1786,"aoName":"increase retained nipples in males","aoNameRaw":"increase, retained nipples in males","keyEvents":[{"keId":26,"keName":"Antagonism, Androgen receptor"},{"keId":1786,"keName":"increase, retained nipples in males"},{"keId":286,"keName":"Altered, Transcription of genes by AR"},{"keId":1614,"keName":"Decrease, androgen receptors (AR) activation"}],"reference":"https://aopwiki.org/aops/344"}
{"aopId":345,"aopName":"Androgen receptor (AR) antagonism leading to decreased fertility in females","aoId":972,"aoName":"Decreased fertility Reduced number of oocytes ovulated","aoNameRaw":"Decreased fertility, Reduced number of oocytes ovulated ","keyEvents":[{"keId":26,"keName":"Antagonism, Androgen receptor"},{"keId":1800,"keName":"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced"},{"keId":972,"keName":"Decreased fertility, Reduced number of oocytes ovulated "},{"keId":286,"keName":"Altered, Transcription of genes by AR"}],"reference":"https://aopwiki.org/aops/345"}
{"aopId":345,"aopName":"Androgen receptor (AR) antagonism leading to decreased fertility in females","targetName":"androgen receptor","targetId":"ENSG00000169083","aoId":972,"aoName":"Decreased fertility Reduced number of oocytes ovulated","aoNameRaw":"Decreased fertility, Reduced number of oocytes ovulated ","keyEvents":[{"keId":26,"keName":"Antagonism, Androgen receptor"},{"keId":1800,"keName":"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced"},{"keId":972,"keName":"Decreased fertility, Reduced number of oocytes ovulated "},{"keId":286,"keName":"Altered, Transcription of genes by AR"}],"reference":"https://aopwiki.org/aops/345"}
{"aopId":346,"aopName":"Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation","targetName":"aromatase","targetId":"ENSG00000137869","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":36,"keName":"Inhibition, Aromatase"},{"keId":1789,"keName":"Reduction, 17beta-estradiol synthesis by the undifferentiated gonad "},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1790,"keName":"Increased, Differentiation to Testis "},{"keId":1791,"keName":"Increased, Male Biased Sex Ratio"}],"reference":"https://aopwiki.org/aops/346"}
{"aopId":346,"aopName":"Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":36,"keName":"Inhibition, Aromatase"},{"keId":1789,"keName":"Reduction, 17beta-estradiol synthesis by the undifferentiated gonad "},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1790,"keName":"Increased, Differentiation to Testis "},{"keId":1791,"keName":"Increased, Male Biased Sex Ratio"}],"reference":"https://aopwiki.org/aops/346"}
{"aopId":347,"aopName":"Toll-like receptor 4 activation and peroxisome proliferator-activated receptor gamma inactivation leading to pulmonary fibrosis","targetName":"TGF-beta","aoId":1458,"aoName":"Pulmonary fibrosis","aoNameRaw":"Pulmonary fibrosis","aoMappedId":"EFO_0009448","keyEvents":[{"keId":1795,"keName":"Latent Transforming growth Factor beta expression"},{"keId":1794,"keName":"Pin-1 activation"},{"keId":1792,"keName":"Toll-like receptor 4 activation"},{"keId":1457,"keName":"Induction, Epithelial Mesenchymal Transition"},{"keId":1458,"keName":"Pulmonary fibrosis"},{"keId":1292,"keName":"Activation, JNK"},{"keId":1283,"keName":"Activation, TGF-beta pathway"},{"keId":1793,"keName":"Activator protein 1 activation"},{"keId":1270,"keName":"Inactivation of PPARγ"}],"reference":"https://aopwiki.org/aops/347"}
{"aopId":347,"aopName":"Toll-like receptor 4 activation and peroxisome proliferator-activated receptor gamma inactivation leading to pulmonary fibrosis","aoId":1458,"aoName":"Pulmonary fibrosis","aoNameRaw":"Pulmonary fibrosis","aoMappedId":"EFO_0009448","keyEvents":[{"keId":1795,"keName":"Latent Transforming growth Factor beta expression"},{"keId":1794,"keName":"Pin-1 activation"},{"keId":1792,"keName":"Toll-like receptor 4 activation"},{"keId":1457,"keName":"Induction, Epithelial Mesenchymal Transition"},{"keId":1458,"keName":"Pulmonary fibrosis"},{"keId":1292,"keName":"Activation, JNK"},{"keId":1283,"keName":"Activation, TGF-beta pathway"},{"keId":1793,"keName":"Activator protein 1 activation"},{"keId":1270,"keName":"Inactivation of PPARγ"}],"reference":"https://aopwiki.org/aops/347"}
{"aopId":348,"aopName":"Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased trajectory in fish","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1799,"keName":"Inhibition of 11β-HSD "},{"keId":1756,"keName":"Decreased,  plasma 11-ketotestosterone level"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":406,"keName":"impaired, Fertility"},{"keId":1758,"keName":"Impaired, Spermatogenesis"}],"reference":"https://aopwiki.org/aops/348"}
{"aopId":349,"aopName":"Inhibition of 11β-hydroxylase leading to decresed trajectory in  fish ","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1837,"keName":"decreased oocyte maturation"},{"keId":1756,"keName":"Decreased,  plasma 11-ketotestosterone level"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1798,"keName":"Decreased spermatogenesis "},{"keId":1796,"keName":"11β-hydroxylase inhibition"},{"keId":406,"keName":"impaired, Fertility"},{"keId":1836,"keName":"Decreased plasma Cortisol level"},{"keId":1835,"keName":"Cortisol and 11β-(OH) testosterone decreased"}],"reference":"https://aopwiki.org/aops/349"}
{"aopId":358,"aopName":"Chitinase inhibition leading to mortality","aoId":350,"aoName":"Increase Mortality","aoNameRaw":"Increase, Mortality","keyEvents":[{"keId":1806,"keName":"Increase, Chitinase inhibition"},{"keId":996,"keName":"Decrease, Digestion of old cuticle"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1524,"keName":"Increase, Premature molting"}],"reference":"https://aopwiki.org/aops/358"}
{"aopId":358,"aopName":"Chitinase inhibition leading to mortality","aoId":350,"keyEvents":[{"keId":1806,"keName":"Increase, Chitinase inhibition"},{"keId":996,"keName":"Decrease, Digestion of old cuticle"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1524,"keName":"Increase, Premature molting"}],"reference":"https://aopwiki.org/aops/358"}
{"aopId":359,"aopName":"Chitobiase inhibition leading to mortality","aoId":350,"keyEvents":[{"keId":996,"keName":"Decrease, Digestion of old cuticle"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1524,"keName":"Increase, Premature molting"},{"keId":1807,"keName":"Increase, Chitobiase inhibition"}],"reference":"https://aopwiki.org/aops/359"}
{"aopId":359,"aopName":"Chitobiase inhibition leading to mortality","aoId":350,"aoName":"Increase Mortality","aoNameRaw":"Increase, Mortality","keyEvents":[{"keId":996,"keName":"Decrease, Digestion of old cuticle"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1524,"keName":"Increase, Premature molting"},{"keId":1807,"keName":"Increase, Chitobiase inhibition"}],"reference":"https://aopwiki.org/aops/359"}
{"aopId":360,"aopName":"Chitin synthase 1 inhibition leading to mortality","aoId":350,"aoName":"Increase Mortality","aoNameRaw":"Increase, Mortality","keyEvents":[{"keId":350,"keName":"Increase, Mortality"},{"keId":1523,"keName":"Decrease, Cuticular chitin content"},{"keId":1524,"keName":"Increase, Premature molting"},{"keId":1522,"keName":"Inhibition, Chitin synthase 1"}],"reference":"https://aopwiki.org/aops/360"}
{"aopId":360,"aopName":"Chitin synthase 1 inhibition leading to mortality","aoId":350,"keyEvents":[{"keId":350,"keName":"Increase, Mortality"},{"keId":1523,"keName":"Decrease, Cuticular chitin content"},{"keId":1524,"keName":"Increase, Premature molting"},{"keId":1522,"keName":"Inhibition, Chitin synthase 1"}],"reference":"https://aopwiki.org/aops/360"}
{"aopId":361,"aopName":"Sulfonylureareceptor binding leading to mortality","aoId":350,"aoName":"Increase Mortality","aoNameRaw":"Increase, Mortality","keyEvents":[{"keId":1525,"keName":"Increase, Sulfonylurea receptor binding"},{"keId":1526,"keName":"Increase, Opening of voltage-dependent calcium channel"},{"keId":1523,"keName":"Decrease, Cuticular chitin content"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1524,"keName":"Increase, Premature molting"},{"keId":1527,"keName":"Increase, Cell membrane depolarization"}],"reference":"https://aopwiki.org/aops/361"}
{"aopId":361,"aopName":"Sulfonylureareceptor binding leading to mortality","aoId":350,"keyEvents":[{"keId":1525,"keName":"Increase, Sulfonylurea receptor binding"},{"keId":1526,"keName":"Increase, Opening of voltage-dependent calcium channel"},{"keId":1523,"keName":"Decrease, Cuticular chitin content"},{"keId":350,"keName":"Increase, Mortality"},{"keId":1524,"keName":"Increase, Premature molting"},{"keId":1527,"keName":"Increase, Cell membrane depolarization"}],"reference":"https://aopwiki.org/aops/361"}
{"aopId":362,"aopName":"Immune mediated hepatitis","aoId":1820,"aoName":"Immune mediated hepatitis","aoNameRaw":"Immune mediated hepatitis","keyEvents":[{"keId":1815,"keName":"Activation of ER stress"},{"keId":1820,"keName":"Immune mediated hepatitis"},{"keId":1819,"keName":"IFNγ signaling"},{"keId":1818,"keName":"Immune cell activation"},{"keId":1817,"keName":"Apoptotic cell death"},{"keId":1633,"keName":"Increase in inflammation"},{"keId":1816,"keName":"Mitochondrial dysfunction"},{"keId":1814,"keName":"benzoquinone imine and acylglucuronide metabolites"}],"reference":"https://aopwiki.org/aops/362"}
{"aopId":363,"aopName":"Thyroperoxidase inhibition leading to increased mortality via altered retinal layer structure","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":1877,"keName":"Altered, retinal layer structure"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/363"}
{"aopId":363,"aopName":"Thyroperoxidase inhibition leading to increased mortality via altered retinal layer structure","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":1877,"keName":"Altered, retinal layer structure"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/363"}
{"aopId":363,"aopName":"Thyroperoxidase inhibition leading to increased mortality via altered retinal layer structure","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":1877,"keName":"Altered, retinal layer structure"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/363"}
{"aopId":363,"aopName":"Thyroperoxidase inhibition leading to increased mortality via altered retinal layer structure","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":1877,"keName":"Altered, retinal layer structure"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/363"}
{"aopId":364,"aopName":"Thyroperoxidase inhibition leading to increased mortality via decreased eye size","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1878,"keName":"Decreased, Eye size"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/364"}
{"aopId":364,"aopName":"Thyroperoxidase inhibition leading to increased mortality via decreased eye size","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1878,"keName":"Decreased, Eye size"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/364"}
{"aopId":364,"aopName":"Thyroperoxidase inhibition leading to increased mortality via decreased eye size","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1878,"keName":"Decreased, Eye size"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/364"}
{"aopId":364,"aopName":"Thyroperoxidase inhibition leading to increased mortality via decreased eye size","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1878,"keName":"Decreased, Eye size"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/364"}
{"aopId":365,"aopName":"Thyroperoxidase inhibition leading to increased mortality via altered photoreceptor patterning","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":1640,"keName":"Altered, Photoreceptor patterning"},{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/365"}
{"aopId":365,"aopName":"Thyroperoxidase inhibition leading to increased mortality via altered photoreceptor patterning","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":1640,"keName":"Altered, Photoreceptor patterning"},{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/365"}
{"aopId":365,"aopName":"Thyroperoxidase inhibition leading to increased mortality via altered photoreceptor patterning","targetName":"thyroid peroxidase","targetId":"ENSG00000115705","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1640,"keName":"Altered, Photoreceptor patterning"},{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/365"}
{"aopId":365,"aopName":"Thyroperoxidase inhibition leading to increased mortality via altered photoreceptor patterning","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1640,"keName":"Altered, Photoreceptor patterning"},{"keId":351,"keName":"Increased Mortality"},{"keId":279,"keName":"Thyroperoxidase, Inhibition"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1003,"keName":"Decreased, Triiodothyronine (T3) in serum"},{"keId":277,"keName":"Thyroid hormone synthesis, Decreased"}],"reference":"https://aopwiki.org/aops/365"}
{"aopId":366,"aopName":"Competitive binding to thyroid hormone carrier protein transthyretin (TTR) leading to altered amphibian metamorphosis ","targetName":"transthyretin","targetId":"ENSG00000118271","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":959,"keName":"Increased, Free serum thyroxine (T4)"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":1158,"keName":"Increased, Hepatic thyroid hormone uptake/transport"},{"keId":401,"keName":"Increase, Biliary excretion TH glucuronide"},{"keId":957,"keName":"Binding, Transthyretin in serum"},{"keId":1830,"keName":"Displacement, Serum thyroxine (T4) from carrier protein"}],"reference":"https://aopwiki.org/aops/366"}
{"aopId":366,"aopName":"Competitive binding to thyroid hormone carrier protein transthyretin (TTR) leading to altered amphibian metamorphosis ","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":959,"keName":"Increased, Free serum thyroxine (T4)"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":1158,"keName":"Increased, Hepatic thyroid hormone uptake/transport"},{"keId":401,"keName":"Increase, Biliary excretion TH glucuronide"},{"keId":957,"keName":"Binding, Transthyretin in serum"},{"keId":1830,"keName":"Displacement, Serum thyroxine (T4) from carrier protein"}],"reference":"https://aopwiki.org/aops/366"}
{"aopId":367,"aopName":"Competitive binding to thyroid hormone carrier protein thyroid binding globulin (TBG) leading to altered amphibian metamorphosis","aoId":1101,"aoName":"Altered Amphibian metamorphosis","aoNameRaw":"Altered, Amphibian metamorphosis","keyEvents":[{"keId":1831,"keName":"Binding, Thyroid binding globulin in serum"},{"keId":959,"keName":"Increased, Free serum thyroxine (T4)"},{"keId":281,"keName":" Thyroxine (T4) in serum, Decreased"},{"keId":1101,"keName":"Altered, Amphibian metamorphosis"},{"keId":1158,"keName":"Increased, Hepatic thyroid hormone uptake/transport"},{"keId":401,"keName":"Increase, Biliary excretion TH glucuronide"},{"keId":1830,"keName":"Displacement, Serum thyroxine (T4) from carrier protein"}],"reference":"https://aopwiki.org/aops/367"}
{"aopId":368,"aopName":"Cytochrome oxidase inhibition leading to olfactory nasal lesions","aoId":872,"aoName":"Increase Site of Contact Nasal Tumors","aoNameRaw":"Increase, Site of Contact Nasal Tumors","keyEvents":[{"keId":872,"keName":"Increase, Site of Contact Nasal Tumors"},{"keId":1840,"keName":"Inhibition, cytochrome oxidase"},{"keId":1825,"keName":"Increase, Cell death"}],"reference":"https://aopwiki.org/aops/368"}
{"aopId":372,"aopName":"Androgen receptor antagonism leading to testicular cancer ","aoId":1839,"aoName":"Testicular Cancer","aoNameRaw":"Testicular Cancer","aoMappedId":"MONDO_0003510","keyEvents":[{"keId":26,"keName":"Antagonism, Androgen receptor"},{"keId":1687,"keName":"decrease, transcription of genes by AR "},{"keId":1839,"keName":"Testicular Cancer"},{"keId":1616,"keName":"Malformation, cryptorchidism - maldescended testis"},{"keId":1614,"keName":"Decrease, androgen receptors (AR) activation"}],"reference":"https://aopwiki.org/aops/372"}
{"aopId":374,"aopName":"Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis","aoId":1841,"aoName":"Encephalitis","aoNameRaw":"Encephalitis","aoMappedId":"MONDO_0019956","keyEvents":[{"keId":352,"keName":"N/A, Neurodegeneration"},{"keId":1739,"keName":"ACE2 binding to viral S-protein "},{"keId":188,"keName":"Neuroinflammation"},{"keId":1841,"keName":"Encephalitis"}],"reference":"https://aopwiki.org/aops/374"}
{"aopId":376,"aopName":"Androgen receptor agonism leading to male-biased sex ratio","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1790,"keName":"Increased, Differentiation to Testis "},{"keId":1791,"keName":"Increased, Male Biased Sex Ratio"},{"keId":25,"keName":"Agonism, Androgen receptor"}],"reference":"https://aopwiki.org/aops/376"}
{"aopId":376,"aopName":"Androgen receptor agonism leading to male-biased sex ratio","targetName":"androgen receptor","targetId":"ENSG00000169083","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1790,"keName":"Increased, Differentiation to Testis "},{"keId":1791,"keName":"Increased, Male Biased Sex Ratio"},{"keId":25,"keName":"Agonism, Androgen receptor"}],"reference":"https://aopwiki.org/aops/376"}
{"aopId":377,"aopName":"Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Acute Respiratory Distress Syndrome (ARDS) and Multiple Organ Dysfunction (MOD)","aoId":1843,"aoName":"Acute Respiratory Distress Syndrome and Multiple Organ Dysfunction","aoNameRaw":"Acute Respiratory Distress Syndrome and Multiple Organ Dysfunction","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1844,"keName":"systemic inflammatory response syndrome"},{"keId":1843,"keName":"Acute Respiratory Distress Syndrome and Multiple Organ Dysfunction"},{"keId":1842,"keName":"Prolonged TLR9 activation"},{"keId":1848,"keName":"Induced Toll Like Receptor (TLR) Dysregulation"}],"reference":"https://aopwiki.org/aops/377"}
{"aopId":377,"aopName":"Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Acute Respiratory Distress Syndrome (ARDS) and Multiple Organ Dysfunction (MOD)","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":351,"keName":"Increased Mortality"},{"keId":1844,"keName":"systemic inflammatory response syndrome"},{"keId":1843,"keName":"Acute Respiratory Distress Syndrome and Multiple Organ Dysfunction"},{"keId":1842,"keName":"Prolonged TLR9 activation"},{"keId":1848,"keName":"Induced Toll Like Receptor (TLR) Dysregulation"}],"reference":"https://aopwiki.org/aops/377"}
{"aopId":379,"aopName":"Increased susceptibility to viral entry and coronavirus production leading to thrombosis and disseminated intravascular coagulation","aoId":1846,"keyEvents":[{"keId":1846,"keName":"Thrombosis and Disseminated Intravascular Coagulation"},{"keId":1845,"keName":"Coagulation"},{"keId":1869,"keName":"Oxidative stress response"},{"keId":1738,"keName":"Increased susceptibility to viral entry"},{"keId":1847,"keName":"Increased coronavirus production"}],"reference":"https://aopwiki.org/aops/379"}
{"aopId":379,"aopName":"Increased susceptibility to viral entry and coronavirus production leading to thrombosis and disseminated intravascular coagulation","aoId":1846,"aoName":"Thrombosis and Disseminated Intravascular Coagulation","aoNameRaw":"Thrombosis and Disseminated Intravascular Coagulation","keyEvents":[{"keId":1846,"keName":"Thrombosis and Disseminated Intravascular Coagulation"},{"keId":1845,"keName":"Coagulation"},{"keId":1869,"keName":"Oxidative stress response"},{"keId":1738,"keName":"Increased susceptibility to viral entry"},{"keId":1847,"keName":"Increased coronavirus production"}],"reference":"https://aopwiki.org/aops/379"}
{"aopId":381,"aopName":"Binding of viral S-glycoprotein to ACE2 receptor leading to dysgeusia","aoId":1850,"aoName":"dysgeusia","aoNameRaw":"dysgeusia","keyEvents":[{"keId":1850,"keName":"dysgeusia"},{"keId":1739,"keName":"ACE2 binding to viral S-protein "},{"keId":1849,"keName":"Impaired gustatory nerve"},{"keId":1787,"keName":"Downregulation, ACE2"},{"keId":1752,"keName":"Increased Angiotensin II "},{"keId":1856,"keName":"Imbalanced salty and sweet taste responses"}],"reference":"https://aopwiki.org/aops/381"}
{"aopId":382,"aopName":"Angiotensin II type 1 receptor (AT1R) agonism leading to lung fibrosis","aoId":1276,"aoName":"Lung fibrosis","aoNameRaw":"Lung fibrosis","keyEvents":[{"keId":68,"keName":"Accumulation, Collagen"},{"keId":1496,"keName":"Increased, secretion of proinflammatory and profibrotic mediators"},{"keId":1851,"keName":"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)"},{"keId":1115,"keName":"Increased, Reactive oxygen species"},{"keId":1172,"keName":"Increase activation, Nuclear factor kappa B (NF-kB)"},{"keId":1276,"keName":"Lung fibrosis"}],"reference":"https://aopwiki.org/aops/382"}
{"aopId":383,"aopName":"Inhibition of Angiotensin-converting enzyme 2 leading to liver fibrosis","aoId":344,"aoName":"Liver fibrosis","aoNameRaw":"N/A, Liver fibrosis","aoMappedId":"HP_0001395","keyEvents":[{"keId":1115,"keName":"Increased, Reactive oxygen species"},{"keId":1852,"keName":"Increased Ang II type 1 receptor (AT1R)"},{"keId":1741,"keName":"Induced, Angiotensin (Ang) II accumulation"},{"keId":344,"keName":"N/A, Liver fibrosis"},{"keId":1501,"keName":"Increased, extracellular matrix deposition"},{"keId":1740,"keName":"ACE2 inhibition"}],"reference":"https://aopwiki.org/aops/383"}
{"aopId":384,"aopName":"Hyperactivation of ACE/Ang-II/AT1R axis leading to chronic kidney disease ","aoId":1603,"aoName":"Chronic kidney disease","aoNameRaw":"Chronic kidney disease","aoMappedId":"EFO_0003884","keyEvents":[{"keId":1853,"keName":"Hyperactivation of ACE/Ang-II/AT1R axis"},{"keId":1115,"keName":"Increased, Reactive oxygen species"},{"keId":1852,"keName":"Increased Ang II type 1 receptor (AT1R)"},{"keId":1855,"keName":"Increased Sodium-sensitive hypertension"},{"keId":1603,"keName":"Chronic kidney disease"},{"keId":1752,"keName":"Increased Angiotensin II "}],"reference":"https://aopwiki.org/aops/384"}
{"aopId":386,"aopName":"Increased reactive oxygen species production leading to population decline via inhibition of photosynthesis","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1863,"keName":"Decrease, Reproduction"},{"keId":1861,"keName":"Increase, D1 protein deactivation"},{"keId":1472,"keName":"Decrease, ATP production"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1862,"keName":"Decrease, Photosystem II efficiency"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1475,"keName":"Decrease, Photosynthesis"},{"keId":1479,"keName":"Decrease, Leaf development"}],"reference":"https://aopwiki.org/aops/386"}
{"aopId":386,"aopName":"Increased reactive oxygen species production leading to population decline via inhibition of photosynthesis","aoId":1863,"aoName":"Decrease Reproduction","aoNameRaw":"Decrease, Reproduction","keyEvents":[{"keId":1863,"keName":"Decrease, Reproduction"},{"keId":1861,"keName":"Increase, D1 protein deactivation"},{"keId":1472,"keName":"Decrease, ATP production"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1862,"keName":"Decrease, Photosystem II efficiency"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1475,"keName":"Decrease, Photosynthesis"},{"keId":1479,"keName":"Decrease, Leaf development"}],"reference":"https://aopwiki.org/aops/386"}
{"aopId":387,"aopName":"Increased reactive oxygen species production leading to population decline via mitochondrial dysfunction","aoId":1863,"aoName":"Decrease Reproduction","aoNameRaw":"Decrease, Reproduction","keyEvents":[{"keId":1477,"keName":"Decrease, Oxidative phosphorylation"},{"keId":40,"keName":"Decrease, Mitochondrial ATP production"},{"keId":1863,"keName":"Decrease, Reproduction"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1770,"keName":"Decrease, Mitochondrial membrane potential"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1479,"keName":"Decrease, Leaf development"}],"reference":"https://aopwiki.org/aops/387"}
{"aopId":387,"aopName":"Increased reactive oxygen species production leading to population decline via mitochondrial dysfunction","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1477,"keName":"Decrease, Oxidative phosphorylation"},{"keId":40,"keName":"Decrease, Mitochondrial ATP production"},{"keId":1863,"keName":"Decrease, Reproduction"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1770,"keName":"Decrease, Mitochondrial membrane potential"},{"keId":257,"keName":"Increase, Reactive Oxygen Species production"},{"keId":1479,"keName":"Decrease, Leaf development"}],"reference":"https://aopwiki.org/aops/387"}
{"aopId":388,"aopName":"DNA damage leading to population decline via programmed cell death","aoId":1863,"aoName":"Decrease Reproduction","aoNameRaw":"Decrease, Reproduction","keyEvents":[{"keId":1864,"keName":"Increase, Programmed cell death"},{"keId":1863,"keName":"Decrease, Reproduction"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1479,"keName":"Decrease, Leaf development"}],"reference":"https://aopwiki.org/aops/388"}
{"aopId":388,"aopName":"DNA damage leading to population decline via programmed cell death","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1864,"keName":"Increase, Programmed cell death"},{"keId":1863,"keName":"Decrease, Reproduction"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":1479,"keName":"Decrease, Leaf development"}],"reference":"https://aopwiki.org/aops/388"}
{"aopId":389,"aopName":" Oxygen-evolving complex damage leading to population decline via inhibition of photosynthesis","aoId":1863,"aoName":"Decrease Reproduction","aoNameRaw":"Decrease, Reproduction","keyEvents":[{"keId":1863,"keName":"Decrease, Reproduction"},{"keId":1472,"keName":"Decrease, ATP production"},{"keId":1865,"keName":"Increase, Oxygen-evolving complex damage"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1862,"keName":"Decrease, Photosystem II efficiency"},{"keId":1475,"keName":"Decrease, Photosynthesis"},{"keId":1479,"keName":"Decrease, Leaf development"}],"reference":"https://aopwiki.org/aops/389"}
{"aopId":389,"aopName":" Oxygen-evolving complex damage leading to population decline via inhibition of photosynthesis","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1863,"keName":"Decrease, Reproduction"},{"keId":1472,"keName":"Decrease, ATP production"},{"keId":1865,"keName":"Increase, Oxygen-evolving complex damage"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1862,"keName":"Decrease, Photosystem II efficiency"},{"keId":1475,"keName":"Decrease, Photosynthesis"},{"keId":1479,"keName":"Decrease, Leaf development"}],"reference":"https://aopwiki.org/aops/389"}
{"aopId":392,"aopName":"Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation","aoId":1868,"aoName":"Hyperinflammation","aoNameRaw":"Hyperinflammation","keyEvents":[{"keId":1867,"keName":"Bradykinin system, hyperactivated"},{"keId":1866,"keName":"Fibrinolysis, decreased"},{"keId":1868,"keName":"Hyperinflammation"},{"keId":1496,"keName":"Increased, secretion of proinflammatory and profibrotic mediators"},{"keId":1497,"keName":"Increased, recruitment of inflammatory cells"}],"reference":"https://aopwiki.org/aops/392"}
{"aopId":394,"aopName":"Sars-cov-2 infection leading to impaired olfactory function (anosmia)","aoId":1873,"aoName":"impaired olfactory function (anosmia)","aoNameRaw":"impaired olfactory function (anosmia) ","keyEvents":[{"keId":1870,"keName":"Sustentacular cells, decrease "},{"keId":1872,"keName":"Olfactory epithelium degeneration"},{"keId":1739,"keName":"ACE2 binding to viral S-protein "},{"keId":1871,"keName":"olfactory sensory neurons, decrease "},{"keId":1873,"keName":"impaired olfactory function (anosmia) "},{"keId":1738,"keName":"Increased susceptibility to viral entry"}],"reference":"https://aopwiki.org/aops/394"}
{"aopId":395,"aopName":"Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on pericytes leads to disseminated intravascular coagulation resulting in cerebrovascular disease (stroke)","aoId":1875,"aoName":"Cerebrovascular disease (stroke)","aoNameRaw":"Cerebrovascular disease (stroke)","keyEvents":[{"keId":1875,"keName":"Cerebrovascular disease (stroke)"},{"keId":1739,"keName":"ACE2 binding to viral S-protein "},{"keId":1846,"keName":"Thrombosis and Disseminated Intravascular Coagulation"},{"keId":1874,"keName":"blood brain barrier disruption "},{"keId":1738,"keName":"Increased susceptibility to viral entry"}],"reference":"https://aopwiki.org/aops/395"}
{"aopId":396,"aopName":"Deposition of ionizing energy leads to population decline via impaired meiosis","aoId":997,"aoName":"Decreased Population size","aoNameRaw":"Decreased, Population size","keyEvents":[{"keId":1550,"keName":"Direct Deposition of Ionizing Energy"},{"keId":1696,"keName":"Decrease of egg production and cummulative fecundity"},{"keId":1115,"keName":"Increased, Reactive oxygen species"},{"keId":1798,"keName":"Decreased spermatogenesis "},{"keId":752,"keName":"Altered, Meiotic chromosome dynamics"},{"keId":406,"keName":"impaired, Fertility"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":997,"keName":"Decreased, Population size"},{"keId":1775,"keName":"Increase, Oocyte apoptosis"}],"reference":"https://aopwiki.org/aops/396"}
{"aopId":396,"aopName":"Deposition of ionizing energy leads to population decline via impaired meiosis","aoId":1696,"keyEvents":[{"keId":1550,"keName":"Direct Deposition of Ionizing Energy"},{"keId":1696,"keName":"Decrease of egg production and cummulative fecundity"},{"keId":1115,"keName":"Increased, Reactive oxygen species"},{"keId":1798,"keName":"Decreased spermatogenesis "},{"keId":752,"keName":"Altered, Meiotic chromosome dynamics"},{"keId":406,"keName":"impaired, Fertility"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":997,"keName":"Decreased, Population size"},{"keId":1775,"keName":"Increase, Oocyte apoptosis"}],"reference":"https://aopwiki.org/aops/396"}
{"aopId":396,"aopName":"Deposition of ionizing energy leads to population decline via impaired meiosis","aoId":1696,"aoName":"Decrease of egg production and cummulative fecundity","aoNameRaw":"Decrease of egg production and cummulative fecundity","keyEvents":[{"keId":1550,"keName":"Direct Deposition of Ionizing Energy"},{"keId":1696,"keName":"Decrease of egg production and cummulative fecundity"},{"keId":1115,"keName":"Increased, Reactive oxygen species"},{"keId":1798,"keName":"Decreased spermatogenesis "},{"keId":752,"keName":"Altered, Meiotic chromosome dynamics"},{"keId":406,"keName":"impaired, Fertility"},{"keId":1088,"keName":"Increased, Oxidative Stress"},{"keId":1194,"keName":"Increase, DNA damage"},{"keId":997,"keName":"Decreased, Population size"},{"keId":1775,"keName":"Increase, Oocyte apoptosis"}],"reference":"https://aopwiki.org/aops/396"}
{"aopId":397,"aopName":"Bulky DNA adducts leading to mutations","aoId":185,"keyEvents":[{"keId":185,"keName":"Increase, Mutations"},{"keId":1879,"keName":"Bulky DNA adducts, increase"},{"keId":155,"keName":"N/A, Inadequate DNA repair"}],"reference":"https://aopwiki.org/aops/397"}
{"aopId":397,"aopName":"Bulky DNA adducts leading to mutations","aoId":185,"aoName":"Increase Mutations","aoNameRaw":"Increase, Mutations","keyEvents":[{"keId":185,"keName":"Increase, Mutations"},{"keId":1879,"keName":"Bulky DNA adducts, increase"},{"keId":155,"keName":"N/A, Inadequate DNA repair"}],"reference":"https://aopwiki.org/aops/397"}
{"aopId":398,"aopName":"Inhibition of ALDH1A2 (RALDH2) causing reduced all-trans retinoic acid levels leading to decreased fertility, females","aoId":972,"aoName":"Decreased fertility Reduced number of oocytes ovulated","aoNameRaw":"Decreased fertility, Reduced number of oocytes ovulated ","keyEvents":[{"keId":1882,"keName":"Disrupted meiotic initiation of fetal oogonia of the ovary"},{"keId":1880,"keName":"Inhibition of ALDH1A2 (RALDH2)"},{"keId":1881,"keName":"Decreased all-trans retinoic acid (ATRA) concentration"},{"keId":972,"keName":"Decreased fertility, Reduced number of oocytes ovulated "},{"keId":1883,"keName":"Reduced size of the ovarian follicle pool "}],"reference":"https://aopwiki.org/aops/398"}
{"aopId":399,"aopName":"Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos)","targetName":"tyrosine-protein kinase fyna (zebrafish)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1885,"keName":"Inhibition of Plxna2"},{"keId":351,"keName":"Increased Mortality"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1886,"keName":"Increase, Overexpression of rasl11b"},{"keId":1878,"keName":"Decreased, Eye size"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1821,"keName":"Decrease, Cell proliferation"},{"keId":1884,"keName":"Inhibition of Fyna"}],"reference":"https://aopwiki.org/aops/399"}
{"aopId":399,"aopName":"Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos)","aoId":360,"aoName":"Decrease Population trajectory","aoNameRaw":"Decrease, Population trajectory","keyEvents":[{"keId":1885,"keName":"Inhibition of Plxna2"},{"keId":351,"keName":"Increased Mortality"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1886,"keName":"Increase, Overexpression of rasl11b"},{"keId":1878,"keName":"Decreased, Eye size"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1821,"keName":"Decrease, Cell proliferation"},{"keId":1884,"keName":"Inhibition of Fyna"}],"reference":"https://aopwiki.org/aops/399"}
{"aopId":399,"aopName":"Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos)","targetName":"tyrosine-protein kinase fyna (zebrafish)","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":1885,"keName":"Inhibition of Plxna2"},{"keId":351,"keName":"Increased Mortality"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1886,"keName":"Increase, Overexpression of rasl11b"},{"keId":1878,"keName":"Decreased, Eye size"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1821,"keName":"Decrease, Cell proliferation"},{"keId":1884,"keName":"Inhibition of Fyna"}],"reference":"https://aopwiki.org/aops/399"}
{"aopId":399,"aopName":"Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos)","aoId":351,"aoName":"Increased Mortality","aoNameRaw":"Increased Mortality","keyEvents":[{"keId":1885,"keName":"Inhibition of Plxna2"},{"keId":351,"keName":"Increased Mortality"},{"keId":360,"keName":"Decrease, Population trajectory"},{"keId":1886,"keName":"Increase, Overexpression of rasl11b"},{"keId":1878,"keName":"Decreased, Eye size"},{"keId":1643,"keName":"Altered, Visual function"},{"keId":1821,"keName":"Decrease, Cell proliferation"},{"keId":1884,"keName":"Inhibition of Fyna"}],"reference":"https://aopwiki.org/aops/399"}
{"aopId":400,"aopName":"Increased (ectopic) concentration of all-trans retinoic acid (ATRA) if fetal testis leading to reduced sperm count, males","aoId":1757,"aoName":"Reduce Sperm count","aoNameRaw":"Reduce, Sperm count","keyEvents":[{"keId":1889,"keName":"Premature initiation of meiosis in fetal male germ cells"},{"keId":1757,"keName":"Reduce, Sperm count"},{"keId":1890,"keName":"Decrease (loss of) fetal male germ cells"},{"keId":1888,"keName":"Increased (ectopic) all-trans retinoic acid concentration"}],"reference":"https://aopwiki.org/aops/400"}
{"aopId":405,"aopName":"Organo-Phosphate Chemicals induced inhibition of AChE  leading to impaired cognitive function","targetName":"acetylcholinesterase","targetId":"ENSG00000087085","aoId":402,"aoName":"Cognitive Function Decreased","aoNameRaw":"Cognitive Function, Decreased ","keyEvents":[{"keId":39,"keName":"Increased Cholinergic Signaling"},{"keId":402,"keName":"Cognitive Function, Decreased "},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"},{"keId":386,"keName":"Decrease of neuronal network function"}],"reference":"https://aopwiki.org/aops/405"}
{"aopId":405,"aopName":"Organo-Phosphate Chemicals induced inhibition of AChE  leading to impaired cognitive function","aoId":402,"aoName":"Cognitive Function Decreased","aoNameRaw":"Cognitive Function, Decreased ","keyEvents":[{"keId":39,"keName":"Increased Cholinergic Signaling"},{"keId":402,"keName":"Cognitive Function, Decreased "},{"keId":10,"keName":"Acetylcholine accumulation in synapses"},{"keId":12,"keName":"Acetylcholinesterase (AchE) Inhibition"},{"keId":386,"keName":"Decrease of neuronal network function"}],"reference":"https://aopwiki.org/aops/405"}
{"aopId":406,"aopName":"SARS-CoV-2 infection leading to hyperinflammation","aoId":1868,"aoName":"Hyperinflammation","aoNameRaw":"Hyperinflammation","keyEvents":[{"keId":1868,"keName":"Hyperinflammation"},{"keId":1739,"keName":"ACE2 binding to viral S-protein "},{"keId":1895,"keName":"NLRP3 inflammasome activity, increased"},{"keId":1869,"keName":"Oxidative stress response"},{"keId":1738,"keName":"Increased susceptibility to viral entry"},{"keId":1847,"keName":"Increased coronavirus production"}],"reference":"https://aopwiki.org/aops/406"}
